Download Annual Report 2014 - Onderzoekschool Oncologie Amsterdam

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Transcript
Onderzoekschool Oncologie Amsterdam
Oncology Graduate School Amsterdam
Annual Report 2014
Address
Oncology Graduate School Amsterdam OOA
VU medisch centrum
Kamer PK 5Z 166
De Boelelaan 1118
1081 HZ Amsterdam
phone
e-mail
website
:
:
:
020 - 444 4981
e.ruhe@vumc.nl
www.ooa-graduateschool.org
Contents
Preface
1
2
3
4
5
Annex
Annex
Annex
Annex
1
2
3
4
Board and organization
09
General report
13
Educational activities
19
PhD research program
25
Awards
47
Faculty and staff
International visitors
PhD theses completed
Scientific publications
51
67
71
79
Oncology Graduate School Amsterdam OOA
preface
Preface
The Oncology Graduate School Amsterdam
(Onderzoekschool Oncologie Amsterdam – OOA) is
dedicated to an increased excellence in research
and education in oncology. The main mission of
OOA is to organize the education in cancer
research of the graduate students in the
Amsterdam area and to ensure proper supervision
and mentoring of these graduate students.
OOA has been established as a joint venture of the
medical faculties the VU University Medical Center
(VUmc) and University of Amsterdam (Universiteit
van Amsterdam- UvA) and the Netherlands Cancer
Institute (Nederlands Kanker Instituut - NKI). These
three organizations strive for excellence in
research and education in oncology and the
realization of which is promoted by their
participation in OOA.
The OOA research covers a wide program ranging
from basic molecular biology to clinical bedside
research. It includes, for instance, fundamental
studies on cellular signal transduction and the
control of gene expression, but also clinical trials
of new (combination) approaches and the
development of new tools to evaluate the quality
of life in cancer patients. A large proportion of
research is translational in nature and aims for the
development of new diagnostic and therapeutic
strategies.
OOA organizes a range of educational activities,
including specialized training courses, seminars
and meet-the-expert sessions. A major effort is put
into the organization of the annual graduate
student retreat. Next to the benefit of
encountering the broadly oriented work of fellow
students, this retreat teaches the graduate
students skills in reporting, presenting and
collaborative activities.
This report presents the activities and scientific
output of OOA in 2014. It includes detailed listings
of our educational activities, such as training
programs, and an overview of the scientific output,
including listings of PhD theses completed and
scientific papers published throughout 2014.
Executive Directors,
Prof. dr. A.W. Griffioen (VUMC)
Prof. dr. H. te Riele (NKI)
Dr. M. Spaargaren (UvA)
Preface - 7
8 - Preface
Oncology Graduate School Amsterdam OOA
board and organization
1
1. Board and organization
Board
Participating institutes
Prof.dr. E. Eldering
Prof.dr. J.P. Medema
Prof.dr. R.H. Medema
Prof.dr. C.J.L.M. Meijer
Prof.dr. P. Postmus
Prof.dr. T.K. Sixma
VU University Amsterdam (VU)/
VU University Medical Center (VUmc)
Administrative center
Contact / secretariat: dr. E.M. Ruhé-Hoogervorst
De Boelelaan 1118
1081 HV Amsterdam
phone : 020-4444981
email : e.ruhe@vumc.nl
Executive directors
Prof. dr. A.W. Griffioen, chairman
prof. dr. H. te Riele
Dr. M. Spaargaren
Faculty and staff
The complete list of founding institutes’ faculty
and staff involved in educational activities and
research projects conducted by OOA is provided in
Annex 1.
University of Amsterdam (UvA)/
Academic Medical Center (AMC)
Meibergdreef 15
1105 AZ Amsterdam
phone : 020-5668502
fax
: 020-5669165
Netherlands Cancer Institute (NKI)
Contact / secretariat: Ms. P. Lagerweij
Plesmanlaan 121
1066 CX Amsterdam
phone : 020-512 6973
fax
: 020-512 1944
email : p.lagerweij@nki.nl
Board and organization - 11
12 – Board and organization
Oncology Graduate School Amsterdam OOA
general report
2
2. General report
Background
The Oncology Graduate School Amsterdam
(Onderzoekschool Oncologie Amsterdam – OOA)
was founded in 1992 in an effort to structure the
education and supervision of the cohort of
Amsterdam-based PhD students. The result was a
large graduate school, hosting 552 PhD students
and with 160 faculty members involved from the
three participating institutes VUMC, AMC an NKI. It
was, and still is, the only Dutch graduate school
specifically focusing on training in cancer research.
The quality of the OOA is shown by its regular
accreditation by the Royal Netherlands Academy of
Sciences regularly, currently for the period 20092015.
Educational activities
The core activity of OOA is training PhD students in
conducting cancer research. For this purpose, OOA
has developed a high-quality curriculum. In 2014,
OOA organized various graduate training courses in
a variety of subjects including transferable skills,
masterclasses, meet-the-expert sessions,
conferences and symposiums. All courses were
evaluated by means of standardized evaluation
procedures. In this way, OOA carefully monitors
the quality of its courses. Based on the outcome of
these evaluations, the training programs are being
improved continuously.
Next to these activities the OOA organizes the
annual graduate student retreat. This retreat is set
up as a conference where all students present their
work and where they are actively involved by
chairing the scientific sessions and catalysing the
discussions.
A detailed description of all training courses
offered in 2014 is provided in chapter 3 of this
Annual Report.
Research program
The oncology research within the three
participating institutes is very broad and
practically every field of research is covered. For
this reason OOA has clustered the research
projects under two main themes. The theme
Experimental Biology covers oncogenesis and tumor
cell biology as the main lines of research. The
second main theme is Experimental Clinical
Research and covers diagnosis of cancer and
prevention and therapy of cancer. Chapter 4
provides a listing of all individual PhD projects
conducted within these main themes. More
detailed descriptions of these research programs
and their output are provided in the annual reports
of the founding institutes.
Theme 1: Experimental Biology
This more fundamental research theme is focussing
on the multiple molecular changes involved in the
transformation of healthy cells into malignant
tumor cells. Studying the genes and proteins
involved in this transformation results in better
understanding of tumor development, progression
and therapy resistance. Candidate markers are
tested for their ability to predict/detect cancer at
an early stage. Disease profiling is being improved
using innovative research tools. Tools applied in
research projects include high-throughput methods
for (epi)genetic, transcriptomic and proteomic
analyses. Examples are large tumor cohort screens
with CGH or expression arrays, gain-of-function
genetic screens with retroviral cDNA expression
libraries, and loss-of-function genetic screens with
RNA interference libraries. Quantitative mass
spectrometry is being used to search for proteins
to distinguish the diseased and disease-free states.
Mechanistic studies using e.g. structural biology
complement the functional studies. Advanced
mouse models or sophisticated xenotransplant
models have been developed for the genetic
dissection of cancer. At the cellular level,
processes like cell-cell communication, adhesion,
migration, survival, proliferation and
differentiation are all being studied in tumor cells
as well as in the different cells making up the
tumor stroma. In all these approaches the studies
on mechanisms of metastasis formation and
therapy resistance have a central role.
Theme 2: Experimental Clinical Research
Improvements in clinical care in oncology are
based on improved detection, development of
innovative therapies and personalized treatment
strategies. The emerging and rapidly growing fields
of molecular imaging and genomics are providing
new opportunities to study the biology of a
malignancy in individual patients and thus allowing
for the development of highly valuable indicators
General report - 15
for diagnosis and prediction of disease outcome.
The development of the 70-gene breast cancer
predictor at the NKI has led to the first FDAapproved diagnostic screen for breast cancer.
Modern state-of-the-art techniques like MRI,
SPECT, PET and PET/CT are enabling imaging
methods with high precision and unique molecular
and biological information at the tissue level.
(Molecular) reporter probes are being developed
and evaluated. Relevant orthotopic and
spontaneous mouse models are developed and used
to follow drug sensitivity in several types of cancer
and for developing clinical strategies for imaging.
Targeted cancer therapy is yet another research
focus. Personalized therapy should ensure optimal
treatment benefits. Projects include (pre)clinical
evaluations of the use of neoadjuvant treatment or
the application of new molecular therapies and
anti-angiogenic agents against novel targets in
tumor and its environment. The pharmacological
optimization of conventional cytotoxic drugs is an
important line of research, as is the passage of
drugs through the blood-brain barrier.
Development of immunotherapies based on
adoptive transfer and vaccination strategies are at
the forefront of research. These, as well as novel
targeted and anti-angiogenic therapies and gene
therapy strategies are being developed and tested
in clinical trials. Another important clinical
research theme is quality of life for childhood and
adult patients with cancer.
PhD projects and students
Overall, 552 PhD projects were actively elaborated
throughout 2014. The names of the PhD students at
the three OOA institutes and the projects in which
they participated are listed in chapter 4.
Of all PhD projects, 18% was funded by the
participating institutes themselves (primary
funding; ‘eerste geldstroom'); 19% was financed by
public funds (secondary funding; 'tweede
geldstroom'), 39% by research contracts from
external organisations including cancer charity and
industrial funds (tertiary funding; ‘derde
geldstroom’) and 24% was financed by other funds
(quaternary funding; 'vierde geldstroom').
A total of 49 PhD students completed and
defended their PhD thesis in 2014. Annex 3
provides the complete list of PhD students who
obtained their degree with details of their theses
and graduation.
16 – General report
International visitors
Training of PhD students can be stimulated and
enhanced by having scientific interactions between
students and foreign experts operating in the field
of the students’ research projects. OOA is part of a
large international network of cancer researchers
and, therefore, international guests from other
research institutes visit OOA’s institutes frequently
to interact with OOA students and staff. In
addition, conferences and symposiums are
frequently organized in the Amsterdam area,
allowing students to interact internationally.
Throughout 2014, we welcomed 75 international
experts in various settings (Annex 2).
Awards
Several PhD students and staff of the OOA
institutes won prestigious awards and honors –
scientific or otherwise – in 2014. Chapter 5
provides a listing of these awards and honours.
OOA has an excellent (inter)national status, as
demonstrated by the large number of research
projects granted in open national and international
calls, including several of the prestigious new
grants. The faculty is strongly represented in the
‘vernieuwingsimpuls’, the Veni-Vidi-Vici
development grants for junior researchers and
participated widely in CTMM and TI Pharma
projects, as well as in numerous EU integrated
projects and networks of excellence. Funding is
also strongly supported by the Dutch science
foundation (NOW) and the Dutch cancer society
(KWF).
A total of 1653 papers have been published by
researchers from the three institutes. Many of
these concerned collaborations between
researchers from VUmc, NKI and AMC. Annex 4
provides the complete list of scientific publications
in 2014.
Research highlights
Our research highlights included work of V.
Oppedijk et. al. who showed that preoperative
chemoradiotherapy plus surgery in patients with
esophageal cancer reduced locoregional recurrence
and peritoneal carcinomatosis as compared to
surgery only. Recurrence within the radiation
target volume occerrud in only 5%, mostly
combined with outfield failures (J Clin Oncol,
32:385).
K. Phoa et. al. who showed that radiofrequency
ablation of Barrett esophagus containing low-grade
dysplasia could decrease the rate of neoplastic
progression to high-grade dysplasia or adenoma
carcinoma by 25% and the risk of progression to
adenocarcinoma by 7.4%. Among patients in the
ablation group, complete eradication occurred in
92.6% for dysplasia and 88.2% for intestinal
metaplasia compared with 27.9% and 0.0% for
intestinal metaplasia among patients in the control
group.(JAMA311:1209).
Work of the group of CJLM Meijer showed that
HPV-based screening provides 60-70% greater
protection against invasive cervical carcinomas
compared with cytology. Data of large-scale
randomized trials support inititation of HPV-based
screening form age 30 years and extension of
screening intervals to at least 5 years (Lancet,
383:524). In addition, it was shown that DNA
methulation analysis of MAL and MiR-124-2 genes
on HPV-test-positive self-samples is non-inferior to
cytology triage in the detection of CIN2 or worse,
opening the way to full molecular screening
(Lancet Oncol 15:315).
Research findings of C. Sun of the group of R.
Bernards provide a rationale for why some BRAF or
MEK inhibitor-resistant melanoma patients may
regain sensitivity to these drugs after a ‘drug
holiday’ and identify patients with EGFR-positive
melanoma as a group that may benefit form retreatment after a drug holiday (Nature 508:118).
Lassa virus, which spreads from rodents to humans,
infecting about half a million people every year,
can lead to deadly hemorrhagic fever. Like many
viruses, Lassa virus binds to cell surface receptors.
Jae et al. showed that to enter a cell, the virus
requires a second receptor, this one inside the
infected cell. This requirement sheds light on the
“enigmatic resistance” of bird cells to Lassa virus
observed three decades ago. Although bird cells
have the cell surface receptor, the intracellular
receptor cannot bind the virus, stopping it in its
tracks (Science 344:1506).
Facilities
State-of-the-art facilities are:
- Biobanking (AMC, VUmc)
- Central Clinical Trial Support (office) (AMC,
VUmc)
- Deep sequencing facility (AMC, NKI)
- Extensive animal facilities (AMC, NKI)
- (Flow) cytometry facilities - Coulter, BD,
Acumen (AMC, NKI, VUmc)
- Genomics: MPS GS-FLEX sequencer (AMC)
- Imaging facilities, microPET, MRI, SPECT (AMC,
NKI, VUmc)
- Lentiviral library for RNA-silencing for human
and mouse (AMC)
- Mass spectrometry facility (AMC, NKI, VUmc)
- Microarray facilities with high resolution
oligonucleotide array and CGH arrays for mouse
and human studies (AMC, NKI, VUmc)
- Microscopy facility, including extensive
confocal and electron microscopy (AMC, NKI)
- (Molecular) Imaging facilities (cyclotrons, GMP
facilities, animal and clinical PET/CT-cameras
and MRI-machines) enabling imaging of
anatomical details with high precision (VUmc)
- Oncoproteomics laboratory for protein and
glycan profiling using mass spectrometry (AMC,
VUmc)
- Protein expression and biophysical
characterization facility (NKI)
- Radiotherapy facilities (NKI, VUMC)
- Robotics and screening facility, including high
content imaging (NKI)
- Tissue microarray facility (AMC, VUmc)
- Tissue and Serum biobanks (NKI, VUmc)
In addition, new initiatives are:
- Human monoclonal antibody phage display
facility (VUmc)
- Imaging Center (including training center)
(VUmc)
- Mouse Clinic (NKI)
- Phase I/II unit for clinical trials (AMC, VUmc)
- Proton center (AMC, VUmc, NKI)
The main goal of all research activities of the 3
OOA institutes is to better understand the
development of cancer and to improve the
perspectives of cancer patients. For this purpose,
many state-of-the-art technologies are present and
new initiatives have been developed. Information
about innovative technologies is communicated at
many occasions, including courses and the OOA
retreat. These technologies are open to PhD
students within OOA. As a result, the OOA PhD
students often have early access to novel
techniques and can apply these in research.
General report - 17
18 – General report
Oncology Graduate School Amsterdam OOA
educational activities
3
3. Educational activities
In line with its mission, i.e. providing graduate
students education in oncology research, OOA
organizes several advanced courses in the field of
oncology annually. The educational program is drawn
up by the Board of Directors based upon evaluations of
previous courses, contemporary developments in
cancer research, and educational needs expressed by
PhD students as well as initiatives from the OOA
faculty. OOA offers courses focused on a wide variety
of topics.
In 2014, 7 courses and 3 Meet-the-Expert sessions
were organized. In addition, the Annual Graduate
Student Retreat was organized again in 2014. Courses
are usually restricted to about 15-20 graduate
students to ensure optimal interaction between
students and faculty. Courses are advertised on the
OOA website and announced by e-mail to the PhD
students.
Courses included lectures given by (inter)national
experts, demonstrations and practical training.
Besides the specialized oncological courses mentioned
below, the graduate students followed several general
courses such as on biostatistics and epidemiology, on
laboratory animal technology and on writing and
(poster)presentations techniques in scientific English.
These courses were organized by the AMC, VUmc and
NKI.
Replication stress and chromosomal
instability
Organization:
Date:
Location:
J. Molenaar
H. te Riele
B. Ylstra
January 6-10
VUmc/NKI
This course took the PhD students from the
fundamentals of DNA replication in human cells and
model organisms to replication defects in cancer and
its consequences for chromosomal instability and
therapeutic intervention. Visualization of DNA
replication, the role of cell cycle checkpoints and
genetic inter- and intra-tumor heterogeneity were
part of the rich pallet of this course.
Besides presenting exciting novel science, a major
goal of this course was the academic training. The
value and limitations of the research presented were
analyzed. This was done by literature study,
discussions with fellow course mates (teams) and
meet-the-expert sessions.
Part of this course was a two-day symposium where
eight experts in the field will present their latest
findings. These included Massimo Lopes (CH), Eva
Petermann (UK), Roman Thomas (GER), Óscar
Fernández-Capetillo (ES), Sarah McClelland (UK),
Johannes Walter (US), Thanos Halazonetis (CH) and
James Brenton(UK).
A total number of 24 students participated in the
course. The overall rating was 8.2 (scale 1-10).
Histopathology of tumors
Organization:
Date:
Location:
K. Grunberg
February 10 - 11
VUmc
Aim of this course was to give an introduction in the
histology of malignant tumors and their precursor
lesions. Microscopical structures, growth patterns,
grading and staging systems, and different cell types
present in selected tumor types were explained and
discussed by pathologists.
Many research projects focus on tumor biology in
order to predict survival or therapy response, using
DNA-, RNA- or protein-based tests. Also,
understanding biological mechanisms of a tumor may
reveal new targets for future treatment. While many
PhD students in cancer research nowadays have a
background in molecular biology, few are well
acquainted with histological characteristics of tumors,
and the clinical significance of histopathological
findings. In daily clinical practice histopathological
examination of tissue is the mainstay and gold
standard of a cancer diagnosis. In addition, the choice
of treatment largely depends on pathological
variables. This OOA course provided introductory
hands-on training in histopathology of tumors. The
course aimed to provide better insight in the
histopathology of various tumor types, in relation to
diagnostic, prognostic and therapeutic significance. As
the course included an introductory session, only basic
knowledge on histology is required.
A total number of 18 students participated in the
course. The overall rating was 4.2 (scale 1-5).
Educational activities - 21
Tumor angiogenesis
Meet-the-Expert
Organization:
Date:
Location:
with Prof. Rakesh Jain
A.W. Griffioen
March 13
VUmc
For almost four decades, prof. Jain’s work has focused
on one challenge: improving the delivery and efficacy
of anticancer therapeutics. Working on the hypothesis
that the abnormal tumor microenvironment fuels
tumor progression and treatment resistance, he
developed an array of sophisticated imaging
technologies and animal models as well as
mathematical models to unravel the complex biology
of tumors. Using these tools, he demonstrated that
the blood and lymphatic vasculature, fibroblasts,
immune cells and the extracellular matrix associated
with tumors are abnormal, which collaborate together
to create a hostile tumor microenvironment
characterized by hypoxia, low pH and high interstitial
fluid pressure. He next hypothesized that agents that
induce “normalization” of the microenvironment can
improve the treatment outcome. Indeed, he
demonstrated that judicious use of antiangiogenic
agents—originally designed to starve tumors—could
transiently “normalize” tumor vasculature, alleviate
hypoxia, increase delivery of drugs and anti-tumor
immune cells, and improve the outcome of various
therapies. In parallel, he provided compelling
evidence for vascular normalization in rectal
carcinoma and glioblastoma patients treated with
antiangiogenic agents. This session was part of the 5th
International Meeting on Angiogenesis.
A total number of 8 students participated in the
session. The overall rating was 4.5 (scale 1-5).
The Microscopic, Macroscopic and
Pathologic Anatomy of the Mouse
Organization:
Date:
Location:
Prof.dr. W. H. Lamers
Dr. E. Wierenga
April 7-10
AMC
This course aimed to provide a practical
understanding of the anatomy and histology of what is
currently the most frequently used experimental
animal, the house mouse. In addition, it focused on
recognition of pathological changes in the mouse.
Most biomedical PhD students perform animal
experiments at some stage in their research career,
but few have ever received any practical instruction
concerning the anatomy, histology, and pathological
anatomy of experimental animals. For this reason, the
animals are not usually subjected to a thorough and
systematic inspection to assess whether other organs,
not just those being studied in the experiment, are
22 – Educational activities
affected as well.
Each student dissected a mouse to learn this species'
topographic anatomy. The microscopic component
focused on studying and understanding the
architecture of normal and pathologically changed
mouse tissues. The practical component involved the
recognition of cell and tissue types, as well as of
changes in the architecture of tissues as a result of
pathological processes, under the microscope.
Standard staining techniques are demonstrated, as are
functional ones.
The overall rating was 8.2 (scale 1-10).
Basic Microscopy Course “In the Footsteps
of Antoni van Leeuwenhoek”
Organization:
Time:
Location:
Dr. J.A.M. Beliën
Dr. L. Brocks
Prof. dr. R. Mebius
Dr. L. Oomen
Dr. E.A.J. Reits
Dr. N van de Wel
April 7-11
VUmc/AMC/NKI
This course focussed on the application of a range of
imaging possibilities within the Centre for Microscopy
at the AMC, the VUmc and the NKI-AvL. They were
presented in lectures, discussions and hands-on
demonstrations. The individual research projects of
the attending participants were discussed in relation
to the demonstrated techniques, allowing exchange of
ideas with fellow participants and microscopy experts
and operators. The course was a guide to implement
cellular imaging in their own research project. A part
of the participants could bring their sample for
analysis after consulting with the organization first.
Topics included: basic principles of microscopy, basic
principles of confocal laser scanning microscopy,
specimen preparation and staining methods,
quantitative analysis of microscopic images, electron
microscopy techniques, Imagestream, ultramicroscoop
and 2-photon and live cell imaging.
A total number of 16 students participated in the
session. The overall rating was 4.1 (scale 1-5).
WHO's next: The past, present and future
of brain tumor classification
Meet-the-expert
Organization:
Date:
Location:
with Dr. David Louis
Prof. P. Wesseling
30 April
VUmc
Dr. Louis' own clinical neuropathology practice and
research focuses on brain tumors, with an emphasis on
the molecular basis of malignant gliomas and the
application of molecular diagnostics to glioma
classification. He has published more than 250 original
articles, as well as numerous reviews, chapters and
books. His laboratory was the first to demonstrate
that molecular approaches could be used to subdivide
malignant gliomas in a biologically relevant manner,
and that molecular approaches could be used to
predict the response of particular malignant gliomas
to specific therapies. This work has contributed to
worldwide adoption of molecular testing for the
management of patients with these tumors.
Right before a meeting they organized together with
Pieter Wesseling in Haarlem (‘WHO’s next; guiding
next steps in brain tumor classification’), Dr. Louis
shared his expertise with OOA PhD students in the
meet-the-expert session in the field of neuro-oncology
A total number of 13 students participated in the
session. The overall rating was 4.5 (scale 1-5).
Resistance to cancer therapy
Meet-the-experts with prof. Harris and prof. Muschel
Organization:
Prof. H. Verheul
Drs. E. Kleibeuker
Date:
13June
Location:
VUmc
Radiation Oncology
Organization:
P. Sminia
J.J. Sonke
L. Stalpers
Date:
Location:
June 16 - 20
VUmc/ NKI
The course provided an overview of (1) radiobiological
and physical principles of radiation oncology (2)
technical innovation in precision radiotherapy (3) the
route of the radiotherapy patient - via diagnosis,
imaging and treatment planning – to therapy.
Topics that were addressed included: effects of
irradiation on the DNA and cellular level, radiation
response of tumours and normal tissues, physics of
modern conformal radiotherapy, imaging, treatment
planning and treatment of cancer patients with
radiation alone or combined with chemotherapy or
targeted agents. New and exciting developments in
radiotherapy were addressed. The course
encompasses three practical trainings: (1) the
radiobiology laboratory (2) computer-based target
volume delineation (3) patient treatment simulation
on a linear accelerator.
A total number of 24 students participated in the
session. The overall rating was 4.0 (scale 1-5).
Professor Harris’ special interest is in breast cancer
and mechanisms of resistance to therapy, regulated by
hypoxic metabolism and tumour angiogenesis. He runs
his research laboratories in the Oncology Department
at the Weatherall Institute of Molecular Medicine, on
tumour angiogenesis and the role of notch signalling,
and hypoxia biology and its regulation. New
angiogenesis pathways involving notch signalling and
G-coupled receptors have been discovered and
therapeutic antibodies have been developed against
them, with funding from CRUK.
Prof. Ruth Muschel’s research focuses on role of
signalling pathways in the response of cancer cells to
radiation therapy and on the mechanisms underlying
development of metastasis. Using fluorescent
microscopy to define the process of metastasis in the
lung, they found adhesion of the tumour cells to the
pulmonary blood vessels followed by spreading on the
vasculature surface. These surviving cells gave rise to
early colonies formed within the blood vessels.
Part of the session was the lecture of Harris and
Muschel. A selection of PhD students was asked to give
a 10 minute presentation on their PhD-projects for
discussion.
Basic Microscopy Course “In the Footsteps
of Antoni van Leeuwenhoek”
A total number of 7 students participated in the
session. The overall rating was 4.4 (scale 1-5).
A highlight of the educational program is the Annual
Graduate Student Retreat. This three-day retreat
focuses entirely on research conducted by the
graduate students themselves. At the retreat,
Organization:
Time:
Location:
Dr. J.A.M. Beliën
Dr. L. Brocks
Dr. L. Oomen
Prof.dr. P. Peters
Dr. E.A.J. Reits
Dr. N van de Wel
October 6-10
VUmc/AMC/NKI
As the number of students interested in the
microscopy course, was very high, this course was
organized twice this year.
Again, 16 students participated in this course. The
overall rating was 4.6 (scale 1-5).
Annual Graduate Student Retreat
Organization:
Time:
Location:
Prof.dr. H. te Riele
P. Lagerweij
Drs. C. Kapper
October 22 - 24
Renesse
Educational activities - 23
students not only present their work as a poster in the
first year of their participation and as an oral
presentation in subsequent years, they are also in
charge of chairing sessions and discussions.
In recent years, student participated in peer review of
the presentation given by others in order to award the
prize for the best poster and best presentation. In this
manner, the retreat trains important skills in
presentation and interaction but it also provides an
overview of research conducted within OOA at a early
stage of the student’s career, contributing
significantly to the interaction between different
groups: clinical and fundamental students.
The location Hotel Opduin on the island of Texel
reached its maximum capacity. This year the retreat
was organized in Ermelo.
A total of 172 PhD students participated in this
retreat. The overall evaluation rate was 4.1 (scale 15).
Basic Medical Statistics
Organization:
Date:
Location:
M. Hauptman
P. Gradowska
K. Jozwiak
W. Heemsbergen
December 1- 5
NKI
This 5-day course explained statistical techniques for
the evaluation of biomedical data. It provided an
introduction into design aspects, methods of
summarizing and presenting data, estimation,
confidence intervals and hypothesis testing, including
multivariable regression methods for the assessment
of association. Although the course focusses somewhat
on methods and examples from clinical research, it
should be useful for experimental researchers as well.
The emphasis will be on practical application and
interpretation rather than theory.
A total of 59 PhD students participated in the course.
The overall rating was 8.3 (scale 1-10).
24 – Educational activities
Oncology Graduate School Amsterdam OOA
PhD research program
4
4. PhD research program
This chapter describes the 49 PhD projects conducted within the two main themes of the OOA research
programs, with the names of the PhD students involved and their supervisor(s).
* PhD students who obtained their PhD degree in 2014
# PhD students who stopped their PhD research in 2014
Funding
1
Financed by participating OOA institute (“eerste geldstroom”)
2
Financed by public funds (“tweede geldstroom”)
3-4
Financed by private funds (“derde / vierde geldstroom”)
Theme 1: Experimental Biology
Name
Title of Project
Supervisor
Start
Fund
Adamopoulos A.
Structural studies of LPA and Sterol signaling
Perrakis
2014
2
Van Beusekom B.
Transfer of evolutionary conserved features for optimised
protein strucutres
Joosten/Sixma
2014
2
Blomen V.
Functional Profiling of a Human knockout collection
Brummelkamp
2010
1
Dharadhar S.
Structural studies USP1
Sixma
2013
3
Groothuizen F.
Structural studies of DNA mismatch repair
Sixma
2009
2
Jae L.
Identification of genes that play a role in human disease
Brummelkamp
2011
1
Kok D.
DNA mismatch repair - studying the activation states of the Sixma
molecular machinery
2013
2
Kim R.
Regulation of the Usp7/HAUSP switch
2012
3
Nieuwenhuis J.
Tissue control and the regulation of Hippo pathway activity Brummelkamp
in mammals
2012
4
Sahtoe D.
Ubiquitin structure and function
Sixma
2009
2
Staring J.
Tissue size control and the regulation of Hippo pathway
activity in mammals
Brummelkamp
2010
4
Uckelmann M.
The balance of ubiquitin conjugation and deconjugation
Sixma
2011
4
Biochemistry (NKI)
Sixma
Biological Stress Response (NKI)
Aslam M.
The role of stable immunoglobulin transcripts in establishing H.Jacobs
allelic exclusion
2014
4
Benedict B.
Replication stress in cancer mechanisms and
consequences for therapy
Te Riele
2014
3
Buoninfante A.
Exploring DNA-damage tolerance as a drug-target for
chemosensitization and a mechanism of chemoresistence
H.Jacobs
2013
3
Harmsen T.
Oligonucleotide-directed gene modification in human
induced pluriipotent stem cells
Te Riele
2011
4
Houlleberghs H.
Characterisation of unclassified allelic variants of DNA
mismatch repair genes to improve genetic counceling
Te Riele
2010
4
Pilzecker B.
Exploring DNA-damage tolerance as a drug-target for
chemosensitization and a mechanism of chemoresistence
H. Jacobs
2014
3
Ravesteyn T.
Oligonucleotide-directed gene targeted: evading mismatch Te Riele
repair
2013
2
Seeman I.
The role of endoglin in induction and repair of
cardiovascular damage after radiation alone or in
combination with trast
Stewart
2008
3
Wielders E.#
Subtle gene modification to study the role of the mismatch Te Riele
repair complex Msh2/Msh5 in mutation avoid
2004
3
Cell Biology I (NKI)
PhD research program - 27
Van den Berg J.
Monitoring cell fate decisions after DNA damage in living
cells
Medema
2014
2
Boekhout M.
Spindle Checkpoint independent control of the APC/C
Wolthuis
2010
4
Clijsters L.*
Targeting protein destriction during cell division
Bernards
2007
3
Elbatsh A.
Dissecting the prophase pathway of cohersin removal
Medema
2012
Feringa F.
Spontaneous recovery after DNA damage
Medema
2011
4
Kedziora K.
Calcium and phosphoinositides in the control of podosome
formation and tumor cell invasion
Jalink
2010
3
Leyton Puig D.
Super-resolution Microscopy (Nanoscopy): From sharp
images towards imaging of molecular interaction
Jalink
2011
4
Te Molder L.
Regulation of tumorogenesis by integrin alpha3beta1
Sonnenberg
2014
3
Nahidi Azar L.
Super-resolution Microscopy("Nanoscopy"): From sharp
images towards imaging of molecular interaction
Jalink
2011
4
Ramovs V.
Regulation of tumorgenesis leg integrin X3Beta1
Sonnenberg
2013
3
Veen van M.
Autotaxin and GDE2: functional and structural analyses
Moolenaar
2011
2
Visser D.*
TRPM7 a novel regulator of cytoskeletal tension
implications for cancer progression, invasion and
metastasis
Jalink
2007
3
Voets E.
Divergent control of Cyclin B1-Cdki in cancer cells: a key
role in therapy
Wolthuis
2008
3
Afanasyev P.
Analysis of 3D structure of molecular machines with cryoelectron tomography using novel nanochambers
Peters
2011
4
Bakker J.
Towards understanding and manipulation of MHC class II
antigen presentation
Neefjes
2010
4
Deventer van S.
Kinome and phosphatome knock-down
Neefjes
2008
2
Djarjath Ahamed S.
Engineering Ubiquitin Related Proteins to Reveal their
Function
Ovaa
2011
4
Ekkebus R.
Pan DUB inhibitors to study the ubiquitinated proteome
Ovaa
2009
2
Hoppes R.
Characterization of peptide-MHC interactions
Ovaa
2007
2
Jong de A.
Post-Translational transpeptidation and immunity
Ovaa
2009
2
Jongsma M.
Manipulating the MHC class II system to control immune
responses in auto immunity
Neefjes
2007
2
Leestemaker Y.
Proteasome activation
Ovaa
2011
1
Luimstra J.
Mass cytometry staining agents for combinattorial MHVexchange Tcell coding
Ovaa
2012
1
Mons E.
Covalent enzyme capture
Ovaa
2014
2
Schunselaar L.
Drug responses with primary cultures of tumor cells from
mesothelioma patients
Neefjes/Baas
2012
1
Shahul Hameed S.
Engineering Ubiquitin Related Proteins to Reveal their
Function
Ovaa
2009
4
Spits M.
Chemical Immunology to modulate cross-presentations for
improved caccins
Neefjes/Ovaa
2014
2
Van Tilburg G.
Decoding the ubiquitin code
Ovaa
2013
4
Wijdeven R.
Towards underfunding and manipulation of MKC clan II
antigen presentation
Neefjes
2009
1
Witting K.
UPStream
Ovaa
2012
4
Wu L.#
Towards underfunding and manipulation of MHC clan II
antigen presentation
Neefjes
2010
4
Van der Zanden S.
Understanding and modulating anthracyclin-induced
immunogenic death
Neefjes
2014
2
Nuclear lamins and chromosome organization
Van Steensel
2012
4
Cell Biology II (NKI)
Gene regulation (NKI)
Brinkman E.
28 – PhD research program
Bruekner L.
Mechanisms that determine chromatin composition
Van Steensel
2013
2
Chen T.
Principles of chromatin organization
Van Steensel
2012
4
Han R.
Genomewide identification of cancer induced alterative in
protein translation
Agami
2013
1
Korthout T.
Principles of Epigenetic Inheritance
Van Leeuwen
2013
2
Li Li
RNA Trmin ncRNA's in cancer
Agami
2014
2
Lopes R.
Identification of Mirnas regulatory mechanismus in cancer
Agami
2011
4
Molenaar T.
Histone dynamics and epigenetic inheritance
Van Leeuwen
2014
2
Poramba D.
Principles of Epigenetic Inheritance
2013
2
Rooijers K.
Analysis of ribosome profiling data
Agami
2011
4
Vlaming H.
Role of histone mthyltransferase Dot1 in gene expression
and leukemic transformation
Van Leeuwen
2010
2
Ahrends T.
Exploring the nature of CD4 T cell-help for the CS8 T-cell
response to optimize immunotherapy of cancer
J. Borst
2013
3
Ariotti S.*
Introvital imaging of epidermal imunne phenomene in virus Haanen
infections and DNA tattooing
2007
1
Babala N.
Contribution of costimulatory receptors to
immunosuppression versus immune activation
J.Borst
2013
3
Bresser K.
Tumor-specific T cell antigens
Schumacher
2014
2
Buuren van M.
The use of MHC-tetramer technology to characterize HCV
specific T-cell responces
Schumacher
2010
4
Ciampricotti M.
The inflammatory tumor microenvironment and its impact
on signal cancer development and therapy
De Visser
2009
2
Deken M.
Combining ragerted therapy and immunotherapy
Blank
2012
2
Dijkgraaf F.
Intravital imaging and computational ignallin of skin
immunity
Schumacher
2012
4
Doornebal C.
The role of cancer cell-interinsic and microenv. Factors
contr. To metastasis formation and its modulatation by
opioid
De Visser
2009
1
Fanchi L.
Immunotherapy of cancer through TCR gene transfer
Schumacher
2012
2
Kelderman S.
Development of adoptive T-cell therapies
Schumacher
2009
1
Kersten K.
Cancer cell-intrinsice and-extrinsic regulation of breast
cancer metastais formation, implications for adjuvant
therapy
De Visser
2011
Kok L.
Single cell tracing within the T cell lineage
Schumacher
2013
4
Kooij van de B.*
A novel type of ubiguintination regulates apoptosis
signalling by BH3 only protein Bid
J.Borst
2008
2
Mezzadra R.
Development of TCR1Ano vector 1 items for TCR gene
therapy
Schumacher
2010
2
Sahillioglu A.
Single cell tracking within the T cell lineage
Schumacher
2013
2
Salvagno C.
The functional significance of myeloid cells and their
mediators in breast cancer and chemotherapy
De Visser
2013
2
Veraar E.#
TNF ligands in cancer: CD70
J.Borst
2006
4
Voabil P.
Understanding melanoma sensitivyt to T cell attack
Schumacher
2014
1
Wellenstein M.
Mechanistic insights into the impact of tumor-associated
neutrophils on metastatic breast cancer
De Visser
2014
4
Immunology (NKI)
Molecular Oncology (NKI)
Barazas M.
Tumor Heterogeneity and Therapy excape mechanisms in
genetically engiNOred mouse models for breast cancer
Rottenberg/Jonkers
2013
2
Boersma V.
Genome-wide identification of factors controlling the
telomere damage response and telomere-driven genomic
instabillity
J.Jacobs
2012
4
PhD research program - 29
Dijkstra K.
Predicting therapy response in oncology using tumour
organoids
Voest
2014
4
Durmus S.*
The impact of ABC transporters on carcinogen resistance
Schinkel
2009
1
Gogola E.
Resistance to PARP inhibition by DNA damage response
alterations
Rottenberg/Jonkers
2012
3
Hoppe van S.
Physiologcal and pharmacological functions of the OATP2B1 Schinkel
drug uptake
2014
1
Huang X.
Optimizing PD-1/PD-L1 therapy in melanoma
Peeper
2013
2
Iskit S.
Dissecting the essential contribution of FRA-1 to human
tumor cell metastasis
Peeper
2009
4
Kas S.
Identification of genes nvolved in breast cancer
development and therapy resistance
Jonkers
2011
2
Kaplon J.
The relationship between cell metabolism, sencescence
and cancer
Peeper
2007
2
Kenski J.
Exploiting T cell immunity to improve melanoma targeted
therapy
Peeper
2014
1
Pramana J.*
Gene expression profiling to predict outcome after
chemoradiation in head and neck cancer
Schinkel
2005
3
Torre van der J.
Novel factors involved in chromosome end protection by
telomeres
J.Jacohs
2006
3
Velden van der D.
Predicting therapy response in oncology using tumour
organoids
Voest
2014
2
Weeber F.
Predicting therapy response in oncology using tumour
organoids
Voest
2014
2
Xu G.
Selective targeting of DNA damage response to eradicate.
HR-deficient tumors
P. Borst
2009
3
Yalcin Z.
How ubiquitiniation controlos telomere-induced genomic
instability
J.Jacobs
2012
3
Molecular Carcinogenesis (NKI)
Aben N.
Mapping molecular determinants of drug response through
data integration
Wessels
2014
4
Bismeijer T.
Multilevel models to prevent overtreatment
Wessels
2013
2
Brunen D.
Finding genetic dependencies in cancer: the missing link in Bernards
personalized medicine
2012
3
Dyk van E.
Modularity and Complex Interaction in Cancer
Wessels
2009
2
Groenendijk F.
ERC functional genomics
Bernards
2010
4
Heynen G.
Determinants of the breast cancer stem cell phenotypes
Bernards
2008
2
Jong de J.
Modularity and Complex Interaction in Cancer
Wessels
Lint de K.
Dissecting genetic dependencies in cancer
Beijersbergen
2010
4
Prahallad A.
Coltheres
Bernards
2010
2
Staiger C.#
Subnetwork module construction for imporved diagnostic
Wessels
2009
1
Sun C.
classification and subtyping
Bernards
2010
4
Sustic T.
Personalized medicine/therapies for lung cancer
Bernards
2013
1
Thijssen B.
Computational modeling of therapy response in breast
cancer
Wessels
2013
2
Wang L.
Cancer Genomics Center
Bernards
2012
4
Molecular Genetics (NKI)
Alendar A.
Identificaiton of the PIM regulatory network by micro array Berns
analysis and high through put retroviral tagging
2002
3
Cioni B.
The Interaction between myoloid cells in the tumor
microenvironment of human prostate cancer on
Berns
2013
2
Galen van P.*
Genetic screening approaches to the characterization of
human blood and leukemia development
Van Lohuizen
2008
4
30 – PhD research program
Gisler S.
Role of Polycomb repressors in reprogramming and breast
cancer
Van Lohuizen
2011
4
Ikink G.
Identification and Characterization of Novel Breast Cancer
Genes Collaborating with ErbB2
Hilkens
2010
1
Isogai T.
Understanding the role of filopodia in cell migration
Innocenti
2009
1
Koppens M.
Role of Polycomb repressors in prostate cancer and breast
cancer models
Van Lohuizen
2009
2
Krijger de I.
A critical role for WHSC1 at telomeres
J.Jacobs
2012
2
Montfort van E.H.M#
Development of a mouse model to study the genetic basis
of malignant mesothelioma
Berns
2000
3
Evaluation of classification strategies for colorectral
cancer
Meijer
2009
1 and 2
Bakker J.L.
Molecular and phenotypic consequences of the
CHEK2*1100delC mutation and targeted therapy for breast
cancer that lacks CHEK2
Waisfisz
2009
1
Corbin M.
Human Genes essential for the defense against oxygen
toxicity
Joenje /Dorsman
2008
3
Dommering C.J.
Retinoblastoom en erfelijkheid
Meijers
2006
1
Greuter M.
ASCCA (Adenoma and Serrated pathway to Colorectal
Cancer)
Coupe
2012
Haitjema A.
Proteins interacting with FANCI and PALB2
Joenje / Dorsman
2008
3
Massink M.
Molecuar classification of familial breast cancer
Joenje / Waisfisz
2008
2
Mol B.M.
Molecular carcinogenesis of retinoblastoma
Dorsman / Cloos
2008
3
Stoepker C.
The Fanconi anemial/BRCA pathway in oral squamous cell
carcinomas
Joenje
2008
1
Kooi EI.
Genomics to improve diagnostics and care of
retinoblastoma patients
te Riele
2011
3
Leeuw de D.C.*
Uncovering the molecular pathways (microRNAs) that
regulate tumor-initiating potential of Leukemic stem cells
Smit
2009
3
Kerkhoff N.
Role of immune responses focussing on DC in the
pathogenesis of low and high risk Myelodyplastic
syndromes: implications for immunotherapy
Ossenkoppele / van
de Loosdrecht
2012
1
Wojtuszkiewicz A.
The role of impared FPGS splicing in methotrexate
response in childhood acute lymphoblastic leukaemia
Jansen
2010
3
Clinical Epidemiology and Biostatistics (VUmc)
Wubulikasimu A.
Clinical Genetics
(VUmc)
Hematology (VUmc)
Medical Oncology (VUmc)
Blijlevens M.
Targeting RNA splicing deregulation in NSCLC
Van Beusechem
2014
3
Hodzic J.
Identification of genes involved in resistance of prostate
cancer cells to irradiation
Van Beusechem
2009
3
Kruger D.T.
PI3K pathway analysis in tumor tissue and circulating DNA
Boven E
2013
4
Lameris R.
Targeting of CD1d in Multiple Myeloma
de Gruijl
2013
3
Oord van den R.
Prognostic and predictive biomarker development for
colorectal cancer
Verheul
2014
3
Roemer M.G.M.
Characterizing genetic alterations in diffuse lage B-cell
lymphomas occuring in immune provileged sites
de Jong
2012
3
Schneiders F.L.
iNKT and Vγ9Vδ-T cell based immunotherapies for solid
tumors
Van der Vliet
2009
1
Siebring van Olst E.
Identification of genes involved in resistance of lung
cancer cells to cisplatin
Van Beusechem
2009
3
Warmoes M.*
Proteomics of breast cancer
Boven
2007
4
Medical Microbiology and Infection Control (VUmc)
PhD research program - 31
Ates L.S.
Live mycobacterium bovis BCG bacteria as a platform for
the induction of enhanced tumor-antigen-specific
immunity
Bitter
2011
1
Beelen
2011
1
da Silva Aresta Belo van Galectins in tumor progression and tumor immunology
Wijk A.I.
Van Kooyk
2009
4
Dinther van D.
Development of a rapid and effective prime-bost
vaccination stratepy for melanoma.
de Haan / van Kooyk
2014
3
Grewal S.
Coelctomy enhances tumor cell adhesion in the liver and
subsequent outgrowth of metastases
van Egmond
2011
2
Grimwal S.
tumor immunology of per cavity mozaiek now
Beelen/ Bonjer/ van
Egmond
2013
2
Rijn van S.
Modulation of miRNAs in glioma stem-like cells
Würdinger
2009
3
Sewing L.
Developing mouse models of diffuse intrinsic pontine
glioma (DIPG) for pre-clinical research
Kaspers
2012
3
Molecular Cellbiology and Immunology (VUmc)
Braster R.
Identification of tumor-derived proteins that modulate
macrophage effector functions
Neurology (VUmc)
Otolaryngology/ Head and Neck Surgery (VUmc)
Graveland A.P.*
Molecular diagnostis of head and neck squamous cell
carcinoma (HNSCC)
Brakenhoff
2005
3
Kemp de S.R.*
Determinants of chemotherapy sensitivity
Braakhuis /
Brakenhoff
2007
1
Mes S.W.
VPH based predictive model for oral cancer reoccurrence
in the clinical practice ("ORAMOD")
Brakenhoff /
Leemans
2014
3
Plas van der M.
Identification of oncogenic microRNAs and classical cancer
genes involved in head and neck SSC by a functional
genomics approach
Brakenhoff /
Braakhuis
2008
3
Rijken J.A.
SDHB-linked head and neck paragangliomas
Hensen / Leemans
2013
3
Pathology (VUmc)
Babion I.
Construction of a discriminatory, biologically relevant miRNA Snijders / Meijer
marker panel for triage in hrHPV-based cervical cancer
screening
2014
3
Broek E. van den
Structural chromosomal rearrangements in colorectal
cancer
Meijer
2011
1
Groen F.L.M. de
Identification of novel oncogenes/oncomirs located at 13q
involved in the progression of colorectal adenoma to
carcinoma
Meijer
2010
1
Hiemstra A.C.
Development of an improved molecular test for
population-wide colorectal cancer screening
Meijer
2011
3
Hoebe E.K. *
Role of soluble BARF1 oncoprotein in Epstein-Barr virus
driven carcinogenesis and its functional inhibition by
antibodies
Middeldorp
2007
3
Hubers A.J.*
Molecular analysis of sputum for lung cancer diagnosis
Meijer / Smit
2010
3
Mendeville M.
Molecular stratification for diffuse large B-cell lymphoma
as a guide for treatment choice.
Ylstra
2013
3
Miok V.
Comprehensive molecular characterisation of a
longitudinal in vitro model of high-risk HPV-mediated
transformation
Snijders
2012
3
Scheinin A.I.
Data mining DNA copy number changes in cancer
Meijer
2011
3
Thuijl H.F. van
Chromosomal aberrations associated with progression
characteristics of low-grade glioma patients
Heimans
2010
3
Vries S. de
Molecular profiling of high-risk adenomas and association
with colorectal interval carcinoma
Meijer
2014
3
Clonal evolution of acute myeloid leukemia stem cells
Cloos
2012
3
Paediatrics (VUmc)
Wouters R.
32 – PhD research program
Radiology & Nuclear Medicine (VUmc)
Pekosak A.
Carbon-11 labeling of peptides
Windhorst / Poot
2013
3
Biomedical Engineering and Physics (UvA)
Bremmer R.
Reflectance Spectroscopy on Ageing Blood Stains
Van Leeuwen
2007
2
Bruin de D.M.*
Reflectance Spectroscopy on Ageing Blood Stains
Van Leeuwen
2007
1
Peinado Cortes L.
Forward looking OCT scope for Bladderr imaging
Van Leeuwen / de la
Rosette
2014
2
Jansen S.M.
Quantitative optical perfusion imaging during surgery
Van Leeuwen /
Aalders
2014
2
Zhang X
Fibero optic probe development
Van Leeuwen /
Sterenborg
2014
2
Swaan A.
Spectroscopic biopsy of the prostate
Van Leeuwen / de la
Rosette
2013
2
Post A.
Spectroscopic biopsy of the prostate
Van Leeuwen /
Sterenborg
2014
1
Center for Experimental Molecular Medicine (AMC/UvA)
Colak S.
Cancer stem cells in colon carcinoma; their flexibility, role Medema
in tumor growth and therapy resistance
2008
2
Fessler E.
Microenvrionmental regulation of CSC
Medema
2011
1
Prasetyanti P.R.
Survival and differentiation of Colon Cancer Stem Cells
Medema
2010
3
Shi K.
Role of Blood coagulation in pancreatic cancer
Richel / Spek
2010
1
Van der Heijden M.
Stem cell biology and cancer
Medema
2012
1
Van Oorschot B.
Prostate cancer radiation side-effects
Medema
2011
3
Oei A.
Radiation damage
Rasch
2012
3
Buikhuisen J.
Colon cancer Subtypes
Medema
2014
1
Ebbing E.
Eosaphageal cancer
van Laarhoven
2013
1
Linnekamp J.
Wnt target Methylation in Colorectal Cancer
Medema van
Laarhoven
2013
2
Klaassen R.
Imaging in pancreatic cancer
van Laarhoven
2014
3
Steins A.
hypoxia in pancreatic cancer
van Laarhoven
2014
3
Zimberlin C.D.
Mouse models for colorectal cancer
Medema / Bots
2010
1
Damhofer H.
Pranceatic cancer stem cells
Medema / Bijlsma
2010
1
Lascano V.*
Cancer stem cells in colon carcinoma; their flexibility, role Medema
in tumor growth and therapy resistance
2008
3
Potze L.
Applicability and mechanism of Betlinic Acid induced
tumor killing
Medema
2009
3
3
Clinical chemistry (AMC/UvA)
Besancon O.G.
Preclinical screening of drug combinations for
neuroblastoma
Caron/ Tytgat/
Kuilenburg
2008
Cuperus R.*
Modulation of fenretinide induced cell death in
neuroblastoma
Caron / Kuilenburg
2004
Experimental Hematology and Immunology (AMC/UvA)
Attekum van M.H.A.
The role of TNFr-family member APRIL on the proliferation kater/Eldering
and survival of CD5+ B-cells in chronic lymphoceutic
leukemia
2011
1
Thijssen R.
Novel targeted therapies in CLL
Kater/Eldering/
Kersten
2012
2 and 4
de Weerdt I.
Γδ-T cel immuuntherapie in CLL
Kater/de Gruijl/vd
Vliet
2014
1
Hofland T.
Virus-specific immunity in CLL
Kater/Tonino
2014
3
Heer de K.
Kinetcs and homing of CLL cells
Van Oers/ Eldering
2010
Raa te D.
Improving Outcome of P53 Dysfunctional Chronic
Van Oers/Eldering/
2010
PhD research program - 33
Lymphocytic Leukemia by Early Detection and
Circumvention of the P53 Pathway
Schot J.J.
Kater
The role of TNFr-family member APRIL on the proliferation Van Oers/Eldering/
and survival of CD5+ B-cells in chronic lymphoceutic
Kater
leukemia
2009
3
2008
1 and 3
Gastroenterology (AMC/UvA)
Davelaar A.L.*
Proteases as biomarkers and analytical tools in
inflammatory diseases of the gastro-intestinal tract
associated cancers
Fockens/ Krishnadat
Luijtgaarden van de W. Evaluation of Dendritic cell immunotherapy in combination Krishnadat
with Curcumin for treating esophageal cancer
2009
Pacha A.F.
Evaluation of Dendritic cell immunotherapy in combination Krishnadat
with Curcumin for treating esophageal cancer
2008
3
Timmer M.
Evaluating molecular strategies for treatment of Barrett's
esophagus
Krishnadat
2011
3
Westra W.M
Investigating molecular targets for treatment of Barrett’s
esophagus
Krishnadat
2008
2
Molecular Cytology (AMC/UvA)
Moosdijk A. van
Wnt signaling and stem cell biology
van Amerongen,
Gadella
2014
Heijmans N.
Mammary stem cell biology
van Amerongen,
Gadella
2014
Oncogenomics (AMC/UvA)
Groningen van T.
The role of Notch signalling in Neuroblastoma
Versteeg
2008
2
Nowakowska N.
Drugging oncogenic pathways in neuroblastoma
Versteeg
2009
Santo E.
FOX03 in neuroblastoma
Versteeg /Westerhout
2007
1
Commandeur M.
neuritogenesis in neuroblastoma
Versteeg/Westerhout
2012
3
Bate Eya L.
BCL2 inhibition in Neuroblastoma
Molenaar/Versteeg
2010
Eleveld T.
Relapse neuroblastoma
Molenaar/Versteeg
2012
Hakkert A.
New targets in DNA damage signaling in neuroblastoma
Molenaar/Versteeg
2014
Andel van H.
WNT signaling and CYLD in multiple myeloma
Pals/Spaargaren
2011
3
Keimpema van M.
The role of the forkhead transcription factor FOXP1 in Bcell non-Hodgkin lymphoma
Spaargaren/Pals
2008
3
Mackovicová K.
Targeting of Activation-induced Cytidine Deaminase (AID)
dependent DNA Double-stranded Breaks and Long-range
DNA interactions
Van Noesel /
Guikema
2010
1
Matlung S.E.
BASIS genetische analyse van mammacarcinomen; (Breast
Cancer Somatic Genetics Study)
Van de Vijver
2011
2
Ren Z.
Heparan sulfate proteoglycans and WNT-signaling in
multiple myeloma
Spaargaren/Pals
2013
2
Rooij de M.
The role of cell adhesion in B-cell malignancies
Spaargaren/Pals
2009
1
Savci C.D
Identification and validation of predictive markers for drug Van de Vijver
response in metastatic breast cancer.
2009
4
Slot L.
Chronic antigenic stimulation and development of lowgrade B cell non-Hodgkin (NHL) lymphomas
2010
3
Pathology (AMC/UvA)
Van Noesel / Bende
Theme 2: Experimental Clinical Research
Name
Title of Project
Supervisor
Fund
Molecular Pathology (NKI)
Annunziato S.
Combination therapies for personalized cancer medicine
Jonkers
2013
4
Beelen K.*
Clinical and molecula evaluation of anti-estrogen
Linn
2009
4
34 – PhD research program
resistance in breast cancer
Brambillasca S.
Finding novel Achilles' heels to prevent and target BRCA1associated cancer
Jonkers
2014
2
Broek van der S.
Genetic determinants of survival and second breast cancer
development in premenopausal breast cancer patients
Schmidt
2009
3
Bronsveld H.
CARING
Schmidt
2012
2
Brummelen van E.
Pharmacological studies with (novel) anticancer agent
Schellens
2014
4
Cornelissen L.
Identification of Genes contributing to breast cancer
development in GEMMSs
Jonkers
2012
2
Dackus G.
Applied breast cancer diagnostics T3-502
Linn
2012
3
Droog M.
Molecular mechanism of endocrine resistance
Zwart
2011
1
Elshof L.
Finding the balance between overdiagnosis an
dundertreatment: risk of ipsilateral and contralateral
Wesseling
2012
3
Flach K.
A genomics-based tool to predict tamoxifen response
Zwart
2012
4
Geel van R.
Clinical Pharmacology of out-coude drufs
Schellens
2011
4
Hasselt van C.*
Population PK-PD-modelling in oncology
Schellens
2009
4
Hendricks L.
Safety, feasability and cost-effectiveness of genotype and
phenotype-derived individualized dosing of fluoropyr…
Schellens
2014
3
Jacobs B.
Development and clinical testing of novel formulations for
oral fluoropyrimides
Schellens
2011
1
Klarenbeek S.
PI3K signaling in mouse models of invasive lobular
carcinoma
Jonkers
2008
2
Koornstra R.#
Predicting hormonal treatment sensitivity in breast cancer
Linn
2007
4
Meulendijks D.
Phase Iand II studies in oncology with focus on gastrointestinal malignancies
Schellens/Cats
2011
4
Milojkovic B.
Clinical Pharmacology of anti-cancer drugs
Schellens
2011
4
Noll van der N.*
Clinical Pharmacology of novel tyrosine kinase inhibition
Schellens
2010
4
Parsi P.#
Cancer risk and insulin analogues (CARING)
Schmidt
2012
4
Rossum van A.
Biomarkers for hormonal and chemotherapy resistance in
breast cancer patients
Zwart
2013
3
Ruiter de J.
Tumor hereogenity and clonal evolution as a function of
therapy response
Jonkers/Wessels
2012
2
Salomon I.
Microban
Linn
2005
2
Schipper K.
Finding novel Achilles' heels to prevent and target BRCA1associated cancer
Jonkers
2014
2
Schouten P.
Prediction of chemotherapy response based on genomic
aberrations
Linn
2010
2
Severson T.
Molecular characterization of ER positive, triple negative
and BRCA1 mutated breast cancer
Linn
2012
2
Sobral Leite M.
Breast Cancer, Biomarkers and Therapeutic Response
Schmidt
2013
4
Stelloo S.
Integrative androgen receptor genomics as read out for
recurrence risk & ttreatment restistance of prostate
cancer
Zwart
2013
4
Stiekema A.
HE4 in gynaecological cancer
Lok
2014
4
Visser L.
Preventing overtreatment of microcalcification associated
in situ breast leasions by more accurate prognostic
biomarkersimplementing
Wesseling
2014
4
Xu G.
Selective targeting of DNA damage response to eradicate.
HR-deficient tumors
Rottenberg/Jonkers
2009
3
Alphen van M.
Virtual Surgery in Oral Cancer
Van der Heijden
2012
1
Baal van J.
Tripple B, rol peritoneum bij epitheliaal ovarium
carcinoom
Lok
2014
1
Medical Oncology (NKI)
PhD research program - 35
Badrising S.
Treatment of metastatic castration resistant prostate
cancer
Bergman, De Boer
2014
1
Boshuizen R.
Selectikine/EMD malegrant pleural effusion
Van der Heuvel
2009
4
Djajadiningrat R.
Penile squamous carcinoma
Horenblas
2011
1
Dohmen A.
Short term cultures of NSCLC and HNSCC for manipulating
and predicting treatment responses
De Zuur
2011
4
Drukker C .*
Outcome prediction and clinical relevance of the 70-gene
signature for decision making in breast cancer treatment
Rutgers
2011
4
Eden van H.
Peritoneal metastatic disese
Verwaal
2014
1
Engelsman-Theelen W.
Identifying novel targets in solid malginancies; FGFRS and
PD-L1
Van den Heuvel
2013
1
Eskes M.
Virtual therapy: towards a virtual lip model
Balm
2013
1
Farag-Kal S.
Nederlandse GIST registratie
Steeghs
2014
4
Fles R.
Optimizing nasopharyngeal carcinoma management
through increasing awareness in Yogyakarta, Indosesia
Tan/Schmidt
2012
3
Fransen van de Putte
Staging of bladder cancer, imaging, histopathology and
clinical parameters
Horenblas
2014
1
Geukes Foppen M.
Clinical aspects of immunotherapy and targeted therapy of Haanen
advanced melanoma
2013
1
Gooijer de M.
Improved treatment of intracranial tumors - focus on the
blood-brain barrier
Van Tellingen
2013
4
Kaaij van der R.
Slokdarmonderzoek
Van Sandick
2014
1
Kist J.
Towards personalised treatment based on evaluation of ET
in recurrent differentiated Hyroid cancer
Vogel
2011
3
Kuijpers A.
Pathway activation in colorectal carcinoma and colorectal
metastasis
Verwaal
2012
1
Mertens L. *
Bladder Cancer
Horenblas
2011
1
Mirck B.
Surgery for metastatic colorectal cancer
Verwaal
2011
4
Nijenhuis C.
Bioanalysis, metabolism and clinical pharmacology of
anticancer drugs (vemurafenib)
Beijnen/Schellens
2012
4
Pengel K.
CTMM breast care
Gilhuijs
2009
4
Pouw B.
Innovations for diagnostics and treatment of breast cancer
by means of using markers and special attention to tumour
margin identification
Stokkel
2013
4
Ramshorst van M.
Optimizing neoadjuvant systemic treatment in HER2
positiive breast cancer - the TRAIN-2 study
G.Sonke
2014
4
Rigter L.
Colorectal neoplasia in high risk populations
Van Leerdam
2013
1
Samuels S.
Safety ethicary and immunogenicity of HPV16E1
caccination in HPV related squamous cell cancer
Kenter
2012
1
Schaake E.*
Individualised therapy in thoracic malignancies
Burgers
2009
4
Stiekema J.
Genetic Profiling in Oesophageal Cancer
Van Sandick
2010
4
Stoker S.
Nasopharyngeal carcinoom
Tan
2011
3
Teixera S.
Breast cancer tailored staging using molecular imaging
Stokkel
2012
4
Uyterlinde W.*
Supportive care in the treatment of NSCLC
v.d. Heuvel
2008
1
Vermeulen R.
The impact of RISO on physical and psychological helath
among women at increased hereditory of familial risk for
ovarian cancer
Van Beurden
2014
1
Vree M.
Risk factors in persistent trophoblastic disease
Lok
2014
1
Weger de V.
Clinical development of anti cancer drugs through
modulated absorption
Schellens
2013
4
Wessels R.
Optical vuvar biopsy by optical coherence tomography
(DCT)
van Beurden
2010
1
Pharmacy and Pharmacology (NKI)
36 – PhD research program
Aalbergsberg E.
Molecular imaging of radiolabeled cisplatin
Vogel
2012
1
Radhakishun N.
The effects and treatment of obesity in children and
adolescents
Van Vliet
2011
1
Psychosocial Research and Epidemiology (NKI)
Boekel N.
Cardiovascular morbility and mortality in breast cancer
survivors
van Leeuwen
2008
3
Eggermond van A.
Long term risk of second hand cancer and cardiovascular
disease followeing treatment of Hodgins lymphoma
Floor van Leeuwen
2009
3
Eijzinga W.*
Identification of psychosocial problems and perceived need Bleiker
for support in cancer genetics
2008
3
Feenstra H.
An online testing approach to assess cognitive problems
associated with cancer and cancer treatment
2011
3
Groot H.
Longterm risk of cardiovascular disease + 2nd malignancies Schaapsveld
after platinumbased CT for malignant testicular germcell
canc
2012
3
Hummel, L.
A randomized study of an internet-based cognitive
behavioral therapy program for sexuality and intimacy
problems in women
Aaronson
2012
3
Kemperman M.
CONNECT Cognition and the Neural Network: Effect of
Chemotherapy
Van Leeuwen
2010
1
Krul I.
Late effects of treatment in female survivors of Hodgkin's
lymphoma with an emphasis on premature menopause
Floor van Leeuwen
2012
3
Kuijpers W.
ACARE2 MOVE. IT supported patient empowerment
Van Harten
2010
3
Menning S.
Structural biochemical and functional indices of CF
inducted cognitive deficits in concepts
Schagen
2010
3
Meulepas J.
Cancer risk due to radiation exposure from paediatric
computed tomography
Hauptmann
2011
2
Miquel Cases A.
CTMM-breast
Van Harten
2011
4
Nimwegen van R.
Long term cardiovascular risks after treatment for Hodgkin Van leeuwen
Lymphoma
2010
3
Rayan A.
Eurocan
Van Harten
2011
4
Schrijver L.
Gene-hormone use interactions in BRCA 1/2 mutation
carriers: modification of breast and ovarian cancer risk
within CIMBA
Rookus
2010
4
Spaan M.
OMEGA, long term risk of cancer after ovarian stimulation
for in-vitro fertilization
Van Leeuwen
2010
3
Vries de S.
Late effects of the treatment for Hodgkin lymphoma
Floor van Leeuwen
2014
3
Waart van H.
Effectivities of physical exercise
Aaronson
2009
3
Wevers M.
Behavioral and psychosocial effects of rapid genetic
counseling and testing in newly diagnosed breast cancer
patients
Aaronson
2008
4
Wind A.
Benchmarking of Compreshensive Cancer Care
Van Harten
2013
2
Boer de J.
image guided corretion strategies to optimize RT precision
Sonke
2006
3
Bosma S.
Radiosensitivity and local recurrence in breast cancer
Elkhuizen
2013
3
Chen W.
Neoadjuvant drug treatment for breast cancer-response
prediction and response monitoring: breast care
Sonke
2009
4
Dees-Ribbers H.
High precesion image guided RT for bladder cancer
Van Herk
2008
3
Diessen van J.
PET and Radiotherapy for lungcancer
Sonke/Belderbos
2013
Haan de R.
Radiotherapy and PARPI ui NSCLC/MNSCC/LABC-clinical
studies
Verheij/Schellens
2011
4
Hamming-Vrieze O.
Dose redistribution in the presence of anatonmical changes Rasch
in head and neck cancer
2011
1
Heukelom J.
ARTFORCE-Adaptive and Innovative Radiation Treatment
For Improving
2012
2
Schagen
Radiotherapy (NKI)
Verheij
PhD research program - 37
Jong de M.
Prediction of local control after radiotherapy in head and
neck cancer
Verheij
2007
3
Kranen van S.
High precision radiotherapy in the presence of anatonical
deformations
Van Herk
2005
3
Kruis M.*
Motion compensation in YD PET
Boellaard
2009
4
Lambrecht M.
Elekta LungTech
Sonke/Hurkmans
2014
4
Leij van der F.
Image guided pre operative accelerated partial breast
radiaton efining radiotherapy sensitivity
Elkhuizen
2010
3
Mencarelli A.
High precission RT in presence of anatomic changes
Sonke
2008
1
Peulen H.
Optimization of sterotactic image guided RT for lung
cancer through detailed toxizing assessment
Sonke
2011
3
Pirpinia K.
Optimized targeting for surgery and RT of breast cancer
with a DCIS component-regsitration
Sonke
2013
3
Protik A.
Motion management for proton therapy
Van Herk
2013
4
Reijden van der A.
Respiratory correlated imaging for positioning and
monitoring in lung cancer radiation therapy
Sonke
2012
4
Stankovic U.
Improving Cone Beam CT Image quality
Sonke
2012
4
Szeto Y.
Probabilistic planning protonen
Van Herk
2012
4
Trip A.
Adjuvant treatment maagcarcinoom i.h.h. critics
Verheij
2011
1
Uilkema B.
An investigation of the possible benefits of the MR-Lina for
the treatment of rectal cancer
Sonke
2013
4
Verhagen C.
Fanconi anemia pathway defects in HNSCC
van den Brekel
2008
1
Voncken F.
Response monitoring & ART bij oesopharynxcarcinoom
Verheij
2013
4
Zhang H.
IGRT-Breast care package
Sonke
2009
1
The molecules of behavior: how brain tumors link cellular
biology to large-scale brain networks and cognition
Geurts / Reijneveld
2014
2
Compensatory survival mechanisms in head and neck
cancer cells from Fanconi anemia patients: novel targets for
cancer therapy?
te Riele / Brakenhoff
2014
3
Anatomy and
Neuroscience (VUmc)
Derks Y.
Clinical genetics
(VUmc)
Pennings C.
Gastroenterology (VUmc)
Pas van der M.
To study possibilities of fluorescence as tool to optimise
staging and preoperative localisation of colon carcinoma
Meijerink
2007
2
Turenhout van S.T.*
Exploring Faecal Immunochemical Test Performance for
Colorectal Cancer Screening: FIT is at its limit, take it to
the next level
Mulder / Meijer
2010
3
Water van de J.M.W.
Predicting T-cell lymphoma development in refractory
coeliac disease patients by profiling of apoptosis pathways
Cillessen
2007
1
van Alphen C.
Phosphoproteomics for personalized treatment of acute
myeloid leukemia with kinase inhibitors
Ossenkoppele /
Janssen
2012
3
Issa D.E.
Treatment and survival of indolent and aggressive NHL
patients; population based studies in the Netherlands
Huijgens
2009
4
Jauw Y.J.
Immuno PET to personalize therapy in malignant lymphoma Zweegman / van
Dongen / Zijlstra
2013
3
Niewerth D.*
Application of bortezomib in pediatric acute lymphoblastic Kaspers
leukemia
2009
3
Verhagen H.
The identification of biomarkers/drugtargets specific for
leukemic stem cells of Acute Myeloid Leukemia
Smit
2011
3
Wondergem M.J.
Can transformation of indolent lymphoma be detected at
an early stage by PET scanning?
Huijgens / Hoekstra
2006
1
Zeijlemaker W.
The role of minimal residual disease, and leukemic stem
Ossenkoppele
2011
3
Hematology (VUmc)
38 – PhD research program
cells herein, in clinical decision making
Internal Medicine
(VUmc)
Jonge de N.
Short trial: long versus short antibiotic treatment for
febrile neutorpenia in hematological malignancies
Kramer / Zweegman
2014
2
Cornelissen L.A.M.
A bitter sweet symphony: how tumor glycans orchestrate
immune evasion
van Kooyk
2014
1
Duinkerken S.
GlycoTreat— Novel vaccine generation for the treatment of van Kooyk
cancer. A glyco-nanomedial approach instructing T cells
2014
2
Dusoswa S.A.
Turning tumor glycans into anti cancer vaccins
van Kooyk
2014
3
Horrevorts H.
GlycoTreat— Novel vaccine generation for the treatment of van Kooyk
cancer. A glyco-nanomedial approach instructing T cells
2014
2
Schetters S.
DC targeting using glycan modified formulations to
enhance anti-tumor immunity
van Kooyk
2014
2
Molecular Celbiology
and Immunology
Medical Oncology (VUmc)
Avan A.*
Genetic and molecular mechanisms underlying Pancreatic
Ductal Adenocarcinoma aggressive behaviour and
chemoresistance
Peters / Giovannetti
2011
3
Azijli K.
TNF ligands in cancer: TRIAL for cancer therapy
Peters
2008
3
Beekhof R.
Phosphoproteomics for personalized treatment of
Colorectal Cancer with kinase inhibitors
Verheul
2014
3
Chondronasiou D.
VHH based therapies for cancer
de Gruijl / Verheul
2013
3
Eisden T.H.D.
DC-targeted autophagosomes and immunity to melanoma
de Gruijl /
Geijtenbeek
2014
1
Giovannetti E.
Correlation of cytidine deaminase and DNA repair genes
polymorphisms with response and survival in advanced
NSCLC patients
Peters
2007
4
Gootjes E.
Novel diagnostic and treatment strategies in metastatic
colorectal cancer
Verheul
2013
4
Gotink K.J.
Sensitivity and resistance of tumor cells to the
antiangiogenic tyrosine kinase inhibitor sunitinib
Verheul
2008
3
Helden van E.
Biomarkers for anti-EGFR therapy in metastatic colorectal
cancer
Verheul
2014
3
Huijts L.
Phase I-II study of everolimus and low-dose oral
cyclophosphamide in patients with metastatic RCC
Verheul
2011
3
Koster B.D.
Immunomodulation of the sentinel lymph node
de Gruijl
2012
3
Lam S.W.
A multicenter, randomized phase II trial of paclitaxel plus
bevacizumab versus paclitaxel, bevacizumab plus
capecitabine
Boven
2010
4
Large T. le
Phosphoproteomics on patient-derived tumor xenografts,
Kazemier
to identify signaling pathways & candidate driver kinases in
Pancreatic Cancer
2014
3
Maftouh M.*
New avenues in pancreatic cancer: Targeting epigenetics
and metabolism
Peters / Giovannetti
2010
3
Mammatas L.
Molecular imaging for insight and optimization of targeted
anticancer therapies
Verheul
2014
4
Neefjes E.C.W.
Early recognition and optimal treatment of delirium in
patients with advanced cancer
Verheul
2011
3
Neerincx M.
Individualized treatment of patients with advanced
colorectal cancer based on miRNA expression profiling
Verheul
2011
3
Offringa T.
Chemotherapy and maximal tumor debulking of multiorgan coloractal cancer metastases
Verheul / Buffart
2012
5
Poel D.
A randomized multicenter clinical trial for patients with
multi-organ, colorectal cancer metastases
Verheul / Buffart
2013
3
PhD research program - 39
Schulkens I.
Exploring the role of endothelial galectins in tumor
angiogenesis
Griffioen
2009
3
Schuurhuizen C.
Screening and treatment of psychological distress in
colorectal cancer with metastasized disease (TES)
Verheul / Dekker
2013
3
Sol N.
Monitoring of response to EGFRvIII-targeted treatment in
patients with glioblastoma through blood profiling
Verheul / Reijneveld
2013
3
Veluchamy J.
NK cell-based therap for EGFR+ tumors
de Gruijl / Verheul
2013
3
Versteeg K.S.
Optimalization of systemic treatment strategies in elderly
patients with advanced solid malignancies
Verheul
2012
3
Walraven M.
Platelet proteomics for cancer biomarker discovery
Verheul/Jimenez
2008
3
Wentink M.
Development of a therapeutic vaccine approach to antiangiogenesis in oncology
Verheul
2012
4
Westgeest H.
Pharmacoeconomical evaluations in castration-resistant
prostate cancer
Verheul / Uyl-de
Groot
2013
3
Zweeden A. van
New therapies for disseminated gastro intestinal cancer
Verheul
2013
4
Froklage F.
Assessment of blood-brain barrier function in
pharmacoresistant patients with tumor-related epilepsy
Reijneveld
2008
2
Koekkoek J.A.F.
Epilepsy in glioma patients during the course of disease
and in the end of life
Taphoorn / Heimans
/ Reijneveld / Dirven
2013
4
Sizoo E.
Health-related quality of life in high-grade glioma patients
and their partners in the end-of-life phase
Taphoorn
2008
3
Nieuwenhuizen van D.
Quality of life and neurocognitive functioning in
meningioma patients
Reijneveld
2008
1
Best M.
Minimally invasive diagnostics of CNS tumors
Wesseling /
Wurdinger
2013
Hiddingh L.
Development of preclinical pediatric brain tumor imaging
models
Würdinger
2010
3
Neurology (VUmc)
Neurosurgery (VUmc)
Nutricion and dietics (VUmc)
Buskermolen S.
Prevalence and biomarkers of pre-cachexia and cachexia in Verheul
advanced cancer patients scheduled for chemotherapy
treatment
2011
3
van der Werf A.
The effect of individualized NUTritional counselling on
muscle mass and treatment outcome
Verheul
2013
3
Heeren M.
Local immune control and metastasis in Cervical Cancer
Kenter / de Gruijl
2014
3
Hooi D.
HPV screening at Curacao
Meijer / Kenter
2013
Peri-implantitis, implan loss and radio-osteomyelitis in
head and necktumor patients
Bloemena
2010
3
Treatment of osteosarcoma lung metastasis through
targeted therapy
Kaspers / van
Beusechem
2008
4
de Boer D.V.
Targeted therapy of precancerous fields in head and neck
mucosa
Brakenhoff RH,
Leemans CR
2012
3
Cnossen I.C.
Prevention of speech, swallowing, and shoulder
impairment after treatment for head and neck cancer
Verdonck-de Leeuw
2009
4
Cohen R.
The selective targeting of angiogenesis and of tumour
stroma
Van Dongen / de Bree
/ Leemans
2008
2
Flach G.B.
The sentinel node procedure in head and neck cancer:
De Bree / Van Dongen
2007
3
Obstretics and
Gynaecology (VUmc)
Oral and Maxillofacial Surgery and Pathology (VUmc)
Dekker H.
Orthopaedics (VUmc)
Posthuma de Boer J.*
Otolaryngology / Head
and Neck Surgery
(VUmc)
40 – PhD research program
clinical value and potential technical improvements
Gogh van C.D.L.
Voice therapy for patients with voice problems after
treatment for early glottic cancer
Mahieu
2002
2
Jansen F.
Need, use, and costs of supportive care in head and neck
cancer patients
Verdonck-de Leeuw/
Leemans
2013
2
Korsten L.
The course of quality of life in head and neck cancer
patients
Leemans /
Verdonck=de Leeuw
2014
3
Lo Galbo A.M.*
Hypothyroidism after treatment for laryngeal cancer
Leemans
2005
1
Heuveling D.H.*
Improvement of the sentinel node procedure in head and
neck cancer by PET-CT lymfoscintigraphy
De Bree / Van Dongen
2008
4
Oskam I.M.
Health related quality of life in head and neck cancer
patients
Leemans
2004
1
Putten van der L.
FDG-PET for avoidance of futile direct laryngoscopies
under general anasthesia with taking of biopsies in
patients
Leemans
2005
3
Rietbergen M.*
Clinical significance of human papillomavirus infection in
oropharyngeal squamous cell carcinoma
Brakenhoff
2009
3
Schouten C.S.
Response evaluation after chemoradiation for advanced
oropharyngeal cancer using PET-CT and MRI
de Bree R
2012
2
Senft A.
Screening for distant metastases and second primary
tumors with FDG-PET (the school study)
Leemans
2002
2
Slobbe P.
The development of radiolabeled tyrosine kinase nhibitors
for PET imaging
Van Dongen
2011
3
Cordes M.
Molecular biomarkers for the stratification of metastatic
colorectal cancer patients
Meijer, Ylstra
2012
3
Goos J.A.C.M.
Personalized therapy in recurrent colorectal cancer
Hoekstra / Meijer
2009
3
Haan J.C.*
Prediction of response to drug therapy in advanced
colorectal cancer based on DNA copy number profiles of
primary tumors
Meijer / Ylstra
2007
3
Hopmans E.
Massively Parallel Sequencing (MPS)
Ylstra
2014
3
Komor M.A.
Tumor-specific protein biomarkers for early detection of
colorectal cancer
Meijer
2014
3
Krijgsman O.
Clinical and biological relevance of focal aberrations in
colorectal cancer
Meijer
2008
3
Lubbers J.
Genomic biomarkers to predict development of RA (VERA,
ERA) and therapy responsiveness (ESRA)
Verweij
2011
3
Mollers M.*
HPV infections and immune status in a cohort of girls who
are eligible for the national HPV immunisation
Meijer
2009
3
Polman N.
Comparison of the clinical performance of HPV screening
via self-sampling with clinician-based sampling in a
population-based screening setting
Meijer / Snijders /
Berkhof
2013
2
Ramayanti O.
Epstein barr virus activation and cytolytic antivirual
therapy in nasopharyngeal patients
Middeldorp
2011
3
Schütze D.M.
Comprehensive analysis of the long-term oncogenic
capacity and in vitro transforming property of the 15 highrisk human papillomavirus types (hrHPVs)
Snijders
2009
3
Snellenberg S.*
Development and clinical validation of a methylation
marker set for the triage of hrHPV positive women
Snijders
2009
3
Snoek B.
Molecular Self Screening for Cervical Cancer Prevention
Snijders / Meijer /
Steenbergen /
Heideman
2013
2
Strooper L. de
Stratifying high-risk HPV positive women for risk of CIN 3
and cervical carcinoma by methylation analysis
Heideman
2010
3
Uil S.H. den
Tumor micro environment and prognosis in stage II and III
colon cancer
Meijer
2014
3
Uijterwaal M.
Simplified monitoring post-treatment CIN 2/3 women by
Meijer
2010
3
Pathology (VUmc)
PhD research program - 41
molecular testing for hrHPV and methylationmarkers
(SiMoNaTh)
Verhoef V.*
HPV self-sampling offered to screening non-attendees
Meijer
2010
3
Verlaat W.
Molecular Self Screening for Cervical Cancer Prevention
Snijders / Meijer /
Steenbergen /
Heideman
2013
3
Verweij F.J.
Involvement of EBV gene products in exosome-mediated
tumor immune escape
Middeldorp
2009
3
van Zummeren M.
Mass-care
Meijer / Snijders
2013
3
Paedriatic Oncology (VUmc)
Bachas C.*
Characterization of relapsed acute myeloid leukaemia
Cloos/ Schuurhuis
2007
1
Blufpand H.N.
Carboplatin study: assessment and optimization of
carboplatin exposure in pediatric oncology using different
markers
Bökenkamp
2010
4
Braam K.I.
Silicone gel sheet to improve cosmetic outcome of scar
after removal of implantable central venous access device
Van Dulmen-den
Broeder/Kaspers
2007
4
Dijk M. van
Fertility impairment in a pan-European cohort of female 5- Kaspers
year survivors of childhood cancer (PanCareLIFE)
2014
2
D'Olivo P.
Fostering the development of teenagers with cancer
Kaspers
2014
3
Franke N.
Drug resistance in childhood leukemia
Cloos / Kaspers
2006
4
Gunawan S.
Clinical challenges of pediatric oncology in Manado,
Indonesia
Kaspers
2013
Jansen M.H.A.
Towards comprehensive therapy for diffuse intrinsic
pontine gliomas in children
Kaspers
2009
4
Janzen J.
Growthfactors for treatment for of diffuse intrinsinc
ponsglioma
Kaspers / Vandertop
/ Hulleman
2013
4
Klein K.
Local ant-CTLA4 and immune modulation of the melanoma
SLN
Kaspers
2014
5
Kors W.A.
Retinoblastoma
Cloos
2005
1
Krebber A.M.H.
A stepped care programme in patients with high distress
after treatment for head and neck cancer
Verdonck-de Leeuw
2008
3
Meel H.
Targeting growth factor-induced signal transduction in
diffuse intrinsic pontine glioma
Kaspers
2014
3
Mir S.E.
Therapeutic potential of histone deacetuylase inhibitors in
the treatment of Medulloblastoma
Kaspers / Cloos
2007
2
Njuguna F.
Compliance with childhood cancer treatment in Kenya
Kaspers / Mostert
2013
Olbara G.
A medication diary-book for childhood cancer patients in
Kenya
Kaspers / Mostert
2013
Steur L.
Sleep in children in with acute lymphoblastic leukemia and Kaspers
its effects on quality of life, fatigue and parental
functioning
2014
Susilawati D.
Compliance with childhood cancer treatment in
Yogyakarta, Indonesia
2013
Kaspers / Mostert
3
Veldhuijzen van Zanten Drug distribution and local drug delivery in diffuse intrinsic Kaspers / Vandertop
S.E.M.
pontine glioma
2012
3
Veringa S.J.E.
In vitro drug response and efflux transporters associated
with drug resistance
Kaspers / Hulleman
2013
3
Vuurden van D.G.*
Targeted therapy in pediatric brain tumors
Kaspers
2005
1
Frings V.*
In vivo quantification of proliferation and glucose
metabolism in lung cancer patients
Boellaard / Smit
2014
3
Mellema W.W.
New treatmentmodalities for lung cancer patients with a
K-RAS mutation
Smit
2011
3
Slotman
2011
3
Pulmonology (VUmc)
Radiation oncology (VUmc)
Narayan R.S.
Targeting resistance to radio-chemotherapy by inhibition
42 – PhD research program
of the PI3Kinase-Akt signaling pathway
Tol J.
Optimization and automation of radiotherapy treatment
planning
Verbakel
2009
2
Hoyng L.L.
Quantitative imaging in cancer: connecting cellular
processes with therapy: Data and Image Analysis (WP4)
Boellaard
2011
3
de Jong A.
Beating malignant lymphoma with an imaging-biomarkers
based personalized treatment strategy
Nievelstein /
Hoekstra
2013
3
de Jong M.C.
Multicenter implementation of MR imaging studies in
children with retinoblastoma
Castelijns
2012
3
Kramer G.
Quantitative Imaging in Cancer: Connecting Cellular
Processes with Therapy
Biekkaard / Hoekstra
2014
3
Makris N.
PET methodology: quantification of long-lived PET tracers
in oncology and immunology
Boellaard
2010
4
Rizvi S.N.
Qualifying imaging biomarkers for response evaluation in
cancer
Hoekstra
2010
4
Rodjan F.*
Optimization of MR imaging studies in retinoblastoma
patients
Castelijns
2010
3
Scheffer H.J.
Evidence based interventional oncology: from last resort to van Kuijk/ Meijerink
potent alternative or additional treatment?
2012
1
Senthi S.*
Treatment of early-stage lung cancer: cure and
survivorship
Senan / Slotman
2011
1
L. Vroomen
Irreversible elektroporation, clinical validation
van Kuijk / Meijerink
2014
3
Proteasome inhibitor targeting of the
(immuno)proteasome: effects on immune effector cells
Dijkmans / Jansen
2008
1
Ankersmit M.
Photoimmunodetection of colorectal cancer
Meijerink
2011
3
De Cuba E.
Peritoneal metastases from colorectal carcinoma;
Diagnostic markers to identify patients thatbenefit from
radical surgical resection
Bonjer
2010
1
Maas K.W.*
Minimally invasive esophagectomy for cancer: beyond
techniques
Cuesta / van der Peet
2010
3
Nielsen K.
Imaging and local treatment of colorectal liver metastasis
Meijer, Comans
2011
3
Sier M.F.
Stoma-related research in colorectal cancer patients
Ubbink, Bemelman
2009
1 and 2
Straatman C.
The STOMACH trial: Surgical Technique
Cuesta MA
2013
4
De patient centraal bij de behandelkeuze voor
prostaatkanker
van Moorselaar RJA
2013
3
T cell kinetics during immune reconstition after
hematopoietic stem vcell transplantation
Van Oers/Hazenberg
2011
1
Radiology & Nuclear
Medicine (VUmc)
Reumatology (VUmc)
Verbrugge C.S.E*
Surgery (VUmc)
Urology (VUmc)
Al-Itejawi H.
Hematology (AMC/UvA)
Munneke J.M.
Gastro-enterology & Hepatology (AMC/UvA)
van Baar A.C.G.
Duodenal ablation for diabetes regulation
Bergman/Nieuwdorp
2014
4
Belghazi K.
Endoscopic treatment of early esophageal neoplasia
Bergman
2014
4
Bureo Gonzalez A.
Epidemiology of Barrett's surveillance
Bergman
2013
4
Duits L.C.
Risk stratification for Barrett's esophagus
Bergman
2012
4
Holz J.A.
Light-tissue interactions in esophageal neoplasia
v. Leeuwen/Bergman
2011
3
Künzli H.T.
New treatment options for esophageal neoplasia
Weusten/Bergman
2012
4
Rosmolen W.D.
Quality of life of patients with Barrett's neoplasia
Sprangers/Bergman
2010
4
Schölvinck D.W.
New endoscopic therapies for early esophageal neoplasia
Weusten/Bergman
2012
4
Swager A.F.
Volumetric laser endomicroscopy in esophageal imaging
Bergman
2012
4
PhD research program - 43
van der Wel M.
Optimizing histological diagnosis making in Barrett's
neoplasia
Bergman/vd. Vijver
2013
4
Alvarez-Herrero L.*
Advances in imaging and therapy in Barrett's esophagus
Weusten/Bergman
2011
4
Boerwinkel D.*
Imaging of early barrett's neoplasia
Bergman
2011
4
Phoa N.*
Endoscopic treatment of early esophageal neoplasia
Bergman/Tijssen
2011
4
Berg M.van den
New endoscopic developments in GI oncology
Fockens/van Hooft
2011
Van Doorn S.
Diverse aspects of colorectal cancer screening
Dekker
2011
2 and 4
Hazewinkel Y.*
Serrated polyposis syndrome: endoscopic treatment and
surveillance of patients and screening of first-degree
relatives
Dekker
2010
3
Verlaan T.
Transmural endoscopy
Fockens/Bemelman
2010
Wanders L.
Advanced colonoscopic imaging
Dekker
2011
2 and 4
IJspeert J.
Serrated polyposis
Dekker
2013
2 and 4
van der Vlugt M.
Fourth round op FIT-screening for CRC
Dekker/Bossuyt
2013
2
Kallenberg F.
Family Matters en FAP
Dekker/Aalfs
2014
2 and 4
Vleugels J.
Optical Diagnosis of colorectal polyps
Dekker/Fockens
2014
3
Bronzwaer M.
Quality in colonoscopy & polypectomy
Dekker/Fockens
2014
2 and 4
Wegdam W.
Role of proteomics in ovarian carcinoma
Buist/Aerts/kenter
2007
1
Rutten M.
Prognostic models in ovarian cancer
Buist/Kenter/
v.d.Vijver
2010
1
Biewenga P.
Prognostic models in carcinoma of the cervix
Buist/Stalpers/Kenter
2007
3
Meurs H. van
Improving treatment strategies in ovarian cancer
Buist/Kenter/Mol
2010
3
Derks M.
Morbidity and QOL after treatment for cervical cancer
v.Lonkhuizen/Kenter
2010
2
Gynaecology (CGOA)
Baal J. van
Lok/Kenter
2014
Stiekema A.
Biomarkers in ovarian cancer
Lok/Kenter
2011
de Haan J.*
Cancer in pregnancy
Lok/de Groot
2014
Medical Oncology (AMC/UvA)
Kleinjan A.
Cancer and (anti)coagulation
Buller / Kamphuisen
/ Richel
2010
1
Anderegg M.C.J.
New treatment strategies of oesophageal cancer
Busch/Van Berge
Henegouwen/Van
Laarhoven
2012
1
Brugel S.D.A.C.
Shared decision making in advanced cancer patients
Smets/
Van Laarhoven/
Henselmans
2014
3
Ebbing E.A.
Receptor signalling in oesophageal cancer
van Laarhoven/
Medema/Bijlsma/
Punt
2012
1
Haj Mohammad N.
Treatment of upper gastrointestinal cancer in daily
practice: toxicity, quality of life and survival
van Laarhoven/tbd
2013
1
Hartog I.D.
Elucidating quaility of life from a narrative perspective
van Laarhoven/
Sprangers/
Scherer-Rath
2014
2
Klaassen R.
Functional imaging of pancreatic cancer
van Laarhoven/
Punt/Nederveen
2013
3
Kruizinga R.
Experiences of contingency in advanced cancer patients
van Laarhoven/
Schilderman/
Scherer-Rath
2012
3
Linnekamp J.F.
Methylation in colon cancer
Medema/
van Laarhoven/
Vermeulen/Dekker
2013
3
Netjes J.E.
Elucidating quaility of life in cardiac patients
Sprangers/van
Laarhoven/Nieuwkerk
2014
2
44 – PhD research program
Rijssen L.B. van
Nationwide databanking of pancreatic cancer
Busch/van
Laarhoven/Besselink/
van Eijck
2014
3
Steins A.
Tumor stroma in pancreatic cancer
van Laarhoven/
Medema/Bijlsma/’
Punt
2014
3
Veenstra V.
Elucidating the stromal response to Sonic Hedgehog in
pancreatic carcinoma
Medema/van
Laarhoven/Bijlsma
2014
3
ter Veer E.
Network metaanlyses of upper GI cancer
van Laarhoven/
van Oijen
2014
3
Woude S.O. van der
New systemic treatment strategies in oesophagogastric
cancer
van
Laarhoven/Bijlsma
2014
3
Bulten B.
Early detection of cardiac malfunction in breast cancer
patients
De Geus-Oei/van
Laarhoven/Oijen
2011
4
Hidding J.
Lymphedema in breast cancer
Nijhuis/vanLaarhoven
/Beurskens/van der
Wees
2011
4
Large T. le
Proteomics of pancreatic cancer
van Laarhoven/
Bijlsma/Jimenez/
Giovanetti
2014
1
Visser A.
Group medical consultations in breast cancer care
Prins/van Laarhoven/
Hoogerbrugge
2011
3
ter Voert E.
Functional imaging of colorectal cancer
Heerschap/van
Laarhoven/De GeusOei
2009
3
de Vries Y.
Sensory changes after cytotoxic treatment
Kampman/tbd/van
Laarhoven/Winkels
2012
3
Pediatric Oncology (AMC/UvA)
Dijk van I.W.E.M.
Late effects of radiotherapy in childhood cancer survivors
Caron / Koning /
Kremer
2010
3
Eijkelenburg van N.
Ealry phase medication studies for childhood cancer
Caron / Verschuur
2007
3
Knops R.R.G.
Quality care in paediatric oncology
Hulscher/Kremer
2009
3
Psychosocial department (UvA/AMC)
Schepers S.A.
Living with chldhood cancer
Grootenhuis/Verhaak
2011
3
Sint Nicolaas S.
Living with chldhood cancer
Grootenhuis/Prins/
Verhaak
2011
3
Ruiter de M.
Pediatric research on improving speed, memory and
attention
Grootenhuis / Caron
/ Oosterlaan/
Schouten
2008
3
Radiotherapy (UvA/AMC)
Balidemaj E.
Improved regional hyperthermia delivery using
hyperthermia treatment planning based on MRI data
Rasch / Crezee / van
den Berg(UMCU) /
Stalpers
2010
3
Dinkla A.
Brachytherapy treatment planning: optimisation and
evaluation
Rasch / Bel
2010
1 and 4
Hamming O.
Dose redistribution in the presence of anatomical changes
in head and neck cancer
Verheij/Rasch
2011
4
van Oorschot B.
Investigation of a gene set classifier for late radiation
toxicity in prostate cancer patients
Medema / Franken
2010
3
Oei A.
Towards biological treatment planning in radiotherapy
combined with hyperthermia to improve clinical outcome
Franken / Kok /
Stalpers / Medema
2012
3
Schooneveldt G.
Optimization of bladder hyperthermia treatment for NMIBC Crezee/Hulshof/
by using loco-regional heating, improved 3-D thermometry Rasch
2012
3
Van Leeuwen C
Towards biological treatment planning in radiotherapy
combined with hyperthermia to improve clinical outcome
Kok/Crezee/Stalpers/
Rasch
2012
3
Van der Schoot S.
ART for cervical cancer
Bel/Stalpers/Rasch
2012
3
Lutkenhaus L.
Advanced ART techniques
Bel/Hulshof/Rasch
2012
3
PhD research program - 45
lens E.
IGRT for pancreas
Bel/vTienhoven/
Rasch
2012
3
Gurney-Champion O.
MRI for pancreas
Bel/Nederveen/Rasch
/Stoker
2012
3
Van Heerden L.
Multimodality dose summation brachy/EB
Bel/Pieters/Rasch
2013
3
Versteijne E.
Pancreas
V Tienhoven/
Bel/Rasch
2013
1
Huijskens S.
Kinderen
Bel/Alderliesten/
Rasch
2014
3
Jin P.
Margin reduction Oes.irradiation
Alderliesten/Hulshof/
Rasch
2013
3
Machiels M.
Target definition in radiation for Oes cancer
Hulshof/Alderliesten/
Rasch
2013
1
Jelvehgaran P.
Oes OCT
Alderliesten/De
Bruin/ Et al.
2013
3
Pirpinia K.
Deformable image registration
Aldrliesten/Bosman/
vHerk
2013
3
De Boer P.
Adaptive radiotherapy for cervical cancer
Stalpers/Rasch
2011
1
Büller N.
The role of Hedgehog signaling in intestinal homeostasis
and carcinogenesis
Van den Brink
2010
2
Rosekrans S.
The role of Hedgehog signaling in esophageal homeostasis
and carcinogenesis
Van den Brink
2010
2
Wielenga T.
The unfolded protein response in colorectal cancer
development and sensitivity to chemotherapy
Van den Brink
2011
3
Westendorp F.
Intestinal mesenchymal cell function in homeostasis and
disease
Van den Brink
2013
2
Meijer B.
The unfolded protein response in colorectal cancer
development and sensitivity to chemotherapy
Van den Brink
2014
3
Lidth de Jeude J.
The role of Hedgehog signaling in intestinal homeostasis
and carcinogenesis
Van den Brink
2011
2
Beemster P.
Cryosurgery of small renal tumors
De la Rosette/
Laguna/ Wijkstra
2005
1
Smeenge M.
Imaging in Urology
De la Rosette/
Laguna
2009
Tytgat Institute (AMC)
Urology (AMC/UvA)
46 – PhD research program
Oncology Graduate School Amsterdam OOA
awards
5
5. Awards
This chapter lists awards and honors won by staff
and students involved in OOA throughout 2014. The
lists are in alphabetical order of the recipients’
last name.
Faculty and staff members of the OOA fulfilled
numerous functions in national and international
organizations, on scientific boards of scientific
journals, as members of study sections, and as
organizers or co-organizers of scientific meetings,
workshops and congresses.
Hoda Al-Itejawi received Value Based Healthcare
Price
Martijn Meijerink received the ´kanker in
beeld´award
Samantha Mostert was invited to write a Personal
View in the Lancet Oncology
Bregje Onwuteaka-Philipsen received the ZonMw
Parel for PaTz project
Martin Taphoorn received the Abihjit Guha Award
Niels van de Donk was awarded with the UMC
Utrecht Research Talent price
J van der Laken received the Aspire award
Ronald Boellaard received the PET center of
excellence award
Thijn Brummelkamp was elected as member of
the EMBO
Remond Fijneman received the price best oral
presentation during the European Congress of
Pathology
Danielle Heideman became member of the
‘Taakgroep Richtlijn moleculaire diagnostiek in de
pathologie’
Erik Hensen received the Heinsius Houboldt
Stipendium
Yvette van Kooyk received the van Loghem
laureate
The department of Radiation Oncology has been
honored with the Emmanuel van der Schueren
Award 2014
Ton Schumacher won San Salvatore Award, Fellow
European Academy of Cancer Sciences en de Queen
Wilhelmina Research Award
Aukje van Tilborg received the ´kanker in
beeld´award
Lilian van Tuyl reveived the Pfizer Inflammation
Competitive grant
Trijn Israels received the SIOP poster award
Kees Jalink was appointed Professor of High
Resolution Microscopy at the UvA
Wilbert Zwart won 2014 Pezcoller Fellowship and
the Bas Mulder Award
Jos Jonkers was awarded with a VICI grant by
NWO.
Adriaan Lammertsma received the Certificate of
Appreciation
Rene Leemans was awarded the I.J. Sendulskii
Commemorative Medal for outstanding
contribution to Russian oncology and surgery and
international multidisciplinary scientific
cooperation
Carsten Linnemann won the NKI-award of 2014.
Awards - 49
50 - Awards
Oncology Graduate School Amsterdam OOA
faculty and staff
annex
1
Annex 1.
Faculty and staff of OOA
FACULTY
Prof. dr. N.K. Aaronson, Department of
Psychosocial Research and Epidemiology, NKI
(Theme 2). Health-related quality of life
assessment and behavioural interventions in
clinical oncology.
Prof. dr. R. Bernards, Department of Molecular
Carcinogenesis, NKI (Theme 1). Functional
genomics.
Prof. dr. A.J.M. Berns, Department of Molecular
Genetics, NKI (Theme 1). Mouse models of cancer.
Prof. Dr. R. Agami, Department of Biological Stress
Response, NKI (Theme 1). Using RNA-based
approaches to identify and characterize cancer
genes.
Prof. dr. J.H. Beijnen, Division of Pharmacology,
NKI (Theme 2). Clinical pharmacology of anticancer
drugs.
Prof. dr. J.T. Annema, Dept of Pulmonology, AMC
(Theme 2). Pulmonary Endoscopy.
Dr. J.A.M. Beliën, Dept of Pathology, Vumc
(Theme 1). ICT and data analysis.
Dr. J.A. Aten, Department of Cell Biology and
Histology, AMC (Theme 1). Interactions of DNA
double strand breaks and repair proteins in the
formation of chromosome translocations and cell
killing by ionizing radiation and other therapeutic
agents.
Dr. J. Berkhof, Dept of Epidemiology and
Biostatistics, VUmc (Theme 1). Comparison selfcollection of specimens for HPV testing with
physician-based HPV screening in a populationbased screening setting.
Prof. dr. A.J.M. Balm, Oral and Maxillofacial
Surgery, AMC (Theme 1). Head and neck oncology
and surgery.
Dr. R. Beijersbergen, Department of Molecular
Carcinogenesis, NKI (Theme 1). Unraveling
signalling networks in cancer.
Dr. A. Bel, Dept of Radiotheapy. AMC (Theme 1).
Image guided adaptive radiotherapy, radiation
treatment planning.
Dr. A. Bergman, Department of Molecular Genetics
NKI (Theme 1). Investigating the role of
microenvironment in prostate cancer development.
Prof. J.J.G.H.M. Bergman, Department of
Gastroenterology and Hepatology, AMC (Theme 1).
Endoscopic detection and treatment of early
neoplasia in the digestive tract.
Dr. V.W. Beusechem, Dept of Oncology, VUmc
(Theme 2). Resistance to therapy.
Dr. C.U. Blank, Department of Immunology, NKI
(Theme 1 and 2). Combating targeted therapy and
immunotherapy.
Dr. E. Bleiker, Department of Psychosocial
Research and Epidemiology, NKI (Theme 2).
Psychosocial issues in cancer genetics and
supportive care.
Prof. dr. E. Bloemena, Department of Pathology,
VUmc (Theme 1 and 2). Molecular profiling of head
& neck tumors.
Prof.dr. R. Boellaard, Dept of Radiology and
Nuclear Medicine, VUmc (Theme 2).
Pharmacokinetic modelling of PET tracers in
oncology.
Prof. dr. J.G. Borst, Department of Immunology,
NKI (Theme 1). Molecular mechanisms that govern
the T-cell response.
Faculty and staff – 53
Prof. dr. P. Borst, Department of Molecular
Oncology, NKI (Theme 1). Drug transporters.
Prof. dr. E. Boven, Department of Medical
Oncology, VUmc (Theme 2). Kinase inhibitors in
renal cancer.
Dr. B.J.M. Braakhuis, Dept of Otolaryngology-Head
& Neck Surgery, Vumc (Theme 1). Head and neck
squamous cell carcinoma.
Prof. dr. R.H. Brakenhoff, Department of
Otolaryngology-Head & Neck Surgery, VUmc
(Theme 1 and 2). Molecular mechanisms in
precursor lesions and early stages of head & neck
cancer for early detection.
Prof. dr. R. de Bree, Department of
Otolaryngology-Head & Neck Surgery, VUmc
(Theme 1 and 2). Molecular mechanisms in
precursor lesions and early stages of head & neck
cancer for early detection.
Dr. T. Brummelkamp, Department of
Biochemistry, NKI (Theme 1). Experimental
Biomedical Genetics.
Prof. dr. H. N. Caron, Paediatric Oncology, AMC
(Theme 1 and 2). Paediatric Oncology: new drug
development, clinical trials and late effects.
Dr. B. Carvalho, Dept of Pathology, VUmc (Theme
1 and 2). Development of an improved molecular
test for population-wide colorectal cancer
screening.
Prof. dr. J.A. Castelijns, Department of Radiology,
VUmc (Theme 2). Imaging in head and neck cancer.
Prof.dr. E.F.I. Comans, Dept of Radiology and
Nuclear Medicine, VUmc (Theme 2). Innovations in
local treatment and imaging of colorectal liver
metastases.
Dr. J. Crezee, Department of Radiation Oncology,
AMC (Theme 2). New hyperthermia techniques and
development and application of hyperthermia
treatment planning.
Prof. dr. E. Dekker, Department of
Gastroenterology and Hepatology, AMC (Theme 1).
Gastrointestinal oncology, special interest in
screening and diagnosis of colorectal cancer
Prof. dr. G.A.M.S. van Dongen, Department of
Otolaryngology-Head & Neck Surgery, VUmc
(Theme 1 and 2). Molecular imaging of cancer for
diagnosis in therapy selection with a focus on PET.
54 – Faculty and staff
Dr. J.C. Dorsman, Dept of Clinical Genetics, Vumc
(Thema 1). Distress and quality of life of patients
treated with autologous stem cell transplantation.
Dr. E.F. Eldering, Department of Experimental
Immunology, AMC (Theme 1). Apoptosis regulation
in immuno-hematology.
Dr. R.J.A. Fijneman, Dept of Pathology, VUmc
(Theme 2). Next Generation Sequencing: from
Prostate to Colorectal cancer.
Prof. dr. P. Fockens, Dept. Of Gastraenterology
and Hepatology, AMC (Theme 1). Advanced
diagnostic and therapeutic gastrointestinal
endoscopy, GI oncology and
neurogastroenterology.
Dr. N.A.P. Franken, Dept of Radiotherapy, AMC
(Theme 2). Radiobiology, DNA damage response,
hyperthermia, chromosome aberrations, normal
tissue damage.
Prof. dr. D.J. Gouma, Department of Surgery, AMC
(Theme 2). Development and optimalization of
treatment modalities for pancreatic cancer
patients.
Prof. dr. A.W. Griffioen, Department of Medical
Oncology, VUmc (Theme 2). Tumor angiogenesis
and drug therapy.
Dr. M. A. Grootenhuis, Department of Pediatrics,
AMC (Theme 2). Psychosocial consequences of
childhood cancer.
Prof.dr. T.D. de Gruijl, Dept of Medical Oncology,
VUmc (Theme 2). Prostate cancer –
immunotherapy.
Prof. dr. T.M. van Gulik, Department of
Experimental Surgery, AMC (Theme 2).
Experimental surgery on colon cancer liver
metastases.
Prof. dr. A. Hagenbeek, Department of
Hematology, AMC (Theme 1 and 2). Phase I, II and
III clinical trials in the non-Hodgkin lymphomas
(NHL) and suicide gene therapy.
Dr. J. Haanen, Department of Immunology and
Medical Oncology NKI (Theme 1 and 2).
Immunotherapy, immunomonitoring and production
facility.
Dr. S.M. van Ham, Department of Immunology,
AMC (Theme 1 and 2). Antigen presentation in
leukemias. 2. Dendritic cell immunotherapy in
cancer.
Dr. M. Hauptmann, Department of Psychosocial
Research and Epidemiology, NKI (Theme 1).
Biostatistics.
Prof. Dr. W. Van Harten, Department of
Psychosocial Research and Epidemiology, NKI
(Theme 2). Early stage technology assessment,
operations research and cancer rehabilitation.
Dr. U. van der Heide, Department of Radiation
Oncology, NKI (Theme 2). Quantitative imaging for
radiotherapy dose painting and follow-up.
Dr. D.A.M. Heideman, Dept of Pathology, Vumc
(Theme 1). Genomic profiling for risk assessment
of preneoplastic endobronchial lesions.
Dr. M. van der Heijden, Department of Molecular
Carcinogenesis, NKI (Theme 1 and 2).
Functional genomics of urothelial cancer.
Prof. dr. J.J. Heimans, Department of Neurology,
VUmc (Theme 1). miRNAs regulating angiogenesis
in gliomas.
Prof.dr. N.H. Hendrikse, Dept of Pharmacy, VUmc
(Theme 2). Image guided treatment optimalization
with cetuximab for patients with metastatic
colorectal cancer.
Prof. Dr. M. van Herk, Department of Radiation
Oncology, NKI (Theme 2). High precision
radiotherapy.
Dr. U. van der Heide, Department of Radiation
Oncology, NKI (Theme 2). Quantitative imaging for
radiotherapay dose painting and follow-up.
Dr. J. Hilkens. Department of Molecular Genetics,
NKI (Theme 1). Genes involved in breast cancer.
Prof. dr. O.S. Hoekstra, Department of Nuclear
Medicine, VUmc (Theme 2). Molecular imaging
using PET for therapy selection and response
monitoring.
Dr. T.J.M. Hulsebos, Department of
Neurogenetics, AMC (Theme 1). Molecular genetics
of nervous system tumors and osteosarcomas.
Dr. H. Jacobs, department of Biological Stress
Response, NKI )Theme 1. Programmed and nonprogrammed mutagenesis.
Dr. J. Jacobs, Department of Molecular Oncology,
NKI (Theme 1). Telomere damage.
Dr. K. Jalink, Department of Cell Biology, NKI
(Theme 1). Biophysics of cell Signaling.
Dr. C.R. Jimenez, Dept of Oncology, Vumc (Theme
2). Proteomics prostate, colorectal, lung and
breast cancer.
Prof.dr. D. de Jong, Dept of Pathology, VUmc
(Theme 1). Towards the implementation of
personalized treatment of diffuse large B-cell
lymphoma in the Netherlands; preparations for a
biomarker-based Bayesian trial.
Prof.Dr. J. Jonkers, Department of Molecular
Pathology, NKI (Theme 1). Mouse models of breast
cancer.
Prof. dr. A.P. Kater, Dept of Hematology, AMC
(Theme 1 and 2). development of circumvention of
and novel strategies for (development of)
chemorefractory CLL.
Prof. dr. G.J. Kaspers, Department of Paediatrics,
VUmc (Theme 2). Innovative therapies in childhood
myeloid leukemia.
Prof.dr. G. Kazemier, Dept of Surgery, Vumc
(Theme 2). Fighting pancreatic cancer: from
research to innovative treatment through
microRNA analysis.
Prof. dr. G.G. Kenter, Department of Obstetrics
and Gynaecology, AMC/VUmc/NKI (Theme 2).
Immunosurveillance and immunotherapy in HPV
related tumours and late complications after
treatment for carcinoma of the cervix.
Prof. dr. M.J. Kersten, Dept of Hematology, AMC
(Theme 1). Non-Hodgkinlymphoma (including
Waldenströmd disease) and multipel myeloma.
Dr. M. Klein, Dept of Medical Psychology, Vumc
(Theme 2). Improving quality of life in glioma
patients.
Prof. dr. Y. van Kooyk, Department of Molecular
Biology and Immunology, VUmc (Theme 1 and 2).
Glycosilation and tumor immunology.
Dr. M. Innocenti, Department of Molecular
Genetics, NKI (Theme 1). Cancer cell migration.
Faculty and staff – 55
Dr. L.C.M. Kremer, Dept of Pediatrics, AMC
(Theme 1). Evidence based medicine & Quality of
care long-term effects of childhood cancer.
Prof. dr. K.K. Krishnadath, Department of
Gastroenterology and Hepatology, AMC (Theme 1).
Understanding the inflammation-dysplasiacarcinoma sequence within the gastrointestinal
tract.
Dr. A.B.P. van Kuilenburg, Department of Clinical
Chemistry, AMC (Theme 1 and 2). Inborn errors of
purine and pyrimidine metabolism and paediatric
oncological diseases.
Prof.dr. C. van Kuijk, Dept of Radiology and
Nuclear Medicine, VUmc (Thema 2). Irreversible
electroporation: a novel image-guided tumor
ablation technique.
Prof. dr. H.W.M. van Laarhoven, Dept of Internal
Medicine. AMC (Theme 1). Translational research
in medical oncology.
Prof. dr. A.A. Lammertsma, Department of
Nuclear Medicine, VUmc (Theme 2).
Standardization and quantification of PET image
analysis.
Prof. dr. Ch.R. Leemans, Department of
Otolaryngology-Head & Neck Surgery, VUmc
(Theme 2). Molecular mechanisms in precursor
lesions and early stages of head & neck cancer for
early detection.
Prof. dr. A.G.J.M. van Leeuwen, LaserCenter,
AMC (Theme 2). Biomedical photonics for
functional and molecular imaging.
Prof. dr. F.E. van Leeuwen, Psychosocial
Research and Epidemiology, NKI (Theme 2). Cancer
Epidemiology.
therapeutic effect of donor lymphocyte infusions in
B cell malignancies.
Prof.dr. A.A. van de Loosdrecht, Dept of
Hematology, Vumc (Theme 2). Dendritic cells and
antigen sources in acute myeloid leukemia.
Prof. dr. R.M. Luiten, Department of
Dermatology, AMC (Theme 2). Immunology of
melanoma and autoimmune or inflammatory skin
diseases.
Dr. A.C.M. Martens, Dept of Hematology, Vumc
(Theme 2). Unraveling interactions in the
hematopoietic niche in multiple myeloma.
Prof. dr. R.A.A. Mathôt, Dept. of Pharmacy, AMC
(Theme 1). Population pharmacokineticpharmacodynamic research.
Prof. dr. J.P. Medema, Laboratory of
Experimental Oncology and Radiobiology, AMC
(Theme 1). Cell death induction and resistance in
tumor cells and cancer stem cells.
Prof. Dr. R.H. Medema, Department of Cell
Biology, NKI (Theme 1). Cell cycle checkpoints and
chromosome segregation.
Prof. dr. C.J.L.M. Meijer, Department of
Pathology, VUmc (Theme 1 and 2). HPV based early
detection of cervical cancer precursors.
Prof. dr. G.A. Meijer, Department of Pathology,
VUmc (Theme 1 and 2). Molecular classification for
early detection and personalized therapy in
gastrointestinal cancer.
Prof. dr. H. Meijers-Heijboer, Department of
Clinical Genetics, VUmc (Theme 1). Genetic cancer
predisposition with a focus on breast cancer.
Dr. F. van Leeuwen, Department of Gene
Regulation, NKI (Theme 1). Chromatin dynamics.
Dr. J.J. Molenaar, Department of Oncogenomics,
AMC (Theme 1). Targeted drug development in
neuroblastoma.
Prof. Dr. S. Linn, Department of Molecular
Pathology, NKI (Theme 2). Molecular dissection of
cancer by differential drug sensitivity.
Prof.dr. A.C. Moll, Dept of Opthalmonology, Vumc
(Theme 2). Early-detection of quality of life
problems in children with retinoblastoma.
Prof. dr. M. van Lohuizen, Department of
Molecular Genetics, NKI (Theme 1). Role of
polycomb-group genes in transcriptional
repression, stem cell fate and tumorgenesis.
Dr. C.F.M. Molthoff, Dept of Nuclear Medicine and
PET Research, Vumc (Theme 2). Multimodal
imaging of orthotopic tumors: validation study.
Prof.dr. H.M. Lokhorst, Dept of Hematology,
Vumc (Theme 2). Minor H antigen UTA2-1-loaded
DC dendritic cells as vaccines to improve the
56 – Faculty and staff
Prof. dr. W.H. Moolenaar, Department of Cell
Biology, NKI (Theme 1). Lipid growth factor
signalling.
Prof.dr. R.J.A. van Moorselaar, Dept of Urology,
Vumc (Theme 2). Prostate cancer.
gastrointestinal cancer, with focus on colorectal
cancer.
Prof. dr. C.J.J Mulder, Department of Gastroenterology and hepatology, institute (Theme 2).
Celiac disease associated lymphomagenesis.
Prof. dr. C.R.N. Rasch, Dept. Of Radiotherapy,
AMC (Theme 1). Radiotherapy
Dr. T. Mutis, Dept of Hematology, Vumc (Theme
2). Multimodal imaging of orthotopic tumors:
validation study.
Prof. dr. D.J. Richel, Department of Medical
Oncology, AMC (Theme 1 and 2). New
chemotherapeutic avenues for neoadjuvant and
adjuvant treatment of cancer patients.
Prof. dr. J.J.C. Neefjes, Department of Cell
Biology, NKI (Theme 1). Chemical cell biology of
immune responces, cancer and anticancer drugs.
Prof. dr. H.P.J. te Riele, Department of Biological
Stress Response, NKI (Theme 1).
Genomic instability and carcinogenesis.
Prof. dr. C.J.M. van Noesel, Department of
Pathology, AMC (Theme 1). B cell biology and the
pathogenesis of B-NHL / The serrated neoplasia
pathway to colorectal cancer.
Prof. dr. J.J.M.C.H. de la Rosette, Department of
Urology, AMC (Theme 2). Improving diagnosis and
treatment of urological cancers.
Prof. dr. C.J.F. van Noorden, Department of
Pathology, AMC (Theme 1). Proteases and protease
inhibitors in cancer.
Prof. dr. M.H.J. van Oers, Department of
Hematology, AMC (Theme 1 and 2). Pathogenesis
and immunotherapy of B cell malignancies.
Prof. dr. G.J. Ossenkoppele, Department of
Haematology, VUmc (Theme 1 and 2). Targeted
therapies in myeloid leukemia.
Prof. Dr. H. Ovaa, Department of Cell Biology, NKI
(Theme 1). Biological chemistry.
Prof. dr. S.T. Pals, Department of Pathology, AMC
(Theme 1 and 2). Molecular pathogenesis of B cell
malignancies and the role of heparan sulfates
proteoglycans in tumorigenesis.
Prof. dr. D. Peeper, Department of Molecular
Oncology. NKI (Theme 1). Dissecting cancer cell
signaling networks and identifying therapeutic
cancer targets.
Dr. A. Perrakis, Department of Biochemistry, NKI
(Theme 1). Structural biology.
Prof.dr. G.J. Peters, Department of Clinical
Oncology, VUmc (Theme 2). Pharmacokinetics and
response prediction in oncology.
Prof. dr. P. Postmus, Department of Pulmonology,
VUmc (Theme 2). Targeted drug therapy in lung
cancer.
Dr. S. Rottenberg, Department of Molecular
Oncology, NKI (Theme 1). Cancer therapy escape.
Prof.dr. T.Ruers, Department of Surgical
Oncology, NKI (Theme 2).
Dr. S. Schagen, Department of Psychosocial
Research and Epidemiology, NKI (Theme 2).
Cognitive function in cancer patients.
Prof. dr. J.H.M. Schellens, Department of
Molecular Pathology, NKI (Theme 2). Combined
targeted therapy for the treatment of patients
with BRAF mutant colorectal cancer.
Dr. A. Schinkel, Department of Molecular
Oncology, NKI (Theme 1). Genes and proteins
involved in anti cancer drug resistance and
pharmacokinetics.
Dr. M. Schmidt, Department of Molecular
Pathology, NKI (Theme 1). Molecular and genetic
breast cancer epidemiology.
Prof. dr. T. Schumacher, Department of
Immunology, NKI (Theme 1). Dissection and
manipulating antigen-specific T-cell immunity.
Dr. G.J. Schuurhuis, Department of Hematology,
VUmc (Theme 2). Disease profiling CML and AML.
Prof. dr. S. Senan, Department of Radiation
Oncology, VUmc (Theme 2). Technological
innovations in applied radiotherapy.
Prof. dr. T.K. Sixma, Department of Biochemistry,
NKI (Theme 1). Structural biology.
Prof. dr. C.J.A. Punt, Dept of Oncology, AMC
(Theme 1). Clinical and translational research in
Faculty and staff – 57
Prof. dr. B.J. Slotman, Department of Radiation
Oncology, VUmc (Theme 1 and 2). Technological
innovations in applied radiotherapy.
Prof. dr. I.M. Verdonck-de Leeuw, Department of
Otolaryngology/Head and Neck Surgery, VUmc
(Theme 2). Innovative care programs in oncology.
Prof. dr. E.F. Smit, Department of Pulmonology,
VUmc (Theme 2). Targeted drug therapy in lung
cancer.
Prof. Dr. M. Verheij, Department of Biological
Stress Response and Radiation Oncology, NKI
(Theme 2). Targeted radiosensitization.
Prof.dr. P.J.F. Snijders, Dept of Pathology, Vumc
(Theme 1). HPV induced tumors.
Prof.dr. H.W.M Verheul, Department of Medical
Oncology, VUmc (Theme 1 and 2). Angiogenesis
and phosphokinase as drug targets in
gastrointestinal and renal cancer.
Dr. J-J. Sonke, Department of Radiation Oncology,
NKI (Theme 2). Adaptive radiation therapy.
Prof. dr. A. Sonnenberg, Department of Cell
Biology, NKI (Theme 1). Receptors for matrix
adhesion.
Dr. M. Spaargaren, Department of Pathology, AMC
(Theme 1). Molecular pathogenesis and targeted
therapy of B cell malignancies.
Dr. C.A. Spek, Department of Experimental and
Molecular Medicine, AMC (Theme 1 and 2). Blood
coagulation in pathophysiology.
Dr. L.J.A. Stalpers, Dept of Radiotherapy, AMC
(Theme 1). Experimental radiotherapy: effects and
side-effects of irradiation.
Prof. dr. B. van Steensel, Department of Gene
Regulation, NKI (Theme1).
Chromation genomics
Prof. dr. J. Stoker, Dept of Radiotherapy, AMC
(Theme 1). Abdominal imaging.
Dr. M. Stokkel, Department of Diagnostic
Oncology, NKI (Theme 2). Nuclear medicine.
Dr. ir. G.J. Strijkers, Dept of Biomedical
Engineering and Physics, AMC (Theme 1).
Preclinical and translational MRI.
Prof. dr. M.J.B. Taphoorn, Department of
Neurology, VUmc (Theme 2). Quality of life in
neurooncology.
Dr. G.A.M. Tytgat, Dept of Pediatrics, AMC
(Theme 2). Neuroblastoma.
Dr. H. van Tinteren, Department of Biometrics,
NKI (Theme 2). Clinical Trials design and logistics.
Prof.dr. W.P. Vandertop, Dept of Neurosurgery,
Vumc (Theme 2). Meningioma.
58 – Faculty and staff
Dr. L. Vermeulen, Center of experimental
medicine. AMC (theme 2). Quantitative oncology
and stem cell dynamics
Prof. dr. R. Versteeg, Department of Human
Genetics, AMC (Theme 1 and 2). Regulatory
networks in cancer.
Prof. dr. M. van de Vijver, AMC (Theme 2).
Genetic alterations and gene expression profiles of
solid tumors.
Dr. K. de Visser, Department of Immunology, NKI
(Theme 1). Impact of the inflammatory tumor
microenvironment on metastatic breast cancer and
therapy.
Prof. dr. E. Voest, Department of Molecular
Oncology and Medical Oncology, NKI (Theme 1 and
2). Host responses to systemic anti-cancer
treatment and Personalized Medicine.
Prof. Dr. J. Wesseling, Department of Molecular
Pathology, NKI (Theme 1). Molecular pathology of
breast cancer.
Prof. Dr. L. Wessels, Department of Molecular
Carcinogenesis, NKI (Theme 1). Computational
cancer biology.
Prof.dr. A.D. Windhorst, Dept of Radiology and
Nuclear Medicine, VUmc (Theme 2). Carbon-11
labelled peptodes as PET tracers.
Dr. R. Wolthuis, Department of Cell Biology, NKI
(theme 1). Mechanisms of cell cycle control in
cancer.
Dr. H. Wijkstra, Department of Urology, AMC
(Theme 2). Minimal invasive technology in
diagnoses, therapy and follow-up of uro-oncology.
Dr. T. Wurdinger, Department of Neurosurgery
Institute (Theme 1). miRNAs regulating
angiogenesis in gliomas.
Dr. C. Zuur, Department of Cell Biology, NKI
(Theme 1 and 2). Altering treatment responses in
Head and Neck Cancer.
Dr. W. Zwart, Department of Molecular Pathology,
NKI (Theme 1). Translational endocrinology and
pathological genomics in breast, prostate and
endometrial cancer.
Prof.dr. S. Zweegman, Dept of Hematology, VUmc
(Theme 2). Multiple myeloom.
Faculty and staff – 59
STAFF
Netherlands Cancer Institute
Biochemistry
Dr. T. Brummelkamp
Dr. A. Perrakis
Prof. dr. T.K. Sixma
Biological Stress Response
Prof. dr. R. Agami
Dr. H. Jacobs
Prof. dr. H. te Riele
Prof. dr. M. Verheij
Cell Biology
Dr. C. Jalink
Prof. dr. R.H. Medema
Prof. dr. W.H. Moolenaar
Prof. dr. J.J. Neefjes
Prof. dr. H. Ovaa
Prof. dr. A. Sonnenberg
Dr. R. Wolthuis
Dr. C. Zuur
Gene Regulation
Dr. F. van Leeuwen
Prof. dr. B. van Steensel
Immunology
Dr. C.H. Blank
Prof. dr. J. Borst
Dr. J.B.A.G. Haanen
Prof. dr. T.N.M. Schumacher
Molecular Carcinogenesis
Prof. dr. R. Bernards
Dr. R. Beijersbergen
Dr. M. van der Heijden
Prof. dr. L. Wessels
Molecular Genetics
Dr. A. Bergman
Prof. dr. A.J.M. Berns
Dr. J. Hilkens
Dr. M.E. Innocenti
Prof. dr. M. van Lohuizen
Molecular Oncology
Prof. dr. P. Borst (honorary staff member)
Dr. J.J.L. Jacobs
Dr. H. van Luenen
Prof. dr. D.S. Peeper
Dr. S. Rottenberg
Dr. A. Schinkel
Molecular Pathology
Prof. dr. J. Jonkers
60 – Faculty and staff
Dr. S. Linn
Prof. dr. J. Schellens
Dr. M. Schmidt
Dr. J. Wesseling
Dr. W. Zwart
Biometrics Department
Dr. K. Sikorska
Dr. H. Van Tinteren
Dr. A. Vincent
E. van Werkhoven
Dr. V. van der Noort
Diagnostic Oncology
P. Baars
Dr. O. Balague Ponz
Dr. A. Bartels-Rutten
P. Besnard
Dr. M. Bol
Dr H. van Boven
Dr. D. van den Broek
Dr. A. Broeks
A. Bruining
M. Donswijk
E. Groen
S. Heijmink
B. van der Hiel
Dr. F. Hogervorst
Dr. J. De Jong
M. Jonker
P. de Koekoek-Doll
C. Lange
F. Lalezari
Dr E. Lips
C. Loo
M. Meijer
Dr. K. Monkhorst
Dr. S. Muller
Dr. P. Nederlof
K. van Os
P. Pevenage
W. Prevoo
Dr. H. van Rossum
Dr. E. Rosenberg
J. Sanders
I.van ’t Sant-Jansen
Dr. M. Sinaasappel
F. Sivro-Prndeij
Dr. L. Smit
P. Snaebjornsson
Dr. M. Stokkel
J. Teertstra
Dr. O. Van Tellingen
Dr. R. Valdes Olmes
Dr. E. Vegt
Dr. L. van Velthuysen
Dr. M. Versleijen
Dr. K. van de Vijver
L. de Wit-van der Veen
Dr. M. Vogel
Dr. W. Vogel
J. de Vries
Dr. J. Wesseling
Dr. I. Westerveld-de Zwart
B. van de Wiel
Dr. G. Winter-Warnars
Radiotherapy
Dr. B.M.P. Aleman
Dr. A. Al-Mamgani
Prof. dr. G.M.M. Bartelink
Dr. J.S.A. Belderbos
Dr. M. Bloemers
Dr. R.W. de Boer
Dr. G. Borst
Dr. E. Damen
Dr. L.G.H. Dewit
J. van Diessen
Dr. P. Elkhuizen
J. Felderhof
Dr. M. Frantzen-Steneker
Y. Van der Geld
Dr. R.L.M. Haas
O. Hamming-Vrieze
Dr. W. Heemsbergen
Dr. U. Van der Heide
Prof. dr. M. van Herk
Dr. E.P.M. Jansen
Dr. J. Van de Kamer
J. Knegjens
F. Koetsveld
Dr. J. Lebesque
Dr. A. Mans
Dr. B.J. Mijnheer
Dr. L.M.F. Moonen
Dr. A. van Mourik
A. Navran
H. Peulen
Dr. F. Pos
Dr. P. Remeijer
Dr. N.S. Russell
J.G. Salverda
Dr. M. Settler
Dr. C. Schneider
Dr. A. Scholten
Dr. J-J. Sonke
Dr. B. van Triest
Dr. C.X. Vens
Prof. dr. M. Verheij
Dr. C. van Vliet-Vroegindeweij
T. Witteveen
Dr. F.W. Wittkämper
Medical Oncology
Dr. J.W. Baars
Dr. P. Baas
Dr. A. Bergman
Prof. dr. J.H. Beijnen
Dr. C. Blank
Dr. J.P. de Boer
Dr. W. Boogerd
Dr. H. Boot
Dr. D. Brandsma
Dr. W. Buikhuizen
Dr. J.A.. Burgers
Dr. A. Cats
Dr. J. van Dieren
Dr. R. van Gijn
Dr. C. Grootscholten
Dr. J.B.A.G. Haanen
Dr. M. van der Heijden
Dr. M van den Heuvel
Dr. A. Huitema
Dr. W. de Kanter
Dr. J.M. Kerst
Dr. M. van Leerdam
Prof. dr. S.C. Linn
Dr. S. Marchetti
Dr. B. Nuijen
F. Opdam
Prof. dr. S. Rodenhuis
Prof. dr. J.H.M. Schellens
Dr. E. Smit
Dr. C. Smorenburg
Dr. G. Sonke
Dr. N. Steeghs
Dr. J. Stouthard
Dr. M Tesselaar
Dr. H. Van Thienen
Dr. W. Verbeek
Prof. Dr. E. Voest
Surgical Oncology
A. Aalbers
Dr. C. an As-Brooks
Dr. M-J. Baas-Vracken Peters
Dr. A. Balm
Dr. M.W.M. van den Brekel
Dr. F. van Coevorden
Dr. F. van Duijnhoven
Dr. J. van der Hage
Dr. K. Hartemink
Dr. F. Hilgers
Dr. B. Karakullukcu
Dr. H. Klomp
Dr. M. Klop
M. Krap
Dr. K. Kuhlmann
M. Lieshout
Dr. P. Lohuis
Dr. H.S.A. Oldenburg
M. Piek-Hartog
Dr. H.G. van de Poel
Faculty and staff – 61
Prof. dr. T. Ruers
Dr. E.J.Th. Rutgers
Dr. J. van Sandick
Dr. L. Smeele
Dr. B. Tan
Dr. B. Tijink
Dr. V.J. Verwaal
Dr. M. Wouters
Dr. C. Zuur
Psychosocial Research and
Epidemiology
Prof. dr. N.K. Aaronson
Dr. E. Bleiker
Prof. dr. W.J. van Harten
Dr. M.Hauptmann
Prof. dr. F.E. van Leeuwen
Dr. M.A. Rookus
Dr. S. Schagen
62 – Faculty and staff
VU University Medical Center
Dr. M.J.D.L. van der Vorst
Anesthesiology
Dr. R.S.G.M. Perez
Prof. dr. W.W.A. Zuurmond
Medical Psychology
Dr. M. Klein
Dr. M.H.M. van der Linden
Clinical Chemistry
Prof. dr. M.A. Blankenstein
Dr. C.B.M. Oudejans
Nefrology
Dr. K. Farhat
Dr. S.A. Nurmohamed
Clinical Genetics
Dr. J.C. Dorsman
Dr. J.J.P. Gille
Dr. L.P. van Hest
Prof. dr. H.E. Meijers-Heijboer
Prof. dr. H. te Riele
Dr. Q. Waisfisz
Neurology
Prof.dr. J.J. Heimans
Dr. T.J. Postma
Dr. J.C. Reijneveld
Prof.dr. M.J.B. Taphoorn
Gastroenterology
Dr. A.A. van Bodegraven
Dr. K.H.N. de Boer
Dr. R.J.F. Felt-Bersma
Prof. dr. C.J.J. Mulder
Dr. C.M.J. van Nieuwkerk
Hematology
Dr. M.E.D. Chamuleau
Dr. J. Cloos
Prof. dr. P.C. Huijgens
Dr. J.J.W.M. Janssen
Prof. dr. H.M. Lokhorst
Prof. dr. A.A. van de Loosdrecht
Dr. A.C.M. Martens
Dr. E. Meijer
Prof. dr. G.J. Ossenkoppele
Dr. G.J. Schuurhuis
Dr. L. Smit
Dr. T. Mutis
Dr. O. Visser
Dr. J.M. Zijlstra
Prof. dr. S. Zweegman
Medical Oncology
Dr. V.W. van Beusechem
Prof.dr. E. Boven
Dr. H.J. Broxterman
Dr. J. Buter
Dr. A.J.M. van den Eertwegh
Prof. dr. A.W. Griffioen
Dr. T.D. de Gruijl
Dr. C.W. van der Houven van Oordt
Dr. C.R. Jimenez
Dr. I.R.H.M. Konings
Dr. M.E. van Linde
Prof. dr. G.J. Peters
Prof. dr. H. Verheul
Dr. J.J. van der Vliet
Dr. J. Voortman
Neurosurgery
Dr. J.C. Baayen
Dr. S. Idema
Dr. D.P. Noske
Dr. S.M. Peerdeman
Prof. dr. W.P. Vandertop
Dr. P.C. de Will Hamer
Dr. T. Würdinger
Obstetrics and Gynaecology
Prof.dr. G. Kenter
Opthalmonology
Dr. A.C. Moll
Oral and Maxillofacial Surgery and Pathology
Prof. dr. E. Bloemena
Dr. E.A.J.M. Schulten
Dr. K.H. Karagozoglu
Prof.dr. E.A.J.M. Schulten
Prof. dr. I. van der Waal
Otolaryngology/Head and Neck Surgery
Dr. B.M. Braakhuis
Prof. dr. R.H. Brakenhoff
Prof. dr. R. de Bree
Dr. S.J. Eerenstein
Prof.d r. C.R. Leemans
Dr. R.N.P.M. Rinkel
Prof. dr. I.M. Verdonck-de Leeuw
Paediatrics
Dr. J. Cloos
Prof. dr. A.M. van Furth
Prof. dr. G.J.L. Kaspers
Dr. M.F. Mulder
Dr. N.A. Oeij
Dr. R.N. van der Plas
Prof. dr. A.J.P. Veerman
Pathology
Dr. J.A.M. Beliën
Faculty and staff – 63
Dr. M.C.G. Bleeker
Prof. dr. E. Bloemena
Dr. B. Carvalho
Dr. S.A.G.M. Cillessen
Prof. dr. W.M.R. van Criekinge
Prof. dr. P.J. van den Elsen
Dr. F.J.A. Fijneman
Dr. N.C. van Grieken
Dr. K. Grünberg
Dr. D.A.M. Heideman
Dr. E. Hooijberg
Prof. dr. D. de Jong
Prof. dr. C.J.L.M. Meijer
Prof. dr. G.A. Meijer
Prof. dr. W.J. Mooi
Dr. D.M. Pegtel
Prof. dr. P.J.F. Snijders
Dr. R.D.M. Steenbergen
Dr. F.B.J.M. Thunnissen
Dr. A.M. Uyterlinde
Prof. dr. P. Wesseling
Prof. dr. C.L. Verweij
Dr. B. Ylstra
Pulmonology
Dr. A. Becker
Dr. J.M.A. Daniels
Dr. S.M.S. Hashemi
Prof. dr. E.F. Smit
Radiation Oncology
Dr. M.R. Dahele
Dr. C.J. Haasbeek
Dr. F.J. Lagerwaard
Prof.dr. S. Senan
Prof.dr. B.J. Slotman
Dr. P. Sminia
Radiology & Nuclear Medicine
Prof.dr. J.A. Castelijns
Dr. R. Boellaard
Prof.dr. E.F.I. Comans
Prof.dr. G.A.M.S. van Dongen
Dr. P. de Graaf
Prof.dr. O.S. Hoekstra
Prof.dr. C. Van Kuijk
Prof.dr. A.A. Lammertsma
Dr. C.F.M. Molthoff
Dr. P.G. Raijmakers
Dr. G.W.M. Visser
Dr. D. Vugts
Dr. J.H.T.M. Waesberghe
Dr. A.D. Windhorst
Surgery
Prof.dr. J.J. Bonjer
Prof.dr. G. Kazemier
Prof.dr. P.A.M. van Leeuwen
64 – Faculty and staff
Dr. W.J. Meijerink
Prof.dr. E.J.H. Meuleman
Dr. M.A. Paul
Dr. D.L. van der Peet
Dr. M.P. van den Tol
Dr. J.B. Tuynman
Dr. L. te Velde
Urology
Dr. A.A. Geldof
Prof.dr. E.J.H. Meuleman
Prof.dr. R.J.A. van Moorselaar
Dr. A. Vis
University of Amsterdam
Biomedical Engineering and Physics
Prof.dr. A.G.J.M. van Leeuwen
Dr.ir. G.J. Streekstra
Dr. ir. G.J. Strijkers
Cell Biology & Histology
Prof.dr. C.J.F. van Noorden
Clinical genetics
Prof. Dr. E.J. Meijers-Heijboer
Dermatology
Prof. Dr. R.M. Luiten
Oral and Maxillofacial Surgery
Prof. dr. A.J.M. Balm
Paediatric Oncology
Prof.dr. H.N. Caron
Prof. Dr. Dr. M.A. Grootenhuis
Dr. L.C.M. Kremer
Dr. A.B.P. van Kuilenburg
Dr. G.A.M. Tytgat
Pathology
Prof. dr. C.J.M. van Noesel
Prof.dr. S.T. Pals
Dr. M. Spaargaren
Prof. dr. M.J. van de Vijver
Experimental and molecular medicine
Prof.dr. J.P. Medema
Dr. N.A.P. Franken
Dr. C.A. Spek
Dr. L. Vermeulen
Pharmacy
Prof. Dr. R.A.A. Mathot
Gastroenterology & Hepatology
Prof. Dr. J.J.G.H.M. Bergman
Prof. Dr. G.R. van den Brink
Dr. E. Dekker
Prof. dr. P. Fockens
Prof. Dr. K.K. Krishnadath
Radiotherapy
Dr. A. Bel
Dr. J. Crezee
Dr. L.J.A. Stalpers
Prof. dr. J. Stoker
Prof. dr. C.R.N. Rasch
General Practice
Prof. Dr. H.C.P.M. van Weert
Surgery
Dr. M. Heger
Hematology
Dr. B.J. Biemond
Prof. dr. A. Hagenbeek
Prof. Dr. A.P. Kater
Prof. dr. M.H.J. van Oers
Urology
Prof.dr. J.J.M.C.H. de la Rosette
Prof.dr.ir. H. Wijkstra
Pulmonolog
Prof. dr. J.T. Annema
Immunology
Prof. Dr. E.F. Eldering
Medical Bioinformatics
Prof. dr. A.H.C. van Kampen
Oncology
Prof. Dr. H.W.M. van Laarhoven
Prof. Dr. C.J.A. Punt
Prof.dr. D.J. Richel
Genome Analysis
Dr. T.J.M. Hulsebos
Obstetrics and Gynaecology
Prof. dr. G.G. Kenter
Oncogenomics
Dr. J.J. Molenaar
Prof.dr. R. Versteeg
Faculty and staff – 65
66 – Faculty and staff
Oncology Graduate School Amsterdam OOA
international visitors
annex
2
Annex 2.
International visitors
Anastasiou D. UK
Anderson D. USA
Murre C. USA
Muschel R.J. UK
Bair K. USA
Baker S. USA
Bird A. UK
Blackwood B. USA
Blauwhoff-Buskermolen S. the Netherlands
Boeke J. USA
Boulton S. UK
Brenton J. UK
Broek van den M. Swiss
Bühler M. Swiss
Budanov A. USA
Nakanishi M. Japan
Naldini L. Italy
Nasmyth, K. UK
Nussenzweig A. USA
Pasman R. the Netherlands
Pastan I. USA
Perry A. USA
Petermann E. UK
Caldas C. UK
Clevers H. the Netherlands
Clijsters L. the Netherlands
Coffer P. the Netherlands
Coombes C. UK
Coussens L. USA
Deasy J. USA
Fernández-Capetillo O. Spain
Frenette P.S. USA
Halazonetis T. China
Harris A.L. UK
Rada-Iglesias A. Germany
Ramsey S. USA
Robers M. USA
Rooij van E. the Netherlands
Rothstein R. USA
Sahai E. UK
Schibler U. UK
Schuurhuizen C. the Netherlands
Shiloh Y. Israel
Shupliakov O. Sweden
Sobeck A. USA
Stocker B.L. New Zealand
Sparreboom A. USA
Spriel van A. the Netherlands
Swerdlow A. UK
Kleijn G. the Netherlands
Koning R. the Netherlands
Kuiper J. the Netherlands
Tanenbaum M. USA
Thomas R. Germany
Tijsterman M. the Netherlands
Timmer M.S.M. New Zealand
Toczyski D. USA
Turner M. UK
Lopes M. Swiss
Lo D. Hong Kong
Louis D.N. USA
Verheijden G. the Netherlands
Verkade P. UK
Vermeulen W. the Netherlands
Marine J.C. Belgium
Marteijn J. the Netherlands
Mazzone M. Belgium
McArthur G. Australia
McClelland S. UK
Meyer S. UK
Minutolo F. Italy
Walter J. USA
Werb Z. USA
West E. UK
Jain R. USA
International visitors - 69
70 – International visitors
Oncology Graduate School Amsterdam OOA
PhD theses completed
annex
3
Annex 3.
PhD theses completed
In 2014, 49 graduate students completed their graduate training and obtained a PhD degree. Their names,
thesis titles, supervisors and institutes are listed below. The institute at which the research described in the
theses was carried out is mentioned between brackets and may differ from the university where the PhD
graduation took place.
Name:
Title:
University:
(co)Promotors:
Date:
Alvarez Herrero L. (AMC)
Advances in imaging and endoscopic therapy in Barrett's esophagus
University of Amsterdam
Bergman J.J.G.H.M., Weusten B.L.A.M.
16-04-2014
Name:
Title:
University:
(co)Promotors:
Date:
Avan A.A. (VUmc)
Genetic analyses and new models to improve therapeutic strategies in pancreatic
cancer
Free University Amsterdam
Peters G.J., Giovannetti E., Würdinger T., Schuurhuis G.J.
13-01-2014
Name :
Title :
University :
(co)Promotors :
Date:
Ariotti S. (NKI)
Function and behavior of CD8+ T cells in the skin.
University of Leiden
Schumacher T.
2-10-2014
Name:
Title:
University:
(co)Promotors:
Date:
Bachas C. (VUmc)
Characterization of relapsed Acute Myeloid Leukemia
Free University Amsterdam
Kaspers G.J.L., Cloos J., Schuurhuis G.J.,
11-11-2014
Name :
Title :
University :
(co)Promotors :
Date :
Beelen K. (NKI)
Clinical and molecular evaluation of anti-estrogen therapy resistance in breast
cancer
University of Utrecht
Linn S.
17-6-2014
Name:
Title:
University:
(co)Promotors:
Date:
Boerwinkel D. (AMC)
Advanced endoscopic imaging of esophageal neoplasia; old looks and new vision
University of Amsterdam
Bergman J.J.G.H.M., Aalders M.C.G., Curvers W.L.
12-03-2014
Name :
Title :
University :
(co)Promotors :
Date:
de Bruin M. (AMC):
Clinical applications of functional optical coherence tomography
University of Amsterdam
van Leeuwen A.G.J.M., Mourits M.P., Faber D.J., Verbraak F.D.
13-03-2014
PhD theses completed –73
Name :
Title :
University :
(co)Promotors :
Date :
Clijsters L. (NKI)
Coupling mitosis to S-phase
University of Utrecht
Bernards R.
16-1-2015
Name :
Title :
University:
(co)Promotors :
Date:
Leeuw D.C. de (VUmc)
MicroRNAs in acute leukemia and leukemic stem cells
Free University Amsterdam
Ossenkoppele G.J., Smit L.
01-2014
Name :
Title :
University :
(co)Promotors :
Date:
Cuperus R. (AMC)
Modulation of fenretinide induced cell death in neuroblastoma
University of Amsterdam
Caron H.N., van Kuilenburg A.B.P., Tytgat G.A.M.
07-10-2014
Name :
Title :
University :
(co)Promotors :
Date:
Davelaar L. (AMC)
A search for molecular biomarkers in gastro intestinal cancer
University of Amsterdam
Krishnadath K.K., Fockens P., Parikh K.B., Calpe S.
05-10-2014
Name :
Title :
Drukker . (NKI)
Gene signature for risk stratification and treatment of breast cancer: incorporating
tumor biology in clinical decision making
University of Amsterdam
Rutgers E.
28-3-2014
University :
(co)Promotors :
Date :
Name :
Title :
University :
(co)Promotors :
Date:
Name :
Title :
Durmus S. (NKI)
Anti-cancer drug disposition: in vitro and in vivo functions of ABC efflux and OATP
uptake transporters
University Utrecht
Schinkel A., Beijnen J.
5-9-2014
University :
(co)Promotors :
Date:
Eijzenga W. (NKI)
Psychosocial problems in cancer genetic counseling: Detecting and facilitating
communication
University of Amsterdam
Aaronson N.
5-9-2014
Name:
Title:
University:
(co)Promotors:
Date:
Frings V. (VUmc)
In vivo quantification of proliferation and glucose metabolism in lung cancer patients
Free University Amsterdam
Boellaard R., Smit E.F.
18-09-2014
Name :
Title :
University :
(co)Promotors :
Date :
van Hasselt C. (NKI)
Integrated quantitative pharmacology for treatment optimization in oncology
University of Utrecht
Schellens J.
29-1-2014
74 - PhD theses completed
Name :
Title :
University :
(co)Promotors :
Date :
van Galen P. (NKI)
Molecular Regulation of Human Hematopoietic Stem Cells
University of Amsterdam
van Lohuizen M.
20-3-2014
Name:
Title:
University:
(co)Promotors:
Date:
Graveland A.P. (VUmc)
Molecular diagnosis of minimal residual head and neck cancer and field cancerization
Free University Amsterdam
Brakenhoff R.H., Leemans C.R., Braakhuis B.J.M., Bloemena E.
21-05-2014
Name:
Title:
University:
(co)Promotors:
Date:
Haan J.C. (VUmc)
Analysis of chromosomal copy number aberrations in gastrointestinal cancer
Free University Amsterdam
Meijer G.A., Punt C.J.A., Ylstra B., Nagtegaal I.D.
17-03-2014
Name:
Title:
University:
(co)Promotors:
Date:
Heuveling D.A. (VUmc)
Novel molecular imaging approaches in the management of head and neck cancer
Free University Amsterdam
de Bree R., van Dongen G.A.M.S.,
05-03-2014
Name :
Title :
University :
(co)Promotors :
Date:
Haan Y. (AMC):
Serrated polyps of the colon and rectum
University of Amsterdam
Fockens P., Dekker E.
07-11-2014
Name:
Title:
University:
(co)Promotors:
Date:
Hoebe E.K. (VUmc)
Epstein-Barr virus encoded BARF1 protein: immunopathogenic role, transcriptional
regulation and diagnostic use in nasopharyngeal carcinoma
Free University Amsterdam
Middeldorp J.M., Greijer A.E.
08-05-2014
Name:
Title:
University:
(co)Promotors:
Date:
Hubers A.J. (VUmc)
Molecular Analysis of Sputum for Lung Cancer Diagnosis
Free University Amsterdam
Meijer G.A., Smit .E.F, Thunnissen F.B.J.M., Heideman D.A.M.
13-11-2014
Name :
Title :
University :
(co)Promotors :
Date :
van der Kooij B. (NKI)
Ubiquitin in apotosis signaling
University of Amsterdam
Borst J.
22-4-2014
Name :
Title :
University :
(co)Promotors :
Date:
Kruis M. (NKI)
Motion Compensation for 4D PET/CT
University of Amsterdam
van Herk M.
18-12-2014
PhD theses completed –75
Name :
Title :
University :
(co)Promotors :
Date:
Lascano V. (AMC)
The role of APRIL (TNFSF13) in carcinogenesis
University of Amsterdam
Medema J.P.
26-11-2014
Name:
Title:
University:
(co)Promotors:
Date:
Lo Galbo A.M. (VUmc)
Hypothyroidism after treatment of laryngeal or hypopharyngeal carcinoma
Free University Amsterdam
de Bree R., Leemans C.R.
22-10-2014
Name:
Title:
University:
(co)Promotors:
Date:
Maas K.W. (VUmc)
Minimally invasive esophagectomy for cancer; beyond techniques
Free University Amsterdam
Cuesta MA, van der Peet DL, Biere SSAY,
12-02-2014
Name:
Title:
University:
(co)Promotors:
Date:
Mina Maftouh M. (VUmc)
New avenues in pancreatic cancer: Targeting epigenetics and metabolism
Free University Amsterdam
Peters G.J., Giovannetti E.
11-06-2014
Name:
Title:
University:
(co)Promotors:
Date:
Martens-de Kemp S.R. (VUmc)
Towards personalized and targeted treatment of head and neck cancer
Free University Amsterdam
Brakenhoff R.H., Leemans C.R., Braakhuis B.J.M., van Beusechem V.W.
19-03-2014
Name:
Title:
University:
(co)Promotors:
Date:
Mertens L.S. (VUmc)
Muscle-invasive bladder cancer: staging and treatment
Free University Amsterdam
Horenblas S., Rhijn B.W.G.
02-05-2014
Name:
Title:
University:
(co)Promotors:
Date:
Mollers M. (VUmc)
Monitoring the impact of HPV vaccination: pre- and early post-vaccination data
Free University Amsterdam
Meijer C.J.L.M., de Melker H.E.
22-04-2014
Name:
Title:
University:
(co)Promotors:
Date:
Niewerth D. (VUmc)
Proteasome Inhibitors in Acute Leukemia
Free University Amsterdam
Kaspers G.J.L., Zweegman S., Cloos J., Jansen G.
14-11-2014
Name:
Title:
University:
(co)Promotors:
Date:
Posthuma de Boer J. (VUmc)
Towards targeted treatment for osteosarcoma
Free University Amsterdam
van Royen B.J., Kaspers G.J.L., Helder M.N., van Beusechem V.W.
03-07-2014
76 - PhD theses completed
Name :
Title :
University :
(co)Promotors :
Date:
van der Noll R. (NKI)
Safety, pharmacokinetics and preliminary anti-tumor activity of novel (combinations
of) targeted anti-cancer drugs.
University of Utrecht
Schellens J.
15-9-2014
Name :
Title :
University :
(co)Promotors :
Date:
Phoa Kai Yi N. (AMC)
Endoscopic management of Barrett's esophagus with dysplasia
University of Amsterdam
Bergman J.J.G.H.M., Tijssen J.G.P., Pouw R.E., Mallant Hent R.C.
30-10-2014
Name :
Title :
University :
(co)Promotors :
Date:
Pramana J. (NKI)
Expression profiling in head and neck cancer: predicting response to chemoradiation
University of Amsterdam
van den Brekel M.
17-10-2014
Name:
Title:
University:
(co)Promotors:
Date:
Rietbergen M.M. (VUmc)
The Role of Human Papillomavirus in Head and Neck Cancer
Free University Amsterdam
Brakenhoff R.H., Leemans C.R., Snijders P.J.F., Bloemena E.
07-05-2014
Name:
Title:
University:
(co)Promotors:
Date:
Rodjan F. (VUmc)
Imaging of retinoblastoma patients: advanced MRI techniques and associated
morbidity
Free University Amsterdam
Castelijns J.A., Moll A.C., de Graaf P.
01-12-2014
Name :
Title :
University :
(co)Promotors :
Date:
Schaake E. (NKI)
Multimodality approach towards individualized non-small cell lung cancer treatment
University of Amsterdam
Baas P., Verheij M.
30-6-2014
Name:
Title:
University:
(co)Promotors:
Date:
Senthi S. (VUmc)
Treatment of early-stage lung cancer: Cure and survivorship
Free University Amsterdam
Senan S., Slotman B.J.
Name:
Title:
Snellenberg S. (VUmc)
Uncovering epigenetic alterations of tumour suppressor and viral genes during HPVinduced cervical carcinogenesis
Free University Amsterdam
Snijders P.J.F., Meijer C.J.L.M., Steenbergen R.D.M., van Criekinge W.
01-07-2014
University:
(co)Promotors:
Date:
Name:
Title:
University:
(co)Promotors:
Date:
van Turenhout S.T. (VUmc)
Exploring Faecal Immunochemical Test Performance for Colorectal Cancer Screening:
FIT is at its limit, take it to the next level
Free University Amsterdam
Mulder C.J.J., Meijer G.A., van Rossum L.G.M., Coupé V.M.H.
26-11-2014
PhD theses completed –77
Name:
Title:
University:
(co)Promotors:
Date:
Verbrugge C.S.E. (VUmc)
Therapeutic targeting of protein degradation in autoimmunity and cancer
Free University Amsterdam
Lems W.F., Scheper R.J., Jansen G., de Gruijl T.D.
18-09-2014
Name:
Title:
University:
(co)Promotors:
Date:
Verhoef V.M.J. (VUmc)
Improving cervical cancer screening by HPV self-sampling
Free University Amsterdam
Meijer C.J.L.M., Snijders P.J.F., van Kemenade F.J., Rozendaal L.
10-12-2014
Name :
Title :
University :
(co)Promotors :
Date :
Visser D. (NKI)
TRPM7: CA2+ signaling, actomyosin remodeling and metastasis
University of Amsterdam
Gadella T., Jalink K.
9-1-2-2014
Name:
Title:
University:
(co)Promotors:
Date:
van Vuurden D.G. (VUmc)
Innovative treatment targets in pediatric high-grade brain tumors
Free University Amsterdam
Kaspers G.J.L., Vandertop W.P., Cloos J., Hulleman E.
17-03-2015
Name:
Title:
University:
(co)Promotors:
Date:
Warmoes M.O. (VUmc)
Proteomics of experimental breast cancer: Towards application of novel protein
biomarkers in the clinic
Free University Amsterdam
Boven E., Jimenez C.R., Jonkers J.
13-01-2014
Name :
Title :
University :
(co)Promotors :
Date:
Uyterlinde W. (NKI)
Toxicity in concurrent chemoradiation for locally advanced non small cell lung cancer
University of Amsterdam
Baas P.
31-10-2014
78 - PhD theses completed
Oncology Graduate School Amsterdam OOA
scientific publications
annex
4
Annex 4. Scientific publications
1.
Aaronson NK, Mattioli V, Minton O, Weis J, Johansen C, Dalton SO, de Leeuw IM, Stein KD, Alfano CM,
Mehnert A, de Boer A, van de Poll-Franse L. Beyond treatment - Psychosocial and behavioural issues in
cancer survivorship research and practice. EJC Suppl 2014; 12: 54-64. (VUmc/NKI/AMC)
2.
Abis GSA, Oosterling SJ, Stockmann HBAC, van der Bij GJ, van Egmond M, Vandenbroucke-Grauls CMJE,
Bonjer HJ. Perioperative selective decontamination of the digestive tract and standard antibiotic
prophylaxis versus standard antibiotic prophylaxis alone in elective colorectal cancer patients. Danish
medical journal 2014; 61: A4695. (VUmc)
3.
Acar C, Schoffelmeer C, Tillier C, De Blok W, Van Muilekom E, van der Poel H. Quality of Life in Patients
with Low-Risk Prostate Cancer. A Comparative Retrospective Study: Brachytherapy Versus RobotAssisted Laparoscopic Prostatectomy Versus Active Surveillance. J Endourol 2014; 28:117-24 (NKI)
4.
Adams HJA, Kwee TC, Lokhorst HM, Westerweel PE, Fijnheer R, Kersten MJ, Verkooijen HM, Stoker J,
Nievelstein RAJ. Potential prognostic implications of whole-body bone marrow MRI in diffuse large B-cell
lymphoma patients with a negative blind bone marrow biopsy. Journal of Magnetic Resonance Imaging
39(6), 2014, p.1394-1400. (AMC)
5.
Adema AD, Floor K, Smid K, Honeywell RJ, Scheffer GL, Jansen G, Peters GJ. Overexpression of MRP4
(ABCC4) and MRP5 (ABCC5) confer resistance to the nucleoside analogs cytarabine and troxacitabine,
but not gemcitabine. SpringerPlus 2014; 3: 732. (VUmc)
6.
Adham M, Stoker SD, Wildeman MA, Rachmadi L, Gondhowiardjo S, Atmakusumah D, Gatot D, Fles R,
Greijer AE, Hermani B, Middeldorp JM, Tan IB. Current status of cancer care for young patients with
nasopharyngeal carcinoma in jakarta, indonesia. PLoS One 2014; 9: e102353. (VUmc/NKI)
7. Aerts HJWL, Velazquez ER, Leijenaar RTH, Parmar C, Grossmann P, Carvalho S, Bussink J, Monshouwer R,
Haibe-Kains B, Rietveld D, Hoebers F, Rietbergen MM, Leemans CR, Dekker A, Quackenbush J, Gillies RJ,
Lambin P. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.
Nature Communications 2014; 5: 4006. (VUmc)
8.
Agarwal D, Pineda S, Michailidou K, Herranz J, Pita G, Moreno LT, Alonso MR, Dennis J, Wang Q, Bolla
MK, Meyer KB, Men+¬ndez-Rodr+¡guez P, Hardisson D, Mendiola M, Gonzalez-Neira A, Lindblom A,
Margolin S, Swerdlow A, Ashworth A, Orr N, Jones M, Matsuo K, Ito H, Iwata H, Kondo N, Hartman M, Hui
M, Lim WY, Iau PTC, Sawyer E, Tomlinson I, Kerin M, Miller N, Kang D, Choi JY, Park S, Noh DY, Hopper
JL, Schmidt DF, Makalic E, Southey MC, Teo SH, Yip CH, Sivanandan K, Tay WT, Brauch H, Br++ning T,
Hamann U, Dunning AM, Shah M, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Schmidt MK, Broeks A,
Rosenberg EH, van't Veer LJ, Fasching PA, Renner SP, Ekici AB, Beckmann MW, Shen CY, Hsiung CN, Yu
JC, Hou MF, Blot W, Cai Q, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Cox A, Brock IW, Reed MWR,
Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Zheng W, Deming-Halverson S, Shrubsole
MJ, Long J, Shu XO, Lu W, Gao YT, Zhang B, Radice P, Peterlongo P, Manoukian S, Mariette F,
Sangrajrang S, McKay J, Couch FJ, Toland AE, Yannoukakos D, Fletcher O, Johnson N, Dos Santos Silva I,
Peto J, Marme F, Burwinkel B, Gu+¬nel P, Truong T, Sanchez M, Mulot C, Bojesen SE, Nordestgaard BG,
Flyer H, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Mannermaa A, Kataja V, Kosma VM,
Hartikainen JM, Lambrechts D, Yesilyurt BT, Floris G, Leunen K, Chang-Claude J, Rudolph A, Seibold P,
Flesch-Janys D, Wang X, Olson JE, Vachon C, Purrington K, Giles GG, Severi G, Baglietto L, Haiman CA,
Henderson BE, Schumacher F, Le Marchand L, Simard J, Dumont M, Goldberg MS, Labr+¿che F, Winqvist
R, Pylk+ñs K, Jukkola-Vuorinen A, Grip M, Devilee P, Tollenaar EM, Seynaeve C, Garc+¡a-Closas M,
Chanock SJ, Lissowska J, Figueroa JD, Czene K, Eriksson M, Humphreys K, Darabi H, Hooning MJ, Kriege
M, Coll+¬e JM, Tilanus-Linthorst M, Li J, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K,
Nevanlinna H, Muranen TA, Aittom+ñki K, Blomqvist C, Bogdanova N, D+¦rk T, Hall P, Chenevix-Trench
G, Easton DF, Pharoah P, Arias-Perez JI, Zamora P, Ben+¡tez J, Milne RL. FGF receptor genes and breast
cancer susceptibility: Results from the Breast Cancer Association Consortium. Br J Cancer 2014;
110:1088-100 (NKI)
9.
Aguila JC, Blak A, van Arensbergen J, Sousa A, Vazquez N, Aduriz A, Gayosso M, Lopez Mato MP, Lopez
de Maturana R, Hedlund E, Sonntag KC, Sanchez-Pernaute R. Selection Based on FOXA2 Expression Is Not
Sufficient to Enrich for Dopamine Neurons From Human Pluripotent Stem Cells. Stem Cells Transl Med
2014; 3:1032-42 (NKI)
10.
Aguilar H, Urruticoechea A, Halonen P, Kiyotani K, Mushiroda T, Barril X, Serra-Musach J, Islam A, Caizzi
L, Di Croce L, Nevedomskaya E, Zwart W, Bostner J, Karlsson E, P+¬rez Tenorio G, Fornander T, Sgroi
DC, Garcia-Mata R, Jansen MPHM, Garc+¡a N, Bonifaci N, Climent F, Soler MT, Rodriguez-Vida A, Gil M,
Brunet J, Martrat G, Gomez-Baldo L, Extremera AI, Figueras A, Balart J, Clarke R, Burnstein KL, Carlson
KE, Katzenellenbogen JA, Vizoso M, Esteller M, Villanueva A, Rodr¡guez-Pena AB, Bustelo XR, Nakamura
Y, Zembutsu H, Stal O, Beijersbergen RL, Pujana MA. VAV3 mediates resistance to breast cancer
endocrine therapy. Breast Cancer Res 2014; 16:R53 (NKI)
11.
Ahsan H, Halpern J, Kibriya MG, Pierce BL, Tong L, Gamazon E, McGuire V, Felberg A, Shi JX, Jasmine F,
Roy S, Brutus R, Argos M, Melkonian S, Chang-Claude J, Andrulis I, Hopper JL, John EM, Malone K, Ursin
G, Gammon MD, Thomas DC, Seminara D, Casey G, Kni. A Genome-wide Association Study of Early-Onset
Breast Cancer Identifies PFKM as a Novel Breast Cancer Gene and Supports a Common Genetic Spectrum
for Breast Cancer at Any Age. Cancer Epidem Biomar 2014; 23: 658-669. (VUmc)
Scientific publications - 81
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
Akbani R, Ng PK, Werner HM, Shahmoradgoli M, Zhang F, Ju Z, Liu W, Yang JY, Yoshihara K, Li J, Ling S,
Seviour EG, Ram PT, Minna JD, Diao L, Tong P, Heymach JV, Hill SM, Dondelinger F, Stadler N, Byers LA,
Meric-Bernstam F, Weinstein JN, Broom BM, Verhaak RG, Liang H, Mukherjee S, Lu Y, Mills GB . A pancancer proteomic perspective on The Cancer Genome Atlas. Nat Commun 2014; 5:3887 (NKI)
Akhtar W, Pindyurin AV, de Jong J, Pagie L, ten Hoeve J, Berns A, Wessels LFA, van Steensel B, van
Lohuizen M. Using TRIP for genome-wide position effect analysis in cultured cells. Nat Protoc 2014;
9:1255-81 (NKI)
Akiyama J, Alexandre L, Baruah A, Buttar N, Chandra R, Clark AB, Hart AR., Hawk E, Kandioler D, Kappel
S, Krishnadath SK, Sharma A, Singh I, Straub D, Triadafilopoulos G, Umar A, Wolf B. Strategy for
prevention of cancers of the esophagus. Annals of the New York Academy of Sciences 1325, 2014,
p.108-126. (AMC)
Akopyan K, Silva Cascales H, Hukasova E, Saurin AT, Mullers E, Jaiswal H, Hollman DA, Kops GJ, Medema
RH, Lindqvist A. Assessing kinetics from fixed cells reveals activation of the mitotic entry network at the
S/G2 transition. Mol Cell 2014; 53:843-53 (NKI)
Albada A, Vernooij M, van Osch L, Pijpe A, van Dulmen S, Ausems MGEM. Does and should breast cancer
genetic counselling include lifestyle advice? Fam Cancer 2014; 13:35-44 (NKI)
Albers G, Francke AL, de Veer AJE, Bilsen J, Onwuteaka-Philipsen BD. Attitudes of nursing staff towards
involvement in medical end-of-life decisions: A national survey study. Patient Educ Couns 2014; 94: 4-9.
(VUmc)
Albers HM, Kuijl C, Bakker J, Hendrickx L, Wekker S, Farhou N, Liu N, Blasco-Moreno B, Scanu T, den
Hertog J, Celie P, Ovaa H, Neefjes J . Integrating chemical and genetic silencing strategies to identify
host kinase-phosphatase inhibitor networks that control bacterial infection. ACS Chem Biol 2014; 9:41422 (NKI)
Alberti P, Rossi E, Cornblath DR, Merkies ISJ, Postma TJ, Frigeni B, Bruna J, Velasco R, Argyriou AA,
Kalofonos HP, Psimaras D, Ricard D, Pace A, Galie E, Briani C, la Torre C, Faber CG, Lalisang RI, Boogerd
W, Brandsma D, Koeppen S, Hense J, Storey D, Ke. Physician-assessed and patient-reported outcome
measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin. Ann
Oncol 2014; 25: 257-264. (VUmc/NKI)
Alders M, Maas SM, Kadouch DJM, van der Lip K, Bliek J, van der Horst CMAM, Mannens MMAM.
Methylation analysis in tongue tissue of BWS patients identifies the (EPI)genetic cause in 3 patients with
normal methylation levels in blood. European Journal of Medical Genetics 57(6), 2014, p.293-297. (AMC)
Aleman BMP, Moser EC, Nuver J, Suter TM, Maraldo MV, Specht L, Vrieling C, Darby SC. Cardiovascular
disease after cancer therapy. Eur J Cancer suppl 2014; 12:18-28 (NKI)
Alentorn A, van Thuijl HF, Marie Y, Alshehhi H, Carpentier C, Boisselier B, Laigle-Donadey F, Mokhtari K,
Scheinin I, Wesseling P, Ylstra B, Capelle L, Hoang-Xuan K, Sanson M, Delattre JY, Reijneveld JC, Idbaih
A. Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas. Neuro-oncology 2014; 16:
400-408. (VUmc)
Alfaro AC, Roberts B, Kwong L, Bijlsma MF, Roelink H. Ptch2 mediates the Shh response in Ptch1-/cells. Development 141(17), 2014, p.3331-3339. (AMC)
Alhan C, Westers TM, Cremers EMP, Cali C, Witte BI, Ossenkoppele GJ, van de Loosdrecht AA. High flow
cytometric scores identify adverse prognostic subgroups within the revised international prognostic
scoring system for myelodysplastic syndromes. Brit J Haematol 2014; 167: 100-109. (VUmc)
Alhan C, Westers TM, van der Helm LH, Eeltink C, Huls G, Witte BI, Buchi F, Santini V, Ossenkoppele GJ,
van de Loosdrecht AA. Absence of aberrant myeloid progenitors by flow cytometry is associated with
favorable response to azacitidine in higher risk myelodysplastic syndromes. Cytom Part B- Clin CY 2014;
86: 207-215. (VUmc)
Ali AM, Schmidt MK, Bolla MK, Wang Q, Gago-Dominguez M, Castelao JE, Carracedo A, Garzon VM,
Bojesen SE, Nordestgaard BG, Flyger H, Chang-Claude J, Vrieling A, Rudolph A, Seibold P, Nevanlinna H,
Muranen TA, Aaltonen K, Blomqvist C, Matsuo K, Ito H, Iwata H, Horio A, John EM, Sherman M, Lissowska
J, Figueroa J, Garcia-Closas M, Anton-Culver H, Shah M, Hopper JL, Trichopoulou A, Bueno-de-Mesquita
B, Krogh V, Weiderpass E, Andersson A, Clavel-Chapelon F, Dossus L, Fagherazzi G, Peeters PH, Olsen A,
Wishart GC, Easton DF, Borgquist S, Overvad K, Barricarte A, Gonzalez CA, Sanchez MJ, Amiano P, Riboli
E, Key T, Pharoah PD. Alcohol consumption and survival after a breast cancer diagnosis: a literaturebased meta-analysis and collaborative analysis of data for 29,239 cases. Cancer Epidemiol Biomarkers
Prev 2014; 23:934-45 (NKI)
Allum WH, Bonavina L, Cassivi SD, Cuesta MA, Dong ZM, Felix VN, Figueredo E, Gatenby PAC, Haverkamp
L, Ibraev MA, Krasna MJ, Lambert R, Langer R, Lewis MPN, Nason KS, Parry K, Preston SR, Ruurda JP,
Schaheen LW, Tatum RP, Turkin IN, van der Horst S, van d. Surgical treatments for esophageal cancers.
Ann NY Acad Sci 2014; 1325: 242-268. (VUmc)
Al-Maawali A, Dupuis L, Blaser S, Heon E, Tarnopolsky M, Al-Murshedi F, Marshall CR, Paton T, Scherer
SW, Roelofsen J, van Kuilenburg ABP, Mendoza-Londono R. Prenatal growth restriction, retinal
dystrophy, diabetes insipidus and white matter disease: expanding the spectrum of PRPS1-related
disorders. European Journal of Human Genetics -, 2014, p.--. (AMC)
Althoff K, Lindner S, Odersky A, Mestdagh P, Beckers A, Karczewski S, Molenaar JJ, Bohrer A, Knauer S,
Speleman F, Epple M, Kozlova D, Yoon S, Baek K, Vandesompele J, Eggert A, Schramm A, Schulte JH.
miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin.
International Journal of Cancer july 20, 2014, p.29091-. (AMC)
82 - Scientific publications
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
Alvarez Herrero L, Curvers WL, Bisschops R, Kara MA, Schoon EJ, ten Kate FJW, Visser M, Weusten BLAM,
Bergman JJGHM. Narrow band imaging does not reliably predict residual intestinal metaplasia after
radiofrequency ablation at the neo-squamo columnar junction. Endoscopy 46(2), 2014, p.98-104. (AMC)
Amant F, Floquet A, Friedlander M, Kristensen G, Mahner S, Nam Eun J, Powell MA, Ray-Coquard I,
Siddiqui N, Sykes P, Westermann AM, Seddon B. Gynecologic Cancer InterGroup (GCIG) Consensus
Review for Endometrial Stromal Sarcoma. Int Journal of Gynecological Cancer 24(9 Suppl 3), 2014,
p.S67-S72. (AMC)
Amendola M, van Steensel B. Mechanisms and dynamics of nuclear lamina-genome interactions. Curr
Opin Cell Biol 2014; 28:61-8 (NKI)
Amos-Landgraf JM, Heijmans J, Wielenga MCB, Dunkin E, Krentz KJ, Clipson L, Ederveen AG, Groothuis
PG, Mosselman S, Muncan V, Hommes DW, Shedlovsky A, Dove WF, van den Brink GR. Sex disparity in
colonic adenomagenesis involves promotion by male hormones, not protection by female hormones.
Proceedings of the National Academy of Sciences of the USA 111(46), 2014, p.16514-16519. (AMC)
Andersen CL, Bjorn ME, McMullin MF, Harrison C, Samuelsson J, Ejerblad E, Zweegman S, Fernandes S,
Bareford D, Knapper S, Lofvenberg E, Linder O, Andreasson B, Ahlstrand E, Jensen MK, Bjerrum OW,
Vestergaard H, Larsen H, Klausen TW, Mourits-Andersen T, Sk. Circulating YKL-40 in patients with
essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor
vorinostat. Leukemia Res 2014; 38: 816-821. (VUmc)
Andersson J, Abis G, Gellerstedt M, Angenete E, Angeras U, Cuesta MA, Jess P, Rosenberg J, Bonjer HJ,
Haglind E. Patient-reported genitourinary dysfunction after laparoscopic and open rectal cancer surgery
in a randomized trial (COLOR II). Brit J Surg 2014; 101: 1272-1279. (VUmc)
Annema JT. Complete endosonographic staging of lung cancer. Thorax 69(7), 2014, p.675-. (AMC)
Annema JT. When will we finally adopt endoscopic ultrasound? Chest 146(3), 2014, p.e117-. (AMC)
Anquinet L, Rietjens J, Heide A, Bruinsma S, Janssens MJPA, Deliens L, Addington-Hall J, Smithson WH,
Seymour J. Physicians' experiences and perspectives regarding the use of continuous sedation until
death for cancer patients in the context of psychological and existential suffering at the end of life.
Psycho-oncology 2014; 23(5): 539-546. (VUmc)
Arbyn M, Verdoodt F, Snijders PJF, Verhoef VMJ, Suonio E, Dillner L, Minozzi S, Bellisario C, Banzi R,
Zhao FH, Hillemanns P, Anttila A. Accuracy of human papillomavirus testing on self-collected versus
clinician-collected samples: a meta-analysis. Lancet Oncol 2014; 15: 172-183. (VUmc)
Arends S, Berden JHM, Grootscholten C, Derksen RHWM, Berger SP, de Sevaux RGL, Voskuyl AE, Bijl M.
Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate
mofetil in proliferative lupus nephritis. Neth J Med 2014; 72: 481-490. (VUmc)
Argenzio E, Margadant C, Leyton-Puig D, Janssen H, Jalink K, Sonnenberg A, Moolenaar WH. CLIC4
regulates cell adhesion and beta1 integrin trafficking. J Cell Sci 2014; 127:5189-203 (NKI)
Ariës IM, van den Dungen RE, Koudijs MJ, Cuppen E, Voest E, Molenaar JJ, Caron HN, Pieters R, den Boer
ML. Towards personalized therapy in pediatric acute lymphoblastic leukemia; RAS mutations and
prednisolone resistance. Haematologica-The Hematology Journal [aheadofprint], 2014, p.-. (AMC)
Ariotti S, Hogenbirk MA, Dijkgraaf FE, Visser LL, Hoekstra ME, Song JY, Jacobs H, Haanen JB,
Schumacher TN. T cell memory. Skin-resident memory CD8(+) T cells trigger a state of tissue-wide
pathogen alert. Science 2014; 346:101-5 (NKI)
Armond JW, Saha K, Rana AA, Oates CJ, Jaenisch R, Nicodemi M, Mukherjee S. A stochastic model
dissects cell states in biological transition processes. Sci Rep 2014; 4:3692 (NKI)
Arndt J, Das E, Schagen SB, Reid-Arndt SA, Cameron LD, Ahles TA. Broadening the cancer and cognition
landscape: The role of self-regulatory challenges. Psychooncology 2014; 23:1-8 (NKI)
Arnold M, Liu L, Kenter GG, Creutzberg CL, Coebergh JW, Soerjomataram I. Second primary cancers in
survivors of cervical cancer in The Netherlands: Implications for prevention and surveillance. Radiother
Oncol 2014; 111:374-81 (NKI)
Arosio D, Chiodo F, Reina JJ, Marelli M, Penades S, van Kooijk Y, Garcia Vallejo JJ, Bernardi A. Effective
Targeting of DC-SIGN by alpha-Fucosylamide Functionalized Gold Nanoparticles. Bioconjug Chem 2014;
25: 2244-2251. (VUmc)
Arthurs OJ, van Rijn RR, Sebire NJ. Current status of paediatric post-mortem imaging: an ESPR
questionnaire-based survey. Pediatric Radiology 44(3), 2014, p.244-251. (AMC)
Arthurs OJ, van Rijn RR. Paediatric and perinatal postmortem imaging: mortui vivos docent. Pediatric
Radiology [aheadofprint], 2014, p.-. (AMC)
Artibani W, Ficarra V, Challacombe BJ, Abbou CC, Bedke J, Boscolo-Berto R, Brausi M, de la Rosette JJ,
Deger S, Denis L, Guazzoni G, Guillonneau B, Heesakkers JPFA, Jacqmin D, Knoll T, Martinez-Pineiro L,
Montorsi F, Mottrie A, Piechaud PT, Rane A, Rasswe. EAU Policy on Live Surgery Events. Eur Urol 2014;
66: 87-97. (VUmc/AMC)
Asbun HJ, Conlon K, Fernandez-Cruz L, Friess H, Shrikhande SV, Adham M, Bassi C, Bockhorn M, Büchler
M, Charnley RM, Dervenis C, Fingerhutt A, Gouma DJ, Hartwig W, Imrie C, Izbicki JR, Lillemoe KD,
Milicevic M, Montorsi M, Neoptolemos JP, Sandberg AA, Sarr M, Vollmer C, Yeo CJ, Traverso LW. When to
perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the
International Study Group of Pancreatic Surgery. Surgery 155(5), 2014, p.887-892. (AMC)
Ashworth AB, Senan S, Palma DA, Riquet M, Ahn YC, Ricardi U, Congedo MT, Gomez DR, Wright GM,
Melloni G, Milano MT, Sole CV, De Pas TM, Carter DL, Warner AJ, Rodrigues GB. An Individual Patient
Scientific publications - 83
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non-SmallCell Lung Cancer. Clin Lung Cancer 2014; 15: 346-355. (VUmc)
Attygalle AD, Cabecadas J, Gaulard P, Jaffe ES, de Jong D, Ko YH, Said J, Klapper W. Peripheral T-cell
and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of
the XVIth meeting of the European Association for Haematopathology and the Society for
Hematopathology. Histopathology 2014; 64: 171-199. (VUmc)
Avan A, Adema AD, Hoebe EK, Huijts CM, Avan A, Veal GJ, Ruijtenbeek R, Wosikowski K, Peters GJ.
Modulation of Signaling Enhances the Efficacy of the Combination of Satraplatin and Erlotinib. Current
Drug Targets 2014; 15: 1312-1321. (VUmc)
Avan A, Avan A, Giovannetti E, Peters GJ. Calcium/Magnesium Infusion for Oxaliplatin-Induced
Neuropathy: Protective or Not?. J Clin Oncol 2014; 32: 3341. (VUmc)
Avan A, Avan A, Le Large TYS, Mambrini A, Funel N, Maftouh M, Ghayour-Mobarhan M, Cantore M, Boggi
U, Peters GJ, Pacetti P, Giovannetti E. AKT1 and SELP Polymorphisms Predict the Risk of Developing
Cachexia in Pancreatic Cancer Patients. PLoS One 2014; 9: e108057. (VUmc)
Avan A, Maftouh M, Avan A, Tibaldi C, Zucali PA, Giovannetti E. SNPs in PI3K-PTEN-mTOR and Brain
Metastases in NSCLC-Letter. Clin Cancer Res 2014; 20: 3623-3624. (VUmc)
Avan A, Maftouh M, Fiuji H, Giovannetti E, Peters GJ. EZH2 (enhancer of zeste homolog 2 (Drosophila)).
Atlas of Genetics and Cytogenetics in Oncology and Haematology 2014; 18: 900-906. (VUmc)
Avan A, Maftouh M, Funel N, Ghayour-Mobarhan M, Boggi U, Peters GJ, Giovannetti E. MET As a Potential
Target for the Treatment of Upper Gastrointestinal Cancers: Characterization of Novel c-Met Inhibitors
from Bench to Bed-side. Curr Med Chem 2014; 21: 975-989. (VUmc)
Azijli K, Stelloo E, Peters GJ, van den Eertwegh AJM. New Developments in the Treatment of Metastatic
Melanoma: Immune Checkpoint Inhibitors and Targeted Therapies. Anticancer Res 2014; 34: 1493-1505.
(VUmc)
Azijli K, van Roosmalen IA, Smit J, Pillai S, Fukushima M, de Jong S, Peters GJ, Bijnsdorp IV, Kruyt FA.
The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate
non-small cell lung cancer cells. Cancer Chemoth Pharm 2014; 73: 1273-1283. (VUmc)
Baard J, Kamphuis GM, Westendarp M, de La Rosette JJMCH. How well tolerated is supine percutaneous
nephrolithotomy? Current Opinion in Urology 24(2), 2014, p.184-188. (AMC)
Baars JE, Bleiker EM, van Riel E, Rodenhuis CC, Velthuizen ME, Schlich KJ, Ausems MG. Active approach
for breast cancer genetic counseling during radiotherapy: long-term psychosocial and medical impact.
Clin Genet 2014; 85:524-31 (NKI)
Baas P, Burgers JA. [Is one single exposure to asbestos life-threatening?] Een keer asbest:
levensgevaarlijk? Ned Tijdschr Geneeskd 2014; 158:A7653 (NKI)
Babae N, Bourajjaj M, Liu Y, van Beijnum JR, Cerisoli F, Scaria PV, Verheul M, van Berkel MPA, Pieters
EHE, van Haastert RJ, Yousefi A, Mastrobattista E, Storm G, Berezikov E, Cuppen E, Woodle M,
Schaapveld RQJ, Prevost GP, Griffioen AW, van Noort PI, Sch. Systemic miRNA-7 delivery inhibits tumor
angiogenesis and growth in murine xenograft glioblastoma. Oncotarget 2014; 5: 6687-6700. (VUmc)
Babu YR, Bhagavanraju M, Reddy GD, Peters GJ, Prasad VVSR. Design and Synthesis of Quinazolinone
Tagged Acridones as Cytotoxic Agents and Their Effects on EGFR Tyrosine Kinase. Arch Pharm 2014; 347:
624-634. (VUmc)
Bachas C, Schuurhuis GJ, Reinhardt D, Creutzig U, Kwidama ZJ, Zwaan CM, van den Heuvel-Eibrink MM,
De Bont ESJM, Elitzur S, Rizzari C, de Haas V, Zimmermann M, Cloos J, Kaspers GJL. Clinical relevance
of molecular aberrations in paediatric acute myeloid leukaemia at first relapse. Brit J Haematol 2014;
166: 902-910. (VUmc)
Badrising S, van der Noort V, van Oort IM, van den Berg HP, Los M, Hamberg P, Coenen JL, van den
Eertwegh AJM, de Jong IJ, Kerver ED, van Tinteren H, Bergman AM. Clinical Activity and Tolerability of
Enzalutamide ( MDV3100) in Patients With Metastatic, Castration- Resistant Prostate Cancer Who
Progress After Docetaxel and Abiraterone Treatment. Cancer 2014; 120: 968-975. (VUmc/NKI)
Bahce I, Huisman MC, Verwer E, Ooijevaar R, Boutkourt F, Vugts DJ, van Dongen GAMS, Boellaard R,
Smit EF. Pilot study of 89Zr-bevacizumab positron emission tomography in patients with advanced nonsmall cell lung cancer. EJNMMI research 2014; 4: 35. (VUmc)
Bahce I, Vos CG, Dickhoff C, Hartemink KJ, Dahele MR, Smit EF, Boellaard R, Hoekstra OS, Thunnissen E.
Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior
sulcus NSCLC. Lung Cancer 2014; 85: 205-212. (VUmc)
Bailey DL, Barthel H, Beuthin-Baumann B, Beyer T, Bisdas S, Boellaard R, Czernin J, Drzezga A,
Ernemann U, Franzius C, Guckel B, Handgretinger R, Hartenbach M, Hellwig D, Nadel H, Nekolla SG,
Pfluger T, Pichler BJ, Quick HH, Sabri O, Sattler B, Schafer J,. Combined PET/MR: Where Are We Now?
Summary Report of the Second International Workshop on PET/MR Imaging April 8-12, 2013, Tubingen,
Germany. Mol Imaging Biol 2014; 16: 295-310. (VUmc)
Bajou K, Herkenne S, Thijssen VLJL, D'Amico S, Nguyen NQN, Bouche A, Tabruyn S, Srahna M, Carabin
JY, Nivelles O, Paques C, Cornelissen I, Lion M, Noel A, van Gils A, Vinckier S, Declerck PJ, Griffioen AW,
Dewerchin M, Martial JA, Carmeliet P, Struman I. PAT-1 mediates the antiangiogenic and profibrinolytic
effects of 16K prolactin. Nat Med 2014; 20: 741-747. (VUmc)
Bakema JE, van Egmond M. Fc receptor-dependent mechanisms of monoclonal antibody therapy of
cancer. Curr Top Microbiol Immunol 2014; 382: 373-392. (VUmc)
84 - Scientific publications
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
Bakker IS, Snijders HS, Wouters MW, Havenga K, Tollenaar RA, Wiggers T, Dekker JW. High complication
rate after low anterior resection for mid and high rectal cancer; results of a population-based study. Eur
J Surg Oncol 2014; 40:692-8 (NKI)
Bakker JL, Thirthagiri E, van Mil SE, Adank MA, Ikeda H, Verheul HMW, Meijers-Heijboer H, de Winter
JP, Sharan SK, Waisfisz Q. A Novel Splice Site Mutation in the Noncoding Region of BRCA2: Implications
for Fanconi Anemia and Familial Breast Cancer Diagnostics. Hum Mutat 2014; 35: 442-446. (VUmc)
Bakker OJ, Issa Y, van Santvoort HC, Besselink MG, Schepers NJ, Bruno MJ, Boermeester MA, Gooszen
HG. Treatment options for acute pancreatitis. Nature Reviews Gastroenterology & Hepatology 11(8),
2014, p.462-469. (AMC)
Bakker OJ, van Brunschot S, Farre A, Johnson CD, Kalfarentzos F, Louie BE, Oláh A, O'Keefe SJ, Petrov
MS, Powell JJ, Besselink MG, van Santvoort HC, Rovers MM, Gooszen HG. Timing of enteral nutrition in
acute pancreatitis: Meta-analysis of individuals using a single-arm of randomised trials. Pancreatology
14(5), 2014, p.340-346. (AMC)
Bakker OJ, van Brunschot S, van Santvoort HC, Besselink MG, Bollen TL, Boermeester MA, Dejong CH,
van Goor H, Bosscha K, Ahmed Ali U, Bouwense S, van Grevenstein WM, Heisterkamp J, Houdijk AP,
Jansen JM, Karsten TM, Manusama ER, Nieuwenhuijs VB, Schaapherder AF, van der Schelling GP,
Schwartz MP, Spanier BWM, Tan A, Vecht J, Weusten BL, Witteman BJ, Akkermans LM, Bruno MJ,
Dijkgraaf MG, van Ramshorst B, Gooszen HG. Early versus On-Demand Nasoenteric Tube Feeding in
Acute Pancreatitis. New England Journal of Medicine 371(21), 2014, p.1983-1993. (AMC)
Balaj L, Momen-Heravi F, Chen W, Sivaraman S, Zhang X, Ludwig N, Meese E, Wurdinger T, Noske DP,
Charest A, Hochberg AH, Vandertop WP, Skog J, Kuo WP. Detection Of Human c-Myc and EGFR
Amplifications in Circulating Extracellular Vesicles in Mouse Tumour Models. Journal of Circulating
Biomarkers 2014; 2014: 6. (VUmc)
Balidemaj E, van Lier ALHMW, Crezee H, Nederveen AJ, Stalpers LJA, van den Berg CAT. Feasibility of
Electric Property Tomography of pelvic tumors at 3T. Magnetic Resonance in Medicine [aheadofprint],
2014, p.-. (AMC)
Balink H, Bennink RJ, Veeger NJGM, van Eck-Smit BLF, Verberne HJ. Diagnostic utility of (18)F-FDG
PET/CT in inflammation of unknown origin. Clinical Nuclear Medicine 39(5), 2014, p.419-425. (AMC)
Balmativola D, Marchi+¦ C, Maule M, Chiusa L, Annaratone L, Maletta F, Montemurro F, Kulka J,
Figueiredo P, Varga Z, Liepniece-Karele I, Cserni G, Arkoumani E, Amendoeira I, Callagy G, ReinerConcin A, Cordoba A, Bianchi S, Decker T, Glãser D, Focke C, van Diest P, Grabau D, Lips E, Wesseling J,
Arisio R, Medico E, Wells C, Sapino A. Pathological non-response to chemotherapy in a neoadjuvant
setting of breast cancer: an inter-institutional study. Breast Cancer Res Treat 2014; 148:511-23 (NKI)
Bancroft EK, Page EC, Castro E, Lilja H, Vickers A, Sjoberg D, Assel M, Foster CS, Mitchell G, Drew K,
Maehle L, Axcrona K, Evans DG, Bulman B, Eccles D, McBride D, van Asperen C, Vasen H, Kiemeney LA,
Ringelberg J, Cybulski C, Wokolorczyk D, Selkirk C, Hulick PJ, Bojesen A, Skytte AB, Lam J, Taylor L,
Oldenburg R, Cremers R, Verhaegh G, Zelst-Stams WA, Oosterwijk JC, Blanco I, Salinas M, Cook J,
Rosario DJ, Buys S, Conner T, Ausems MG, Ong KR, Hoffman J, Domchek S, Powers J, Teixeira MR, Maia
S, Foulkes WD, Taherian N, Ruijs M, den Enden AT, Izatt L, Davidson R, Adank MA, Walker L, Schmutzler
R, Tucker K, Kirk J, Hodgson S, Harris M, Douglas F, Lindeman GJ, Zgajnar J, Tischkowitz M, Clowes VE,
Susman R, Ramon YC, Patcher N, Gadea N, Spigelman A, van Os T, Liljegren A, Side L, Brewer C, Brady
AF, Donaldson A, Stefansdottir V, Friedman E, Chen-Shtoyerman R, Amor DJ, Copakova L, Barwell J, Giri
VN, Murthy V, Nicolai N, Teo SH, Greenhalgh L, Strom S, Henderson A, McGrath J, Gallagher D, Aaronson
N, Ardern-Jones A, Bangma C, Dearnaley D, Costello P, Eyfjord J, Rothwell J, Falconer A, Gronberg H,
Hamdy FC, Johannsson O, Khoo V, Kote-Jarai Z, Lubinski J, Axcrona U, Melia J, McKinley J, Mitra AV,
Moynihan C, Rennert G, Suri M, Wilson P, Killick E, Moss S, Eeles RA. Targeted Prostate Cancer Screening
in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study.
Eur Urol 2014; 66:489-99 (NKI/VUmc)
Bandino A, Geerts D, Koster J, Bachmann AS. Deoxyhypusine synthase (DHPS) inhibitor GC7 induces
p21/Rb-mediated inhibition of tumor cell growth and DHPS expression correlates with poor prognosis in
neuroblastoma patients. Cellular Oncology 37(6), 2014, p.387-398. (AMC)
Barbieri E, de Preter K, Capasso M, Chen Z, Hsu DM, Tonini Gian P, Lefever S, Hicks J, Versteeg R,
Pession A, Speleman F, Kim ES, Shohet JM. Histone chaperone CHAF1A inhibits differentiation and
promotes aggressive neuroblastoma. Cancer Research 74(3), 2014, p.765-774. (AMC)
Bard-Chapeau EA, Nguyen AT, Rust AG, Sayadi A, Lee P, Chua BQ, New LS, de Jong J, Ward JM, Chin CK,
Chew V, Toh HC, Abastado JP, Benoukraf T, Soong R, Bard FA, Dupuy AJ, Johnson RL, Radda GK, Chan
EC, Wessels LFA, Adams DJ, Jenkins NA, Copeland NG. Transposon mutagenesis identifies genes driving
hepatocellular carcinoma in a chronic hepatitis B mouse model. Nat Genet 2014; 46:24-32 (NKI)
Bardin C, Veal G, Paci A, Chatelut E, Astier A, Leveque D, Widmer N, Beijnen J. Therapeutic drug
monitoring in cancer - Are we missing a trick? Eur J Cancer 2014; 50:2005-9 (NKI)
Barrientos G, Freitag N, Tirado-Gonzalez I, Unverdorben L, Jeschke U, Thijssen VLJL, Blois SM.
Involvement of galectin-1 in reproduction: past, present and future. Human Reproduction Update 2014;
20: 175-193. (VUmc)
Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Mueller SP, Schwartz LH, Zucca E,
Fisher RI, Trotman J, Hoekstra OS, Hicks RJ, O'Doherty MJ, Hustinx R, Biggi A, Cheson BD. Role of
Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International
Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 2014; 32: 3048-3058. (VUmc)
Scientific publications - 85
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
Basters A, Geurink PP, El Oualid F, Ketscher L, Casutt MS, Krause E, Ovaa H, Knobeloch KP, Fritz G.
Molecular characterization of ubiquitin-specific protease 18 reveals substrate specificity for interferonstimulated gene 15. FEBS J 2014; 281:1918-28 (NKI)
Bate-Eya LT, Ebus ME, Koster J, den Hartog IJM, Zwijnenburg DA, Schild L, van der Ploeg I, Dolman MEM,
Caron HN, Versteeg R, Molenaar JJ. Newly-derived neuroblastoma cell lines propagated in serum-free
media recapitulate the genotype and phenotype of primary neuroblastoma tumours. European Journal
of Cancer 50(3), 2014, p.628-637. (AMC)
Bauer S, Rutkowski P, Hohenberger P, Miceli R, Fumagalli E, Siedlecki JA, Nguyen BP, Kerst M, Fiore M,
Nyckowski P, Hoiczyk M, Cats A, Casali PG, Treckmann J, van Coevorden F, Gronchi A. Long-term followup of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic
factors (EORTC-STBSG collaborative study). Eur J Surg Oncol 2014; 40:412-9 (NKI)
Bazargani YT, de Boer A, Schellens JHM, Leufkens HGM, Mantel-Teeuwisse AK. Selection of oncology
medicines in low-and middle-income countries. Ann Oncol 2014; 25:270-6 (NKI)
Beelen K, Hoefnagel LD, Opdam M, Wesseling J, Sanders J, Vincent AD, van Diest PJ, Linn SC.
PI3K/AKT/mTOR pathway activation in primary and corresponding metastatic breast tumors after
adjuvant endocrine therapy. Int J Cancer 2014; 135:1257-63 (NKI)
Beelen K, Opdam M, Severson TM, Koornstra RHT, Vincent AD, Wesseling J, Muris JJ, Berns EMJJ,
Vermorken JB, van Diest PJ, Linn SC. Phosphorylated p-70S6K predicts tamoxifen resistance in
postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic
treatment. Breast Cancer Res 2014; 16:R6 (NKI)
Beelen K, Opdam M, Severson TM, Koornstra RHT, Vincent AD, Wesseling J, Muris JJ, Berns EMJJ,
Vermorken JB, van Diest PJ, Linn SC. PIK3CA mutations, phosphatase and tensin homolog, human
epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen
resistance in postmenopausal breast cancer patients. Breast Cancer Res 2014; 16:R13 (NKI)
Beetz I, Steenbakkers RJHM, Chouvalova O, Leemans CR, Doornaert P, van Laan BFAM, Christianen
MEMC, Vissink A, Bijl HP, van Luijk P, Langendijk JA. The QUANTEC criteria for parotid gland dose and
their effi cacy to prevent moderate to severe patient-rated xerostomia. ACTA Oncol 2014; 53: 597-604.
(VUmc)
Belcaid Z, Lamfers MLM, van Beusechem VW, Hoeben RC. Changing Faces in Virology: The Dutch Shift
from Oncogenic to Oncolytic Viruses. Hum Gene Ther 2014; 25: 875-884. (VUmc)
Belkacemi Y, Kaidar-Person O, Poortmans P, Ozsahin M, Valli M-C, Russell N, Kunkler I, Hermans J,
Kuten A, van Tienhoven G, Westenberg H. Patterns of Practice of Regional Nodal Irradiation in Breast
Cancer: Results of the European Organization for Research and Treatment of Cancer (EORTC) NOdal
RAdiotherapy (NORA) Survey. Annals of Oncology [aheadofprint], 2014, p.-. (AMC)
Belt EJT, Stockmann HBAC, van Diemen PM, Bril H, Tijssen M, van Essen HF, Heymans MW, Belien JAM,
Carvalho B, Cillessen SAGM, Meijer GA. Expression of Apoptosis Regulating Proteins Identifies Stage II
and III Colon Cancer Patients With High Risk of Recurrence. J Surg Oncol 2014; 109: 255-265. (VUmc)
Benard A, Janssen CM, van den Elsen PJ, van Eggermond MCJA, Hoon DSB, van de Velde CJH, Kuppen
PJK. Chromatin status of apoptosis genes correlates with sensitivity to chemo-, immune- and radiation
therapy in colorectal cancer cell lines. Apoptosis 2014; 19: 1769-1778. (VUmc)
Bende RJ, Slot LM, Hoogeboom R, Wormhoudt TAM, Adeoye AO, Guikema JEJ, van Noesel CJM.
Stereotypic rheumatoid factors that are frequently expressed by MALT lymphomas are rare in labial
salivary glands of Sjögren's syndrome patients. Arthritis & Rheumatology [aheadofprint], 2014, p.-.
(AMC)
Berghoff AS, Sax C, Klein M, Furtner J, Dieckmann K, Gatterbauer B, Widhalm G, Rudas M, Zielinski CC,
Bartsch R, Preusser M. Alleviation of Brain Edema and Restoration of Functional Independence by
Bevacizumab in Brain-Metastatic Breast Cancer: A Case Report. Breast care 2014; 9: 134-136. (VUmc)
Bernard V, Schultheiss SJ, Michaut M. Learn from the best. PLoS Comput Biol 2014; 10:e1003645 (NKI)
Bernards N, Haj Mohammad N, Creemers G-J, de Hingh IHJT, van Laarhoven HWM, Lemmens VEPP. Ten
weeks to live: A population-based study on treatment and survival of patients with metastatic
pancreatic cancer in the south of the Netherlands. ACTA Oncologica -, 2014, p.--8. (AMC)
Bernards R. Finding effective cancer therapies through loss of function genetic screens. Curr Opin Genet
Dev 2014; 24:23-9 (NKI)
Bernards R. Unlikely suspects identified in neuroblastoma conspiracy. Cancer Discov 2014; 4:392-3 (NKI)
Berns A, Pandolfi PP. Tumor microenvironment revisited. EMBO Rep 2014; 15:458-9 (NKI)
Besse B, Adjei A, Baas P, Meldgaard P, Nicolson M, Paz-Ares L, Reck M, Smit EF, Syrigos K, Stahel R,
Felip E, Peters S. 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer firstline/second and further lines of treatment in advanced disease. Ann Oncol 2014; 25:1475-84 (NKI)
Besse B, Adjei A, Baas P, Meldgaard P, Nicolson M, Paz-Ares L, Reck M, Smit EF, Syrigos K, Stahel R,
Felip E, Peters S. 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer firstline/second and further lines of treatment in advanced disease. Ann Oncol 2014; 25: 1475-1484. (VUmc)
Bex A, Fournier L, Lassau N, Mulders P, Nathan P, Oyen WJ, Powles T. Assessing the response to
targeted therapies in renal cell carcinoma: technical insights and practical considerations. Eur Urol
2014; 65:766-77 (NKI)
Bex A, Haanen J. Do targeted agents offer clinical benefit as presurgical therapy? World J Urol 2014;
32:3-8 (NKI)
86 - Scientific publications
113.
114.
115.
116.
117.
118.
119.
120.
121.
122.
123.
124.
125.
126.
127.
128.
129.
130.
131.
132.
133.
134.
Bex A, Haanen JBAG, Blank CU. Doelgerichte therapie van het heldercellig niercelcarcinoom anno 2014.
Ned Tijdschr Oncol 2014; 11:105-13 (NKI)
Bieze M, Klümpen H-J, Verheij J, Beuers U, Phoa SSKS, van Gulik TM, Bennink RJ. Diagnostic Accuracy of
(18) F-Methylcholine Positron Emission Tomography/Computed Tomography for Intra- and Extrahepatic
Hepatocellular Carcinoma. Hepatology 59(3), 2014, p.996-1006. (AMC)
Bieze Matthanja, Busch Olivier R. C., Tanis Pieter J., Verheij Joanne, Phoa Saffire S. K. S., Gouma Dirk
J., van Gulik TM. Outcomes of liver resection in hepatocellular adenoma and focal nodular hyperplasia.
HPB 16(2), 2014, p.140-149. (AMC)
Bijlsma MW, Blufpand HN, Kaspers GJL, Bokenkamp A. Why Pediatricians Fail to Diagnose Hypertension:
A Multicenter Survey. J Pediatr 2014; 164: 173-177. (VUmc)
Bin Ali R, van der Ahe F, Braumuller TM, Pritchard C, Krimpenfort P, Berns A, Huijbers IJ. Improved
pregnancy and birth rates with routine application of nonsurgical embryo transfer. Transgenic Res 2014;
23:691-5 (NKI)
Bins S, Schellens JHM, Voest EE, Sleijfer S. [Drug research in oncology; advances in the genome era]
Geneesmiddelenonderzoek in de oncologie; vorderingen in het genoomtijdperk. Ned Tijdschr Geneeskd
2014; 158:A6801 (NKI)
Blackhall FH, Peters S, Bubendorf L, Dafni U, Kerr KM, Hager H, Soltermann A, O'Byrne KJ, Dooms C,
Sejda A, Hernandez-Losa J, Marchetti A, Savic S, Tan Q, Thunnissen E, Speel EJM, Cheney R, Nonaka D,
de Jong J, Martorell M, Letovanec I, Rosell R, Stahel R. Prevalence and Clinical Outcomes for Patients
With ALK-Positive Resected Stage I to III Adenocarcinoma: Results From the European Thoracic Oncology
Platform Lungscape Project. J Clin Oncol 2014; 32: 2780-2787. (VUmc/NKI)
Blank CU. The perspective of immunotherapy: new molecules and new mechanisms of action in immune
modulation. Curr Opin Oncol 2014; 26:204-14 (NKI)
Blazeby JM, Hall E, Aaronson NK, Lloyd L, Waters R, Kelly JD, Fayers P. Validation and Reliability Testing
of the EORTC QLQ-NMIBC24 Questionnaire Module to Assess Patient-reported Outcomes in Non-Muscleinvasive Bladder Cancer. Eur Urol 2014; 66:1148-56 (NKI)
Bleeker FE, Hopman SM, Hennekam RC. Co-occurrence in body site of malformations and cancer.
European Journal of Medical Genetics 57(8), 2014, p.480-485. (AMC)
Bleeker FE, Hopman SMJ, Merks JHM, Aalfs CM, Hennekam RCM. Brain tumors and syndromes in children.
Neuropediatrics 45(3), 2014, p.137-161. (AMC)
Bleeker FE, Lamba S, Zanon C, Molenaar RJ, Hulsebos TJM, Troost D, van Tilborg AA, Vandertop WP,
Leenstra S, van Noorden CJF, Bardelli A. Mutational profiling of kinases in glioblastoma. BMC Cancer
2014; 14: 718. (VUmc/AMC)
Bleeker G, van Eck-Smit BL, Zwinderman KH, Versteeg R, van Noesel MM, Kam BL, Kaspers GJ, van Schie
A, Kreissman SG, Yanik G, Hero B, Schmidt M, Laureys G, Lambert B, Ora I, Schulte JH, Caron HN, Tytgat
GA.MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated
with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis. European
Journal of Nuclear Medicine and Molecular Imaging [aheadofprint], 2014, p.-. (AMC)
Blom RLGM, Sosef MN, Nap M, Lammering G, van den Berkmortel F, Hulshof MCCM, Meijer SL, Wilmink
HW, van Berge Henegouwen MI. Comparison of two neoadjuvant chemoradiotherapy regimens in
patients with potentially curable esophageal carcinoma. Diseases of the Esophagus 27(4), 2014,
p.380-387. (AMC)
Blommestein HM, Franken MG, Verelst SGR, van Agthoven M, Huijgens PC, Uyl-de Groot CA. Access to
expensive cancer drugs in Dutch daily practice: Should we be concerned?. Neth J Med 2014; 72: 235-241.
(VUmc)
Blommestein HM, Issa DE, Pompen M, Ten Hoor G, Hogendoorn M, Joosten P, Zweegman S, Huijgens PC,
Uyl-de Groot CA. Cost-effectiveness of rituximab as maintenance treatment for relapsed follicular
lymphoma: results of a population-based study. Eur J Haematol 2014; 92: 398-406. (VUmc)
Blufpand HN, Hes N, Bokenkamp A, van de Wetering MD, Kaspers GJL. Diversity in Renal Function
Monitoring and Dose Modifications During Treatment for Childhood Cancer: A Call for Standardization.
Pediatr Blood Cancer 2014; 61: 337-344. (VUmc/AMC)
Boccon-Gibod L, Albers P, Morote J, van Poppel H, de la Rosette J, Villers A, Malmberg A, Neijber A,
Montorsi Fr. Degarelix as an Intermittent Androgen Deprivation Therapy for One or More Treatment
Cycles in Patients with Prostate Cancer. European Urology 66(4), 2014, p.655-663. (AMC)
Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA, Asbun HJ, Bassi C, Büchler M,
Charnley RM, Conlon K, Cruz Laureano F, Dervenis C, Fingerhutt A, Friess H, Gouma DJ, Hartwig W,
Lillemoe KD, Montorsi M, Neoptolemos JP, Shrikhande SV, Takaori K, Traverso W, Vashist YK, Vollmer C,
Yeo CJ, Izbicki JR. Borderline resectable pancreatic cancer: a consensus statement by the International
Study Group of Pancreatic Surgery (ISGPS). Surgery 155(6), 2014, p.977-988. (AMC)
Bodner L, Manor E, Friger MD, van der Waal I. Oral squamous cell carcinoma in patients twenty years of
age or younger - Review and analysis of 186 reported cases. Oral Oncol 2014; 50: 84-89. (VUmc)
Boekel NB, Schaapveld M, Gietema JA, Rutgers EJ, Versteegh MI, Visser O, Aleman BM, van Leeuwen FE.
Cardiovascular morbidity and mortality after treatment for ductal carcinoma in situ of the breast. J Natl
Cancer Inst 2014; 106:...-(9 pp) (NKI)
Boele FW, de Leeuw IM, Cuijpers P, Reijneveld JC, Heimans JJ, Klein M. Internet-based guided self-help
for glioma patients with depressive symptoms: design of a randomized controlled trial. BMC Neurol
2014; 14: 81. (VUmc)
Scientific publications - 87
135.
136.
137.
138.
139.
140.
141.
142.
143.
144.
145.
146.
147.
148.
149.
150.
151.
152.
153.
154.
Boele FW, Klein M, Reijneveld JC, de Leeuw IM, Heimans JJ. Symptom management and quality of life in
glioma patients. CNS Oncology 2014; 3: 37-47. (VUmc)
Boele FW, Zant M, Heine ECE, Aaronson NK, Taphoorn MJB, Reijneveld JC, Postma TJ, Heimans JJ, Klein
M. The association between cognitive functioning and health-related quality of life in low-grade glioma
patients. Neuro-Oncology Practice 2014; 1: 40-46. (VUmc)
Boelens MC, Wu TJ, Nabet BY, Xu B, Qiu Y, Yoon T, Azzam DJ, Twyman-Saint Victor C, Wiemann BZ,
Ishwaran H, Ter Brugge PJ, Jonkers J, Slingerland J, Minn AJ. Exosome transfer from stromal to breast
cancer cells regulates therapy resistance pathways. Cell 2014; 159:499-513 (NKI)
Boellaard R, Hofman MBM, Hoekstra OS, Lammertsma AA. Accurate PET/MR Quantification Using Time of
Flight MLAA Image Reconstruction. Mol Imaging Biol 2014; 16: 469-477. (VUmc)
Boerebach BCM, Arah OA, Heineman MJ, Busch ORC, Lombarts KMJMH. The Impact of Resident- and
Self-Evaluations on Surgeon's Subsequent Teaching Performance. World Journal of Surgery 38(11), 2014,
p.2761-2769. (AMC)
Boerlage-van Dijk K, Kooiman KM, Yong Ze Y, Wiegerinck EMA, Damman P, Bouma BJ, Tijssen JGP, Piek
JJ, Knops RE, Baan J.Jr: Predictors and Permanency of Cardiac Conduction Disorders and Necessity of
Pacing after Transcatheter Aortic Valve Implantation. Pace-Pacing and Clinical Electrophysiology 37(11),
2014, p.1520-1529. (AMC)
Boers A, Bosgraaf RP, van Leeuwen RW, Schuuring E, Heideman DAM, Massuger LFAG, Verhoef VMJ,
Bulten J, Melchers WJG, van der Zee AGJ, Bekkers RLM, Wisman GBA. DNA methylation analysis in selfsampled brush material as a triage test in hrHPV-positive women. Brit J Cancer 2014; 111: 1095-1101.
(VUmc)
Boerwinkel DF, Di Pietro M, Liu X, Shariff MK, Lao-Sirieix P, Walker CE, Visser M, O' Donovan M, Kaye P,
Bergman JJGHM, Fitzgerald RC. Endoscopic TriModal imaging and biomarkers for neoplasia conjoined: a
feasibility study in Barrett's esophagus. Diseases of the Esophagus 27(5), 2014, p.435-443. (AMC)
Boerwinkel DF, Holz JA, Aalders MCG, Visser M, Meijer SL, van Berge Henegouwen MI, Weusten BLAM,
Bergman JJGHM. Third-generation autofluorescence endoscopy for the detection of early neoplasia in
Barrett's esophagus: a pilot study. Diseases of the Esophagus 27(3), 2014, p.276-284. (AMC)
Boerwinkel DF, Holz JA, Kara MA, Meijer SL, Wallace MB, Wong Kee Song L-M, Ragunath K, Wolfsen HC,
Iyer PG, Wang KK, Weusten BL, Aalders MC, Curvers WL, Bergman JJGHM. Effects of Autofluorescence
Imaging on Detection and Treatment of Early Neoplasia in Patients With Barrett's Esophagus. Clinical
Gastroenterology and Hepatology 12(5), 2014, p.774-781. (AMC)
Boerwinkel DF, Shariff MK, Di Pietro M, Holz JA, Aalders MC, Curvers WL, Fitzgerald RC, Bergman JJ.
Fluorescence imaging for the detection of early neoplasia in Barrett's esophagus: old looks or new
vision?. European Journal of Gastroenterology&Hepatology 26(7), 2014, p.691-698. (AMC)
Boerwinkel DF, Swager A-F, Curvers WL, Bergman JJGHM. The clinical consequences of advanced
imaging techniques in Barrett's esophagus. Gastroenterology 146(3), 2014, p.622-629.e4. (AMC)
Bohte AE, de Niet A, Jansen L, Bipat S, Nederveen AJ, Verheij J, Terpstra V, Sinkus R, van Nieuwkerk
CMJ, de Knegt RJ, Baak BC, Jansen PLM, Reesink HW, Stoker J. Non-invasive evaluation of liver fibrosis:
a comparison of ultrasound-based transient elastography and MR elastography in patients with viral
hepatitis B and C. Eur J Radiol 2014; 24: 638-648. (VUmc/AMC)
Boix-Perales H, Borregaard J, Jensen KB, Ersboll J, Galluzzo S, Giuliani R, Ciceroni C, Melchiorri D,
Salmonson T, Bergh J, Schellens JHM, Pignatti F. The European Medicines Agency Review of Pertuzumab
for the Treatment of Adult Patients With HER2-Positive Metastatic or Locally Recurrent Unresectable
Breast Cancer: Summary of the Scientific Assessment of the Committee for Medicinal Products for
Human Use. Oncologist 2014; 19:766-73 (NKI)
Bol KF, Mensink HW, Aarntzen EHJG, Schreibelt G, Keunen JEE, Coulie PG, de Klein A, Punt CJA.,
Paridaens D, Figdor CG, de Vries IJM. Long overall survival after dendritic cell vaccination in metastatic
uveal melanoma patients. American Journal of Ophthalmology 158(5), 2014, p.939-947. (AMC)
Bolt EE, Heide A, Onwuteaka-Philipsen BD. Reducing questionnaire length did not improve physician
response rate: a randomized trial. J Clin Epidemiol 2014; 67: 477-481. (VUmc)
Bondt A, Rombouts Y, Selman MH, Hensbergen PJ, Reiding KR, Hazes JM, Dolhain RJ, Wuhrer M.
Immunoglobulin G (IgG) Fab Glycosylation Analysis Using a New Mass Spectrometric High-throughput
Profiling Method Reveals Pregnancy-associated Changes. Molecular Cell 2014; 13: 3029-3039. (VUmc)
Bonnetain F, Bonsing B, Conroy T, Dousseau A, Glimelius B, Haustermans K, Lacaine F, van Laethem JL,
Aparicio T, Aust D, Bassi C, Berger V, Chamorey E, Chibaudel B, Dahan L, de Gramont A, Delpero JR,
Dervenis C, Ducreux M, Gal J, Gerber E, Ghaneh P, Hammel P, Hendlisz A, Jooste V, Labianca R,
Latouche A, Lutz M, Macarulla T, Malka D, Mauer M, Mitry E, Neoptolemos J, Pessaux P, Sauvanet A,
Tabernero J, Taieb J, van Tienhoven G, Gourgou-Bourgade S, Bellera C, Mathoulin-Pélissier S, Collette
L. Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the
DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials).
European Journal of Cancer 50(17), 2014, p.2983-2993. (AMC)
Booij KAC, de Reuver PR, Nijsse B, Busch ORC., van Gulik TM, Gouma DJ. Insufficient safety measures
reported in operation notes of complicated laparoscopic cholecystectomies. Surgery 155(3), 2014,
p.384-389. (AMC)
Boons CCLM, Swart EL, Timmers L, van de Ven PM, Janssen JJWM, Hugtenburg JG. Study protocol of the
RAND-study: a multicenter, prospective cohort study investigating response and adherence to nilotinib
treatment in chronic myeloid leukemia. BMC Cancer 2014; 14: 247. (VUmc)
88 - Scientific publications
155.
156.
157.
158.
159.
160.
161.
162.
163.
164.
165.
166.
167.
168.
169.
170.
171.
172.
173.
174.
175.
176.
177.
Borbón-Arce M, Brouwer OR, van den Berg NS, Mathéron H, Klop WMC, Balm AJM, van Leeuwen FWB,
Valdés-Olmos RA. An innovative multimodality approach for sentinel node mapping and biopsy in head
and neck malignancies. Revista Espanola de Medicina Nuclear e Imagen Molecular 33(5), 2014,
p.274-279. (AMC/NKI)
Borgstein E, Kamiza S, Vujanic G, Pidini D, Bailey S, Tomoka T, Banda K, Kaspers G, Molyneux E, Israels
T. Wilms Tumour in Malawi: Surgical Staging to Stratify Postoperative Chemotherapy?. Pediatr Blood
Cancer 2014; 61: 2180-2184. (VUmc)
Boschman JS, van der Molen HF, Frings-Dresen MHW, Sluiter JK. The impact of common mental disorders
on work ability in mentally and physically demanding construction work. International Archive of
Occupational and Environmental Health 87(1), 2014, p.51-59. (AMC)
Bosgraaf RP, Ketelaars PJW, Verhoef VMJ, Massuger LFAG, Meijer CJLM, Melchers WJG, Bekkers RLM.
Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch
women. Prev Med 2014; 64: 108-113. (VUmc)
Bosschaart N, van Leeuwen TG, Aalders Maurice CG, Faber DJ. Quantitative comparison of analysis
methods for spectroscopic optical coherence tomography: reply to comment. Biomedical Optics Express
5(9), 2014, p.3034-3035. (AMC)
Both J, Krijgsman O, Bras J, Schaap GR, Baas F, Ylstra B, Hulsebos TJM. Focal Chromosomal Copy
Number Aberrations Identify CMTM8 and GPR177 as New Candidate Driver Genes in Osteosarcoma. PLOS
One 9(12), 2014, p.e115835-. (AMC)
Both J, Krijgsman O, Bras J, Schaap JR, Baas F, Ylstra B, Hulsebos TJM. Focal Chromosomal Copy
Number Aberrations Identify CMTM8 and GPR177 as New Candidate Driver Genes in Osteosarcoma. PLoS
One 2014; 9: e115835. (VUmc)
Botman D, Rottinger E, Martindale MQ, de Jong J, Kaandorp JA. A Computational Approach towards a
Gene Regulatory Network for the Developing Nematostella vectensis Gut. PLoS One 2014; 9:e103341
(NKI)
Botman D, Tigchelaar W, van Noorden CJF. Determination of glutamate dehydrogenase activity and its
kinetics in mouse tissues using metabolic mapping (quantitative enzyme histochemistry). Journal of
Histochemistry &Cytochemistry 62(11), 2014, p.802-812. (AMC)
Botman D, Tigchelaar W, van Noorden CJF. Determination of phosphate-activated glutaminase activity
and its kinetics in mouse tissues using metabolic mapping (quantitative enzyme histochemistry). Journal
of Histochemistry & Cytochemistry 62(11), 2014, p.813-826. (AMC)
Boto T, Louis T, Jindachomthong K, Jalink K, Tomchik SM. Dopaminergic modulation of cAMP drives
nonlinear plasticity across the Drosophila mushroom body lobes. Curr Biol 2014; 24:822-31 (NKI)
Bots M, Verbrugge I, Martin BP, Salmon JM, Ghisi M, Baker A, Stanley K, Shortt J, Ossenkoppele GJ,
Zuber J, Rappaport AR, Atadja P, Lowe SW, Johnstone RW. Differentiation therapy for the treatment of
t(8;21) acute myeloid leukemia using histone deacetylase inhibitors. Blood 2014; 123: 1341-1352.
(VUmc)
Bottomley A, Tridello G, Coens C, Rolland F, Tesselaar MET, Leemans CR, Hupperets P, Licitra L,
Vermorken JB, Van den Weyngaert D, Truc G, Barillot I, Lefebvre JL. An International Phase 3 Trial in
Head and Neck Cancer: Quality of Life and Symptom Results. Cancer 2014; 120: 390-398. (VUmc/NKI)
Bouman MB, van Zeijl MCT, Buncamper ME, Meijerink WJHJ, van Bodegraven AA, Mullender MG.
Intestinal Vaginoplasty Revisited: A Review of Surgical Techniques, Complications, and Sexual Function.
Journal of Sexual Medicine 2014; 11: 1835-1847. (VUmc)
Bourgonje AM, Navis AC, Schepens JTG, Verrijp K, Hovestad L, Hilhorst R, Harroch S, Wesseling P,
Leenders WPJ, Hendriks WJAJ. Intracellular and extracellular domains of protein tyrosine phosphatase
PTPRZ-B differentially regulate glioma cell growth and motility. Oncotarget 2014; 5: 8690-8702. (VUmc)
Bouwens MWE, van Herwaarden YJ, Winkens B, Rondagh EJA, de Ridder R, Riedl RG, Driessen A, Dekker
E, Masclee AAM, Sanduleanu S. Endoscopic characterization of sessile serrated adenomas/polyps with
and without dysplasia. Endoscopy 46(3), 2014, p.225-235. (AMC)
Bouwman P, Jonkers J. Molecular Pathways: How Can BRCA-Mutated Tumors Become Resistant to PARP
Inhibitors? Clin Cancer Res 2014; 20:540-7 (NKI)
Braakhuis BJM, Leemans CR, Visser O. Incidence and survival trends of head and neck squamous cell
carcinoma in the Netherlands between 1989 and 2011. Oral Oncol 2014; 50: 670-675. (VUmc)
Braakhuis BJM, Rietbergen MM, Buijze M, Snijders PJF, Bloemena E, Brakenhoff RH, Leemans CR. TP53
mutation and human papilloma virus status of oral squamous cell carcinomas in young adult patients.
Oral Dis 2014; 20: 602-608. (VUmc)
Braamse AMJ, van Meijel B, Visser O, Huijgens PC, Beekman ATF, Dekker J. Distress, problems and
supportive care needs of patients treated with auto- or allo-SCT. Bone Marrow Transpl 2014; 49: 292298. (VUmc)
Braat AE, Pol RA, Oosterhuis JWA, de Vries JE, Mesker WE, Tollenaar RAEM. Excellent prognosis of node
negative patients after sentinel node procedure in colon carcinoma: A 5-year follow-up study. EJSO-Eur
J Surg Oncol 2014; 40: 747-755. (VUmc)
Bran G, Borjesson P, Boahene K, Gosepath J, Lohuis P. Effect of endoscopic browlift on contractures and
synkinesis of the facial muscles in patients with a regenerated post-paralytic facial nerve syndrome.
Plast Reconstr Surg 2014; 133(1):121-9:121-9 (NKI)
Branderhorst W, Blezer ELA, Houtkamp M, Ramakers RM, van den Brakel JH, Witteveen H, van der Have
F, van Andel HAG, Vastenhouw B, Wu C, Stigter-van Walsum M, van Dongen GAMS, Viergever MA, Bleeker
Scientific publications - 89
178.
179.
180.
181.
182.
183.
184.
185.
186.
187.
188.
189.
190.
191.
192.
193.
194.
195.
196.
197.
WK, Beekman FJ. Three-Dimensional Histologic Validation of High-Resolution SPECT of Antibody
Distributions Within Xenografts. J Nucl Med 2014; 55: 830-837. (VUmc)
Branderhorst W, de Groot JE, Highnam R, Chan A, Böhm-Vélez M, Broeders MJM, den Heeten GJ,
Grimbergen CA. Mammographic compression - A need for mechanical standardization. European Journal
of Radiology [aheadofprint], 2014, p.-. (AMC)
Braster R, O'Toole TG, van Egmond M. Myeloid cells as effector cells for monoclonal antibody therapy of
cancer. Methods 2014; 65: 28-37. (VUmc)
Braun L, Kim PJ, Margolis D, Peters EJG, Lavery LA. What's new in the literature: An update of new
research since the original WHS diabetic foot ulcer guidelines in 2006. Wound Repair Regen 2014; 22:
594-604. (VUmc)
Bredenoord AJ, Rösch T, Fockens P. Peroral endoscopic myotomy for achalasia. Neurogastroenterology
and Motility 26(1), 2014, p.3-12. (AMC)
Breugom AJ, van Gijn W, Muller EW, Berglund A, van den Broek CBM, Fokstuen T, Gelderblom H,
Kapiteijn E, Leer JWH, Marijnen CAM, Martijn H, Meershoek-Klein Kranenbarg E, Nagtegaal ID, Påhlman
L, Punt CJA, Putter H, Roodvoets AGH, Rutten HJT, Steup WH, Glimelius B, van de Velde CJH. Adjuvant
chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total
mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomised phase III trial. Annals of
Oncology [aheadofprint], 2014, p.-. (AMC)
Brinkman-Stoppelenburg A, Vergouwe Y, Heide A, Onwuteaka-Philipsen BD. Obligatory consultation of an
independent physician on euthanasia requests in the Netherlands: What influences the SCEN physicians
judgment of the legal requirements of due care?. Health Policy 2014; 115: 75-81. (VUmc)
Broeders MJM, ten Voorde M, Veldkamp WJH, van Engen RE, van Landsveld-Verhoeven C, 't
Jong-Gunneman MNL, de Win J, Droogh-de Greeve K, Paap E, den Heeten GJ. Comparison of a flexible
versus a rigid breast compression paddle: pain experience, projected breast area, radiation dose and
technical image quality. European Radiology -, 2014, p.--. (AMC)
Brohet RM, Velthuizen ME, Hogervorst FBL, Meijers-Heijboer HEJ, Seynaeve C, Collee MJ, Verhoef S,
Ausems MGEM, Hoogerbrugge N, van Asperen CJ, Garcia EG, Menko F, Oosterwijk JC, Devilee P, van 't
Veer LJ, van Leeuwen FE, Easton DF, Rookus MA, Antoniou AC. Breast and ovarian cancer risks in a large
series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder
mutations. J Med Genet 2014; 51: 98-107. (VUmc/AMC/NKI)
Brom L, Hopmans W, Pasman HRW, Timmermans DRM, Widdershoven GAM, Onwuteaka-Philipsen BD.
Congruence between patients' preferred and perceived participation in medical decision-making: a
review of the literature. BMC Medical Informatics and Decision Making 2014; 14: 25. (VUmc)
Brom L, Pasman HRW, Widdershoven GAM, van der Vorst MJDL, Reijneveld JC, Postma TJ, OnwuteakaPhilipsen BD. Patients' Preferences for Participation in Treatment Decision-Making at the End of Life:
Qualitative Interviews with Advanced Cancer Patients. PLoS One 2014; 9: e100435. (VUmc)
Bronte G, Rolfo C, Giovannetti E, Cicero G, Pauwels P, Passiglia F, Castiglia M, Rizzo S, Lo Vullo F,
Fiorentino E, van Meerbeeck J, Russo A. Are erlotinib and gefitinib interchangeable, opposite or
complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical
aspects. Crit Rev Oncol Hemat 2014; 89: 300-313. (VUmc)
Brooks J, Srivastava ED, Mathus-Vliegen EMH. One-year adjustable intragastric balloons: results in 73
consecutive patients in the U.K. Obesity Surgery 24(5), 2014, p.813-819. (AMC)
Brosens LAA, Leguit RJ, Vleggaar FP, Veldhuis WB, van Leeuwen MS, Offerhaus GJ.A. EUS-guided FNA
cytology diagnosis of paraduodenal pancreatitis (groove pancreatitis) with numerous giant cells:
conservative management allowed by cytological and radiological correlation. Cytopathology
[aheadofprint], 2014, p.-. (AMC)
Brouns EREA, Baart JA, Karagozoglu KH, Aartman IHA, Bloemena E, van der Waal I. Malignant
transformation of oral leukoplakia in a well-defined cohort of 144 patients. Oral Dis 2014; 20: e19-e24.
(VUmc)
Brouwer OR, van den Berg NS, Matheron HM, van der Poel HG, van Rhijn BW, Bex A, Van Tinteren H,
Valdes Olmos RA, van Leeuwen FW, Horenblas S. A hybrid radioactive and fluorescent tracer for sentinel
node biopsy in penile carcinoma as a potential replacement for blue dye. Eur Urol 2014; 65:600-9 (NKI)
Brouwer OR, van den Berg NS, Matheron HM, Wendler T, van der Poel HG, Horenblas S, Valdes Olmos RA,
van Leeuwen FW. Feasibility of intraoperative navigation to the sentinel node in the groin using
preoperatively acquired SPECT/CT data; transferring functional imaging to the operating room. J Urol
2014; 192:1810-6 (NKI)
Brown P, de Graaf S, Hillen M, Smets E, van Laarhoven H. The interweaving of pharmaceutical and
medical expectations as dynamics of micro-pharmaceuticalisation: Advanced-stage cancer patients' hope
in medicines alongside trust in professionals. Social Science&Medicine 14, 2014, p.S0277-. (AMC)
Brown P, de Graaf S, Hillen M. The inherent tensions and ambiguities of hope: Towards a post-formal
analysis of experiences of advanced-cancer patients. Health [aheadofprint], 2014, p.-. (AMC)
Brucher BL, Lyman G, van HR, Pollock RE, Lordick F, Yang HK, Ushijima T, Yeoh KG, Skricka T, Polkowski
W, Wallner G, Verwaal V, Garofalo A, D'Ugo D, Roviello F, Steinau HU, Wallace TJ, Daumer M, Maihle N,
Reid TJ, III, Ducreux M, Kitagawa Y, Knuth A, Zilberstein B, Steele SR, Jamall IS. Imagine a world
without cancer. BMC Cancer 2014; 14:186 (NKI)
Brücher BLDM, Lyman G, van Hillegersberg R, Pollock RE, Lordick F, Yang HK, Ushijima T, Yeoh KG,
Skricka T, Polkowski W, Wallner G, Verwaal V, Garofalo A, D'Ugo D, Roviello F, Steinau HU, Wallace TJ,
90 - Scientific publications
198.
199.
200.
201.
202.
203.
204.
205.
206.
207.
208.
209.
210.
211.
212.
213.
214.
215.
216.
217.
218.
219.
Daumer M, Maihle N, Reid III TJ, Ducreux M, Kitagawa Y, Knuth A, Zilberstein B, Steele SR, Jamall IS.
Imagine a world without cancer. BMC Cancer 2014; 14:166 (NKI)
Bruinsma SM, Brown J Heide A, Deliens L, Anquinet L, Payne SA, Seymour JE, Rietjens JAC. Making sense
of continuous sedation in end-of-life care for cancer patients: an interview study with bereaved
relatives in three European countries. Supportive Care in Cancer 2014; 22(12): 3243-3252. (VUmc)
Bruinsma W, Macurek L, Freire R, Lindqvist A, Medema RH. Bora and Aurora-A continue to activate Plk1
in mitosis. J Cell Sci 2014; 127:801-11 (NKI)
Bryan K, Terrile M, Bray IM, Domingo-Fernandéz R, Watters KM, Koster J, Versteeg R, Stallings RL.
Discovery and visualization of miRNA-mRNA functional modules within integrated data using bicluster
analysis. Nucleic Acids Research 42(3), 2014, p.e17-. (AMC)
Buffi N, van der Poel H, Guazzoni G, Mottrie A. Reply to Jacques Hubert and Richard M. Satava's letter
to the editor re: Nicolomaria Buffi, Henk Van Der Poel, Giorgio Guazzoni, Alexander Mottrie, on behalf
of the Junior European Association of Urology (EAU) Robotic Urology Section with the collaboration of
the EAU Young Academic Urologists Robotic Section. Methods and priorities of robotic surgery training
program. Eur Urol 2014;65:1-2. Eur Urol 2014; 66:e11-e12 (NKI)
Buijs N, Brinkmann SJH, Oosterink JE, Luttikhold J, Schierbeek H, Wisselink W, Beishuizen A, van
Goudoever JB, Houdijk APJ, van Leeuwen PAM, Vermeulen MAR. Intravenous glutamine supplementation
enhances renal de nova arginine synthesis in humans: a stable isotope study. Am J Clin Nutr 2014; 100:
1385-1391. (VUmc)
Buis DR, Idema S, Feller R, Vandertop WP. Standardization of Surgical Procedures: Beyond Checklists?.
World neurosurgery 2014; 82: E376-E377. (VUmc)
Buiting HM, Sonke GS. Optimising end of life care requires an individualised approach. BMJ (Online)
2014; 348:g2312 (NKI)
Bull SJ, Bin JM, Beaumont E, Boutet A, Krimpenfort P, Sadikot AF, Kennedy TE. Progressive
Disorganization of Paranodal Junctions and Compact Myelin Due to Loss of DCC Expression by
Oligodendrocytes. J Neurosci 2014; 34:9768-78 (NKI)
Bulten BF, Mavinkurve-Groothuis AMC, de Geus-Oei L-F, de Haan AFJ, de Korte CL, Bellersen L, van
Laarhoven HWM, Kapusta L. Early myocardial deformation abnormalities in breast cancer survivors.
Breast Cacner Research and Treatment 146(1), 2014, p.127-135 (AMC)
Bunse M, Bendle GM, Linnemann C, Bies L, Schulz S, Schumacher TN, Uckert W. RNAi-mediated TCR
knockdown prevents autoimmunity in mice caused by mixed TCR dimers following TCR gene transfer.
Mol Ther 2014; 22:1983-91 (NKI)
Bus MTJ, de Bruin DM, Faber DJ, Kamphuis G, Zondervan P, Laguna P, de Reijke TM, Traxer O, van
Leeuwen TG, de la Rosette J. Optical diagnostics for Upper Urinary Tract Urothelial cancer: technology,
thresholds and clinical applications. Journal of Endourology -, 2014, p.--. (AMC)
Busard MPH, van den Pieters-van den Bos, van Kuijk C, van Waesberghe JHTM. Magnetic resonance
imaging of deep infiltrating endometriosis: comparison of 2DT2- and 3DT2-weighted TSE sequences.
Journal of Endometriosis and Pelvic Pain Disorders 2014; 6: 34-40. (VUmc)
Buskermolen S, van Bokhorst-de van der Schueren, Verheul HMW, Langius JAE. 'Pre-cachexia': a nonexisting phenomenon in cancer?. Ann Oncol 2014; 25: 1668-1669. (VUmc)
Cagnet S, Faraldo MM, Kreft M, Sonnenberg A, Raymond K, Glukhova MA. Signaling events mediated by
a3+ß1 integrin are essential for mammary tumorigenesis. Oncogene 2014; 33:4286-95 (NKI)
Cai Y, Geutjes EJ, de Lint K, Roepman P, Bruurs L, Yu LR, Wang W, van Blijswijk J, Mohammad H, de
Rink I, Bernards R, Baylin SB. The NuRD complex cooperates with DNMTs to maintain silencing of key
colorectal tumor suppressor genes. Oncogene 2014; 33:2157-68 (NKI)
Cangelosi D, Muselli M, Parodi S, Blengio F, Becherini P, Versteeg R, Conte M, Varesio L. Use of Attribute
Driven Incremental Discretization and Logic Learning Machine to build a prognostic classifier for
neuroblastoma patients. BMC Bioinformatics 15(Suppl. 5), 2014, p.S4-. (AMC)
Caretti V, Bugiani M, Freret M, Schellen P, Jansen MHA, van Vuurden DG, Kaspers G, Fisher PG,
Hulleman E, Wesseling P, Vogel H, Monje M. Subventricular spread of diffuse intrinsic pontine glioma.
ACTA Neuropathol 2014; 128: 605-607. (VUmc)
Caretti V, Sewing ACP, Lagerweij T, Schellen P, Bugiani M, Jansen MHA, van Vuurden DG, Navis AC,
Horsman I, Vandertop WP, Noske DP, Wesseling P, Kaspers GJ, Nazarian J, Vogel H, Hulleman E, Monje
M, Wurdinger T. Human pontine glioma cells can induce murine tumors. ACTA Neuropathol 2014; 127:
897-909. (VUmc)
Casale FP, Giurato G, Nassa G, Armond JW, Oates CJ, Cora D, Gamba A, Mukherjee S, Weisz A, Nicodemi
M. Single-cell states in the estrogen response of breast cancer cell lines. PLoS One 2014; 9:e88485 (NKI)
Cassier PA, Polivka V, Judson I, Soria JC, Penel N, Marsoni S, Verweij J, Schellens JHM, Morales-Barrera
R, Schoffski P, Voest EE, Gomez-Roca C, Evans TR, Plummer R, Gallerani E, Kaye SB, Olmos D. Outcome
of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset
analysis of a European Phase I database. Ann Oncol 2014; 25:1222-8 (NKI)
Castro FA, Dominguez A, Puschel K, van de Wyngard V, Snijders PJF, Franceschi S, Pawlita M, Ferreccio
C. Serological prevalence and persistence of high-risk human papillomavirus infection among women in
Santiago, Chile. BMC Infect Dis 2014; 14: 361. (VUmc)
Ceresa C, Avan A, Giovannetti E, Geldof AA, Avan A, Cavaletti G, Peters GJ. Characterization of and
Protection from Neurotoxicity Induced by Oxaliplatin, Bortezomib and Epothilone-B. Anticancer Res
2014; 34: 517-523. (VUmc)
Scientific publications - 91
220.
221.
222.
223.
224.
225.
226.
227.
228.
229.
230.
231.
232.
233.
234.
235.
236.
237.
238.
239.
240.
Cernohorsky P, Kok AC, de Bruin DM, Brandt MJ, Faber DJ, Tuijthof GJ, Kerkhoffs GM, Strackee SD, van
Leeuwen TG. Comparison of optical coherence tomography and histopathology in quantitative
assessment of goat talus articular cartilage. ACTA Ortopaedica -, 2014, p.--7. (AMC)
Chagaluka G, Stanley C, Banda K, Depani S, Nijram'madzi J, Katangwe T, Israels T, Bailey S, Mukaka M,
Molyneux E. Kaposi's sarcoma in children: An open randomised trial of vincristine, oral etoposide and a
combination of vincristine and bleomycin. Eur J Cancer 2014; 50: 1472-1481. (VUmc)
Chamberlain M, Soffietti R, Raizer J, Ruda R, Brandsma D, Boogerd W, Taillibert S, Groves MD, Le Rhun
E, Junck L, van den Bent M, Wen PY, Jaeckle KA. Leptomeningeal metastasis: a Response Assessment in
Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical
trials. Neuro Oncol 2014; 16:1176-85 (NKI)
Charehbili A, van de Ven S, Smit VTHBM, Meershoek-Klein Kranenbarg E, Hamdy NAT, Putter H, Heijns
JB, van Warmerdam LJC, Kessels L, Dercksen M, Pepels MJ, Maartense E, van Laarhoven HWM, Vriens B,
Wasser MN, van Leeuwen-Stok AE, Liefers GJ, van de Velde CJH, Nortier JWR, Kroep JR. Addition of
zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with
HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01). Annals of Oncology 25(5),
2014, p.998-1004. (AMC)
Chaturvedi N, Goeman JJ, Boer JM, van Wieringen WN, Menezes R. A test for comparing two groups of
samples when analyzing multiple omics profiles. BMC Bioinformatics 2014; 15: 236. (VUmc)
Chaturvedi N, Menezes R, Goeman JJ. Fused lasso algorithm for Cox proportional hazards and binomial
logit models with application to copy number profiles. Biometrical journal 2014; 56: 477-492. (VUmc)
Chen AA, Heideman DAM, Boon D, Chen ZG, Burk RD, de Vuyst H, Gheit T, Snijders PJF, Tommasino M,
Franceschi S, Clifford GM. Human papillomavirus 33 worldwide genetic variation and associated risk of
cervical cancer. Virology 2014; 448: 356-362. (VUmc)
Chen AA, Heideman DAM, Boon D, Gheit T, Snijders PJF, Tommasino M, Franceschi S, Clifford GM.
Human Papillomavirus 45 Genetic Variation and Cervical Cancer Risk Worldwide. J Virol 2014; 88: 45144521. (VUmc)
Chen W, Gilhuijs K, Stroom J, Bartelink H, Sonke JJ. A simulation framework for modeling tumor control
probability in breast conserving therapy. Radiother Oncol 2014; 111:289-95 (NKI)
Chen WW, Birsoy K, Mihaylova MM, Snitkin H, Stasinski I, Yucel B, Bayraktar EC, Carette JE, Clish CB,
Brummelkamp TR, Sabatini DD, Sabatini DM. Inhibition of ATPIF1 ameliorates severe mitochondrial
respiratory chain dysfunction in mammalian cells. Cell Rep 2014; 7:27-34 (NKI)
Chiasserini D, van Weering JRT, Piersma SR, Pham TV, Malekzadeh A, Teunissen CE, de Wit H, Jimenez
CR. Proteomic analysis of cerebrospinal fluid extracellular vesicles: A comprehensive dataset. Journal of
Proteomics 2014; 106: 191-204. (VUmc)
Chiodo F, Marradi M, Park J, Ram AFJ, Penades S, van Die I, Tefsen B. Galactofuranose-Coated Gold
Nanoparticles Elicit a Pro-inflammatory Response in Human Monocyte-Derived Dendritic Cells and Are
Recognized by DC-SIGN. Acs chemical biology 2014; 9: 383-389. (VUmc)
Chow EJ, Chen Y, Kremer LC, Breslow NE, Hudson MM, Armstrong GT, Border WL, Feijen EAM, Green DM,
Meacham LR, Meeske KA, Mulrooney DA, Ness KK, Oeffinger KC, Sklar CA, Stovall M, van der Pal HJ,
Weathers RE, Robison L., Yasui Yutaka. Individual Prediction of Heart Failure Among Childhood Cancer
Survivors. Journal of Clinical Oncology [aheadofprint], 2014, p.-. (AMC)
Cieslak KP, Runge JH, Heger M, Stoker J, Bennink RJ, van Gulik TM. New Perspectives in the Assessment
of Future Remnant Liver. Digestive Surgery 31(4-5), 2014, p.255-268. (AMC)
Cieslak KP, van Santvoort HC, Vleggaar FP, van Leeuwen MS, ten Kate FJ, Besselink MG, Molenaar IQ.
The role of routine preoperative EUS when performed after contrast enhanced CT in the diagnostic
work-up in patients suspected of pancreatic or periampullary cancer. Pancreatology 14(2), 2014,
p.125-130. (AMC)
Cirkel GA, Gadellaa-van Hooijdonk CG, Koudijs MJ, Willems SM, Voest EE. Tumor heterogeneity and
personalized cancer medicine: Are we being outnumbered? Future Oncol 2014; 10:417-28 (NKI)
Clapham R, Middag C, Hilgers F, Martens JP, van den Brekel M, Van Son R. Developing automatic
articulation, phonation and accent assessment techniques for speakers treated for advanced head and
neck cancer. Speech Commun 2014; 59:44-54 (NKI)
Clapham RP, Middag C, Hilgers FJM, Martens J, van den Brekel MWM, Son RJJH. Automatic assessment of
articulation, voice quality and accent; Developing automatic articulation, voice quality and accent
assessment techniques for speakers treated for advanced head and neck cancer. Speech Comm 2014;
59:44-54 (NKI)
Clavel CM, Paunescu E, Nowak-Sliwinska P, Griffioen AW, Scopelliti R, Dyson PJ. Discovery of a Highly
Tumor-Selective Organometallic Ruthenium(II)-Arene Complex. J Med Chem 2014; 57: 3546-3558.
(VUmc)
Clavo B, Robaina F, Jorge IJ, Cabrera R, Ruiz-Egea E, Szolna A, Otermin E, Llontop P, Carames MA,
Santana-Rodriguez N, Sminia P. Spinal Cord Stimulation as Adjuvant During Chemotherapy and
Reirradiation Treatment of Recurrent High-Grade Gliomas. Integrative cancer therapies 2014; 13: 513519. (VUmc)
Clement SC, Kraal KCJM, van Eck-Smit BLF, van den Bos C, Kremer LCM, Tytgat GAM, van Santen
HM.Primary Ovarian Insufficiency in Children After Treatment With I-131-Metaiodobenzylguanidine for
Neuroblastoma: Report of the First Two Cases. Journal of Clinical Endocrinology and Metabolism 99(1),
2014, p.E112-E116. (AMC)
92 - Scientific publications
241.
242.
243.
244.
245.
246.
247.
248.
249.
250.
251.
252.
253.
254.
255.
256.
257.
258.
259.
260.
261.
262.
Clement SC, Meeteren AY, Schouten-van N, Kremer LCM, van Trotsenburg ASPaul, Caron HN, van Santen
HM. High Prevalence of Early Hypothalamic-Pituitary Damage in Childhood Brain Tumor Survivors: Need
for Standardized Follow-Up Programs. Pediatric Blood & Cancer 61(12), 2014, p.2285-2289. (AMC)
Clement SC, van Rijn RR, van Eck-Smit BLF, van Trotsenburg ASP, Caron HN, Tytgat GAM, van Santen
HM. Long-term efficacy of current thyroid prophylaxis and future perspectives on thyroid protection
during (131)I-metaiodobenzylguanidine treatment in children with neuroblastoma. Eur Journal of
Nuclear Medicine and Molecular Imaging [aheadofprint], 2014, p.-. (AMC)
Clerici M, Luna-Vargas MP, Faesen AC, Sixma TK. The DUSP-Ubl domain of USP4 enhances its catalytic
efficiency by promoting ubiquitin exchange. Nat Commun 2014; 5:5399 (NKI)
Clijsters L, van Zon W, ter Riet B, Voets E, Boekhout M, Ogink J, Rumpf-Kienzl C, Wolthuis RMF.
Inefficient degradation of cyclin B1 re-activates the spindle checkpoint right after sister chromatid
disjunction. Cell Cycle 2014; 13: 2370-2378. (VUmc/NKI)
Clijsters L, Wolthuis RMF. PIP-box-mediated degradation prohibits re-accumulation of Cdc6 during S
phase. J Cell Sci 2014; 127: 1336-1345. (VUmc/NKI)
Clive AO, Kahan BC, Hooper CE, Bhatnagar R, Morley AJ, Zahan-Evans N, Bintcliffe OJ, Boshuizen RC,
Fysh ET, Tobin CL, Medford AR, Harvey JE, van den Heuvel MM, Lee YC, Maskell NA. Predicting survival
in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax 2014;
69:1098-104 (NKI)
Cnossen IC, Uden-Kraan CF, Rinkel RN, Aalders IJ, de Goede CJ, de Bree R, Doornaert P, Rietveld DHF,
Langendijk JA, Witte BI, Leemans CR, de Leeuw IM. Multimodal guided self-help exercise program to
prevent speech, swallowing, and shoulder problems among head and neck cancer patients: a feasibility
study. J Med Internet Res 2014; 16: e74. (VUmc)
Cobben JM, Oostra RJ, van Dijk FS. Pectus excavatum and carinatum. Eur J Med Genet 2014; 57: 414417. (VUmc)
Coca-Pelaz A, Rodrigo JP, Triantafyllou A, Hunt JL, Fernandez-Miranda JC, Strojan P, de Bree R, Rinaldo
A, Takes RP, Ferlito A. Chondrosarcomas of the head and neck. Eur Arch Oto-Rhino-L 2014; 271: 26012609. (VUmc)
Coenen EA, Zwaan CM, Stary J, Baruchel A, de Haas V, Stam RW, Reinhardt D, Kaspers GJL, rentsenPeters STCJ, Meyer C, Marschalek R, Nigro LL, Dworzak M, Pieters R, van den Heuvel-Eibrink MM. Unique
BHLHB3 overexpression in pediatric acute myeloid leukemia with t(6;11)(q27;q23). Leukemia 2014; 28:
1564-1568. (VUmc)
Coffelt SB, de Visser KE. Cancer: Inflammation lights the way to metastasis. Nature 2014; 507:48-9 (NKI)
Coghill AE, Hsu WL, Pfeiffer RM, Juwana H, Yu KJ, Lou PJ, Wang CP, Chen JY, Chen CJ, Middeldorp JM,
Hildesheim A. Epstein-Barr Virus Serology as a Potential Screening Marker for Nasopharyngeal Carcinoma
among High-Risk Individuals from Multiplex Families in Taiwan. Cancer Epidem Biomar 2014; 23: 12131219. (VUmc)
Cohen J, van Wesemael Y, Smets T, Bilsen J, Onwuteaka-Philipsen BD, Distelmans W, Deliens L.
Nationwide survey to evaluate the decision-making process in euthanasia requests in Belgium: do
specifically trained 2nd physicians improve quality of consultation?. BMC Health Serv Res 2014; 14: 307.
(VUmc)
Cohen R, Vugts DJ, Visser GWM, Stigter-van Walsum M, Bolijn M, Spiga M, Lazzari P, Shankar S, Sani M,
Zanda M, van Dongen GAMS. Development of Novel ADCs: Conjugation of Tubulysin Analogues to
Trastuzumab Monitored by Dual Radiolabeling. Cancer Res 2014; 74: 5700-5710. (VUmc)
Colak S, Medema JP. Cancer stem cells--important players in tumor therapy resistance. FEBS Journal
281(21), 2014, p.4779-4791. (AMC)
Colak S, Medema JP. Human colonic fibroblasts regulate stemness and chemotherapy resistance of colon
cancer stem cells. Cell Cycle [aheadofprint], 2014, p.-. (AMC)
Colak S, Zimberlin CD, Fessler E, Hogdal L, Prasetyanti PR, Grandela CM, Letai A, Medema JP. Decreased
mitochondrial priming determines chemoresistance of colon cancer stem cells. Cell Death and
Differentation 21(7), 2014, p.1170-1177. (AMC)
Combes JD, Pawlita M, Waterboer T, Hammouda D, Rajkumar T, Vanhems P, Snijders PJF, Herrero R,
Franceschi S, Clifford G. Antibodies against high-risk human papillomavirus proteins as markers for
invasive cervical cancer. Int J Cancer 2014; 135: 2453-2461. (VUmc)
Coolen BF, Simonis FFJ, Geelen T, Moonen RPM, Arslan F, Paulis LEM, Nicolay K, Strijkers GJ.
Quantitative T-2 Mapping of the Mouse Heart by Segmented MLEV Phase-Cycled T-2 Preparation.
Magnetic Resonance in Medicine 72(2), 2014, p.409-417. (AMC)
Cordeiro Feijoo ER, Geijsen DE, Zum Vörde Sive Vörding PJ, Schooneveldt G, Sijbrands J, Hulshof MC, de
la Rosette J, de Reijke TM, Crezee H. Novel multi-sensor probe for monitoring bladder temperature
during loco-regional chemo-hyperthermia for non-muscle invasive bladder cancer: technical feasibility
study. Journal of Endourology [aheadofprint], 2014, p.-. (AMC)
Cornelissen JJ, Versluis J, Passweg JR, van Putten WLJ, Manz MG, Maertens J, Beverloo HB, Valk PJM,
van Marwijk KM, Wijermans PW, Schaafsma MR, Biemond BJ, Vekemans M-C, Breems DA, Verdonck LF,
Fey MF, Jongen-Lavrencic M, Janssen JJWM, Huls G, Kuball J, Pabst T, Graux C, Schouten HC, Gratwohl
A, Vellenga E, Ossenkoppele G, Löwenberg B. Comparative therapeutic value of post remission
approaches in patients with acute myeloid leukemia aged 40-60 years. Leukemia [aheadofprint], 2014,
p.-. (AMC)
Cornu J-N, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, McVary K, Novara G, Woo H,
Scientific publications - 93
263.
264.
265.
266.
267.
268.
269.
270.
271.
272.
273.
274.
275.
276.
277.
278.
279.
280.
281.
282.
Madersbacher S. A Systematic Review and Meta-analysis of Functional Outcomes and Complications
Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic
Obstruction: An Update. European Urology [aheadofprint], 2014, p.-. (AMC)
Costa DS, Aaronson NK, Fayers PM, Grimison PS, Janda M, Pallant JF, Rowen D, Velikova G, Viney R,
Young TA, King MT. Deriving a preference-based utility measure for cancer patients from the European
Organisation for the Research and Treatment of Cancer's Quality of Life Questionnaire C30: a
confirmatory versus exploratory approach. Patient Relat Outcome Meas 2014; 5:119-29 (NKI)
Coutinho JM, Idema S, Vandertop WP. Decompressive craniectomy. J Neurosurg 2014; 120: 577. (VUmc)
Cox JA, Lukande RL, Kalungi S, Van de Vijver K, Van Marck E, Nelson AM, Munema A, Manabe YC,
Colebunders R. Practice of percutaneous needle autopsy; a descriptive study reporting experiences from
Uganda. BMC Clin Pathol 2014; 14:44 (NKI)
Cox JA, Lukande RL, Kalungi S, Van Marck E, Van de Vijver K, Kambugu A, Nelson AM, Manabe YC,
Colebunders R. Needle autopsy to establish the cause of death in HIV-infected hospitalized adults in
Uganda; a comparison to complete autopsy. J Acquir Immune Defic Syndr 2014; 67:169-76 (NKI)
Cree IA, Deans Z, Ligtenberg MJL, Normanno N, Edsjo A, Rouleau E, Sole F, Thunnissen E, Timens W,
Schuuring E, Dequeker E, Murray S, Dietel M, Groenen P, van Krieken JH. Guidance for laboratories
performing molecular pathology for cancer patients. J Clin Oncol 2014; 67: 923-931. (VUmc)
Creutzig U, Semmler J, Kaspers G, Reinhardt D, Zimmermann M. Re-induction with L-DNR/FLAG
Improves Response after AML Relapse, but not Long-term Survival. Klin Padiatr 2014; 226: 323-331.
(VUmc)
Creutzig U, Zimmermann M, Dworzak MN, Gibson B, Tamminga R, Abrahamsson J, Ha SY, Hasle H,
Maschan A, Bertrand Y, Leverger G, von Neuhoff C, Razzouk B, Rizzari C, Smisek P, Smith OP, Stark B,
Reinhardt D, Kaspers GJL. The prognostic significance of early treatment response in pediatric relapsed
acute myeloid leukemia: results of the international study Relapsed AML 2001/01. Haematol-Hematol J
2014; 99: 1472-1478. (VUmc)
Croci DO, Cerliani JP, otto-Moreno T, Mendez-Huergo SP, Mascanfroni ID, rgan-Dylon S, Toscano MA,
Caramelo JJ, Garcia Vallejo JJ, Ouyang J, Mesri EA, Junttila MR, Bais C, Shipp MA, Salatino M,
Rabinovich GA. Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in AntiVEGF Refractory Tumors. Cell 2014; 156: 744-758. (VUmc)
Crombag MR, Vries Schultink AH, Schellens JH, Beijnen JH, Huitema AD. Incidence of Hematologic
Toxicity in Older Adults Treated with Gemcitabine or a Gemcitabine-Containing Regimen in Routine
Clinical Practice: A Multicenter Retrospective Cohort Study. Drugs Aging 2014; 31:737-47 (NKI)
Cserni G, Voros A, Liepniece-Karele I, Bianchi S, Vezzosi V, Grabau D, Sapino A, Castellano I, Regitnig P,
Foschini MP, Zolota V, Varga Z, Figueiredo P, Decker T, Focke C, Kulka J, Kaya H, Reiner-Concin A,
Amendoeira I, Callagy G, Caffrey E, Wesseling J, Wells C. Distribution pattern of the Ki67 labelling index
in breast cancer and its implications for choosing cut-off values. Breast 2014; 23:259-63 (NKI)
Custers JAE, van den Berg SW, van Laarhoven HWM, Bleiker EMA, Gielissen MFM, Prins JB. The Cancer
Worry Scale: detecting fear of recurrence in breast cancer survivors. Cancer Nurs 2014; 37:E44-E50
(NKI/AMC)
Dabestani S, Marconi L, Hofmann F, Stewart F, Lam TB, Canfield SE, Staehler M, Powles T, Ljungberg B,
Bex A. Local treatments for metastases of renal cell carcinoma: a systematic review. Lancet Oncol 2014;
15:e549-e561 (NKI)
Dafni U, Karlis D, Smit E, Peters S. Second line treatment for EGFR wild-type advanced NSCLC: The Jury
is Still Out. Lung Cancer 2014; 84: 314-315. (VUmc)
Dagan M, Sanderman R, Hoff C, Meijerink WJHJ, Baas PC, van Haastert M, Hagedoorn M. The interplay
between partners' responsiveness and patients' need for emotional expression in couples coping with
cancer. J Behav Med 2014; 37: 828-838. (VUmc)
Daleke-Schermerhorn MH, Felix T, Soprova Z, Hagen-Jongman CM, Vikstrom D, Majlessi L, Beskers J,
Follmann F, de Punder K, van der Wel NN, Baumgarten T, Pham TV, Piersma SR, Jimenez CR, van Ulsen
P, de Gier JW, Leclerc C, Jong WS, Luirink J. Decoration of outer membrane vesicles with multiple
antigens using an autotransporter approach. Appl Environ Microbiol 2014; 80:5854-65 (NKI)
Daniels L, Unlü C, de Wijkerslooth TR, Dekker E, Boermeester MA. Routine colonoscopy after left-sided
acute uncomplicated diverticulitis: a systematic review. Gastrointestinal Endoscopy 79(3), 2014,
p.378-89; quiz 498-498.e5. (AMC)
Daniels L, Unlü C, de Wijkerslooth TR, Stockmann HB, Kuipers EJ, Boermeester MA, Dekker E. Yield of
colonoscopy after recent CT-proven uncomplicated acute diverticulitis: a comparative cohort study.
Surgical Endoscopy and Other Interventional Techniques [aheadofprint], 2014, p.-. (AMC)
Dassen A, Dikken J, Bosscha K, Wouters M, Cats A, van de Velde C, Coebergh J, Lemmens V. Gastric
cancer: Decreasing incidence but stable survival in the Netherlands. Acta Oncol 2014; 53:138-42 (NKI)
Dávila Fajardo R, Lekkerkerker SJ, van der Horst A, Lens E, Bergman JJ, Fockens P, Bel A, van Hooft JE.
EUS-guided fiducial markers placement with a 22-gauge needle for image-guided radiation therapy in
pancreatic cancer. Gastrointestinal Endoscopy 79(5), 2014, p.851-855. (AMC)
Dávila Fajardo R, van Os R, Buist MR, Uitterhoeve L, Westermann AM, Kenter GG, Rasch CRN, Stalpers
LJA. Post-operative radiotherapy in patients with early stage cervical cancer. Gyneacolic Oncology
134(1), 2014, p.52-59. (AMC)
94 - Scientific publications
283.
284.
285.
286.
287.
288.
289.
290.
291.
292.
293.
294.
295.
296.
297.
298.
299.
300.
301.
302.
303.
304.
Davis FM, Azimi I, Faville RA, Peters AA, Jalink K, Putney JW, Jr., Goodhill GJ, Thompson EW, RobertsThomson SJ, Monteith GR. Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is
calcium signal dependent. Oncogene 2014; 33:2307-16 (NKI)
Day J, Zienius K, Gehring K, Grosshans D, Taphoorn MJ, Grant R, Li J, Brown PD. Interventions for
preventing and ameliorating cognitive deficits in adults treated with cranial irradiation. Cochrane
Database Syst Rev 2014; 2014: CD011335. (VUmc)
De Boer AGEM. The European Cancer and Work Network: CANWON. Journal of Occupational
Rehabilitation 24(3), 2014, p.393-398. (AMC)
de Boer KHN, de Meij TGJ, Oort FA, Ben Larbi I, Mulder CJJ, van Bodegraven AA, van der Schee MP. The
Scent of Colorectal Cancer: Detection by Volatile Organic Compound Analysis. Clin Gastroenterol
Hepatol 2014; 12: 1085-1089. (VUmc)
De Boer M, Ramrattan MA, Boeker EB, Kuks PFM, Boermeester MA, Lie-A-Huen L. Quality of
Pharmaceutical Care in Surgical Patients. PLOS ONE 9(7), 2014, p.e101573-. (AMC)
de Bree E, Zoras O, Hunt JL, Takes RP, Suarez C, Mendenhall WM, Hinni ML, Rodrigo JP, Shaha AR,
Rinaldo A, Ferlito A, de Bree R. Desmoid tumors of the head and neck: A therapeutic challenge. Head
Neck-J Sci Spec 2014; 36: 1517-1526. (VUmc)
de Bruin EC, Cowell C, Warne PH, Jiang M, Saunders RE, Melnick MA, Gettinger S, Walther Z, Wurtz A,
Heynen GJ, Heideman DAM, Gomez-Roman J, Garcia-Castano A, Gong YX, Ladanyi M, Varmus H,
Bernards R, Smit EF, Politi K, Downward J. Reduced NF1 Expression Confers Resistance to EGFR
Inhibition in Lung Cancer. Cancer discovery 2014; 4: 606-619. (VUmc/NKI)
De Bruin R, van Furth WR, Verbaan D, Georgalas C, Fokkens WF, Reinartz SM. Initial experiences with
endoscopic rhino-neurosurgery in Amsterdam. European Archives of Oto-Rhino-Laryngology 271(6), 2014,
p.1525-1532. (AMC)
de Cortie K, Russell NS, Coppes RP, Stewart FA, Scharpfenecker M. Bone marrow-derived macrophages
incorporate into the endothelium and influence vascular and renal function after irradiation. Int J
Radiat Biol 2014; 90:769-77 (NKI)
De Craene B, Denecker G, Vermassen P, Taminau J, Mauch C, Derore A, Jonkers J, Fuchs E, Berx G.
Epidermal Snail expression drives skin cancer initiation and progression through enhanced
cytoprotection, epidermal stem/progenitor cell expansion and enhanced metastatic potential. Cell
Death Differ 2014; 21:310-20
de Cuba EMV, Verwaal VJ, de Hingh IHJT, van Mens LJJ, Nienhuijs SW, Aalbers AGJ, Bonjer HJ, te Velde
EA. Morbidity Associated with Colostomy Reversal After Cytoreductive Surgery and HIPEC. Ann Surg
Oncol 2014; 21: 883-890. (VUmc/NKI)
de Glas NA, Fontein DB, Bastiaannet E, Pijpe A, De Craen AJ, Liefers GJ, Nortier HJ, de Haes HJ, Van de
Velde CJ, van Leeuwen FE. Physical activity and survival of postmenopausal, hormone receptor-positive
breast cancer patients: results of the Tamoxifen Exemestane Adjuvant Multicenter Lifestyle study.
Cancer 2014; 120:2847-54 (NKI)
de Goede B, Eker HH, Klitsie PJ, van Kempen BJH, Polak WG, Hop WCJ, Metselaar HJ, Tilanus HW,
Lange JF, Kazemier G. Incisional hernia after liver transplantation: risk factors and health-related
quality of life. Clin Transplant 2014; 28: 829-836. (VUmc)
de Graaf EL, Kaplon J, Zhou H, Heck AJ, Peeper DS, Altelaar AF. Phosphoproteome Dynamics in Onset
and Maintenance of Oncogene-induced Senescence. Mol Cell Proteomics 2014; 13:2089-100 (NKI)
de Graauw M, Cao L, Winkel L, van Miltenburg MHAM, le Dévédec SE, Klop M, Yan K, Pont C, Rogkoti VM,
Tijsma A, Chaudhuri A, Lalai R, Price L, Verbeek F, van de Water B. Annexin A2 depletion delays EGFR
endocytic trafficking via cofilin activation and enhances EGFR signaling and metastasis formation.
Oncogene 2014; 33:2610-9 (NKI)
de Groen FLM, Krijgsman O, Tijssen M, Vriend LEM, Ylstra B, Hooijberg E, Meijer GA, Steenbergen RDM,
Carvalho B. Gene-Dosage Dependent Overexpression at the 13q Amplicon Identifies DIS3 as Candidate
Oncogene in Colorectal Cancer Progression. Gene Chromosome Canc 2014; 53: 339-348. (VUmc)
De Groot JE, Branderhorst W, Grimbergen CA, den Heeten GJ, Broeders MJM. Towards personalized
compression in mammography: A comparison study between pressure- and force-standardization.
European Journal of Radiology [aheadofprint], 2014, p.-. (AMC)
De Groot JE, Broeders MJM, Branderhorst W, den Heeten GJ, Grimbergen CA.Mammographic
compression after breast conserving therapy: controlling pressure instead of force. Medical Physics
41(2), 2014, p.023501-. (AMC)
de Jong J, Akhtar W, Badhai J, Rust AG, Rad R, Hilkens J, Berns A, van Lohuizen M, Wessels LF, de
Ridder J. Chromatin landscapes of retroviral and transposon integration profiles. PLoS Genet 2014;
10:e1004250 (NKI)
De Jong M, de Boer AGEM, Tamminga SJ, Frings-Dresen MHW. Quality of Working Life Issues of
Employees with a Chronic Physical Disease: A Systematic Review. Journal of Occupational Rehabilitation
[aheadofprint], 2014, p.-. (AMC)
de Jong MC, de Graaf P, Noij DP, Goricke S, Maeder P, Galluzzi P, Brisse HJ, Moll AC, Castelijns JA.
Diagnostic Performance of Magnetic Resonance Imaging and Computed Tomography for Advanced
Retinoblastoma: A Systematic Review and Meta-analysis. Ophthalmology 2014; 121: 1109-1118. (VUmc)
de Jong MC, Kors WA, de Graaf P, Castelijns JA, Kivela T, Moll AC. Trilateral retinoblastoma: a
systematic review and meta-analysis. Lancet Oncol 2014; 15: 1157-1167. (VUmc)
Scientific publications - 95
305.
306.
307.
308.
309.
310.
311.
312.
313.
314.
315.
316.
317.
318.
319.
320.
321.
322.
323.
324.
325.
de Kock L, Sabbaghian N, Druker H, Weber E, Hamel N, Miller S, Choong CS, Gottardo NG, Kees UR,
Rednam SP, van Hest LP, Jongmans MC, Jhangiani S, Lupski JR, Zacharin M, Bouron-Dal Soglio D, Huang
A, Priest JR, Perry A, Mueller S, Albrecht S, Malkin D, Gru. Germ-line and somatic DICER1 mutations in
pineoblastoma. ACTA Neuropathol 2014; 128: 583-595. (VUmc)
de Korte-Verhoef MC, Pasman HRW, Schweitzer BPM, Francke AL, Onwuteaka-Philipsen BD, Deliens L.
Burden for family carers at the end of life; a mixed-method study of the perspectives of family carers
and GPs. BMC Palliative Care 2014; 13: 16. (VUmc)
de Korte-Verhoef MC, Pasman HRW, Schweitzer BPM, Francke AL, Onwuteaka-Philipsen BD, Deliens L.
General practitioners' perspectives on the avoidability of hospitalizations at the end of life: A mixedmethod study. Palliative Med 2014; 28: 949-958. (VUmc)
de Korte-Verhoef MC, Pasman HRW, Schweitzer BPM, Francke AL, Onwuteaka-Philipsen BD, Deliens L.
Reasons for hospitalisation at the end of life: differences between cancer and non-cancer patients.
Support Care Cancer 2014; 22: 645-652. (VUmc)
De la Rosette J, Denstedt J, Geavlete P, Keeley F, Matsuda T, Pearle M, Preminger G, Traxer O. The
clinical research office of the endourological society ureteroscopy global study: indications,
complications, and outcomes in 11,885 patients. Journal of Endourology 28(2), 2014, p.131-139. (AMC)
De la Rosette J. Prevention of Kidney Stones: A Call for More Evidence-Based Research. Journal of
Urology 192(2), 2014, p.325-326. (AMC)
De La Rosette JJMCH. Lower urinary tract symptoms in the elderly male: choosing wisely. Journal of
Urology 191(2), 2014, p.289-290. (AMC)
de Leeuw DC, Denkers F, Olthof MC, Rutten AP, Pouwels W, Schuurhuis GJ, Ossenkoppele GJ, Smit L.
Attenuation of microRNA-126 Expression That Drives CD34(+)38 Stem/Progenitor Cells in Acute Myeloid
Leukemia Leads to Tumor Eradication. Cancer Res 2014; 74: 2094-2105. (VUmc)
de Leeuw IM, Buffart LM, Heijmans MW, Rietveld DHF, Doornaert P, de Bree R, Buter J, Aaronson NK,
Slotman BJ, Leemans CR, Langendijk JA. The course of health-related quality of life in head and neck
cancer patients treated with chemoradiation: A prospective cohort study. Radiother Oncol 2014; 110:
422-428. (VUmc)
De Lijster MS, Smets AM, van den Berg H, Reekers JA. Embolisation for caecal bleeding in a child with
typhlitis. Pediatric Radiology [aheadofprint], 2014, p.-. (AMC)
de Meij TGJ, Ben Larbi I, van der Schee MP, Lentferink YE, Paff T, Droste JSTS, Mulder CJ, van
Bodegraven AA, de Boer KHN. Electronic nose can discriminate colorectal carcinoma and advanced
adenomas by fecal volatile biomarker analysis: proof of principle study. Int J Cancer 2014; 134: 11321138. (VUmc)
De Ridder M, Balm AJM, Smeele LE, Wouters MWJM, van Dijk BAC. An epidemiological evaluation of
salivary gland cancer in the Netherlands (1989-2010). Cancer Epidemiology [aheadofprint], 2014, p.-.
(AMC)
de Ridder M, Smeele L, van den Brekel M, van Harten M, Wouters M, Balm A. Letter to the editor:
Volume criteria for the treatment of Head and Neck cancer: Are they evidence based? Head Neck 2014;
36:760-2 (NKI)
De Ridder M, Smeele LE, van den Brekel MWM, van Harten MC, Wouters MWJM, Balm AJM. Volume
criteria for the treatment of head and neck cancer: Are they evidence based? Head and Neck Journal for
the sciences and Specialties of the Head and Neck 36(5), 2014, p.760-762. (AMC/NKI)
de Ronde JJ, Bonder MJ, Lips EH, Rodenhuis S, Wessels LFA. Breast cancer subtype specific classifiers of
response to neoadjuvant chemotherapy do not outperform classifiers trained on all subtypes. PLoS One
2014; 9:e88551 (NKI)
De Roo ML, Miccinesi G, Onwuteaka-Philipsen BD, Den Noortgate N, Block L, Bonacchi A, Donker GA,
Alonso JEL, Moreels S, Deliens L, Francke AL. Actual and Preferred Place of Death of Home-Dwelling
Patients in Four European Countries: Making Sense of Quality Indicators. PLoS One 2014; 9: e93762.
(VUmc)
De Rooij T, Jilesen AP, Boerma D, Bonsing BA, Bosscha K, van Dam RM, van Dieren S, Dijkgraaf MG, van
Eijck CH, Gerhards MF, van Goor H, van der Harst E, de Hingh IH, Kazemier G, Klaase JM, Molenaar IQ,
Nieveen van Dijkum EJ, Patijn GA, van Santvoort HC, Scheepers JJ, van der Schelling GP, Sieders E,
Vogel JA, Busch OR, Besselink MG. A Nationwide Comparison of Laparoscopic and Open Distal
Pancreatectomy for Benign and Malignant Disease.
Journal of the American College of Surgeons [aheadofprint], 2014, p.-. (AMC)
de Ruiter M. Onderzoek naar cognitieve problemen bij borstkankerpatiënten na chemotherapie - De
toepassing van neuroimaging technieken. Gamma Prof 2014; 64:24-7 (NKI)
de Ruiter MH, Smeele L, de LJ. [Unilateral angioedema of the tongue and the floor of the mouth as a
side-effect of ACE-inhibitors]. Unilateraal angio-oedeem van de tong en de mondbodem door ACEremmers. Ned Tijdschr Tandheelkd 2014; 121:259-60 (NKI)
de Ruiter RD, Gordijn MS, Gemke RJBJ, van den Bos CG, Bierings MB, Rotteveel J, Koper JW, Rossum
EFC, Kaspers GJL. Adrenal insufficiency during treatment for childhood acute lymphoblastic leukemia is
associated with glucocorticoid receptor polymorphisms ER22/23EK and BclI. Haematol-Hematol J 2014;
99: E136-E137. (VUmc/AMC)
De Ruysscher D, Faivre-Finn C, Le Pechoux C, Peeters S, Belderbos J. High-dose re-irradiation following
radical radiotherapy for non-small-cell lung cancer. Lancet Oncol 2014; 15:e620-e624 (NKI)
96 - Scientific publications
326.
327.
328.
329.
330.
331.
332.
333.
334.
335.
336.
337.
338.
339.
340.
341.
342.
343.
344.
345.
346.
347.
de Steur WO, Henneman D, Allum WH, Dikken JL, van Sandick JW, Reynolds J, Mariette C, Jensen L,
Johansson J, Kolodziejczyk P, Hardwick RH, Van de Velde CJ. Common data items in seven European
oesophagogastric cancer surgery registries: towards a European upper GI cancer audit (EURECCA Upper
GI). Eur J Surg Oncol 2014; 40:325-9 (NKI)
de Strooper LMA, Hesselink AT, Berkhof J, Meijer CJLM, Snijders PJF, Steenbergen RDM, Heideman DAM.
Combined CADM1/MAL methylation and cytology testing for colposcopy triage of high-risk HPV-positive
women. Cancer Epidem Biomar 2014; 23: 1933-1937. (VUmc)
de Strooper LMA, Meijer CJLM, Berkhof J, Hesselink AT, Snijders PJF, Steenbergen RDM, Heideman DAM.
Methylation Analysis of the FAM19A4 Gene in Cervical Scrapes Is Highly Efficient in Detecting Cervical
Carcinomas and Advanced CIN2/3 Lesions. Cancer Prevention Research 2014; 7: 1251-1257. (VUmc)
de Strooper LMA, van Zummeren M, Steenbergen RDM, Bleeker MCG, Hesselink AT, Wisman GB, Snijders
PJF, Heideman DAM, Meijer CJLM. CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to
detect cervical and endometrial cancer. J Clin Pathol 2014; 67: 1067-1071. (VUmc)
de Viron S, Morré SA, van Oyen H, Brand A, Ouburg S. Genetic similarities between tobacco use disorder
and related comorbidities: an exploratory study. BMC Med Genet 2014; 15: 85. (VUmc)
De Vleminck A, Pardon K, Beernaert K, Deschepper R, Houttekier D, van Audenhove C, Deliens L, van
der Stichele R. Barriers to Advance Care Planning in Cancer, Heart Failure and Dementia Patients: A
Focus Group Study on General Practitioners' Views and Experiences. PLoS One 2014; 9: e84905. (VUmc)
De Vleminck A, Pardon K, Beernaert K, Deschepper R, Houttekier D, Van Audenhove C, Deliens L, van
der Stichele R. Barriers to Advance Care Planning in Cancer, Heart Failure and Dementia Patients: A
Focus Group Study on General Practitioners' Views and Experiences. PLoS One 2014; 9: e84905. (VUmc)
de Vos FY, Kaal SE, Wesseling P, Gijtenbeek JM. Successful third-line chemotherapy for an adult with
recurrent medulloblastoma. International Cancer Conference Journal 2014; 3: 32-37. (VUmc)
de Vree PJ, de Wit E, Yilmaz M, van de Heijning M, Klous P, Verstegen MJ, Wan Y, Teunissen H, Krijger
PH, Geeven G, Eijk PP, Sie D, Ylstra B, Hulsman LO, van Dooren MF, van Zutven LJ, van den Ouweland A,
Verbeek S, van Dijk KW, Cornelissen M, Das AT, Berkhout B, Sikkema-Raddatz B, van den Berg E, van der
Vlies P, Weening D, den Dunnen JT, Matusiak M, Lamkanfi M, Ligtenberg MJ, Ter Brugge P, Jonkers J,
Foekens JA, Martens JW, van der Luijt R, van Amstel HK, van Min M, Splinter E, de Laat W. Targeted
sequencing by proximity ligation for comprehensive variant detection and local haplotyping. Nat
Biotechnol 2014; 32:1019-25 (NKI/VUmc)
De Vries A, Moonen R, Yildirim M, Langereis S, Lamerichs R, Pikkemaat JA, Baroni S, Terreno E, Nicolay
K, Strijkers GJ, Grüll H. Relaxometric studies of gadolinium-functionalized perfluorocarbon
nanoparticles for MR imaging. Contrast Media & Molecular Imaging 9(1), 2014, p.83-91. (AMC)
de Vuyst H, Mugo NR, Franceschi S, McKenzie K, Tenet V, Njoroge J, Rana FS, Sakr SR, Snijders PJF,
Chung MH. Residual Disease and HPV Persistence after Cryotherapy for Cervical Intraepithelial Neoplasia
Grade 2/3 in HIV-Positive Women in Kenya. PLoS One 2014; 9: e111037. (VUmc)
De Waele J., Lipman J, Sakr Y, Marshall JC, Vanhems P, Barrera GC, Leone M, Vincent JL. Abdominal
infections in the intensive care unit: characteristics, treatment and determinants of outcome. BMC
Infect Dis 2014; 14:420 (NKI)
de Weger VA, Beijnen JH, Schellens JHM. Cellular and clinical pharmacology of the taxanes docetaxel
and paclitaxel--a review. Anticancer Drugs 2014; 25:488-94 (NKI)
de Wit M, Kant H, Piersma SR, Pham TV, Mongera S, van Berkel MPA, Boven E, Ponten F, Meijer GA,
Jimenez CR, Fijneman RJA. Colorectal cancer candidate biomarkers identified by tissue secretome
proteome profiling. Journal of Proteomics 2014; 99: 26-39. (VUmc)
Decristoforo C, Penuelas I, Elsinga P, Ballinger J, Windhorst AD, Verbruggen A, Verzijlbergen F, Chiti A.
Radiopharmaceuticals are special, but is this recognized? The possible impact of the new Clinical Trials
Regulation on the preparation of radiopharmaceuticals. Eur J Nucl Med Mol I 2014; 41: 2005-2007.
(VUmc)
Dees-Ribbers HM, Betgen A, Pos FJ, Witteveen T, Remeijer P, van Herk M. Inter- and intra-fractional
bladder motion during radiotherapy for bladder cancer: A comparison of full and empty bladders.
Radiation and Oncology 113(2), 2014, p.254-259. (AMC)
Dees-Ribbers HM, Betgen A, Pos FJ, Witteveen T, Remeijer P, van Herk M. Inter- and intra-fractional
bladder motion during radiotherapy for bladder cancer: A comparison of full and empty bladders.
Radiother Oncol 2014; 113:254-9 (NKI)
Deganello A, Leemans CR. The infrahyoid flap: A comprehensive review of an often overlooked
reconstructive method. Oral Oncol 2014; 50: 704-710. (VUmc)
Dekkers-Sánchez PM, Wind H, Frings-Dresen MHW, Sluiter JK. Implementation of a checklist to assess
factors relevant for work ability assessments of employees on long-term sick leave. International
Archives of Occupational and Environmental Health [aheadofprint], 2014, p.-. (AMC)
Denters MJ, Deutekom M, Essink-Bot M-L, Bossuyt PM, Fockens P, Dekker E. Assessing knowledge and
attitudes towards screening among users of faecal immunochemical test. Health
Expectations[aheadofprint], 2014, p.-. (AMC)
Dentler K, Cornet R, ten Teije A, Tanis P, Klinkenbijl J, Tytgat K, de Keizer N. Influence of data quality
on computed Dutch hospital quality indicators: a case study in colorectal cancer surgery. BMC Medical
Informations and Decision Making 14, 2014, p.32-. (AMC)
Depla AL, Scharloo-Karels CH, de Jong MA, Oldenborg S, Kolff MW, Oei SB, van Coevorden F, van Rhoon
GC, Baartman EA, Scholten RJ, Crezee J, van Tienhoven G. Treatment and prognostic factors of
Scientific publications - 97
348.
349.
350.
351.
352.
353.
354.
355.
356.
357.
358.
359.
360.
361.
362.
363.
364.
365.
366.
367.
368.
radiation-associated angiosarcoma (RAAS) after primary breast cancer: a systematic review. Eur J
Cancer 2014; 50:1779-88 (NKI/AMC)
Derissen EJB, Hillebrand MJX, Rosing H, Otten HMMB, Laille E, Schellens JHM, Beijnen JH. Quantitative
determination of azacitidine triphosphate in peripheral blood mononuclear cells using liquid
chromatography coupled with high-resolution mass spectrometry. J Pharm Biomed Anal 2014; 90:7-14
(NKI)
Derks J, Reijneveld JC, Douw L. Neural network alterations underlie cognitive deficits in brain tumor
patients. Curr Opin Oncol 2014; 26: 627-633. (VUmc)
Derks S, Cleven AHG, Melotte V, Smits KM, Brandes JC, Azad N, Van Criekinge W, de Bruine AP, Herman
JG, van Engeland M. Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision
medicine. Cancer Metast Rev 2014; 33: 161-171. (VUmc)
Despierre E, Yesilyurt BT, Lambrechts S, Johnson N, Verheijen R, van der Burg M, Casado A, Rustin G,
Berns , Leunen K, Amant F, Moerman P, Lambrechts D, Vergote I. Epithelial ovarian cancer: rationale for
changing the one-fits-all standard treatment regimen to subtype-specific treatment. International
Journal of Gyecological Cancer 24(3), 2014, p.468-477. (AMC)
Devriese LA, Koch KM, Mergui-Roelvink M, Matthys GM, Ma WW, Robidoux A, Stephenson JJ, Chu QS,
Orford KW, Cartee L, Botbyl J, Arya N, Schellens JHM. Effects of low-fat and high-fat meals on steadystate pharmacokinetics of lapatinib in patients with advanced solid tumours. Invest New Drugs 2014;
32:481-8 (NKI)
Deyaert J, Chambaere K, Cohen J, Roelands M, Deliens L. Labelling of end-of-life decisions by
physicians.. Journal of Medical Ethics 2014; 40(7): 505-507. (VUmc)
Dias MM, Pignon J-P, Karapetis CS, Boige V, Glimelius B, Kweekel DM, Lara PN, Laurent-Puig P,
Martinez-Balibrea E, Páez D, Punt CJA, Redman MW, Toffoli G, Wadelius M, McKinnon RA, Sorich MJ. The
effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative
meta-analysis. Pharmacogenomics Journal 14(5), 2014, p.424-431. (AMC)
Dickhoff C, Hartemink KJ, Slebos DJ, Symersky P, Vonk-Noordegraaf A. Extrathoracic proof of
intrathoracic trouble. Thorax 2014; 69:785 (NKI)
Dickhoff C, Hartemink KJ, van de Ven PM, van Reij EJ, Senan S, Paul MA, Smit EF, Dahele M. Trimodality
therapy for stage IIIA non-small cell lung cancer: Benchmarking multi-disciplinary team decision-making
and function. Lung Cancer 2014; 85:218-23 (NKI)
Dickhoff C, Hartemink KJ, van de Ven PM, van Reije EJF, Senan S, Paul MA, Smit EF, Dahele M.
Trimodality therapy for stage IIIA non-small cell lung cancer: Benchmarking multi-disciplinary team
decision-making and function. Lung Cancer 2014; 85: 218-223. (VUmc)
Diekstra MH, Klumpen HJ, Lolkema MP, Yu H, Kloth JS, Gelderblom H, van Schaik RH, Gurney H, Swen
JJ, Huitema AD, Steeghs N, Mathijssen RH. Association analysis of genetic polymorphisms in genes
related to sunitinib pharmacokinetics, specifically clearance of sunitinib and SU12662. Clin Pharmacol
Ther 2014; 96:81-9 (NKI)
Diekstra MHM, Klümpen HJ, Lolkema MPJK, Yu H, Kloth JSL, Gelderblom H, van Schaik RHN, Gurney H,
Swen JJ, Huitema ADR, Steeghs N, Mathijssen RHJ. Association analysis of genetic polymorphisms in
genes related to sunitinib pharmacokinetics, specifically clearance of sunitinib and SU12662. Clinical
Pharmacology & Therapeutics 96(1), 2014, p.81-89. (AMC)
Dijkstra MG, Snijders PJF, Arbyn M, Rijkaart DC, Berkhof J, Meijer CJLM. Cervical cancer screening: on
the way to a shift from cytology to full molecular screening. Ann Oncol 2014; 25: 927-935. (VUmc)
Dijkstra MG, van Niekerk D, Rijkaart DC, van Kemenade FJ, Heideman DAM, Snijders PJF, Meijer CJLM,
Berkhof J. Primary hrHPV DNA Testing in Cervical Cancer Screening: How to Manage ScreenPositiveWomen? APOBASCAMTrial Substudy. Cancer Epidem Biomar 2014; 23: 55-63. (VUmc)
Dijkstra S, Birker IL, Smit FP, Leyten GHJM, de Reijke TM, van Oort IM, Mulders PFA, Jannink SA,
Schalken JA. Prostate cancer biomarker profiles in urinary sediments and exosomes. Journal of Urology
191(4), 2014, p.1132-1138. (AMC)
Dijxhoorn DN, Boutall A, Mulder CJJ, Ssebuufu R, Mall A, Kalungi S, Baigrie C, Goldberg PA. Colorectal
cancer in patients from Uganda: A histopathological study. East and Central African Journal of Surgery
2014; 19: 112-119. (VUmc)
Dikken JL, Coit DG, Baser RE, Gonen M, Goodman KA, Brennan MF, Jansen EP, Boot H, Van de Velde CJ,
Cats A, Verheij M. Performance of a nomogram predicting disease-specific survival after an R0 resection
for gastric cancer in patients receiving postoperative chemoradiation therapy. Int J Radiat Oncol Biol
Phys 2014; 88:624-9 (NKI)
Dimopoulos MA, Leleu X, Palumbo A, Moreau P, Delforge M, Cavo M, Ludwig H, Morgan GJ, Davies FE,
Sonneveld P, Schey SA, Zweegman S, Hansson M, Weisel K, Mateos MV, Facon T, Miguel JFS. Expert
panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple
myeloma. Leukemia 2014; 28: 1573-1585. (VUmc)
Dinami R, Ercolani C, Petti E, Piazza S, Ciani Y, Sestito R, Sacconi A, Biagioni F, le Sage C, Agami R,
Benetti R, Mottolese M, Schneider C, Blandino G, Schoeftner S. miR-155 Drives Telomere Fragility in
Human Breast Cancer by Targeting TRF1. Cancer Res 2014; 74:4145-56 (NKI)
Ding XT, Liu WJ, Weiss A, Li YY, Wong I, Griffioen AW, van den Bergh H, Xu HQ, Nowak-Sliwinska P, Ho
CM. Discovery of a low order drug-cell response surface for applications in personalized medicine.
Physical Biology 2014; 11: 065003. (VUmc)
Dinkla AM, Pieters BR, Koedooder K, van Wieringen N, van der Laarse R, Bel A. Prostate volume and
98 - Scientific publications
369.
370.
371.
372.
373.
374.
375.
376.
377.
378.
379.
380.
381.
382.
383.
384.
385.
386.
387.
388.
implant configuration during 48 hours of temporary prostate brachytherapy: limited effect of oedema.
Radiation Oncology 9(1), 2014, p.272-. (AMC)
Dinmohamed A, van Norden Y, Visser O, Posthuma E, Huijgens PC, Sonneveld P, van de Loosdrecht AA,
Jongen-Lavrencic M. The Use of Medical Claims to Assess Incidence, Diagnostic Procedures and Initial
Treatment Among Patients with Myelodysplastic Syndromes in the Netherlands. Haematol-Hematol J
2014; 99: 92-93. (VUmc)
Dinmohamed AG, Visser O, van Norden Y, Huijgens PC, Sonneveld P, van de Loosdrecht AA, JongenLavrencic M. Trends in incidence, initial treatment and survival of myelodysplastic syndromes: A
population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010. Eur J Cancer
2014; 50: 1004-1012. (VUmc)
Diot Q, Marks LB, Bentzen SM, Senan S, Kavanagh BD, Lawrence MV, Miften M, Palma DA. Comparison of
Radiation-Induced Normal Lung Tissue Density Changes for Patients From Multiple Institutions Receiving
Conventional or Hypofractionated Treatments. Int J Radiat Oncol 2014; 89: 626-632. (VUmc)
Dirven L, Aaronson NK, Heimans JJ, Taphoorn MJB. Health-related quality of life in high-grade glioma
patients. Chinese journal of cancer 2014; 33: 40-45. (VUmc)
Dirven L, Reijneveld JC, Taphoorn MJB. Health-Related Quality of Life or Quantity of Life: A Difficult
Trade-Off in Primary Brain Tumors?. Semin Oncol 2014; 41: 541-552. (VUmc)
Dirven L, Taphoorn MJB, Reijneveld JC, Blazeby J, Jacobs M, Pusic A, La Sala E, Stupp R, Fayers P,
Efficace F. The level of patient-reported outcome reporting in randomised controlled trials of brain
tumour patients: a systematic review. European Journal of Cancer 50(14), 2014, p.2432-2448. (AMC)
Dirven L, Taphoorn MJB, Reijneveld JC, Blazeby J, Jacobs M, Pusic A, La Sala E, Stupp R, Fayers P,
Efficace F. The level of patient-reported outcome reporting in randomised controlled trials of brain
tumour patients: A systematic review. Eur J Cancer 2014; 50: 2432-2448. (VUmc)
Dixon JM, Rutgers E, Hunt KK. Intraoperative assessment of axillary lymph nodes in patients with breast
cancer. BMJ 2014; 349:g6803 (NKI)
Djajadiningrat R, Graafland N, van Werkhoven E, Meinhardt W, Bex A, van der Poel H, van Boven H,
Valdes Olmos R, Horenblas S. Contemporary Management of Regional Nodes in Penile CancerImprovement of Survival? J Urol 2014; 191:68-73 (NKI)
Djajadiningrat RS, Teertstra HJ, van Werkhoven E, van Boven HH, Horenblas S. Ultrasound examination
and fine needle aspiration cytology-useful for followup of the regional nodes in penile cancer? J Urol
2014; 191:652-5 (NKI)
Djajadiningrat RS, van Werkhoven E, Meinhardt W, van Rhijn BW, Bex A, van der Poel HG, Horenblas S.
Penile Sparing Surgery for Penile Cancer-Does it Affect Survival? J Urol 2014; 192:120-6 (NKI)
Dobbe JGG, Kievit AJ, Schafroth MU, Blankevoort L, Streekstra GJ. Evaluation of a CT-based technique
to measure the transfer accuracy of a virtually planned osteotomy. Medical Engineering & Physics 36(8),
2014, p.1081-1087. (AMC)
Dolman ME, den Hartog I, Molenaar J, Schellens J, Beijnen J, Sparidans R. Liquid chromatographytandem mass spectrometric assay for the cyclin-dependent kinase inhibitor AT7519 in mouse plasma. J
Pharm Biomed Anal 2014; 88:216-20 (NKI)
Dolman MEM, den Hartog IJM, Molenaar JJ, Schellens JHM, Beijnen JH, Sparidans RW. Liquid
chromatography-tandem mass spectrometric assay for the light sensitive survivin suppressant
sepantronium bromide (YM155) in mouse plasma. Journal of Pharmaceutical and Biomedical Analysis 92,
2014, p.144-148. (AMC/NKI)
Dolman MM, den Hartog IJM, Molenaar JJ, Schellens JHM, Beijnen JH, Sparidans RW. Liquid
chromatography-tandem mass spectrometric assay for the cyclin-dependent kinase inhibitor AT7519 in
mouse plasma. Journal of Pharmaceutical and Biomedical Analysis 88, 2014, p.216-220. (AMC)
Dominguez-Soto A, de las Casas-Engel M, Bragado R, Medina-Echeverz J, ragoneses-Fenoll L, Martin-Gayo
E, van Rooijen N, Berraondo P, Toribio ML, Moro MA, Cuartero I, Castrillo A, Sancho D, Sanchez-Torres
C, Bruhns P, Sanchez-Ramon S, Corbi AL. Intravenous Immunoglobulin Promotes Antitumor Responses by
Modulating Macrophage Polarization. J Immunol 2014; 193: 5181-5189. (VUmc)
Dommering CJ, Mol BM, Moll AC, Burton M, Cloos J, Dorsman JC, Meijers-Heijboer H, van der Hout AH.
RB1 mutation spectrum in a comprehensive nationwide cohort of retinoblastoma patients. J Med Genet
2014; 51: 366-374. (VUmc)
Dong WL, van Ginkel JWH, Au KY, Alemany R, Meulenberg JJM, van Beusechem VW. ORCA-010, a Novel
Potency-Enhanced Oncolytic Adenovirus, Exerts Strong Antitumor Activity in Preclinical Models. Hum
Gene Ther 2014; 25: 897-904. (VUmc)
Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJH, Mansel RE, Cataliotti L,
Westenberg AH, Klinkenbijl JHG, Orzalesi L, Bouma WH, van der Mijle HCJ, Nieuwenhuijzen GAP,
Veltkamp SC, Slaets L, Duez NJ, de Graaf PW, van Dalen T, Marinelli A, Rijna H, Snoj M, Bundred NJ,
Merkus JWS, Belkacemi Y, Petignat P, Schinagl DAX, Coens C, Messina CGM, Bogaerts J, Rutgers EJT.
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023
AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncology 15(12),
2014, p.1303-1310. (AMC/NKI)
Dores GM, Curtis RE, van Leeuwen FE, Stovall M, Hall P, Lynch CF, Smith SA, Weathers RE, Storm HH,
Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala
E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Fraumeni JF, Jr., Aleman BM, Morton LM, Gilbert ES.
Pancreatic cancer risk after treatment of Hodgkin lymphoma. Ann Oncol 2014; 25:2073-9 (NKI)
Scientific publications - 99
389.
390.
391.
392.
393.
394.
395.
396.
397.
398.
399.
400.
401.
402.
403.
404.
405.
406.
407.
408.
Douma KFL, Meiser B, Kirk J, Mitchell G, Saunders C, Rahman B, Sousa MS, Barlow-Stewart K, Gleeson M,
Tucker K. Health professionals' evaluation of delivering treatment-focused genetic testing to women
newly diagnosed with breast cancer. Familial Cancer [aheadofprint], 2014, p.-. (AMC)
Dragomir A, de Wit M, Johansson C, Uhlen M, Ponten F. The Role of SATB2 as a Diagnostic Marker for
Tumors of Colorectal Origin. Am J Clin Pathol 2014; 141: 630-638. (VUmc)
Draht MXG, Smits KM, Tournier B, Jooste V, Chapusot C, Carvalho B, Cleven AHG, Derks S, Wouters KAD,
Belt EJTH, Stockmann HBAC, Bril H, Weijenberg MP, van den Brandt PA, de Bruine AP, Herman JG,
Meijer GA, Piard F, Melotte V, van Engeland M. Promoter CpG island methylation of RET predicts poor
prognosis in stage II colorectal cancer patients. Molecular oncology 2014; 8: 679-688. (VUmc)
Drost R, Jonkers J. Opportunities and hurdles in the treatment of BRCA1-related breast cancer.
Oncogene 2014; 33:3753-63 (NKI)
Drosten M, Sum EY, Lechuga CG, Simon-Carrasco L, Jacob HK, Garcia-Medina R, Huang S, Beijersbergen
RL, Bernards R, Barbacid M. Loss of p53 induces cell proliferation via Ras-independent activation of the
Raf/Mek/Erk signaling pathway. Proc Natl Acad Sci U S A 2014; 111:15155-60 (NKI)
Drukker CA, Elias SG, Nijenhuis MV, Wesseling J, Bartelink H, Elkhuizen P, Fowble B, Whitworth PW,
Patel RR, de Snoo FA, van 't Veer LJ, Beitsch PD, Rutgers EJT. Gene expression profiling to predict the
risk of locoregional recurrence in breast cancer: a pooled analysis. Breast Cancer Res Treat 2014;
148:599-613 (NKI)
Drukker CA, Nijenhuis MV, Bueno-de-Mesquita JM, Retèl VP, van Harten WH, van Tinteren H, Wesseling
J, Schmidt MK, van't Veer LJ, Sonke GS, Rutgers EJT, van de Vijver MJ, Linn SC. Optimized outcome
prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms.
Breast Cancer Research and Treatment 145(3), 2014, p.697-705. (AMC/NKI)
Drukker CA, Schmidt MK, Rutgers EJT, Cardoso F, Kerlikowske K, Esserman LJ, van Leeuwen FE,
Pijnappel RM, Slaets L, Bogaerts J, van't Veer LJ. Mammographic screening detects low-risk tumor
biology breast cancers. Breast Cancer Res Treat 2014; 144:103-11 (NKI)
Drukker CA, Schmidt MK, van Dalen T, van der Hoeven JJ, Linn SC, Rutgers EJT. [Gene expression
classifiers in the prognosis of breast cancer]. Nut van genexpressieprofielen voor prognose borstkanker.
Ned Tijdschr Geneeskd 2014; 158:A7001 (NKI)
Drukker CA, van den Hout HC, Sonke GS, Brain E, Bonnefoi H, Cardoso F, Goldhirsch A, Harbeck N,
Honkoop AH, Koornstra RHT, van Laarhoven HWM, Portielje JEA, Schneeweiss A, Smorenburg CH,
Stouthard J, Linn SC, Schmidt MK. Risk estimations and treatment decisions in early stage breast cancer:
agreement among oncologists and the impact of the 70-gene signature. European Journal of Cancer
50(6), 2014, p.1045-1054. (AMC/NKI)
Drukker CA, van Tinteren H, Schmidt MK, Rutgers EJTh, Bernards R, van de Vijver MJ, van't Veer LJ.
Long-term impact of the 70-gene signature on breast cancer outcome. Breast Cancer Research and
Treatment 143(3), 2014, p.587-592. (AMC/NKI)
Duijts SFA, Egmond MP van, Spelten E, Muijen P van, Anema JR, Beek AJ van der. Physical and
psychosocial problems in cancer survivors beyond return to work: a systematic review. Psycho-oncology
2014; 23(5): 481-492. (VUmc)
Duitman J, Borensztajn KS, Pulskens WPC, Leemans JC, Florquin S, Spek CA. CCAAT-enhancer binding
protein delta (C/EBPδ) attenuates tubular injury and tubulointerstitial fibrogenesis during chronic
obstructive nephropathy. Laboratory Investigation 94(1), 2014, p.89-97. (AMC)
Duitman J, Ruela-de-Sousa RR, Shi K, de Boer OJ, Borensztajn KS, Florquin S, Peppelenbosch MP, Spek
CA. Protease Activated Receptor-1 Deficiency Diminishes Bleomycin-Induced Skin Fibrosis. Molecular
Medicine 20, 2014, p.410-416 (AMC)
Duits LC, Phoa KN, Curvers WL, ten Kate FJW, Meijer GA, Seldenrijk CA, Offerhaus GJ, Visser M , Meijer
SL, Krishnadath KK, Tijssen JGP, Mallant-Hent RC, Bergman JJGHM. Barrett's oesophagus patients with
low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology
panel. GUT [aheadofprint], 2014, p.-. (AMC)
Dunscombe P, Grau C, Defourny N, Malicki J, Borras JM, Coffey M, Bogusz M, Gasparotto C, Slotman B,
Lievens Y. Guidelines for equipment and staffing of radiotherapy facilities in the European countries:
Final results of the ESTRO-HERO survey. Radiother Oncol 2014; 112: 165-177. (VUmc)
Durmus S, Naik J, Buil L, Wagenaar E, van Tellingen O, Schinkel AH. In vivo disposition of doxorubicin is
affected by mouse Oatp1a/1b and human OATP1A/1B transporters. Int J Cancer 2014; 135:1700-10 (NKI)
EBCTCG (Early Breast Cancer Trialists' Collaborative Group: 635 collaborators), McGale P, Taylor C,
Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang Y, Wang Z, Darby S.
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast
cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.
Lancet 2014; 383:2127-35 (NKI)
Eberl S, Polderman JAW, Preckel B, Kalkman CJ, Fockens P, Hollmann MW. Is "really conscious" sedation
with solely an opioid an alternative to every day used sedation regimes for colonoscopies in a teaching
hospital? Midazolam/fentanyl, propofol/alfentanil, or alfentanil only for colonoscopy: a randomized
trial. Techniques in Zoloproctology 18(8), 2014, p.745-752. (AMC)
Ediebah DE, Coens C, Zikos E, Quinten C, Ringash J, King MT, von Koch JS, Gotay C, Greimel E,
Flechtner H, Weis J, Reeve BB, Smit EF, Taphoorn MJB, Bottomley A. Does change in health-related
quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial. Brit J Cancer 2014; 110:
2427-2433. (VUmc)
100 - Scientific publications
409.
410.
411.
412.
413.
414.
415.
416.
417.
418.
419.
420.
421.
422.
423.
424.
425.
426.
427.
428.
429.
430.
Eekman DA, ter Wee MM, Coupe VMH, Erisek-Demirtas S, Kramer MH, Lems WF. Indirect costs account
for half of the total costs of an osteoporotic fracture: a prospective evaluation. Osteoporosis Int 2014;
25: 195-204. (VUmc)
Efficace F, Jacobs M, Pusic A, Greimel E, Piciocchi A, Kieffer JM, Gilbert A, Fayers P, Blazeby J.
Patient-reported outcomes in randomised controlled trials of gynaecological cancers: investigating
methodological quality and impact on clinical decision-making.European Journal of Cancer 50(11), 2014,
p.1925-1941. (AMC/NKI)
Efficace F, Rees J, Fayers P, Pusic A, Taphoorn M, Greimel E, Reijneveld J, Whale K, Blazeby J.
Overcoming barriers to the implementation of patient-reported outcomes in cancer clinical trials: the
PROMOTION Registry. Health Qual Life Outcomes 2014; 12: 86. (VUmc)
Efficace F, Rosti G, Aaronson N, Cottone F, Angelucci E, Molica S, Vignetti M, Mandelli F, Baccarani M.
Patient versus physician symptom and health status reporting in chronic myeloid leukemia.
Haematologica 2014; 99:788-3 (NKI)
Eggermont AM, Caldas C, Ringborg U, Medema R, Tabernero J, Wiestler O. Cancer Core Europe: a
consortium to address the cancer care-cancer research continuum challenge. Eur J Cancer 2014;
50:2745-6 (NKI)
Eijzenga W, Aaronson NK, Hahn DE, Sidharta GN, van der Kolk LE, Velthuizen ME, Ausems MG, Bleiker
EM. Effect of Routine Assessment of Specific Psychosocial Problems on Personalized Communication,
Counselors' Awareness, and Distress Levels in Cancer Genetic Counseling Practice: A Randomized
Controlled Trial. J Clin Oncol 2014; 32:2998-3004 (NKI)
Eijzenga W, Aaronson NK, Kluijt I, Sidharta GN, Hahn DE, Ausems MG, Bleiker EMA. The efficacy of a
standardized questionnaire in facilitating personalized communication about problems encountered in
cancer genetic counseling: design of a randomized controlled trial. BMC Cancer 2014; 14:26 (NKI)
Eijzenga W, Bleiker EM, Hahn DE, Kluijt I, Sidharta GN, Gundy C, Aaronson NK. Psychosocial Aspects of
Hereditary Cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use
in clinical cancer genetics. Psychooncology 2014; 23:862-9 (NKI)
Eijzenga W, Hahn DE, Aaronson NK, Kluijt I, Bleiker EM. Specific Psychosocial Issues of Individuals
Undergoing Genetic Counseling for Cancer - A Literature Review. J Genet Couns 2014; 23:133-46 (NKI)
Ekkebus R, Flierman D, Geurink PP, Ovaa H. Catching a DUB in the act: novel ubiquitin-based active site
directed probes. Curr Opin Chem Biol 2014; 23C:63-70 (NKI)
Ekkelenkamp VE, Koch AD, Rauws EAJ, Borsboom GJJM, de Man RA, Kuipers EJ. Competence
development in ERCP: the learning curve of novice trainees. Endoscopy 46(11), 2014, p.949-955. (AMC)
Elbatsh AM, Medema RH, Rowland BD. Genomic stability: boosting cohesion corrects CIN. Curr Biol 2014;
24:R571-R573 (NKI)
Elias SG, Adams A, Wisner DJ, Esserman LJ, van't Veer LJ, Mali WP, Gilhuijs KG, Hylton NM. Imaging
Features of HER2 Overexpression in Breast Cancer: A Systematic Review and Meta-analysis. Cancer
Epidemiol Biomarkers Prev 2014; 23:1464-83 (NKI)
El-Naggar M, Ebbing E, Bijnsdorp I, van den Berg J, Peters GJ. Radiosensitization by Thymidine
Phosphorylase Inhibitor in Thymidine Phosphorylase Negative and Overexpressing Bladder Cancer Cell
Lines. Nucleos Nucleot Nucl 2014; 33: 413-421. (VUmc)
Emmens RW, Naaijkens BA, Roem D, Kramer K, Wouters D, Zeerleder S, van Ham MS, Niessen HW,
Krijnen PA. Evaluating the efficacy of subcutaneous C1-esterase inhibitor administration for use in rat
models of inflammatory diseases. Drug Delivery 21(4), 2014, p.302-306. (AMC)
Emmink BL, Laoukili J, Kipp AP, Koster J, Govaert KM, Fatrai S, Verheem A, Steller EJA, Brigelius-Flohe
R, Jimenez CR, Rinkes IHMB, Kranenburg O. GPx2 Suppression of H2O2 Stress Links the Formation of
Differentiated Tumor Mass to Metastatic Capacity in Colorectal Cancer. Cancer Res 2014; 74: 6717-6730.
(VUmc/AMC)
Eshuis WJ, Tol JAMG, Nio CY, Busch ORC, van Gulik TM, Gouma DJ. Leakage of the gastroenteric
anastomosis after pancreatoduodenectomy. Surgery 156(1), 2014, p.75-82. (AMC)
Eshuis WJ, van Eijck CHJ, Gerhards MF, Coene PP, de Hingh IHJT, Karsten TM, Bonsing BA, Gerritsen
JJGM, Bosscha K, Spillenaar BEJ, Haverkamp JA, Busch ORC, van Gulik TM, Reitsma JB, Gouma DJ.
Antecolic Versus Retrocolic Route of the Gastroenteric Anastomosis After Pancreatoduodenectomy A
Randomized Controlled Trial. Annals of Surgery 259(1), 2014, p.45-51. (AMC)
Eskens FALM, van Erpecum KJ, de Jong KP, van Delden OM, Klumpen HJ, Verhoef C, Jansen PLM, van
den Bosch MAAJ, Romero AM, Verheij J, Bloemena E, de Man RA. Hepatocellular carcinoma: Dutch
guideline for surveillance, diagnosis and therapy. Neth J Med 2014; 72: 299-304. (VUmc/AMC)
Eslami S, Askari M, Medlock S, Arts DL, Wyatt JC, van Weert HCPM, de Rooij SE, Abu-Hanna A. From
assessment to improvement of elderly care in general practice using decision support to increase
adherence to ACOVE quality indicators: study protocol for randomized control trial. Trials 15(1), 2014,
p.81-. (AMC)
ESMO/European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO Clinical
Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2014; 25 Suppl 3:iii102-iii112
(NKI)
Esquivel J, Piso P, Verwaal V, Bachleitner-Hofmann T, Glehen O, Gonzalez-Moreno S, Deraco M, Pelz J,
Alexander R, Glockzin G. American Society of Peritoneal Surface Malignancies opinion statement on
defining expectations from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in
patients with colorectal cancer. J Surg Oncol 2014; 110:777-8 (NKI)
Scientific publications - 101
431.
432.
433.
434.
435.
436.
437.
438.
439.
440.
441.
442.
443.
444.
445.
446.
447.
448.
449.
450.
451.
Esser C, Bachmann A, Kuhn D, Schuldt K, Forster B, Thiel M, May J, Koch-Nolte F, Yanez-Mo M, SanchezMadrid F, Schinkel AH, Jalkanen S, Craig AG, Bruchhaus I, Horstmann RD. Evidence of promiscuous
endothelial binding by Plasmodium falciparum-infected erythrocytes. Cell Microbiol 2014; 16:701-8 (NKI)
Essletzbichler P, Konopka T, Santoro F, Chen D, Gapp BV, Kralovics R, Brummelkamp TR, Nijman SM,
Burckstummer T. Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell
line. Genome Res 2014; 24:2059-65 (NKI)
Evans N, Costantini M, Pasman HRW, Block L, Donker GA, Miccinesi G, Bertolissi S, Gil M, Boffin N,
Zurriaga O, Deliens L, Onwuteaka-Philipsen BD. End-of-Life Communication: A Retrospective Survey of
Representative General Practitioner Networks in Four Countries. J Pain Symptom Manag 2014; 47: 604619. (VUmc)
Evans N, Pasman HRW, Deeg DJH, Onwuteaka-Philipsen BD. How do general end-of-life treatment goals
and values relate to specific treatment preferences? A population-based study. Palliative Med 2014; 28:
1206-1212. (VUmc)
Evans N, Pasman HRW, Donker GA, Deliens L, Block L, Onwuteaka-Philipsen BD. End-of-life care in
general practice: A cross-sectional, retrospective survey of 'cancer', 'organ failure' and 'oldage/dementia' patients. Palliative Med 2014; 28: 965-975. (VUmc)
Evers B, Bernards R, Beijersbergen RL. The Good, the Bad, and the Ugly: in search of gold standards for
assessing functional genetic screen quality. Mol Syst Biol 2014; 10:738 (NKI)
Ewer M, Gianni L, Pane F, Sandri MT, Steiner RK, Wojnowski L, Yeh ET, Carver JR, Lipshultz SE, Minotti
G, Armstrong GT, Cardinale D, Colan SD, Darby SC, Force TL, Kremer LC, Lenihan DJ, Sallan SE, Sawyer
DB, Suter TM, Swain SM, van Leeuwen FE. Report on the international colloquium on cardio-oncology
(rome, 12-14 march 2014). Ecancermedicalscience 2014; 8:433-(10 pp) (NKI)
Exner R, Bago-Horvath Z, Bartsch R, Mittlboeck M, Retel VP, Fitzal F, Rudas M, Singer C, Pfeiler G,
Gnant M, Jakesz R, Dubsky P. The multigene signature MammaPrint impacts on multidisciplinary team
decisions in ER(+), HER2(-) early breast cancer. Br J Cancer 2014; 111:837-42 (NKI)
Fang Q, Inanc B, Schamus S, Wang XH, Wei L, Brown AR, Svilar D, Sugrue KF, Goellner EM, Zeng X, Yates
NA, Lan L, Vens C, Sobol RW. HSP90 regulates DNA repair via the interaction between XRCC1 and DNA
polymerase beta. Nat Commun 2014; 5:5513 (NKI)
Farazi TA, ten Hoeve JJ, Brown M. Mihailovic A, Horlings HM, van de Vijver MJ, Tuschl T, Wessels LFA.
Identification of distinct miRNA target regulation between breast cancer molecular subtypes using
AGO2-PAR-CLIP and patient datasets. Genome Biology 15(1), 2014, p.R9-. (AMC/NKI)
Farin HF, Karthaus WR, Kujala P, Rakhshandehroo M, Schwank G, Vries RG, Kalkhoven E, Nieuwenhuis
EE, Clevers H. Paneth cell extrusion and release of antimicrobial products is directly controlled by
immune cell-derived IFN-gamma. J Exp Med 2014; 211:1393-405 (NKI)
Fegrachi S, Besselink MG, van Santvoort HC, van Hillegersberg R, Molenaar IQ. Radiofrequency ablation
for unresectable locally advanced pancreatic cancer: a systematic review. HPB 16(2), 2014, p.119-123.
(AMC)
Fehres CM, Bruijns SCM, van Beelen AJ, Kalay H, Ambrosini M, Hooijberg E, Unger WWJ, de Gruijl TD,
van Kooijk Y. Topical rather than intradermal application of the TLR7 ligand imiquimod leads to human
dermal dendritic cell maturation and CD8(+) T-cell cross-priming. Eur J Immunol 2014; 44: 2415-2424.
(VUmc)
Fehres CM, Unger WWJ, Garcia Vallejo JJ, van Kooijk Y. Understanding the biology of antigen crosspresentation for the design of vaccines against cancer. Frontiers in Microbiology 2014; 5: 149. (VUmc)
Feijen ELAM, van der Pal HJ, van Dalen EC, Mulder RL, Bardi E, Kuehni C, Tissing WJE, Kremer LCM. A
New Method to Facilitate Valid and Consistent Grading Cardiac Events in Childhood Cancer Survivors
Using Medical Records. PLOS ONE 9(7), 2014, p.e100432-. (AMC)
Feine O, Hukasova E, Bruinsma W, Freire R, Fainsod A, Gannon J, Mahbubani HM, Lindqvist A, Brandeis
M. Phosphorylation-mediated stabilization of Bora in mitosis coordinates Plx1/Plk1 and Cdk1
oscillations. Cell Cycle 2014; 13:1727-36
Ferrari A, de Salvo GL, Brennan B, van Noesel MM, de Paoli A, Casanova M, Francotte N, Kelsey A,
Alaggio R, Oberlin O, Carli M, Ben-Arush M, Bergeron C, Merks JHM, Jenney M, Stevens MC, Bisogno G,
Orbach D. Synovial sarcoma in children and adolescents: the European pediatric Soft tissue sarcoma
Study Group prospective trial (EpSSG NRSTS 2005). Annals of Oncology [aheadofprint], 2014, p.-. (AMC)
Fitzal F, Galimberti V, Kuhn T, Rutgers EJ, Untch M. Lymph node staging in invasive breast cancer.
Breast Care (Basel) 2014; 9:211-4 (NKI)
Fitzpatrick JM, Bellmunt J, Fizazi K, Heidenreich A, Sternberg CN, Tombal B, Alcaraz A, Bahl A,
Bracarda S, Di Lorenzo G, Efstathiou E, Finn SP, Fosså S, Gillessen S, Kellokumpu-Lehtinen P-L, Lecouvet
FE, Oudard S, de Reijke TM, Robson CN, de Santis M, Seruga B, de Wit R. Optimal management of
metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel.
European Journal of Cancer 50(9), 2014, p.1617-1627. (AMC)
Flach GB, Bloemena E, Klop WMC, van Es RJJ, Schepman KP, Hoekstra OS, Castelijns JA, Leemans CR, de
Bree R. Sentinel lymph node biopsy in clinically N0 T1-T2 staged oral cancer: The Dutch multicenter
trial. Oral Oncol 2014; 50: 1020-1024. (VUmc/NKI)
Flach GB, van Schie A, Witte BI, Olmos RA, V, Klop W, Hoekstra OS, de Bree R. Practice variation in
defining sentinel lymph nodes on lymphoscintigrams in oral cancer patients. Eur J Nucl Med Mol I 2014;
41: 2249-2256. (VUmc/NKI)
102 - Scientific publications
452.
453.
454.
455.
456.
457.
458.
459.
460.
461.
462.
463.
464.
465.
466.
467.
468.
469.
Foijer F, Xie SZ, Simon JE, Bakker PL, Conte N, Davis SH, Kregel E, Jonkers J, Bradley A, Sorger PK.
Chromosome instability induced by Mps1 and p53 mutation generates aggressive lymphomas exhibiting
aneuploidy-induced stress. Proc Natl Acad Sci U S A 2014; 111:13427-32 (NKI)
Foliaki S, Brewer N, Pearce N, Snijders PJF, Meijer CJLM, Waqatakirewa L, Clifford GM, Franceschi S.
Prevalence of HPV infection and other risk factors in a Fijian population. Infectious Agents and Cancer
2014; 9: 14. (VUmc)
Fontein DB, Charehbili A, Nortier JW, Meershoek-Klein Kranenbarg E, Kroep JR, Putter H, van Riet Y,
Nieuwenhuijzen GA, de Valk B, Terwogt JM, Algie GD, Liefers GJ, Linn S, Van de Velde CJH. Efficacy of
six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer
patients - A phase II trial. Eur J Cancer 2014; 50:2190-200 (NKI)
Foth M, Ahmad I, van Rhijn BW, van der KT, Bergman AM, King L, Ridgway R, Leung HY, Fraser S, Sansom
OJ, Iwata T. Fibroblast growth factor receptor 3 activation plays a causative role in urothelial cancer
pathogenesis in cooperation with Pten loss in mice. J Pathol 2014; 233:148-58 (NKI)
Frampton AE, Castellano L, Colombo T, Giovannetti E, Krell J, Jacob J, Pellegrino L, Roca-Alonso L,
Funel N, Gall TMH, Giorgio A, Pinho FG, Fulci V, Britton DJ, Ahmad R, Habib NA, Coombes RC, Harding
V, Knosel T, Stebbing J, Jiao LR. MicroRNAs Cooperatively Inhibit a Network of Tumor Suppressor Genes
to Promote Pancreatic Tumor Growth and Progression. Gastroenterology 2014; 146: 268-277. (VUmc)
Frampton AE, Giovannetti E, Jamieson NB, Krell J, Gall TMH, Stebbing J, Jiao LR, Castellano L. A
microRNA meta-signature for pancreatic ductal adenocarcinoma. Expert review of molecular diagnostics
2014; 14: 267-271. (VUmc)
Franken MG, Gaultney JG, Blommestein HM, Huijgens PC, Sonneveld P, Redekop WK, Uyl-de Groot CA.
Policymaker, Please Consider Your Needs Carefully: Does Outcomes Research in Relapsed or Refractory
Multiple Myeloma Reduce Policymaker Uncertainty Regarding Value for Money of Bortezomib?. Value
Health 2014; 17: 245-253. (VUmc)
Franken NAP, Barendsen GW. Enhancement of radiation effectiveness by hyperthermia and
incorporation of halogenated pyrimidines at low radiation doses as compared with high doses:
implications for mechanisms. International Journal of Radiation Biology 90(4), 2014, p.313-317. (AMC)
Fransen van de Putte EE, van Rhijn BW. Word of wisdom. Re: prognostic interest in discriminating
muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national
multicenter study with central pathology review. Eur Urol 2014; 66:787-8 (NKI)
Frederix G, van Hasselt J, Schellens J, Hovels A, Raaijmakers J, Huitema A, Severens J. The impact of
structural uncertainty on cost-effectiveness models for adjuvant endocrine breast cancer treatments:
the need for disease-specific model standardization and improved guidance. Pharmacoeconomics 2014;
32:47-61 (NKI)
Frings V, de Langen AJ, Yaqub MM, Schuit RC, van der Veldt AAM, Hoekstra OS, Smit EF, Boellaard R.
Methodological Considerations in Quantification of 3 '-Deoxy-3 '-[F-18]Fluorothymidine Uptake Measured
with Positron Emission Tomography in Patients with Non-Small Cell Lung Cancer. Mol Imaging Biol 2014;
16: 136-145. (VUmc)
Frings V, van Velden FHP, Velasquez LM, Hayes W, van de Ven PM, Hoekstra OS, Boellaard R.
Repeatability of Metabolically Active Tumor Volume Measurements with FDG PET/CT in Advanced
Gastrointestinal Malignancies: A Multicenter Study. Radiology 2014; 273: 539-548. (VUmc)
Frings V, Yaqub MM, Hoyng LL, Golla SSV, Windhorst AD, Schuit RC, Lammertsma AA, Hoekstra OS, Smit
EF, Boellaard R. Assessment of Simplified Methods to Measure F-18-FLT Uptake Changes in EGFRMutated Non-Small Cell Lung Cancer Patients Undergoing EGFR Tyrosine Kinase Inhibitor Treatment. J
Nucl Med 2014; 55: 1417-1423. (VUmc)
Froklage FE, Oosterbaan LJ, Sizoo EM, de Groot M, Bosma I, Sanchez E, Douw L, Heimans JJ, Reijneveld
JC, Lagerwaard FJ, Buter J, Uitdehaag BMJ, Klein M, Postma TJ. Central neurotoxicity of standard
treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal study. J
Neuro-Oncol 2014; 116: 387-394. (VUmc)
Gabriels K, Hoving S, Gijbels MJ, Pol JF, Te Poele JA, Biessen EA, Daemen MJ, Stewart FA, Heeneman S.
Irradiation of existing atherosclerotic lesions increased inflammation by favoring pro-inflammatory
macrophages. Radiother Oncol 2014; 110:455-60 (NKI)
Gad H, Koolmeister T, Jemth AS, Eshtad S, Jacques SA, Strom CE, Svensson LM, Schultz N, Lundback T,
Einarsdottir BO, Saleh A, Gokturk C, Baranczewski P, Svensson R, Berntsson RP, Gustafsson R, Stromberg
K, Sanjiv K, Jacques-Cordonnier MC, Desroses M, Gustavsson AL, Olofsson R, Johansson F, Homan EJ,
Loseva O, Brautigam L, Johansson L, Hoglund A, Hagenkort A, Pham T, Altun M, Gaugaz FZ, Vikingsson S,
Evers B, Henriksson M, Vallin KS, Wallner OA, Hammarstrom LG, Wiita E, Almlof I, Kalderen C, Axelsson
H, Djureinovic T, Puigvert JC, Haggblad M, Jeppsson F, Martens U, Lundin C, Lundgren B, Granelli I,
Jensen AJ, Artursson P, Nilsson JA, Stenmark P, Scobie M, Berglund UW, Helleday T. MTH1 inhibition
eradicates cancer by preventing sanitation of the dNTP pool. Nature 2014; 508:215-21 (NKI)
Gadhamsetty S, Maree AF, Beltman JB, De Boer RJ. A general functional response of cytotoxic T
lymphocyte-mediated killing of target cells. Biophys J 2014; 106:1780-91 (NKI)
Gaillard PJ, Appeldoorn CCM, van Dorland R, van Kregten J, Manca F, Vugts DJ, Windhorst AD, van
Dongen GAMS, de Vries HE, Maussang D, van Tellingen O. Pharmacokinetics, Brain Delivery, and Efficacy
in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101). PLoS One 2014;
9: e82331. (VUmc/NKI)
Scientific publications - 103
470.
471.
472.
473.
474.
475.
476.
477.
478.
479.
480.
481.
482.
483.
484.
485.
486.
487.
Galvani E, Toffalorio F, Peters GJ, De Pas T, Giovannetti E. Pharmacogenetics of Non-small Cell Lung
Cancer (NSCLC): Time to "Work it Out"?. Curr Pharm Design 2014; 20: 3863-3874. (VUmc)
Gameiro S, van den Belt-Dusebout AW, Bleiker E, Braat D, van Leeuwen FE, Verhaak CM. Do children
make you happier? Sustained child-wish and mental health in women 11-17 years after fertility
treatment. Hum Reprod 2014; 29:2238-46 (NKI)
Gamper EM, Groenvold M, Petersen MA, Young T, Costantini A, Aaronson N, Giesinger JM, Meraner V,
Kemmler G, Holzner B. The EORTC emotional functioning computerized adaptive test: phases I-III of a
cross-cultural item bank development. Psychooncology 2014; 23:397-403 (NKI)
Garajova I, Le Large TYS, Frampton AE, Rolfo C, Voortman J, Giovannetti E. Molecular Mechanisms
Underlying the Role of MicroRNAs in the Chemoresistance of Pancreatic Cancer. Biomed research
international 2014; 2014: 678401. (VUmc)
Gargiulo G, Serresi M, Cesaroni M, Hulsman D, van Lohuizen M. In vivo shRNA screens in solid tumors.
Nat Protoc 2014; 9:2880-902 (NKI)
Gaudichon J, Milano F, Cahu J, DaCosta L, Martens ACM, Renoir JM, Sola B. Deazaneplanocin A Is a
Promising Drug to Kill Multiple Myeloma Cells in Their Niche. PLoS One 2014; 9: e107009. (VUmc)
Geelen E, Krumeich A, Schellevis FG, Akker M van den. General practitioners' perceptions of their role in
cancer follow-up care: A qualitative study in the Netherlands. The European Journal of General Practice
2014; 20(1): 17-24. (VUmc)
Geisler CH, van T' Veer MB, Jurlander J, Walewski J, Tjønnfjord G, Itälä Remes M, Kimby E, Kozak T,
Polliack A, Wu Ka L, Wittebol S, Abrahamse-Testroote MCJ, Doorduijn J, Ghidey Alemayehu W, van Oers
MHJ. Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free
survival in high-risk CLL. Blood 123(21), 2014, p.3255-3262. (AMC)
Gelderblom H, Blay JY, Seddon BM, Leahy M, Ray-Coquard I, Sleijfer S, Kerst JM, Rutkowski P, Bauer S,
Ouali M, Marreaud S, van der Straaten RJHM, Guchelaar HJ, Weitman SD, Hogendoorn PCW,
Hohenberger P. Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or
metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft
Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study. Eur J Cancer 2014;
50:388-96 (NKI)
Georgalas C, Cornet M, Adriaensen G, Reinartz S, Holland C, Prokopakis E, Fokkens W. Evidence-based
Surgery for Chronic Rhinosinusitis with and without Nasal Polyps. Current Allergy and Asthma Reports
14(4), 2014, p.427-. (AMC)
Georgalas C, Vlastos I, Picavet V, van Drunen C, Garas G, Prokopakis E. Is chronic rhinosinusitis related
to allergic rhinitis in adults and children? Applying epidemiological guidelines for causation. Allergy
69(7), 2014, p.828-833. (AMC)
Geraets DT, Cuschieri K, de Koning MNC, van Doorn LJ, Snijders PJF, Meijer CJLM, Quint WGV, Arbyn M.
Clinical Evaluation of a GP5+/6+-Based Luminex Assay Having Full High-Risk Human Papillomavirus
Genotyping Capability and an Internal Control. J Clin Microbiol 2014; 58: 3996-4002. (VUmc)
Gerritsen A, de Rooij T, van der Poel MJ, Dijkgraaf MGW, Bemelman WA, Busch Olivier RC, Besselink
MGH, Mathus-Vliegen EMH. Endoscopic Versus Bedside Electromagnetic-Guided Placement of
Nasoenteral Feeding Tubes in Surgical Patients. Journal of Gastrointestinal Surgery 18(9), 2014,
p.1664-1672. (AMC)
Gerritsen A, Molenaar IQ, Bollen TL, Nio C. Y, Dijkgraaf MG, van Santvoort HC, Offerhaus GJ, Brosens
LA, Biermann K, Sieders E, de Jong KP, van Dam RM, van der Harst E, van Goor H, van Ramshorst B,
Bonsing BA, de Hingh IH, Gerhards MF, van Eijck CH, Gouma DJ, Borel Rinkes IHM, Busch ORC, Besselink
MG. Preoperative Characteristics of Patients with Presumed Pancreatic Cancer but Ultimately Benign
Disease: A Multicenter Series of 344 Pancreatoduodenectomies. Annals of Surgical Oncology 21(12),
2014, p.3999-4006. (AMC)
Gerritsen A, Wennink RAW, Besselink MGH, van Santvoort HC, Tseng DSJ, Steenhagen E, Borel Rinkes
IHM, Molenaar IQ. Early oral feeding after pancreatoduodenectomy enhances recovery without
increasing morbidity. HPB 16(7), 2014, p.656-664. (AMC)
Geyer HL, Scherber RM, Dueck AC, Kiladjian JJ, Xiao ZJ, Slot S, Zweegman S, Sackmann F, Fuentes AK,
Hernandez-Maraver D, Dohner K, Harrison CN, Radia D, Muxi P, Besses C, Cervantes F, Johansson PL,
Andreasson B, Rambaldi A, Barbui T, Vannucchi AM, Passamo. Distinct clustering of symptomatic burden
among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients. Blood 2014;
123: 3803-3810. (VUmc)
Gholamin S, Fiuji H, Maftouh M, Mirhafez SR, Homaei Shandiz F, Avan A. Targeting c-MET/HGF Signaling
Pathway in Upper Gastrointestinal Cancers: Rationale and Progress. Current Drug Targets 2014; 15:
1302-1311. (VUmc)
Ghoussaini M, Edwards SL, Michailidou K, Nord S, Cowper-Sal Lari R, Desai K, Kar S, Hillman KM,
Kaufmann S, Glubb DM, Beesley J, Dennis J, Bolla MK, Wang Q, Dicks E, Guo Q, Schmidt MK, Shah M,
Luben R, Brown J, Czene K, Darabi H, Eriksson M, Klevebring D, Bojesen SE, Nordestgaard BG, Nielsen
SF, Flyger H, Lambrechts D, Thienpont B, Neven P, Wildiers H, Broeks A, van't Veer LJ, Th Rutgers EJ,
Couch FJ, Olson JE, Hallberg E, Vachon C, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Peto J,
Dos-Santos-Silva I, Gibson L, Nevanlinna H, Muranen TA, Aittomaki K, Blomqvist C, Hall P, Li J, Liu J,
Humphreys K, Kang D, Choi JY, Park SK, Noh DY, Matsuo K, Ito H, Iwata H, Yatabe Y, Guenel P, Truong
T, Menegaux F, Sanchez M, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Wu AH, Tseng CC, Van Den
Berg D, Stram DO, Benitez J, Zamora MP, Perez JI, Menendez P, Shu XO, Lu W, Gao YT, Cai Q, Cox A,
104 - Scientific publications
488.
489.
490.
491.
492.
493.
494.
495.
496.
497.
498.
499.
500.
501.
502.
503.
504.
505.
Cross SS, Reed MW, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Sawyer EJ, Tomlinson I, Kerin MJ,
Miller N, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Lindblom A, Margolin S, Teo SH, Yip
CH, Lee DS, Wong TY, Hooning MJ, Martens JW, Collee JM, van Deurzen CH, Hopper JL, Southey MC,
Tsimiklis H, Kapuscinski MK, Shen CY, Wu PE, Yu JC, Chen ST, Alnaes GG, Borresen-Dale AL, Giles GG,
Milne RL, Mclean C, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Hartman M, Miao H,
Buhari SA, Teo YY, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Brenner H, Dieffenbach AK, Arndt
V, Stegmaier C, Swerdlow A, Ashworth A, Orr N, Schoemaker MJ, Garcia-Closas M, Figueroa J, Chanock
SJ, Lissowska J, Simard J, Goldberg MS, Labreche F, Dumont M, Winqvist R, Pylkas K, Jukkola-Vuorinen
A, Brauch H, Bruning T, Koto YD, Radice P, Peterlongo P, Bonanni B, Volorio S, Dork T, Bogdanova NV,
Helbig S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Devilee P, Tollenaar RA, Seynaeve C, van
Asperen CJ, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Slager S, Toland AE, Ambrosone CB,
Yannoukakos D, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Hamann U, Torres D, Zheng W, Long J,
Anton-Culver H, Neuhausen SL, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, Gonzalez-Neira
A, Pita G, Alonso MR, Alvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, de Santiago I, Carroll J,
Caldas C, Brown MA, Lupien M, Kristensen VN, Pharoah PD, Chenevix-Trench G, French JD, Easton DF,
Dunning AM. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
Nat Commun 2014; 4:4999 (NKI)
Giammarile F, Vidal-Sicart S, Valdes Olmos RA. Uncommon applications of sentinel lymph node mapping:
urogenital cancers. Q J Nucl Med Mol Imaging 2014; 58:161-79 (NKI)
Giesinger JM, Wintner LM, Zabernigg A, Gamper EM, Oberguggenberger AS, Sztankay MJ, Kemmler G,
Holzner B. Assessing quality of life on the day of chemotherapy administration underestimates patients'
true symptom burden. BMC Cancer 2014; 14:758 (NKI)
Giesinger K, Hamilton DF, Jost B, Holzner B, Giesinger JM. Comparative responsiveness of outcome
measures for total knee arthroplasty. Osteoarthritis Cartilage 2014; 22:184-9 (NKI)
Gijezen LC, Vernooij M, Martens H, Oduber CEU, Henquet CJM, Starink TM, Prins MH, Menko FH,
Nelemans PJ, van Steensel MAM. Topical Rapamycin as a Treatment for Fibrofolliculomas in Birt-HoggDube Syndrome: A Double-Blind Placebo-Controlled Randomized Split-Face Trial. PLoS One 2014; 9:
e99071. (VUmc)
Gillet E, Alentorn A, Doukoure B, Mundwiller E, van Thuij H, Reijneveld JC, Medina JAM, Liou A, Marie Y,
Mokhtari K, Hoang-Xuan K, Sanson M, Delattre JY, Idbaih A. TP53 and p53 statuses and their clinical
impact in diffuse low grade gliomas. J Neuro-Oncol 2014; 118: 131-139. (VUmc)
Gillison ML, Castellsague X, Chaturvedi A, Goodman MT, Snijders PJF, Tommasino M, Arbyn M,
Franceschi S. Eurogin Roadmap: Comparative epidemiology of HPV infection and associated cancers of
the head and neck and cervix. Int J Cancer 2014; 134: 497-507. (VUmc)
Gingold H, Tehler D, Christoffersen NR, Nielsen MM, Asmar F, Kooistra SM, Christophersen NS,
Christensen LL, Borre M, Sorensen KD, Andersen LD, Andersen CL, Hulleman E, Wurdinger T, Ralfkiaer E,
Helin K, Gronbaek K, Omtoft T, Waszak SM, Dahan O, Pedersen. A Dual Program for Translation
Regulation in Cellular Proliferation and Differentiation. Cell 2014; 158: 1281-1292. (VUmc)
Giovannetti E, Giaccone G. CYB5A and autophagy-mediated cell death in pancreatic cancer. Autophagy
2014; 10: 697-698. (VUmc)
Giovannetti E, Leon LG. New Strategies and Applications for Drugs Targeting EGFR and c-Met. Current
Drug Targets 2014; 15: 1261-1262. (VUmc)
Giovannetti E, Wang QY, Avan A, Funel N, Lagerweij T, Lee J, Caretti V, van der Velde A, Boggi U, Wang
YS, Vasile E, Peters GJ, Wurdinger T, Giaccone G. Role of CYB5A in Pancreatic Cancer Prognosis and
Autophagy Modulation. J Natl Cancer I 2014; 106: djt346. (VUmc)
Goedhart J, Hink M, Jalink K. An introduction to fluorescence imaging techniques geared towards
biosensor applications. Methods Mol Biol 2014; 1071:17-28 (NKI)
Goey A, Meijerman I, Rosing H, Marchetti S, Mergui-Roelvink M, Keessen M, Burgers J, Beijnen J,
Schellens J. The Effect of St John's Wort on the Pharmacokinetics of Docetaxel. Clin Pharmacokinet
2014; 53:103-10 (NKI)
Goey AK, Beijnen JH, Schellens JHM. Herb-drug interactions in oncology. Clin Pharmacol Ther 2014;
95:354-5 (NKI)
Gomez-Eerland R, Nuijen B, Heemskerk B, van Rooij N, van den Berg JH, Beijnen JH, Uckert W,
Kvistborg P, Schumacher T, Haanen JB, Jorritsma A. Manufacture of gene modified human T cells with a
memory stem/ central memory phenotype. Hum Gene Ther Methods 2014; 25:277-87 (NKI)
Gooiker GA, Lemmens VEPP, Besselink MG, Busch OR, Bonsing BA, Molenaar IQ, Tollenaar RAEM, de
Hingh IHJT, Wouters MWJM. Impact of centralization of pancreatic cancer surgery on resection rates and
survival. British Journal of Surgery 101(8), 2014, p.1000-1005. (AMC/NKI)
Goos JACM, Hiemstra AC, Coupe VMH, Diosdado B, Kooijman W, van Diemen PM, Karga C, Belien JAM,
van Oordt CWM, Geldof AA, Meijer GA, Hoekstra OS, Fijneman RJA. Epidermal growth factor receptor
(EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with
resected colorectal cancer liver metastases. Brit J Cancer 2014; 111: 749-755. (VUmc)
Gooskens SL, Furtwangler R, Spreafico F, Van Tinteren H, de Kraker J, Vujanic GM, Leuschner I,
Coulomb-L'Hermine A, Godzinski J, Schleiermacher G, Stoneham S, Bergeron C, Pritchard-Jones K, Graf
N, van den Heuvel-Eibrink MM. Treatment and outcome of patients with relapsed clear cell sarcoma of
the kidney: a combined SIOP and AIEOP study. Br J Cancer 2014; 111:227-33 (NKI)
Goossens-Laan CA, Leliveld AM, Verhoeven RHA, Kil PJM, de Bock GH, Hulshof MCCM, de Jong IJ,
Scientific publications - 105
506.
507.
508.
509.
510.
511.
512.
513.
514.
515.
516.
517.
518.
519.
520.
521.
522.
523.
524.
525.
526.
Coebergh JWW. Effects of age and comorbidity on treatment and survival of patients with
muscle-invasive bladder cancer. International Journal of Cancer 135(4), 2014, p.905-912. (AMC)
Gotink KJ, Broxterman HJ, Honeywell RJ, Dekker H, de Haas RR, Miles KM, Adelaiye R, Griffioen AW,
Peters GJ, Pili R, Verheul HMW. Acquired tumor cell resistance to sunitinib causes resistance in a HT-29
human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor
microvasculature. Oncoscience 2014; 1: 844-853. (VUmc)
Gouttebarge V, Inklaar H, Frings-Dresen MH. Risk and consequences of osteoarthritis after a professional
football career: a systematic review of the recent literature. Journal of Sports Medicine and Physical
Fitness 54(4), 2014, p.494-504. (AMC)
Gouttebarge V, Plat M-CJ., Kuijer PPFM, Sluiter JK, Frings-Dresen MHW. The reproducibility of two
task-specific functional capacity evaluation protocols for household waste collectors. Work-A Journal of
Prevention Assessment & Rehabilitation [aheadofprint], 2014, p.-. (AMC)
Grabinger T, Luks L, Kostadinova F, Zimberlin C, Medema JP, Leist M, Brunner T. Ex vivo culture of
intestinal crypt organoids as a model system for assessing cell death induction in intestinal epithelial
cells and enteropathy. Cell Death & Disease 5, 2014, p.e1228-. (AMC)
Grau C, Defourny N, Malicki J, Dunscombe P, Borras JM, Coffey M, Slotman B, Bogusz M, Gasparotto C,
Lievens Y. Radiotherapy equipment and departments in the European countries: Final results from the
ESTRO-HERO survey. Radiother Oncol 2014; 112: 155-164. (VUmc)
Grebenchtchikov N, Geurts-Moespot AJ, Heijmen L, van Laarhoven HWM, van Herpen CML, Thijs AMJ.,
Span PN, Sweep FCGJ. Quantification of Patient-Specific Assay Interference in Different Formats of
Enzyme-Linked Immunoassays for Therapeutic Monoclonal Antibodies.Therapeutic Drug Monitoring 36(6),
2014, p.765-770. (AMC)
Greco F, Cadeddu JA, Gill IS, Kaouk JH, Remzi M, Thompson RH, van Leeuwen FW, van der Poel HG,
Fornara P, Rassweiler J. Current perspectives in the use of molecular imaging to target surgical
treatments for genitourinary cancers. Eur Urol 2014; 65:947-64 (NKI)
Greuter MJE, Xu XM, Lew JB, Dekker E, Kuipers EJ, Canfell K, Meijer GA, Coupe VMH. Modeling the
Adenoma and Serrated Pathway to Colorectal CAncer (ASCCA). Risk Anal 2014; 34: 889-910. (VUmc/AMC)
Griffioen AW, Thijssen VLJL. Galectins in tumor angiogenesis. Annals of translational medicine 2014; 2:
90. (VUmc)
Griffioen AW, Weiss A, Berndsen RH, Abdul UK, Winkel MTT, Nowak-Sliwinska P. The emerging quest for
the optimal angiostatic combination therapy. Biochem Soc T 2014; 42: 1608-1615. (VUmc)
Griffioen AW. Angiostatic vaccines, an underestimated approach of cancer therapy. Oncotarget 2014; 5:
10961-10962. (VUmc)
Griffioen GHMJ, Dahele M, de Haan PF, van de Ven PM, Slotman BJ, Senan S. High-dose, conventionally
fractionated thoracic reirradiation for lung tumors. Lung Cancer 2014; 83: 356-362. (VUmc)
Griffioen GHMJ, Lagerwaard FJ, Haasbeek CJA, Slotman BJ, Senan S. A Brief Report on Outcomes of
Stereotactic Ablative Radiotherapy for a Second Primary Lung Cancer: Evidence in Support of Routine CT
Surveillance. Journal of Thoracic Oncology 2014; 9: 1222-1225. (VUmc)
Griffith KA, Dorsey SG, Renn CL, Zhu SJ, Johantgen ME, Cornblath DR, Argyriou AA, Cavaletti G, Merkies
ISJ, Alberti P, Postma TJ, Rossi E, Frigeni B, Bruna J, Velasco R, Kalofonos HP, Psimaras D, Ricard D,
Pace A, Galie E, Briani C, la Torre C, Faber CG,. Correspondence between neurophysiological and
clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from
the CI-PeriNomS study. J Peripher Nerv Syst 2014; 19: 127-135. (VUmc/NKI)
Groenendijk FH, Bernards R. Drug resistance to targeted therapies: Deja vu all over again. Mol Oncol
2014; 8:1067-83 (NKI)
Groenendijk MR, Hartemink KJ, Dickhoff C, Geeraedts LMG, Terra M, Thoral P, Hashemi SM.
Pneumomediastinum and (bilateral) pneumothorax after high energy trauma: Indications for emergency
bronchoscopy. Respiratory Medicine Case Reports 2014; 13: 9-11. (VUmc)
Groettrup M, Ovaa H. Editorial Overview: Molecular immunology: Targeting the immune system. Curr
Opin Chem Biol 2014; 23C:v-vii (NKI)
Groot Koerkamp B, Wiggers JK, Allen PJ, Busch ORC, D'Angelica MI, DeMatteo RP, Fong Y, Gonen M.
Gouma DJ, Kingham TP, van Gulik TM, Jarnagin WR. American Joint Committee on Cancer staging for
resected perihilar cholangiocarcinoma: a comparison of the 6th and 7th editions. HPB 16(12), 2014,
p.1074-1082. (AMC)
Grubb A, Horio M, Hansson LO, Bjork J, Nyman U, Flodin M, Larsson A, Bokenkamp A, Yasuda Y, Blufpand
H, Lindstrom V, Zegers I, Althaus H, Blirup-Jensen S, Itoh Y, Sjostrom P, Nordin G, Christensson A, Klima
H, Sunde K, Hjort-Christensen P, Armbruster D, F. Generation of a New Cystatin C-Based Estimating
Equation for Glomerular Filtration Rate by Use of 7 Assays Standardized to the International Calibrator.
Clin Chem 2014; 60: 974-986. (VUmc)
Gu Y, Bouwman P, Greco D, Saarela J, Yadav B, Jonkers J, Kuznetsov SG. Suppression of BRCA1
sensitizes cells to proteasome inhibitors. Cell Death Dis 2014; 5:e1580-(12 pp) (NKI)
Gubin MM, Zhang X, Schuster H, Caron E, Ward JP, Noguchi T, Ivanova Y, Hundal J, Arthur CD, Krebber
WJ, Mulder GE, Toebes M, Vesely MD, Lam SS, Korman AJ, Allison JP, Freeman GJ, Sharpe AH, Pearce
EL, Schumacher TN, Aebersold R, Rammensee HG, Melief CJ, Mardis ER, Gillanders WE, Artyomov MN,
Schreiber RD. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.
Nature 2014; 515:577-81 (NKI)
106 - Scientific publications
527.
528.
529.
530.
531.
532.
533.
534.
535.
536.
537.
538.
539.
540.
541.
542.
543.
544.
545.
546.
547.
Guchelaar HJ, Gelderblom H, van der Straaten T, Schellens JHM, Swen JJ. Pharmacogenetics in the
cancer clinic: from candidate gene studies to next-generation sequencing. Clin Pharmacol Ther 2014;
95:383-5 (NKI)
Guikema JEJ, Linehan EK, Esa N, Tsuchimoto D, Nakabeppu Y, Woodland RT, Schrader CE.
Apurinic/apyrimidinic endonuclease 2 regulates the expansion of germinal centers by protecting against
activation-induced cytidine deaminase-independent DNA damage in B cells. Journal of Immunology
193(2), 2014, p.931-939. (AMC)
Gül N, Babes L, Kubes P, van Egmond M. Macrophages in the liver prevent metastasis by efficiently
eliminating circulating tumor cells after monoclonal antibody immunotherapy. Oncoimmunology 2014; 3:
e28441. (VUmc)
Gül N, Babes L, Siegmund K, Korthouwer R, Bögels M, Braster R, Vidarsson G, ten Hagen TLM, Kubes P,
van Egmond M. Macrophages eliminate circulating tumor cells after monoclonal antibody therapy. J Clin
Invest 2014; 124: 812-823. (VUmc)
Gunawan S, Wolters E, van Dongen J, van der Ven P, Sitaresmi M, Veerman A, Mantik M, Kaspers G,
Mostert S. Parents' and Health-Care Providers' Perspectives on Side-Effects of Childhood Cancer
Treatment in Indonesia. Asian Pacific Journal of Cancer Prevention 2014; 15: 3593-3599. (VUmc)
Gwynne S, Wijnhoven BPL, Hulshof M, Bateman A. Role of Chemoradiotherapy in Oesophageal Cancer Adjuvant and Neoadjuvant Therapy. Clinical Oncology 26(9), 2014, p.522-532. (AMC)
Haan JC, Labots M, Rausch C, Koopman M, de Nooy-van Tol J, Mekenkamp LJM, van de Wiel MA, Israeli
D, van Essen HF, van Grieken NCT, Voorham QJM, Bosch LJW, Qu X, Kabbarah O, Verheul HMW,
Nagtegaal ID, Punt CJA, Ylstra B, Meijer GA. Genomic landscape of metastatic colorectal cancer. Nature
Communications 2014; 5: 5457. (VUmc/AMC)
Haanstra JF, Al-Toma A, Dekker E, Vanhoutvin SALW, Nagengast FM, Mathus-Vliegen EM, van Leerdam
ME, de Vos tot Nederveen Cappel W., Sanduleanu S, Veenendaal RA, Cats A, Vasen HFA, Kleibeuker JH,
Koornstra JJ. Prevalence of small-bowel neoplasia in Lynch syndrome assessed by video capsule
endoscopy. GUT [aheadofprint], 2014, p.-. (AMC)
Haarhuis JH, Elbatsh AM, Rowland BD. Cohesin and Its Regulation: On the Logic of X-Shaped
Chromosomes. Dev Cell 2014; 31:7-18 (NKI)
Haas RL. Present and future of radiotherapy before and after surgery for sarcoma patients. Eur J Surg
Oncol 2014; 40:1595-7 (NKI)
Habets EJJ, Kloet A, Walchenbach R, Vecht CJ, Klein M, Taphoorn MJB. Tumour and surgery effects on
cognitive functioning in high-grade glioma patients. ACTA Neurochir 2014; 156: 1451-1459. (VUmc)
Habets EJJ, Taphoorn MJB, Nederend S, Klein M, Delgadillo D, Hoang-Xuan K, Bottomley A, Allgeier A,
Seute T, Gijtenbeek AMM, de Gans J, Enting RH, Tijssen CC, van den Bent MJ, Reijneveld JC. Healthrelated quality of life and cognitive functioning in longterm anaplastic oligodendroglioma and
oligoastrocytoma survivors. J Neuro-Oncol 2014; 116: 161-168. (VUmc)
Hage JJ, van der Heeden JF, Lankhorst KM, Romviel SM, Vluttters ME, Woerdeman LA, Visser B, Veeger
HE. Impact of Combined Skin Sparing Mastectomy and Immediate Subpectoral Prosthetic Reconstruction
on the Pectoralis Major Muscle Function: A Preoperative and Postoperative Comparative Study. Ann Plast
Surg 2014; 72:631-7 (NKI)
Hagenbeek TJ, Wu X, Choy L, Sanchez-Irizarry C, Seshagiri S, Stinson J, Siebel CW, Spits H. Murine
Pten(-/-) T-ALL requires non-redundant PI3K/mTOR and DLL4/Notch1 signals for maintenance and
gammac/TCR signals for thymic exit. Cancer Lett 2014; 346:237-48 (NKI)
Haitjema A, Mol BM, Kooi EI, Massink MPG, Jorgensen JAL, Rockx DAP, Rooimans MA, de Winter JP,
Meijers-Heijboer H, Joenje H, Dorsman JC. Coregulation of FANCA and BRCA1 in human cells.
SpringerPlus 2014; 3: 381. (VUmc)
Haj Mohammad N, Hulshof MCCM, Bergman JJGHM, Geijsen D, Wilmink JW, van Berge Henegouwen MI,
van Laarhoven HWM. Acute toxicity of definitive chemoradiation in patients with inoperable or
irresectable esophageal carcinoma. BMC CANCER 14(1), 2014, p.56-. (AMC)
Haloua MH, Krekel NMA, Jacobs GJA, Zonderhuis BM, Bouman MB, Buncamper ME, Niessen FB, Winters
HAH, Terwee CB, Meijer S, van den Tol MP. Cosmetic Outcome Assessment following Breast-Conserving
Therapy: A Comparison between BCCT.core Software and Panel Evaluation. International journal of
breast cancer 2014; 2014: 716860. (VUmc)
Haloua MH, Krekel NMA, Meijer S, van den Tol MP. Ultrasound-guided surgery for palpable breast cancer:
a historical perspective. Expert Rev Anticancer Ther 2014; 3: 433-439. (VUmc)
Hamaker ME, Seynaeve C, Wymenga ANM, Van Tinteren H, Nortier JWR, Maartense E, de Graaf H, de
Jongh FE, Braun JJ, Los M, Schrama JG, Leeuwen-Stok AE, de Groot SM, Smorenburg CH. Baseline
comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast
cancer patients receiving single-agent chemotherapy: Results from the OMEGA study of the Dutch Breast
Cancer Trialists' Group. Breast 2014; 23:81-7 (NKI)
Hanff LM, Mathot RAA, Smeets O, Postma DJ, Ramnarain S, Vermes A, Pieters R, Zwaan CM. A novel
6-mercaptopurine oral liquid formulation for pediatric acute lymphoblastic leukemia patients - results of
a randomized clinical trial. International Journal of Clinical Pharmacology and Pharmacology and
Therapeutics 52(8), 2014, p.653-662. (AMC)
Hanna WM, Rüschoff J, Bilous M, Coudry RA, Dowsett M, Osamura RY, Penault-Llorca F, van de Vijver M,
Viale G. HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic
heterogeneity. Modern Pathology 27(1), 2014, p.4-18. (AMC)
Scientific publications - 107
548.
549.
550.
551.
552.
553.
554.
555.
556.
557.
558.
559.
560.
561.
562.
563.
564.
565.
566.
567.
568.
Hanson IM, Hansen VN, Olaciregui-Ruiz I, van Herk M. Clinical implementation and rapid commissioning
of an EPID based in-vivo dosimetry system. Physics in Medicine and Biology 59(19), 2014, p.N171-N179.
(AMC)
Hanson IM, Hansen VN, Olaciregui-Ruiz I, van HM. Clinical implementation and rapid commissioning of an
EPID based in-vivo dosimetry system. Phys Med Biol 2014; 59:N171-N179 (NKI)
Harlaar JJ, Gosselink MP, Hop WC, Lange JF, Busch ORC, Jeekel H. Reply to Letter: "Blood Transfusions
and Prognosis in Colorectal Cancer. Long-term Results of a Randomized Controlled Trial". Annals of
Surgery [aheadofprint], 2014, p.-. (AMC)
Harris EJ, Mukesh M, Jena R, Baker A, Bartelink H, Brooks C, Dean J, Donovan EM, Collette S, Eagle S,
Fenwick JD, Graham PH, Haviland JS, Kirby AM, Mayles H, Mitchell RA, Perry R, Poortmans P, Poynter A,
Shentall G, Titley J, Thompson A, Yarnold JR, Coles CE, Evans PM, Heemskerk-Gerritsen BA, Rookus MA,
Aalfs CM, Ausems MG, Collee JM, Jansen L, Kets CM, Keymeulen KB, Koppert LB, Meijers-Heijboer HE,
Mooij TM, Tollenaar RA, Vasen HF, Hooning MJ, Seynaeve C. Improved overall survival after
contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast
cancer: a prospective analysis. Int J Cancer 2014; 136:668-77 (NKI)
Hart A, Baars JW, Kersten MJ, Brandsma D, Van Tinteren H, De Jong D, Spiering M, Dewit L, Boogerd W.
Outcome of patients with primary central nervous system lymphoma treated outside clinical trials. Neth
J Med 2014; 72:218-23 (NKI/AMC)
Hartwig W, Vollmer CM, Fingerhut A, Yeo CJ, Neoptolemos JP, Adham M, Andrén-Sandberg A, Asbun HJ,
Bassi C, Bockhorn M, Charnley R, Conlon KC, Dervenis C, Fernandez-Cruz L, Friess H, Gouma DJ, Imrie
CW, Lillemoe KD, Milićević MN, Montorsi M, Shrikhande SV, Vashist YK, Izbicki JR, Büchler MW. Extended
pancreatectomy in pancreatic ductal adenocarcinoma: definition and consensus of the International
Study Group for Pancreatic Surgery (ISGPS). Surgery 156(1), 2014, p.1-14.
Hasan B, Greillier L, Pallis A, Menis J, Gaafar R, Sylvester R, Fennell DA, Baas P, Surmont V, Van
Meerbeeck JP, O'brien ME. Progression free survival rate at 9 and 18weeks predict overall survival in
patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European
Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent
study validation. Eur J Cancer 2014; 50:2771-82(NKI)
Hashemi SMS, Dahele M, Daniels JMA, Smit EF. Complications of endoscopic ultrasound-guided needle
aspiration. ACTA Oncol 2014; 53: 1265-1268. (VUmc)
Hassan C, Kester MGD, Oudgenoeg G, De Ru AH, Janssen GMC, Drijfhout JW, Spaapen RM, Jimenez CR,
Heemskerk MHM, Falkenburg JHF, van Veelen PA. Accurate quantitation of MHC-bound peptides by
application of isotopically labeled peptide MHC complexes. Journal of Proteomics 2014; 109: 240-244.
(VUmc/NKI)
Hatzmann J, Peek N, Heymans H, Maurice-Stam H, Grootenhuis M. Consequences of caring for a child
with a chronic disease: Employment and leisure time of parents. Journal of child Health Care 18(4),
2014, p.346-357. (AMC)
Haverkort EB, Binnekade JM, de van der Schueren MAE, Gouma DJ, de Haan RJ. Estimation of Body
Composition Depends on Applied Device in Patients Undergoing Major Abdominal Surgery. Nutrition in
Clinical Practice [aheadofprint], 2014, p.-. (AMC)
Haverman L, Limperg PF, van Oers HA, van Rossum MAJ, Maurice-Stam H, Grootenhuis MA. Psychometric
properties and Dutch norm data of the PedsQL Multidimensional Fatigue Scale for Young Adults. Quality
of Life Research 23(10), 2014, p.2841-2847. (AMC)
Haverman TM, Raber-Durlacher JE, Rademacher WMH, Vokurka S, Epstein JB, Huisman C, Hazenberg MD,
de Soet JJ, de Lange J, Rozema FR. Oral complications in hematopoietic stem cell recipients: the role of
inflammation. Mediators of Inflammation 2014, 2014, p.378281-. (AMC)
Hazenberg MD, Spits H. Human innate lymphoid cells. Blood 124(5), 2014, p.700-709. (AMC)
Hazewinkel Y, de Wijkerslooth TR, Stoop EM, Bossuyt PM, Biermann K, van de Vijver MJ, Fockens P, van
Leerdam ME, Kuipers EJ, Dekker E. Prevalence of serrated polyps and association with synchronous
advanced neoplasia in screening colonoscopy. Endoscopy 46(3), 2014, p.219-224. (AMC)
Hazewinkel Y, Koornstra J-J, Boparai KS, van Os TAM, Tytgat KMAJ, van Eeden S, Fockens P, Dekker E.
Yield of Screening Colonoscopy in First-degree Relatives of Patients With Serrated Polyposis Syndrome.
Journal of Clinical Gastroenterology [aheadofprint], 2014, p.-. (AMC)
Hazewinkel Y, Tytgat KMAJ, van Eeden S, Bastiaansen B, Tanis PJ, Boparai KS, Fockens P, Dekker E.
Incidence of Colonic Neoplasia in Patients With Serrated Polyposis Syndrome Who Undergo Annual
Endoscopic Surveillance. Gatroenterology 147(1), 2014, p.88-95. (AMC)
Hazewinkel Y, Tytgat KMAJ, van Leerdam ME, Koornstra J-J, Bastiaansen BA, van Eeden S, Fockens P,
Dekker E. Narrow-band imaging for the detection of polyps in patients with serrated polyposis
syndrome: a multicenter, randomized, back-to-back trial. Gastrointestinal Endoscopy [aheadofprint],
2014, p.-. (AMC)
Hectors SJCG, Jacobs I, Strijkers GJ, Nicolay K. Amide proton transfer imaging of high intensity focused
ultrasound-treated tumor tissue. Magnetic Resonance in Medicine 72(4), 2014, p.1113-1122. (AMC)
Hectors SJCG, Jacobs I, Strijkers GJ, Nicolay K. Multiparametric MRI Analysis for the Identification of
High Intensity Focused Ultrasound-Treated Tumor Tissue. PLOS ONE 9(6), 2014, p.e99936-. (AMC)
Hectors SJCG, Moonen RPM, Strijkers GJ, Nicolay K. T1 ρ mapping for the evaluation of high intensity
focused ultrasound tumor treatment. Magnetic Resonance in Medicine -, 2014, p.--. (AMC)
108 - Scientific publications
569.
570.
571.
572.
573.
574.
575.
576.
577.
578.
579.
580.
581.
582.
583.
584.
585.
586.
587.
588.
589.
590.
591.
Heemsbergen WD, Al Mamgani A, Slot A, Dielwart MF, Lebesque JV. Long-term results of the Dutch
randomized prostate cancer trial: Impact of dose-escalation on local, biochemical, clinical failure, and
survival. Radiother Oncol 2014; 110:104-9 (NKI)
Hegarty P, Eardley I, Heidenreich A, McDougal WS, Minhas S, Spiess P, Watkin N, Horenblas S. Penile
Cancer: Organ-sparing techniques. BJU Int 2014; 114:799-805 (NKI)
Heger M, van Golen RF, Broekgaarden M, Michel MC. The molecular basis for the pharmacokinetics and
pharmacodynamics of curcumin and its metabolites in relation to cancer. Pharmacological Reviews.
66(1), 2014, p.222-307. (AMC)
Heger M, van Golen RF, Broekgaarden M, van den Bos RR, Neumann HAM, van Gulik TM, van Gemert
MJC. Endovascular laser-tissue interactions and biological responses in relation to endovenous laser
therapy. Lasers in Medical Science 29(2), 2014, p.405-422. (AMC)
Heideman MR, Lancini C, Proost N, Yanover E, Jacobs H, Dannenberg JH. Sin3a-associated Hdac1 and
Hdac2 are essential for hematopoietic stem cell homeostasis and contribute differentially to
hematopoiesis. Haematologica 2014; 99:1292-303 (NKI)
Heijblom M, Meijer LM, van Leeuwen TG, Steenbergen W, Manohar S. Monte Carlo simulations shed light
on Bathsheba's suspect breast. Journal of Biophotonics 7(5), 2014, p.323-331. (AMC)
Heijkoop ST, van Doorn HC., Stalpers LJA, Boere IA, van der Velden J, Franckena M, Westermann AM.
Results of concurrent chemotherapy and hyperthermia in patients with recurrent cervical cancer after
previous chemoradiation. International Journal of Hyperthermia 30(1), 2014, p.6-10. (AMC)
Heijmans J, Wielenga MCB, Rosekrans SL, van Lidth de Jeude JF, Roelofs J, Groothuis P, Ederveen A, de
Jonge-Muller ESM, Biemond I, Hardwick JCH, D'Haens G, Hommes DW, Muncan V, van den Brink GR.
Oestrogens promote tumorigenesis in a mouse model for colitis-associated cancer. GUT 63(2), 2014,
p.310-316. (AMC)
Heijmen L, ter Voert EGW, Punt CJA, Heerschap A, Oyen WJG, Bussink J, Sweep CGJ, Laverman P, Span
PN, de Geus-Oei LF, Boerman OC, van Laarhoven HWM. Monitoring hypoxia and vasculature during
bevacizumab treatment in a murine colorectal cancer model. Contrast Media & Molecular Imaging 9(3),
2014, p.237-245. (AMC)
Helgason HH, Koolen SL, Werkhoven E, Malingre MM, Kruijtzer CM, Huitema AD, Schot ME, Smit WM,
Beijnen JH, Schellens JHM. Phase II and pharmacological study of oral docetaxel plus cyclosporin a in
anthracycline pre-treated metastatic breast cancer. Curr Clin Pharmacol 2014; 9:139-47 (NKI)
Helmers R, Milstein DMJ, van Hulst RA, de Lange J. Hyperbaric oxygen therapy accelerates
vascularization in keratinized oral mucosal surgical flaps. Head and Neck Journal for the Sciences and
Specialties of the Head and Neck 36(9), 2014, p.1241-1247. (AMC)
Hemke R, Lavini C, Nusman CM, van den Berg JM, Dolman KM, Schonenberg-Meinema D, van Rossum
MAJ, Kuijpers TW, Maas M. Pixel-by-pixel analysis of DCE-MRI curve shape patterns in knees of active
and inactive juvenile idiopathic arthritis patients. European Radiology 24(7), 2014, p.1686-1693. (AMC)
Hendriks LEL, Smit EF, Vosse BAH, Mellema WW, Heideman DAM, Bootsma GP, Westenend M, Pitz C, de
Vries GJ, Houben R, Grunberg K, Bendek M, Speel EJM, Dingemans AMC. EGFR mutated non-small cell
lung cancer patients: More prone to development of bone and brain metastases?. Lung Cancer 2014; 84:
86-91. (VUmc)
Hendrikx JJ, Beijnen JH, Schinkel AH. P-gp and taxanes. Oncoscience 2014; 1:478-9 (NKI)
Hendrikx JJ, Lagas JS, Daling R, Hooijberg JH, Schellens JHM, Beijnen JH, Brandjes DP, Huitema ADR.
Severe lactic acidosis in a diabetic patient after ethanol abuse and floor cleaner intake. Basic Clin
Pharmacol Toxicol 2014; 115:472-5 (NKI)
Hendrikx JJ, Lagas JS, Wagenaar E, Rosing H, Schellens JHM, Beijnen JH, Schinkel AH. Oral coadministration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without
affecting relative brain accumulation. Br J Cancer 2014; 110:2669-76 (NKI)
Hendrikx JJ, Rosing H, Schinkel AH, Schellens JHM, Beijnen JH. Quantification of taxanes in biological
matrices: a review of bioanalytical assays and recommendations for development of new assays.
Bioanalysis 2014; 6:993-1010 (NKI)
Hendrikx JJMA, Rosing H, Schinkel AH, Schellens JHM, Beijnen JH. Combined quantification of
paclitaxel, docetaxel and ritonavir in human feces and urine using LC-MS/MS. Biomed Chromatogr 2014;
28:302-10
Henneman D, Dekker JW, Wouters MW, Fiocco M, Tollenaar RA. Benchmarking clinical outcomes in
elective colorectal cancer surgery: The interplay between institutional reoperation- and mortality rates.
Eur J Surg Oncol 2014; 40:1429-35 (NKI)
Henneman D, Dikken JL, Putter H, Lemmens VE, Van der Geest LG, van HR, Verheij M, van d, V, Wouters
MW. Centralization of esophagectomy: how far should we go? Ann Surg Oncol 2014; 21:4068-74 (NKI)
Henneman D, Ten Berge MG, Snijders HS, Van Leersum NJ, Fiocco M, Wiggers T, Tollenaar RA, Wouters
MW. Safety of elective colorectal cancer surgery: non-surgical complications and colectomies are targets
for quality improvement. J Surg Oncol 2014; 109:567-73 (NKI)
Henneman D, van Bommel AC, Snijders A, Snijders HS, Tollenaar RA, Wouters MW, Fiocco M. Ranking
and rankability of hospital postoperative mortality rates in colorectal cancer surgery. Ann Surg 2014;
259:844-9 (NKI)
Hensley ML, Barrette BA, Baumann K, Gaffney D, Hamilton AL, Kim J-W, Maenpaa JU, Pautier Pa,
Siddiqui NA, Westermann AM, Ray-Coquard I. Gynecologic Cancer InterGroup (GCIG) Consensus Review:
Uterine and Ovarian Leiomyosarcomas. International Journal of Gynecological Cancer 24(9 Suppl 3),
Scientific publications - 109
592.
593.
594.
595.
596.
597.
598.
599.
600.
601.
602.
603.
604.
605.
606.
607.
608.
609.
610.
611.
612.
2014, p.S61-S66. (AMC)
Hes FJ, Ruano D, Nieuwenhuis M, Tops CM, Schrumpf M, Nielsen M, Huijts PEA, Wijnen JT, Wagner A,
Garcia EBG, Sijmons RH, Menko FH, Letteboer TGW, Hoogerbrugge N, Harryvan J, Kampman E, Morreau
H, Vasen HFA, van Wezel T. Colorectal cancer risk variants on 11q23 and 15q13 are associated with
unexplained adenomatous polyposis. J Med Genet 2014; 51: 55-60. (VUmc)
Heskamp S, Boerman OC, Molkenboer-Kuenen JD, Koornstra RH, Linn SC, Oyen WJ, van der Graaf WT,
van Laarhoven HW. Dynamics of IGF-1R expression during endocrine breast cancer treatment. Mol
Imaging Biol 2014; 16:529-37 (NKI)
Heskamp S, Boerman OC, Molkenboer-Kuenen JDM, Koornstra RHT, Linn SC, Oyen WJG, van der Graaf
WTA, van Laarhoven HWM. Dynamics of IGF-1R Expression During Endocrine Breast Cancer Treatment.
Molecular Imaging and Biology 16(4), 2014, p.529-537. (AMC)
Heskamp S, Boerman OC, Molkenboer-Kuenen JDM, Sweep FCGJ, Geurts-Moespot A, Engelhardt MS, van
der Graaf WTA, Oyen WJG, van Laarhoven HWM. Cetuximab Reduces the Accumulation of Radiolabeled
Bevacizumab in Cancer Xenografts without Decreasing VEGF Expression. Molecular Pharmaceutics
11(11), 2014, p.4249-4257. (AMC)
Heskamp S, van Laarhoven HWM, van der Graaf WTA, Oyen WJG, Boerman OC. Radionuclide imaging of
drug delivery for patient selection in targeted therapy. Expert Opinion on Drug Delivery 11(2), 2014,
p.175-185. (AMC)
Hesselink AT, Berkhof J, van der Salm ML, van Splunter AP, Geelen TH, van Kemenade FJ, Bleeker MGB,
Heideman DAM. Clinical Validation of the HPV-Risk Assay, a Novel Real-Time PCR Assay for Detection of
High-Risk Human Papillomavirus DNA by Targeting the E7 Region. J Clin Microbiol 2014; 52: 890-896.
(VUmc)
Hesselink AT, Heideman DAM, Steenbergen RDM, Gok M, van Kemenade FJ, Wilting SM, Berkhof J, Meijer
CJLM, Snijders PJF. Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to
triage high-risk HPV-positive women for colposcopy. Int J Cancer 2014; 135: 880-886. (VUmc)
Hettich J, Ryan SD, de Souza ON, Saraiva Macedo Timmers LF, Tsai S, Atai NA, da Hora CC, Zhang X,
Kothary R, Snapp E, Ericsson M, Grundmann K, Breakefield XO, Nery FC. Biochemical and Cellular
Analysis of Human Variants of the DYT1 Dystonia Protein, TorsinA/TOR1A. Human Mutation 35(9), 2014,
p.1101-1113. (AMC)
Heusschen R, Schulkens IA, van Beijnum J, Griffioen AW, Thijssen VLJL. Endothelial LGALS9 splice
variant expression in endothelial cell biology and angiogenesis. Biochim Biophys Acta Mol Basis Dis 2014;
1842: 284-292. (VUmc)
Heynen GJ, Fonfara A, Bernards R. Resistance to targeted cancer drugs through hepatocyte growth
factor signaling. Cell Cycle 2014; 13:3808-17 (NKI)
Hidalgo M, Amant F, Biankin AV, Budinska E, Byrne AT, Caldas C, Clarke RB, de Jong S, Jonkers J,
Maelandsmo GM, Roman-Roman S, Seoane J, Trusolino L, Villanueva A. Patient-derived xenograft
models: an emerging platform for translational cancer research. Cancer Discov 2014; 4:998-1013 (NKI)
Hidding JT, Beurskens CHG, van der Wees PJ, van Laarhoven HWM, Nijhuis-van der Sanden MWG.
Treatment related impairments in arm and shoulder in patients with breast cancer: a systematic review.
PLOS ONE 9(5), 2014, p.e96748-. (AMC)
Hiddingh L, Raktoe RS, Jeuken J, Hulleman E, Noske DP, Kaspers GJ, Vandertop WP, Wesseling P,
Wurdinger T. Identification of temozolomide resistance factors in glioblastoma via integrative
miRNA/mRNA regulatory network analysis. Sci Rep 2014; 4: 5260. (VUmc)
Hiddingh L, Tannous BA, Teng J, Tops B, Jeuken J, Hulleman E, Boots-Sprenger SH, Vandertop WP,
Noske DP, Kaspers GJL, Wesseling P, Wurdinger T. EFEMP1 induces gamma-secretase/Notch-mediated
temozolomide resistance in glioblastoma. Oncotarget 2014; 5: 363-374. (VUmc)
Hiemstra IH, Beijer MR, Veninga H, Vrijland K, Borg EGF, Olivier BJ, Mebius RE, Kraal G, den Haan JMM.
The identification and developmental requirements of colonic CD169+macrophages. Immunology 2014;
142: 269-278. (VUmc)
Higginson IJ, Gomes B, Calanzani N, Gao W, Bausewein C, Daveson BA, Deliens L, Ferreira PL, Toscani F,
Gysels M, Ceulemans L, Simon ST, Cohen J, Harding R. Priorities for treatment, care and information if
faced with serious illness: A comparative population-based survey in seven European countries.
Palliative Medicine 2014; 28(2): 101-110. (VUmc)
Hillen MA, de Haes HCJM, Stalpers LJA, Klinkenbijl JHG, Eddes E-H, Verdam MGE, Smets EMA. How
attachment style and locus of control influence patients' trust in their oncologist. Journal of
Psychosomatic Research 76(3), 2014, p.221-226. (AMC)
Hillen MA, de Haes HCJM, Stalpers LJA, Klinkenbijl JHG, Eddes EH, Butow PN, van der Vloodt J, van
Laarhoven HWM., Smets EMA. How can communication by oncologists enhance patients' trust? An
experimental study. Annals of Oncology 25(4), 2014, p.896-901. (AMC)
Hillen MA, de Haes HCJM, Verdam MGE, Smets EMA. Does source of patient recruitment affect the
impact of communication on trust? Patient Education and Counseling 95(2), 2014, p.226-230. (AMC)
Hillen MA. Capsule commentary on Tokes et al. disease and treatment perceptions among Asian
Americans diagnosed with chronic hepatitis B infection. Journal of General Internal Medicine 29(3),
2014, p.517-. (AMC)
Hitzerd SM, Verbrugge SE, Ossenkoppele GJ, Jansen G, Peters GJ. Positioning of aminopeptidase
inhibitors in next generation cancer therapy. Amino Acids 2014; 46: 793-808. (VUmc)
110 - Scientific publications
613.
614.
615.
616.
617.
618.
619.
620.
621.
622.
623.
624.
625.
626.
627.
628.
629.
630.
631.
Ho VKY, Reijneveld JC, Enting RH, Bienfait HP, Robe P, Baumert BG, Visser O. Changing incidence and
improved survival of gliomas. Eur J Cancer 2014; 50: 2309-2318. (VUmc)
Hochberg FH, Atai NA, Gonda D, Hughes MS, Mawejje B, Balaj L, Carter RS. Glioma diagnostics and
biomarkers: an ongoing challenge in the field of medicine and science. Expert Review of Molecular
Diagnostics 14(4), 2014, p.439-452. (AMC)
Hoefnagels FWA, Hamer PD, Sanz-Arigita E, Idema S, Kuijer JPA, Pouwels PJW, Barkhof F, Vandertop
WP. Differentiation of edema and glioma infiltration: proposal of a DTI-based probability map. J NeuroOncol 2014; 120: 187-198. (VUmc)
Holstege H, Pfeiffer W, Sie DLS, Hulsman M, Nicholas TJ, Lee CC, Ross T, Lin J, Miller MA, Ylstra B,
Meijers-Heijboer HE, Brugman MH, Staal FJT, Holstege G, Reinders MJT, Harkins TT, Levy S, Sistermans
EA. Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate
oligoclonal hematopoiesis. Genome Res 2014; 24: 733-742. (VUmc)
Holtzer-Goor KM, Bouwmans-Frijters CAM, Schaafsma MR, de Weerdtc O, Joosten P, Posthuma EFM,
Wittebol S, Huijgens PC, Matthssen EJM, Vreugdenhil G, Visser H, Peters WG, Erjavec Z, Wijermans PW,
Daenen SMGJ, van der Hem KG, van Oers MHJ, Uyl-de Groot CA. Real-world costs of chronic lymphocytic
leukaemia in the Netherlands. Leukemia Res 2014; 38: 84-90. (VUmc)
Hompes D, Aalbers A, Boot H, van Velthuysen ML, Vogel W, Prevoo W, Van Tinteren H, Verwaal V. A
prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis
from colorectal cancer. Colorectal Dis 2014; 16:O264-O272 (NKI)
Hompes D, D'Hoore A, Wolthuis A, Fieuws S, Mirck B, Bruin S, Verwaal V. The use of Oxaliplatin or
Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative
study. J Surg Oncol 2014; 109:527-32 (NKI)
Hoogendoorn E, Crosby KC, Leyton-Puig D, Breedijk RM, Jalink K, Gadella TW, Postma M. The fidelity of
stochastic single-molecule super-resolution reconstructions critically depends upon robust background
estimation. Sci Rep 2014; 4:3854 (NKI)
Hooijberg JH, Jansen G, Kathmann I, Pieters R, Laan AC, van Zantwijk I, Kaspers GJL, Peters GJ. Folates
provoke cellular efflux and drug resistance of substrates of the multidrug resistance protein 1 (MRP1).
Cancer Chemoth Pharm 2014; 73: 911-917. (VUmc)
Hooijman PE, Beishuizen A, de Waard MC, de Man FS, Vermeijden JW, Steenvoorde P, Bouwman RA,
Lommen W, van Hees HW, Heunks LM, Dickhoff C, van der Peet DL, Girbes AR, Jasper JR, Malik FI,
Stienen GJ, Hartemink KJ, Paul MA, Ottenheijm CA. Diaphragm fiber strength is reduced in critically ill
patients and restored by a troponin activator. Am J Respir Crit Care Med 2014; 189:863-5 (NKI)
Hoornweg MJ, Saeed P, Tanck MWT, Hage JJ, Coumou AD, van der Horst CMAM. Comparison of
intralesional corticosteroid and propranolol treatment of periorbital infantile hemangiomas: an outcome
study of 61 cases. Eur J Ophthalmol 2014; 24:940-7 (NKI)
Hopmans W, Damman OC, Timmermans DRM, Haasbeek CJA, Slotman BJ, Senan S. Communicating
cancer treatment information using the Web: utilizing the patient's perspective in website development.
BMC Medical Informatics and Decision Making 2014; 14: 116. (VUmc)
Hoppes R, Oostvogels R, Luimstra JJ, Wals K, Toebes M, Bies L, Ekkebus R, Rijal P, Celie PH, Huang JH,
Emmelot ME, Spaapen RM, Lokhorst H, Schumacher TNM, Mutis T, Rodenko B, Ovaa H. Altered Peptide
Ligands Revisited: Vaccine Design through Chemically Modified HLA-A2-Restricted T Cell Epitopes. J
Immunol 2014; 193:4803-13 (NKI)
Horeweg N, Scholten ET, de Jong PA, van der Aalst CM, Weenink C, Lammers JWJ, Nackaerts K,
Vliegenthart R, ten Haaf K, Yousaf-Khan UA, Heuvelmans MA, Thunnissen E, Oudkerk M, Mali W, Koning
HJ. Detection of lung cancer through low-dose CT screening (NELSON): a prespecifi ed analysis of
screening test performance and interval cancers. Lancet Oncol 2014; 15: 1342-1350. (VUmc)
Horjus DL, Nieuwland R, Boateng KB, Schaap MCL, van Montfrans GA, Clark JF, Sturk A, Brewster LM.
Creatine kinase inhibits ADP-induced platelet aggregation. Scientific Reports 4, 2014, p.6551-. (AMC)
Horton TM, Perentesis JP, Gamis AS, Alonzo TA, Gerbing RB, Ballard J, Adlard K, Howard DS, Smith FO,
Jenkins G, Kelder A, Schuurhuis GJ, Moscow JA. A Phase 2 Study of Bortezomib Combined with Either
Idarubicin/Cytarabine or Cytarabine/Etoposide in Children with Relapsed, Refractory or Secondary
Acute Myeloid Leukemia: A Report from the Children's Oncology Group. Pediatr Blood Cancer 2014; 61:
1754-1760. (VUmc)
Houthuijzen JM, Daenen LGM, Roodhart JML, Oosterom I, van Jaarsveld MTM, Govaert KM, Smith ME,
Sadatmand SJ, Rosing H, Kruse F, Helms BJ, van Rooijen N, Beijnen JH, Haribabu B, van de Lest CHA,
Voest EE. Lysophospholipids secreted by splenic macrophages induce chemotherapy resistance via
interference with the DNA damage response. Nature Communications 2014; 5: 5275. (VUmc/NKI)
Houtzager BA, Möller EL, Maurice-Stam H, Last BF, Grootenhuis MA. Parental perceptions of child
vulnerability in a community-based sample: Association with chronic illness and health-related quality of
life. Journal of Child Health Care [aheadofprint], 2014, p.-. (AMC)
Hovestadt V, Jones DTW, Picelli S, Wang W, Kool M, Northcott PA, Sultan M, Stachurski K, Ryzhova M,
Warnatz H-J, Ralser M, Brun S, Bunt J, Jäger N, Kleinheinz K, Erkek S, Weber UD, Bartholomae CC, von
Kalle C, Lawerenz C, Eils J, Koster J, Versteeg R, Milde T, Witt O, Schmidt S, Wolf S, Pietsch T,
Rutkowski S, Scheurlen W, Taylor MD, Brors B, Felsberg J, Reifenberger G, Borkhardt A, Lehrach H,
Wechsler-Reya RJ, Eils R, Yaspo M-L, Landgraf P, Korshunov A, Zapatka M, Radlwimmer B, Pfister SM,
Lichter P. Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing.
Nature 510(7506), 2014, p.537-541. (AMC)
Scientific publications - 111
632.
633.
634.
635.
636.
637.
638.
639.
640.
641.
642.
643.
644.
645.
646.
647.
648.
649.
650.
651.
Howick J, Cals JWL, Jones C, Price CP, Plüddemann A, Heneghan C, Berger MY, Buntinx F, Hickner J,
Pace W, Badrick T, van den Bruel A, Laurence C, van Weert HC, van Severen E, Parrella A, Thompson M.
Current and future use of point-of-care tests in primary care: an international survey in Australia,
Belgium, The Netherlands, the UK and the USA. BMJ OPEN 4(8), 2014, p.e005611-. (AMC)
Hoytema van Konijnenburg EMM, Teeuw AH, Zwaard SA, van der Lee JH, van Rijn RR. Screening methods
to detect child maltreatment: high variability in Dutch emergency departments. Emergency Medicine
Journal 31(3), 2014, p.196-200. (AMC)
Hubers AJ, Brinkman P, Boksem RJ, Rhodius RJ, Witte BI, Zwinderman AH, Heideman DAM, Duin S,
Koning R, Steenbergen RDM, Snijders PJF, Smit EF, Sterk PJ, Thunnissen E. Combined sputum
hypermethylation and eNose analysis for lung cancer diagnosis. J Clin Pathol 2014; 67: 707-711. (VUmc)
Hubers AJ, van der Drift MA, Prinsen CFM, Witte BI, Wang YH, Shivapurkar N, Stastny V, Bolijn AS, Hol
BEA, Feng ZD, Dekhuijzen PNR, Gazdar AF, Thunnissen E. Methylation analysis in spontaneous sputum for
lung cancer diagnosis. Lung Cancer 2014; 84: 127-133. (VUmc)
Hufner K, Kandler C, Koudouovoh-Tripp P, Egeter J, Hochstrasser T, Stemer B, Malik P, Giesinger J,
Humpel C, Sperner-Unterweger B. Bioprofiling of platelets in medicated patients with depression. J
Affect Disord 2014; 172C:81-8 (NKI)
Hughes TP, Hochhaus A, Kantarjian HM, Cervantes F, Guilhot F, Niederwieser D, le Coutre PD, Rosti G,
Ossenkoppele GJ, Lobo C, Shibayama H, Fan XL, Menssen HD, Kemp C, Larson RA, Saglio G. Safety and
efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in
chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily.
Haematol-Hematol J 2014; 99: 1204-1211. (VUmc)
Hui KF, Leung YY, Yeung PL, Middeldorp JM, Chiang AKS. Combination of SAHA and bortezomib upregulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt
lymphoma and lymphoblastoid cell lines. Brit J Haematol 2014; 167: 639-650. (VUmc)
Huijbers IJ, Bin Ali R, Pritchard C, Cozijnsen M, Kwon MC, Proost N, Song JY, de Vries H, Badhai J,
Sutherland K, Krimpenfort P, Michalak EM, Jonkers J, Berns A. Rapid target gene validation in complex
cancer mouse models using re-derived embryonic stem cells. EMBO Mol Med 2014; 6:212-25 (NKI)
Huis-Tanja LH, Kweekel DM, Lu X, Franken K, Koopman M, Gelderblom H, Antonini NF, Punt CJ,
Guchelaar HJ, van der Straaten T. Excision Repair Cross-Complementation group 1 (ERCC1) C118T SNP
does not affect cellular response to oxaliplatin. Mutat Res Fundam Mol Mech Mutagen 2014; 759:37-44
(NKI)
Hulsebos TJ, Kenter S, Siebers-Renelt U, Hans V, Wesseling P, Flucke U. SMARCB1 Involvement in the
Development of Leiomyoma in a Patient With Schwannomatosis. American Journal of Surgical Pathology
2014; 38: 421-425. (VUmc/AMC)
Hulsebos TJM, Kenter S, Verhagen WIM, Baas F, Flucke U, Wesseling P. Premature termination of
SMARCB1 translation may be followed by reinitiation in schwannomatosis-associated schwannomas, but
results in absence of SMARCB1 expression in rhabdoid tumors. ACTA Neuropathol 2014; 128: 439-448.
(VUmc/AMC)
Hulshof MCCM, Oppedijk V, van der Gaast A. Reply to E.C. Smyth et al. Journal of Clinical Oncology
32(27), 2014, p.3081-3082. (AMC)
Hulson OS, van Rijn RR, Offiah AC. European survey of imaging in non-accidental injury demonstrates a
need for a consensus protocol. Pediatric Radiology 44(12), 2014, p.1557-1563. (AMC)
Hutajulu SH, Kurnianda J, Tan IB, Middeldorp JM. Therapeutic implications of Epstein-Barr virus
infection for the treatment of nasopharyngeal carcinoma. Therapeutics and Clinical Risk Management
2014; 10: 721-736. (VUmc/NKI)
Illidge T, Specht L, Yahalom J, Aleman B, Berthelsen AK, Constine L, Dabaja B, Dharmarajan K, Ng A,
Ricardi U, Wirth A. Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and
dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys
2014; 89:49-58 (NKI)
Infantino S, Jones SA, Walker JA, Maxwell MJ, Light A, O'Donnell K, Tsantikos E, Peperzak V, Phesse T,
Ernst M, Mackay F, Hibbs ML, Fairfax KA, Tarlinton DM. The tyrosine kinase Lyn limits the cytokine
responsiveness of plasma cells to restrict their accumulation in mice. Science Signaling 7(338), 2014,
p.ra77-. (AMC)
Israels T, Bailey S, Verschoor R, Kaspers GJL, Kennedy N, Molyneux EM. Management of Children with
Wilms Tumor in Africa and Europe; Thoughts About Costs, Priorities and Collaboration. Pediatr Hemat
Oncol 2014; 31: 395-399. (VUmc)
Israels T, Molyneux EM. Collaborating in Africa-small steps to sustainable success. Nature reviews
clinical oncology 2014; 11: 691-692. (VUmc)
Issa Y, Bruno MJ, Bakker OJ, Besselink MG, Schepers NJ, van Santvoort HC, Gooszen HG, Boermeester
MA. Treatment options for chronic pancreatitis. Nature Reviews gastroenterology & Hepatology 11(9),
2014, p.556-564. (AMC)
Iusuf D, Ludwig M, Elbatsh A, Van Esch A, Van De Steeg E, Wagenaar E, van der Valk M, Lin F, van
Tellingen O, Schinkel AH. OATP1A/1B Transporters Affect Irinotecan and SN-38 Pharmacokinetics and
Carboxylesterase Expression in Knockout and Humanized Transgenic Mice. Mol Cancer Ther 2014;
13:492-503 (NKI)
112 - Scientific publications
652.
653.
654.
655.
656.
657.
658.
659.
660.
661.
662.
663.
664.
665.
666.
667.
668.
669.
670.
671.
672.
673.
Jacobs JJL, Snackey C, Geldof AA, Characiejus D, van Moorselaar RJA, den Otter W. Inefficacy of
Therapeutic Cancer Vaccines and Proposed Improvements. Casus of Prostate Cancer. Anticancer Res
2014; 34: 2689-2700. (VUmc)
Jae LT, Raaben M, Herbert AS, Kuehne AI, Wirchnianski AS, Soh TK, Stubbs SH, Janssen H, Damme M,
Saftig P, Whelan SP, Dye JM, Brummelkamp TR. Virus entry. Lassa virus entry requires a trigger-induced
receptor switch. Science 2014; 344:1506-10 (NKI)
Jager NG, Rosing H, Schellens JHM, Beijnen JH, Linn SC. Use of dried blood spots for the determination
of serum concentrations of tamoxifen and endoxifen. Breast Cancer Res Treat 2014; 146:137-44 (NKI)
Jager NG, Rosing H, Schellens JHM, Beijnen JH. Determination of tamoxifen and endoxifen in dried
blood spots using LC-MS/MS and the effect of coated DBS cards on recovery and matrix effects.
Bioanalysis 2014; 6:2999-3009 (NKI)
Jager NG, Rosing H, Schellens JHM, Beijnen JH. Procedures and practices for the validation of
bioanalytical methods using dried blood spots: a review. Bioanalysis 2014; 6:2481-514 (NKI)
Jager NG, Rosing H, Schellens JHM, Linn SC, Beijnen JH. Tamoxifen dose and serum concentrations of
tamoxifen and six of its metabolites in routine clinical outpatient care. Breast Cancer Res Treat 2014;
143:477-83 (NKI)
Jager NG, Stuurman FE, Baars JW, Opdam FL. Cerebrovascular events during nilotinib treatment. Neth J
Med 2014; 72:113-4 (NKI)
Jalink K, Adjobo-Hermans MJ. GqPCR-mediated signalling in the spotlight: from visualization towards
dissection and quantification. Curr Pharm Biotechnol 2014; 15:893-915 (NKI)
Jalving M, Heijink DM, Koornstra JJ, Boersma-van EW, Zwart N, Wesseling J, Sluiter WJ, de Vries EG,
Kleibeuker JH, de JS. Regulation of TRAIL receptor expression by beta-catenin in colorectal tumours.
Carcinogenesis 2014; 35:1092-9 (NKI)
Janjigian YY, Smit EF, Groen HJM, Horn L, Gettinger S, Camidge DR, Riely GJ, Wang BS, Fu Y, Chand VK,
Miller VA, Pao W. Dual Inhibition of EGFR with Afatinib and Cetuximab in Kinase Inhibitor-Resistant
EGFR-Mutant Lung Cancer with and without T790M Mutations. Cancer discovery 2014; 4: 1036-1045.
(VUmc)
Jansen JG, Temviriyanukul P, Wit N, Delbos F, Reynaud CA, Jacobs H, de Wind N. Redundancy of
mammalian Y family DNA polymerases in cellular responses to genomic DNA lesions induced by
ultraviolet light. Nucleic Acids Res 2014; 42:11071-82 (NKI)
Jansen M, Menko FH, Brosens LA, Giardiello FM, Offerhaus G. Establishing a clinical and molecular
diagnosis for hereditary colorectal cancer syndromes: Present tense, future perfect?. Gastrointest
Endosc 2014; 80: 1145-1155. (VUmc)
Jansen M, Menko FH, Brosens LA, Giardiello FM, Offerhaus GJ. Establishing a clinical and molecular
diagnosis for hereditary colorectal cancer syndromes: Present tense, future perfect? Gastrointest Endosc
2014; 80:1145-55 (NKI)
Jansen M, Schölvinck DW, Kushima R, Sekine S, Weusten BLAM, Wang GQ, Fleischer DE, Yoshinaga S,
Dawsey SM, Meijer SL, Bergman JJGHM, Oda I. Is it justified to ablate flat-type esophageal squamous
cancer? An analysis of endoscopic submucosal dissection specimens of lesions meeting the selection
criteria of radiofrequency studies. Gastrointestinal Endoscopy 80(6), 2014, p.995-1002. (AMC)
Jansen MHA, Kloet RW, van Vuurden DG, Veldhuijzen van Zanten SEM, Witte BI, Goldman S, Vandertop
WP, Comans EFI, Hoekstra OS, Boellaard R, Kaspers GJL. 18F-FDG PET standard uptake values of the
normal pons in children: establishing a reference value for diffuse intrinsic pontine glioma. EJNMMI
research 2014; 4: 8. (VUmc)
Jansen RS, Duijst S, Mahakena S, Sommer D, Szeri F, Varadi A, Plomp A, Bergen AA, Oude Elferink RP,
Borst P, van de Wetering K. ABCC6-Mediated ATP Secretion by the Liver Is the Main Source of the
Mineralization Inhibitor Inorganic Pyrophosphate in the Systemic Circulation-Brief Report. Arterioscler
Thromb Vasc Biol 2014; 34:1985-9 (NKI)
Janssen JJ, van Delden OM, van Lienden KP, Rauws EAJ, Busch ORC, van Gulik TM, Gouma DJ, Laméris
JS. Percutaneous Balloon Dilatation and Long-Term Drainage as Treatment of Anastomotic and
Nonanastomotic Benign Biliary Strictures. Cardiovascular and Interventional Radiology 37(6), 2014,
p.1559-1567. (AMC)
Janssen-Heijnen MLG, Maas HAAM, Koning CCE, van der Bruggen-Bogaarts BAHA, Groen HJM, Wymenga
ANM. Tolerance and benefits of treatment for elderly patients with limited small-cell lung cancer.
Journal of Geriatric Oncology 5(1), 2014, p.71-77. (AMC)
Janssens GO, Rademakers SE, Terhaard CH, Doornaert PA, Bijl HP, van den Ende P, Chin A, Takes RP, de
Bree R, Hoogsteen IJ, Bussink J, Span PN, Kaanders JH. Improved Recurrence-Free Survival with ARCON
for Anemic Patients with Laryngeal Cancer. Clin Cancer Res 2014; 20: 1345-1354. (VUmc)
Janssens GO, van Bockel LW, Doornaert P, Bijl HP, van den Ende P, de Jong MA, van den Broek GB,
Verbist BM, Terhaard CH, Span PN, Kaanders JH. Computed tomography-based tumour volume as a
predictor of outcome in laryngeal cancer: Results of the phase 3 ARCON trial. Eur J Cancer 2014; 50:
1112-1119. (VUmc)
Jellema HM, Merckel-Timmer E, Kloos R, Saeed P, Mourits MP. Quality of life improves after strabismus
surgery in patients with Graves' orbitopathy. European Journal of Endocrinology 170(5), 2014, p.785-789.
(AMC)
Jenney M, Oberlin O, Audry G, Stevens MCG, Rey A, Merks JHM, Kelsey A, Gallego S, Haie-Meder C,
Martelli H. Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: Results
Scientific publications - 113
674.
675.
676.
677.
678.
679.
680.
681.
682.
683.
684.
685.
686.
687.
688.
689.
from International Society of Paediatric Oncology (SIOP) studies: Malignant mesenchymal tumour (MMT)
84, 89 and 95. Pediatric Blood & Cancer 61(2), 2014, p.217-222. (AMC)
Jenssen C, Annema JT, Zels K, Dietrich CF. Lung and Mediastinum: Evaluation by Endoscopic Ultrasound.
Endoscopie Heute 27(1), 2014, p.37-44. (AMC)
Jilesen APJ, Tol JAMG, Busch ORC, van Delden OM, van Gulik ThoM., van Dijkum EJM, Gouma DJ.
Emergency Management in Patients with Late Hemorrhage after Pancreatoduodenectomy for a
Periampullary Tumor. World Journal of Surgery 38(9), 2014, p.2438-2447. (AMC)
Jimenez CR, Verheul HM. Mass spectrometry-based proteomics: from cancer biology to protein
biomarkers, drug targets, and clinical applications. American Society of Clinical Oncology educational
book 2014; 2014: e504-e510. (VUmc)
Jiwa LS, van Diest PJ, Hoefnagel LD, Wesseling J, Wesseling P, Moelans CB. Upregulation of Claudin-4,
CAIX and GLUT-1 in distant breast cancer metastases. BMC Cancer 2014; 14: 864. (VUmc)
Joerger M, Huitema ADR, Koeberle D, Rosing H, Beijnen JH, Hitz F, Cerny T, Schellens JHM, Gillessen S.
Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary
cancer and hepatic dysfunction. Cancer Chemother Pharmacol 2014; 73:113-24 (NKI)
Johannesma PC, Starink TM, van Moorselaar RJA, Postmus PE. Facial Fibrofolliculomas as Indicator for
Renal Cell Cancer. Japanese Journal of Clinical Oncology 2014; 44: 609-610. (VUmc)
Johannesma PC, van den Borne BE, Gille JJ, Nagelkerke AF, van Waesberghe JT, Paul MA, van
Moorselaar RJ, Menko FH, Postmus PE. Spontaneous pneumothorax as indicator for Birt-Hogg-Dube
syndrome in paediatric patients. BMC Pediatr 2014; 14:171 (NKI)
Johannesma PC, van Moorselaar RJA, Horenblas S, van der Kolk LE, Thunnissen E, van Waesberghe
JHTM, Menko FH, Postmus PE. Bilateral renal tumour as indicator for birt-hogg-dube syndrome. Case
reports in medicine 2014; 2014: 618675. (VUmc/NKI)
Johnson N, Dudbridge F, Orr N, Gibson L, Jones ME, Schoemaker MJ, Folkerd EJ, Haynes BP, Hopper JL,
Southey MC, Dite GS, Apicella C, Schmidt MK, Broeks A, Van T, V, Atsma F, Muir K, Lophatananon A,
Fasching PA, Beckmann MW, Ekici AB, Renner SP, Sawyer E, Tomlinson I, Kerin M, Miller N, Burwinkel B,
Marme F, Schneeweiss A, Sohn C, Guenel P, Truong T, Cordina E, Menegaux F, Bojesen SE, Nordestgaard
BG, Flyger H, Milne R, Zamora MP, rias Perez JI, Benitez J, Bernstein L, nton-Culver H, Ziogas A, Clarke
DC, Brenner H, Muller H, Arndt V, Dieffenbach AK, Meindl A, Heil J, Bartram CR, Schmutzler RK, Brauch
H, Justenhoven C, Ko YD, Nevanlinna H, Muranen TA, Aittomaki K, Blomqvist C, Matsuo K, Dork T,
Bogdanova NV, Antonenkova NN, Lindblom A, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM,
Chenevix-Trench G, Beesley J, Wu AH, Van den BD, Tseng CC, Lambrechts D, Smeets D, Neven P,
Wildiers H, Chang-Claude J, Rudolph A, Nickels S, Flesch-Janys D, Radice P, Peterlongo P, Bonanni B,
Pensotti V, Couch FJ, Olson JE, Wang X, Fredericksen Z, Pankratz VS, Giles GG, Severi G, Baglietto L,
Haiman C, Simard J, Goldberg MS, Labreche F, Dumont M, Soucy P, Teo S, Yip CH, Phuah SY, Cornes BK,
Kristensen VN, Grenaker AG, Borresen-Dale AL, Zheng W, Winqvist R, Pylkas K, Jukkola-Vuorinen A, Grip
M, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Devillee P, Figueroa J, Chanock SJ, Lissowska J,
Sherman ME, Hall P, Schoof N, Hooning M, Hollestelle A, Oldenburg RA, Tilanus-Linthorst M, Liu J, Cox
A, Brock IW, Reed MW, Cross SS, Blot W, Signorello LB, Pharoah PD, Dunning AM, Shah M, Kang D, Noh
DY, Park SK, Choi JY, Hartman M, Miao H, Lim WY, Tang A, Hamann U, Forsti A, Rudiger T, Ulmer HU,
Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Sangrajrang S, Gaborieau V, Brennan P, McKay
J, Slager S, Toland AE, Vachon C, Yannoukakos D, Shen CY, Yu JC, Huang CS, Hou MF, Gonzalez-Neira A,
Tessier DC, Vincent D, Bacot F, Luccarini C, Dennis J, Michailidou K, Bolla MK, Wang J, Easton DF,
Garcia-Closas M, Dowsett M, Ashworth A, Swerdlow AJ, Peto J, Dos SS, I, Fletcher O. Genetic variation
at CYP3A is associated with age at menarche and breast cancer risk: a case-control study. Breast Cancer
Res 2014; 16:R51 (NKI)
Jong A, Kwee TC, de Klerk JMH, Adam JA, de Keizer B, Fijnheer R, Kersten MJ, Ludwig I, Jauw YWS,
Zijlstra JM, van den Bos IC, Stoker J, Hoekstra OS, Nievelstein RAJ. Relationship between pretreatment
FDG-PET and diffusion-weighted MRI biomarkers in diffuse large B-cell lymphoma. Am J Nucl Med Mol Im
2014; 4: 231-238. (VUmc)
Joosten RP, Long F, Murshudov GN, Perrakis A. The PDB_REDO server for macromolecular structure
model optimization. IUCrJ 2014; 1:213-20 (NKI)
Judson I, Verweij J, Gelderblom H, Hartmann JT, Schoffski P, Blay JY, Kerst JM, Sufliarsky J, Whelan J,
Hohenberger P, Krarup-Hansen A, Alcindor T, Marreaud S, Litiere S, Hermans C, Fisher C, Hogendoorn
PC, dei Tos AP, van der Graaf WT. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for
first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3
trial. Lancet Oncol 2014; 15:415-23 (NKI)
Julsing J, Peters GJ. Methylation of DNA repair genes and the efficacy of DNA targeted anticancer
treatment. Oncology Discovery 2014; 2: 3. (VUmc)
Kadouch DJ, Fortuin S, Kadouch JA, Ovadia SA, Karim RB, de Rie MA. Improvement of efficacy in surgical
management of facial basal cell carcinoma: an interdisciplinary pilot study in The Netherlands.
European Journal of Plastic Surgery 2014; 37: 589-594. (VUmc)
Kalpathy-Cramer J, Awan M, Bedrick S, Rasch CRN, Rosenthal DI, Fuller CD. Development of a Software
for Quantitative Evaluation Radiotherapy Target and Organ-at-Risk Segmentation Comparison. Journal of
Sigital Imaging 27(1), 2014, p.108-119. (AMC)
Kamiński MF., Hassan C, Bisschops R, Pohl J, Pellisé M, Dekker E, Ignjatovic-Wilson A, Hoffman A,
Longcroft-Wheaton G, Heresbach D, Dumonceau J-M, East JE. Advanced imaging for detection and
114 - Scientific publications
690.
691.
692.
693.
694.
695.
696.
697.
698.
699.
700.
701.
702.
703.
704.
705.
706.
707.
708.
709.
710.
711.
differentiation of colorectal neoplasia: European Society of Gastrointestinal Endoscopy (ESGE)
Guideline. Endoscopy 46(5), 2014, p.435-449. (AMC)
Kamphuis GM, de Bruin DM, de Reijke TM, de la Rosette J. íSPIES--a novel approach to advanced
endoscopic imaging. Journal of Endourology 28(8), 2014, p.894-895. (AMC)
Kamphuis GM., Baard J, Westendarp M, de La Rosette JJMCH. Lessons learned from the CROES
percutaneous nephrolithotomy global study. World Journal of Urology [aheadofprint], 2014, p.-. (AMC)
Kandasami SV, Mamoulakis C, El-Nahas Ahmed R, Averch T, Tuncay OL, Rawandale-Patil A, Cormio L, de
la Rosette JJ. Impact of Case Volume on Outcomes of Ureteroscopy for Ureteral Stones: The Clinical
Research Office of the Endourological Society Ureteroscopy Global Study. European Urology 66(6), 2014,
p.1046-1051. (AMC)
Kaplon J, Homig-Holzel C, Gao L, Meissl K, Verdegaal EM, van der Burg SH, van Doorn R, Peeper DS.
Near-genomewide RNAi screening for regulators of BRAF(V600E) -induced senescence identifies RASEF, a
gene epigenetically silenced in melanoma. Pigment Cell Melanoma Res 2014; 27:640-52 (NKI)
Karagozoglu KH, Dekker HA, Rietveld D, de Bree R, Schulten EAJM, Kantola S, Forouzanfar T, van der
Waal I. Proposal for a new staging system for osteoradionecrosis of the mandible. Medicina oral
patologia oral y cirugia bucal 2014; 19: E433-E437. (VUmc)
Karakullukcu B, van Laarhoven CM, Smeele LE, Lohuis PJ. Functional and aesthetic recontouring of free
flap reconstructions of the head and neck region with microdebrider. Kulak Burun Bogaz Ihtis Derg 2014;
24:118-22 (NKI)
Kasper B, Sleijfer S, Litiere S, Marreaud S, Verweij J, Hodge RA, Bauer S, Kerst JM, van der Graaf WT.
Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two
European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072.
Ann Oncol 2014; 25:719-24 (NKI)
Kaspers G. How I treat paediatric relapsed acute myeloid leukaemia. Brit J Haematol 2014; 166: 636645. (VUmc)
Kater AP, Eldering E. miR in CLL: more than mere markers of prognosis? Blood 124(1), 2014, p.2-4.
(AMC)
Kater AP, Spiering M, Liu RD, te Raa DG, Slinger E, Tonino SH, Beckers MM, Daenen S, Doorduijn JK,
Lankheet NAG, Luijks DM, Eldering E, van Oers MHJ. Dasatinib in combination with fludarabine in
patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study. Leukemia Research
38(1), 2014, p.34-41. (AMC/NKI)
Kater AP, Tonino SH, Egle A, Ramsay AG. How does lenalidomide target the chronic lymphocytic
leukemia microenvironment? Blood 124(14), 2014, p.2184-2189. (AMC)
Kelderman S, Heemskerk B, van Tinteren H, van den Brom RRH, Hospers GAP, van den Eertwegh AJM,
Kapiteijn EW, de Groot JWB, Soetekouw P, Jansen RL, Fiets E, Furness AJS, Renn A, Krzystanek M,
Szallasi Z, Lorigan P, Gore ME, Schumacher TNM, Haanen JBAG, Lar. Lactate dehydrogenase as a
selection criterion for ipilimumab treatment in metastatic melanoma. Cancer Immunol Immun 2014; 63:
449-458. (VUmc/NKI)
Kelderman S, Schumacher TNM, Haanen JBAG. Acquired and intrinsic resistance in cancer
immunotherapy. Mol Oncol 2014; 8:1132-9 (NKI)
Kemper K, de Goeje PL, Peeper DS, van Amerongen R. Phenotype switching: tumor cell plasticity as a
resistance mechanism and target for therapy. Cancer Res 2014; 74:5937-41 (NKI)
Kerkhof MH, Ruiz-Zapata AM, Bril H, Bleeker MCG, Belien JAM, Stoop R, Helder MN. Changes in tissue
composition of the vaginal wall of premenopausal women with prolapse. Am J Obstet Gynecol 2014;
210: 168. (VUmc)
Kerkhofs TMA, Ettaieb MHT, Verhoeven RHA, Kaspers GJL, Tissing WJE, Loeffen J, van den HeuvelEibrink MM, de Krijger RR, Haak HR. Adrenocortical carcinoma in children: First population-based
clinicopathological study with long-term follow-up. Oncol Rep 2014; 32: 2836-2844. (VUmc)
Kersten MJ, Kraan W, Doorduijn J, Bromberg J, Lam K, Kluin PM, van der Holt BJ, Spaargaren M, Pals ST.
Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations. Bloos
Cancer Journal 4, 2014, p.e266-. (AMC)
Kessing BF, Smout AJPM, Bennink RJ, Kraaijpoel N, Oors JM, Bredenoord AJ. Prucalopride decreases
esophageal acid exposure and accelerates gastric emptying in healthy subjects. Neurogastroenterology
and Motility 26(8), 2014, p.1079-1086. (AMC)
Kestin L, Grills I, Guckenberger M, Belderbos J, Hope AJ, Werner-Wasik M, Sonke JJ, Bissonnette JP,
Xiao Y, Yan D. Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy
(SBRT) delivered via online image guidance. Radiother Oncol 2014; 110:499-504 (NKI)
Keyzer-Dekker CM, de Vries J, Mertens MC, Roukema JA, van der Steeg AFW. The impact of diagnosis
and trait anxiety on psychological distress in women with early stage breast cancer: A prospective study.
Brit J Health Psych 2014; 19: 783-794. (VUmc)
Khair L, Guikema JEJ, Linehan EK, Ucher AJ, Leus NGJ, Ogilvie C, Lou Z, Schrader CE, Stavnezer J. ATM
increases activation-induced cytidine deaminase activity at downstream S regions during class-switch
recombination. Journal of Immunology 192(10), 2014, p.4887-4896. (AMC)
Khalil EA, Weldegebreal T, Younis BM, Omollo R, Musa AM, Hailu W, Abuzaid AA, Dorlo TP, Hurissa Z,
Yifru S, Haleke W, Smith PG, Ellis S, Balasegaram M, EL Hassan AM, Schoone GJ, Wasunna M, Kimutai R,
Edwards T, Hailu A. Safety and efficacy of single dose versus multiple doses of AmBisome for treatment
of visceral leishmaniasis in eastern Africa: a randomised trial. PLoS Negl Trop Dis 2014; 8:e2613 (NKI)
Scientific publications - 115
712.
713.
714.
715.
716.
717.
718.
719.
720.
721.
722.
723.
724.
725.
726.
727.
728.
Khan S, Greco D, Michailidou K, Milne RL, Muranen TA, Heikkinen T, Aaltonen K, Dennis J, Bolla MK, Liu
J, Hall P, Irwanto A, Humphreys K, Li J, Czene K, Chang-Claude J, Hein R, Rudolph A, Seibold P, FleschJanys D, Fletcher O, Peto J, Dos Santos Silva I, Johnson N, Gibson L, Aitken Z, Hopper JL, Tsimiklis H,
Bui M, Makalic E, Schmidt DF, Southey MC, Apicella C, Stone J, Waisfisz Q, Meijers-Heijboer H, Adank
MA, van der Luijt RB, Meindl A, Schmutzler RK, Muller-Myhsok B, Lichtner P, Turnbull C, Rahman N,
Chanock SJ, Hunter DJ, Cox A, Cross SS, Reed MW, Schmidt MK, Broeks A, Veer LJ, Hogervorst FB,
Fasching PA, Schrauder MG, Ekici AB, Beckmann MW, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H,
Benitez J, Zamora PM, Perez JI, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Pharoah PD,
Dunning AM, Shah M, Luben R, Brown J, Couch FJ, Wang X, Vachon C, Olson JE, Lambrechts D, Moisse M,
Paridaens R, Christiaens MR, Guenel P, Truong T, Laurent-Puig P, Mulot C, Marme F, Burwinkel B,
Schneeweiss A, Sohn C, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Andrulis IL, Knight JA, Tchatchou S,
Mulligan AM, Dork T, Bogdanova NV, Antonenkova NN, Anton-Culver H, Darabi H, Eriksson M, GarciaClosas M, Figueroa J, Lissowska J, Brinton L, Devilee P, Tollenaar RA, Seynaeve C, van Asperen CJ,
Kristensen VN, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Lindblom A, Margolin S, Radice P,
Peterlongo P, Barile M, Mariani P, Hooning MJ, Martens JW, Collee JM, Jager A, Jakubowska A, Lubinski
J, Jaworska-Bieniek K, Durda K, Giles GG, Mclean C, Brauch H, Bruning T, Ko YD, Brenner H,
Dieffenbach AK, Arndt V, Stegmaier C, Swerdlow A, Ashworth A, Orr N, Jones M, Simard J, Goldberg MS,
Labreche F, Dumont M, Winqvist R, Pylkas K, Jukkola-Vuorinen A, Grip M, Kataja V, Kosma VM,
Hartikainen JM, Mannermaa A, Hamann U, Chenevix-Trench G, Blomqvist C, Aittomaki K, Easton DF,
Nevanlinna H. MicroRNA Related Polymorphisms and Breast Cancer Risk. PLoS One 2014; 9:e109973-(11
pp) (NKI/VUmc)
Khongkow P, Karunarathna U, Khongkow M, Gong C, Gomes AR, Yague E, Monteiro LJ, Kongsema M, Zona
S, Man EP, Tsang JW, Coombes RC, Wu KJ, Khoo US, Medema RH, Freire R, Lam EW. FOXM1 targets NBS1
to regulate DNA damage-induced senescence and epirubicin resistance. Oncogene 2014; 33:4144-55
(NKI)
Kieffer JM, Djajadiningrat RS, van Muilekom EA, Graafland NM, Horenblas S, Aaronson NK. Quality of Life
in Patients Treated for Penile Cancer. J Urol 2014; 192:1105-10 (NKI)
Kierkels RG, Korevaar EW, Steenbakkers RJ, Janssen T, Van't Veld AA, Langendijk JA, Schilstra C, van
der Schaaf A. Direct use of multivariable normal tissue complication probability models in treatment
plan optimisation for individualised head and neck cancer radiotherapy produces clinically acceptable
treatment plans. Radiother Oncol 2014; 112:430-6 (NKI)
Kilsdonk MJ, van Dijk BA, Otter R, Siesling S, Van Harten WH. The impact of organisational external peer
review on colorectal cancer treatment and survival in the Netherlands. Br J Cancer 2014; 110:850-8
(NKI)
Kilsdonk MJ, van Dijk BA, Otter R, Van Harten WH, Siesling S. Regional variation in breast cancer
treatment in the Netherlands and the role of external peer review: a cohort study comprising 63,516
women. BMC Cancer 2014; 14:596 (NKI)
Kim Dae-Kyum, Gho Yong Song et all. EVpedia: A Community Web Portal for Extracellular Vesicles
Research. Bioinformatics [aheadofprint], 2014, p.-. (AMC)
Kim J, D'Annibale S, Magliozzi R, Low TY, Jansen P, Shaltiel IA, Mohammed S, Heck AJ, Medema RH,
Guardavaccaro D. U. Mol Cell Biol 2014; 34:4177-85 (NKI)
Kind J, van Steensel B. Stochastic genome-nuclear lamina interactions: modulating roles of Lamin A and
BAF. Nucleus 2014; 5:124-30 (NKI)
Kirsch M, Berben L, Johansson E, Calza S, Eeltink CM, Stringer J, Liptrott S, van der Geest S. Nurses'
practice patterns in relation to adherence-enhancing interventions in stem cell transplant care: a survey
from the Nurses Group of the European Group for Blood and Marrow Transplantation. European Journal
of Cancer Care 2014; 23: 607-615. (VUmc)
Kist JW, de Keizer B, Stokkel MPM, Hoekstra OS, Vogel WV . Recurrent differentiated thyroid cancer:
towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET
Study): study protocol of a multicenter observational cohort study. BMC Cancer 2014; 14:405 (NKI)
Kist JW, de Keizer B, Stokkel MPM, Hoekstra OS, Vogel WV. Recurrent differentiated thyroid cancer:
towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET
Study): study protocol of a multicenter observational cohort study. BMC Cancer 2014; 14: 405. (VUmc)
Klarenbeek J, Jalink K. Detecting cAMP with an Epac-based FRET sensor in single living cells. Methods
Mol Biol 2014; 1071:49-58 (NKI)
Klein S, Hoving S, Werker P, Russell N. Is There an Indication for Digital Subtraction Angiography in the
Assessment of Irradiation-Induced Vascular Damage before Free Flap Surgery by the Means of the
Internal Mammary Vessels? J Reconstr Microsurg 2014; 30:47-52 (NKI)
Kleinjan GH, van den Berg NS, Brouwer OR, de Jong J, Acar C, Wit EM, Vegt E, van der Noort V, Valdes
Olmos RA, van Leeuwen FW, van der Poel HG. Optimisation of Fluorescence Guidance During Robotassisted Laparoscopic Sentinel Node Biopsy for Prostate Cancer. Eur Urol 2014; 66:991-8 (NKI)
Kloke BP, Rae R, Mahr A, Burkhardt UE, Kvistborg P, Britten CM. Toward the next waves of cancer
immunotherapy: 11th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz,
Germany, May 14-16, 2013. Cancer Immunol Immunother 2014; 63:749-55 (NKI)
Klompenhouwer EG, Duijm LEM, Voogd AC, den Heeten GJ, Nederend J, Jansen FH, Broeders MJM.
Variations in screening outcome among pairs of screening radiologists at non-blinded double reading of
screening mammograms: a population-based study. European Radiology 24(5), 2014, p.1097-1104. (AMC)
116 - Scientific publications
729.
730.
731.
732.
733.
734.
735.
736.
737.
738.
739.
740.
741.
742.
743.
744.
745.
746.
747.
Klompenhouwer EG, Duijm LEM, Voogd AC, den Heeten GJ, Strobbe LJ, Louwman MW, Coebergh JW,
Venderink D, Broeders MJM. Re-attendance at biennial screening mammography following a repeated
false positive recall. Breast Cancer Research and Treatment 145(2), 2014, p.429-437. (AMC)
Kloosterman WP, Koster J, Molenaar JJ. Prevalence and clinical implications of chromothripsis in cancer
genomes. Current Opinion in Oncology 26(1), 2014, p.64-72. (AMC)
Kloth JSL, Klümpen H-J, Yu H, Eechoute K, Samer CF, Kam BLR, Huitema ADR, Daali Y, Zwinderman AH,
Balakrishnar B, Bennink RJ, Wong M, Schellens JHM, Mathijssen RHJ, Gurney H. Predictive value of
CYP3A and ABCB1 phenotyping probes for the pharmacokinetics of sunitinib: the ClearSun study. Clinical
Pharmacokinetcs 53(3), 2014, p.261-269. (AMC/NKI)
Knijnenburg TA, Ramsey SA, Berman BP, Kennedy KA, Smit AF, Wessels LFA, Laird PW, Aderem A,
Shmulevich I. Multiscale representation of genomic signals. Nat Methods 2014; 11:689-94 (NKI)
Knol JC, de Wit M, Albrethsen J, Piersma SR, Pham TV, Mongera S, Carvalho B, Fijneman RJA, Meijer
GA, Jimenez CR. Proteomics of differential extraction fractions enriched for chromatin-binding proteins
from colon adenoma and carcinoma tissues. Biochimica et Biophysica Acta (BBA) - Proteins and
Proteomics 2014; 1844: 1034-1043. (VUmc)
Knopf A, Nill S, Yohannes I, Graeff C, Dowdell S, Kurz C, Sonke JJ, Biegun AK, Lang S, McClelland J,
Champion B, Fast M, Wolfelschneider J, Gianoli C, Rucinski A, Baroni G, Richter C, van de Water S,
Grassberger C, Weber D, Poulsen P, Shimizu S, Bert C. Challenges of radiotherapy: Report on the 4D
treatment planning workshop 2013. Phys Med 2014; 30:809-15 (NKI)
Ko W, Deliens L, Miccinesi G, Giusti F, Moreels S, Donker GA, Onwuteaka-Philipsen BD, Zurriaga O,
Lopez-Maside A, Block L. Care provided and care setting transitions in the last three months of life of
cancer patients: a nationwide monitoring study in four European countries. BMC Cancer 2014; 14: 960.
(VUmc)
Ko W, Miccinesi G, Beccaro M, Moreels S, Donker GA, Onwuteaka-Philipsen BD, Alonso TV, Deliens L,
Block L. Factors Associated with Fulfilling the Preference for Dying at Home among Cancer Patients: The
role of general practitioners. J Palliat Care 2014; 30: 141-150. (VUmc)
Koekkoek JAF, Dirven L, Reijneveld JC, Postma TJ, Grant R, Pace A, Oberndorfer S, Heimans JJ,
Taphoorn MJB. Epilepsy in the end of life phase of brain tumor patients: a systematic review. NeuroOncology Practice 2014; 1: 134-140. (VUmc)
Koekkoek JAF, Dirven L, Reijneveld JC, Sizoo EM, Pasman HRW, Postma TJ, Deliens L, Grant R,
McNamara S, Grisold W, Medicus E, Stockhammer G, Oberndorfer S, Flechl B, Marosi C, Taphoorn MJB,
Heimans JJ. End of life care in high-grade glioma patients in three European countries: a comparative
study. J Neuro-Oncol 2014; 120: 303-310. (VUmc)
Koekkoek JAF, Dirven L, Sizoo EM, Pasman HRW, Heimans JJ, Postma TJ, Deliens L, Grant R, McNamara
S, Stockhammer G, Medicus E, Taphoorn MJB, Reijneveld JC. Symptoms and medication management in
the end of life phase of high-grade glioma patients. J Neuro-Oncol 2014; 120: 589-595. (VUmc)
Koekkoek JAF, Kerkhof M, Dirven L, Heimans JJ, Postma TJ, Vos MJ, Bromberg JEC, van den Bent MJ,
Reijneveld JC, Taphoorn MJB. Withdrawal of antiepileptic drugs in glioma patients after long-term
seizure freedom: design of a prospective observational study. BMC Neurol 2014; 14: 157. (VUmc)
Kok HP, Ciampa S, de Kroon-Oldenhof R, Steggerda-Carvalho EJ, van Stam G, Zum Vörde Sive Vörding
PJ, Stalpers LJA, Geijsen ED, Bardati F, Bel A, Crezee J. Toward online adaptive hyperthermia
treatment planning: correlation between measured and simulated specific absorption rate changes
caused by phase steering in patients. International Journal of Radiation Oncology Biology Physics 90(2),
2014, p.438-445. (AMC)
Kok HP, Crezee J, Franken NAP, Stalpers LJA, Barendsen GW, Bel A. Quantifying the combined effect of
radiation therapy and hyperthermia in terms of equivalent dose distributions. International Journal of
Radiation Oncology Biology Physics 88(3), 2014, p.739-745. (AMC)
Koldenhof JJ, Witteveen PO, de Vos R, Walraven M, Tillier CN, Verheul HMW, Teunissen SCCM.
Symptoms from treatment with sunitinib or sorafenib: a multicenter explorative cohort study to explore
the influence of patient-reported outcomes on therapy decisions. Support Care Cancer 2014; 22: 23712380. (VUmc)
Kolfschoten NE, Marang-van de Mheen PJ, Wouters MWJM, Eddes E-H, Tollenaar RAEM, Stijnen T, Kievit
J. A combined measure of procedural volume and outcome to assess hospital quality of colorectal
cancer surgery, a secondary analysis of clinical audit data. PLOS ONE 9(2), 2014, p.e88737-. (AMC/NKI)
Komen L, da Graca V, Wolkerstorfer A, de Rie MA, Terwee CB, van der Veen JPW. The VASI and the VETF
assessment: reliable and responsive instruments to measure the degree of depigmentation in vitiligo.
British Journal of Dermatology [aheadofprint], 2014, p.-. (AMC)
Konings R, Lely RJ, Nurmohamed SA, Hoksbergen AWJ. Successful reversal of acute kidney failure by
ultrasound-accelerated thrombolysis of an occluded renal artery. Case reports in medicine 2014; 2014:
205646.. (VUmc)
Kool M, Jones DTW, Jäger N, Northcott PA, Pugh TJ, Hovestadt V, Piro RM, Esparza LA, Markant SL,
Remke M, Milde T, Bourdeaut F, Ryzhova M, Sturm D, Pfaff E, Stark S, Hutter S, Seker-Cin H, Johann P,
Bender S, Schmidt C, Rausch T, Shih D, Reimand J, Sieber L, Wittmann A, Linke L, Witt H, Weber UD,
Zapatka M, König R, Beroukhim R, Bergthold G, van Sluis P, Volckmann R, Koster J, Versteeg R, Schmidt
S, Wolf S, Lawerenz C, Bartholomae CC, von Kalle C, Unterberg A, Herold-Mende C, Hofer S, Kulozik AE,
von Deimling A, Scheurlen W, Felsberg J, Reifenberger G, Hasselblatt M, Crawford JR, Grant GA, Jabado
N, Perry A, Cowdrey C, Croul S, Zadeh G, Korbel JO, Doz F, Delattre O, Bader GD, McCabe MG, Collins
Scientific publications - 117
748.
749.
750.
751.
752.
753.
754.
755.
756.
757.
758.
759.
760.
761.
762.
763.
764.
765.
766.
767.
768.
769.
VP, Kieran MW., Cho Y-J, Pomeroy SL, Witt O, Brors B, Taylor MD, Schüller U, Korshunov A, Eils R,
Wechsler-Reya RJ, Lichter P, Pfister SM. Genome sequencing of SHH medulloblastoma predicts
genotype-related response to smoothened inhibition. Cancer Cell 25(3), 2014, p.393-405. (AMC)
Koolen BB, Pengel KE, Wesseling J, Vogel WV, Vrancken Peeters MJ, Vincent A, Gilhuijs KG, Rodenhuis S,
Rutgers EJ, Valdes Olmos RA. Sequential F-FDG PET/CT for early prediction of complete pathological
response in breast and axilla during neoadjuvant chemotherapy. Eur J Nucl Med Mol Imaging 2014;
41:32-40 (NKI)
Koolen BB, van der Leij F, Vogel WV, Rutgers EJT, Vrancken Peeters MJFTD, Elkhuizen PH, Valdes Olmos
RA. Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer. Acta
Oncol 2014; 53:50-7 (NKI)
Koolen BB, Vidal-Sicart S, Benlloch JM, Valdés Olmos RA. Evaluating heterogeneity of primary tumor
(18)F-FDG uptake in breast cancer with a dedicated breast PET (MAMMI): a feasibility study based on
correlation with PET/CT. Nucl Med Commun 2014; 35:446-52 (NKI)
Koolen BB, Wesseling J. Reply to "Anti-cytokeratin CAM5.2 recognized CK8 mainly, but not CK18:
comment on 'Early assessment of axillary response with 18F-FDG PET/CT during neoadjuvant
chemotherapy in stage II-III breast cancer: implications for surgical management of the axilla. Ann Surg
Oncol. 2013;20(7):2227-35'". Ann Surg Oncol 2014; 21:700 (NKI)
Koper I, Heide A, Janssens MJPA, Swart S, Perez RSGM, Rietjens JAC. Consultation with specialist
palliative care services in palliative sedation: considerations of Dutch physicians. Supportive Care in
Cancer 2014; 22(1): 225-231. (VUmc)
Koppelmans V, de Groot M, de Ruiter MB, Boogerd W, Seynaeve C, Vernooij MW, Niessen WJ, Schagen
SB, Breteler MM. Global and focal white matter integrity in breast cancer survivors 20 years after
adjuvant chemotherapy. Hum Brain Mapp 2014; 35:889-99 (NKI)
Kordes S, Cats A, Meijer SL, van Laarhoven HW. Targeted therapy for advanced esophagogastric
adenocarcinoma. Crit Rev Oncol Hematol 2014; 90:68-76 (NKI/AMC)
Kordes S, Henegouwen MIV, Hulshof MC, Bergman JJGH, van der Vliet HJ, Kapiteijn E, van Laarhoven
HWM, Richel DJ, Klinkenbijl JHG, Meijer SL, Wilmink JW. Preoperative Chemoradiation Therapy in
Combination With Panitumumab for Patients With Resectable Esophageal Cancer: The PACT Study. Int J
Radiat Oncol 2014; 90: 190-196. (VUmc/NKI)
Kotov IN, van Olst E, Knobel PA, van der Meulen-Muileman I, Felley-Bosco E, van Beusechem VW, Smit
EF, Stahel RA, Marti TM. Whole genome RNAi screens reveal a critical role of REV3 in coping with
replication stress. Molecular oncology 2014; 8: 1747-1759. (VUmc)
Kraaijenga S, van der Molen L, Van Tinteren H, Hilgers FJM, Smeele LE. Treatment of myogenic
temporomandibular disorder: a prospective randomized clinical trial, comparing a mechanical stretching
device (TheraBite®) with standard physical therapy exercise. Cranio 2014; 32:208-16 (NKI)
Kraaijenga SA, van der Molen L, van den Brekel MWM, Hilgers FJM. Current assessment and treatment
strategies of dysphagia in head and neck cancer patients: a systematic review of the 2012/13 literature.
Curr Opin Support Palliat Care 2014; 8:152-63 (NKI)
Kraan W, van Keimpema M, Horlings HM, Schilder-Tol EJM, Oud MECM, Noorduyn LA, Kluin PM, Kersten
MJ, Spaargaren M, Pals ST. High prevalence of oncogenic MYD88 and CD79B mutations in primary
testicular diffuse large B-cell lymphoma. Leukemia 28(3), 2014, p.719-720. (AMC)
Kraima AC, Derks M, Smit NN, van Munsteren JC, van der Velden J, Kenter GG, DeRuiter MC. Lymphatic
drainage pathways from the cervix uteri: implications for radical hysterectomy? Gynecologic Oncology
132(1), 2014, p.107-113. (AMC)
Krebber AMH, Buffart LM, Kleijn G, Riepma IC, de Bree R, Leemans CR, Becker A, Brug J, van Straten A,
Cuijpers P, de Leeuw IM. Prevalence of depression in cancer patients: a meta-analysis of diagnostic
interviews and self-report instruments. Psycho-Oncol 2014; 23: 121-130. (VUmc)
Krenning L, Feringa FM, Shaltiel IA, van den Berg J, Medema RH. Transient Activation of p53 in G2 Phase
Is Sufficient to Induce Senescence. Mol Cell 2014; 55:59-72 (NKI)
Krenning L, Medema RH. Enter the nucleus to exit the cycle. Cell Cycle 2014; 13:2651-2 (NKI)
Krens LL, Simkens LHJ, Baas JM, Koomen ER, Gelderblom H, Punt CJA, Guchelaar H-J. Statin Use Is Not
Associated with Improved Progression Free Survival in Cetuximab Treated KRAS Mutant Metastatic
Colorectal Cancer Patients: Results from the CAIRO2 Study. PLOS ONE 9(11), 2014, p.e112201-. (AMC)
Krijgsman O, Benner C, Meijer GA, van de Wiel MA, Ylstra B. FocalCall: An R Package for the Annotation
of Focal Copy Number Aberrations. Cancer Inform 2014; 13: 153-156. (VUmc)
Krijgsman O, Carvalho B, Meijer GA, Steenbergen RDM, Ylstra B. Focal chromosomal copy number
aberrations in cancer-Needles in a genome haystack. Biochim Biophys Acta Mol Cell Res 2014; 1843:
2698-2704. (VUmc)
Kronig H, Kremmler L, Haller B, Englert C, Peschel C, Andreesen R, Blank C. Interferon-induced
programmed death-ligand 1 (PD-L1/B7-H1) expression increases on human AML blast cells during
treatment. Eur J Haematol 2014; 92:195-203 (NKI)
Kruger DT, Beelen K, Sleijfer S, Jansen MPHM, Jimenez CR, Linn SC, Boven E. Biomarker Study
Everolimus, een studie van de Borstkanker Onderzoek Groep Nederland. Kanker Breed 2014; 6:23-5 (NKI)
Kruis MF, van de Kamer JB, Belderbos JS, Sonke JJ, van Herk M. 4D CT amplitude binning for the
generation of a time-averaged 3D mid-position CT scan. Phys Med Biol 2014; 59:5517-29 (NKI/AMC)
118 - Scientific publications
770.
771.
772.
773.
774.
775.
776.
777.
778.
779.
780.
781.
782.
783.
784.
785.
786.
787.
788.
789.
790.
Kruse AJ, Croce S, Kruitwagen RF, Riedl RG, Slangen BF, Van Gorp T, Van de Vijver KK. Aggressive
Behavior and Poor Prognosis of Endometrial Stromal Sarcomas With YWHAE-FAM22 Rearrangement
Indicate the Clinical Importance to Recognize This Subset. Int J Gynecol Cancer 2014; 24:1616-22 (NKI)
Kuijer PPFM, van der Molen HF, Schop A, Moeijes F, Frings-Dresen MHW, Hulshof CTJ. Annual incidence
of non-specific low back pain as an occupational disease attributed to whole-body vibration according to
the National Dutch Register 2005-2012. Ergonomics [aheadofprint], 2014, p.1-7. (AMC)
Kuijpers AM, Mehta AM, Aalbers AG, Van Driel WJ, Boot H, Verwaal VJ. Treatment of ovarian metastases
of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic
intraperitoneal chemotherapy. Eur J Surg Oncol 2014; 40:937-42 (NKI)
Kuijpers AM, Mehta AM, Boot H, van Leerdam ME, Hauptmann M, Aalbers AG, Verwaal VJ. Perioperative
systemic chemotherapy in peritoneal carcinomatosis of lymph node positive colorectal cancer treated
with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Oncol 2014; 25:864-9
(NKI)
Kuiper JL, Heideman DAM, Thunnissen E, Paul MA, van Wijk AW, Postmus PE, Smit EF. Incidence of
T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patients. Lung Cancer 2014; 85: 1924. (VUmc)
Kuiper JL, Heideman DAM, Thunnissen E, van Wijk AW, Postmus PE, Smit EF. High-dose, weekly erlotinib
is not an effective treatment in EGFR-mutated non-small cell lung cancer-patients with acquired
extracranial progressive disease on standard dose erlotinib. Eur J Cancer 2014; 50: 1399-1401. (VUmc)
Kuiper JL, Smit EF. Challenges in the Management of EGFR-Mutated Non-Small Cell Lung Cancer Patients
with Acquired Resistance to Tyrosine Kinase Inhibitors. Oncology- Basel 2014; 87: 83-94. (VUmc)
Kumari S, Walchli S, Fallang LE, Yang W, Lund-Johansen F, Schumacher TN, Olweus J. Alloreactive
cytotoxic T cells provide means to decipher the immunopeptidome and reveal a plethora of tumorassociated self-epitopes. Proc Natl Acad Sci U S A 2014; 111:403-8 (NKI)
Kupelian P, Sonke JJ. Magnetic resonance-guided adaptive radiotherapy: a solution to the future. Semin
Radiat Oncol 2014; 24:227-32 (NKI)
Kurakula K, Vos M, Otermin RI, Marinković G, Buettner R, Heukamp LC, Stap J, de Waard V, van Tiel CM,
de Vries CJM. The LIM-only protein FHL2 reduces vascular lesion formation involving inhibition of
proliferation and migration of smooth muscle cells. PLOS ONE 9(4), 2014, p.e94931-(9 p.). (AMC)
Kusters-Vandevelde HV, Willemsen AE, Groenen PJT, Kusters B, Lammens M, Wesseling P,
Djafarihamedani M, Rijntjes J, Delye H, Willemsen MA, van Herpen CM, Blokx WA. Experimental
treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor. Acta
Neuropathologica Communinications 2014; 2: 41. (VUmc)
Kvistborg P, Philips D, Kelderman S, Hageman L, Ottensmeier C, Joseph-Pietras D, Welters MJ, van der
Burg S, Kapiteijn E, Michielin O, Romano E, Linnemann C, Speiser D, Blank C, Haanen JB, Schumacher
TN. Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response. Sci Transl Med 2014;
6:254ra128-(9 pp) (NKI)
Kwast AB, Voogd AC, Menke-Pluijmers MB, Linn SC, Sonke GS, Kiemeney LA, Siesling S. Prognostic
factors for survival in metastatic breast cancer by hormone receptor status. Breast Cancer Res Treat
2014; 145:503-11 (NKI)
Kwee TC, Vermoolen MA, Akkerman EA, Kersten MJ, Fijnheer R, Ludwig I, Beek FJA, van Leeuwen MS,
Bierings MB, Bruin MCA, Zsíros J, Quarles van Ufford HME, de Klerk JMH, Adam J, Stoker J, Uiterwaal CS,
Nievelstein RAJ. Whole-Body MRI, Including Diffusion-Weighted Imaging, for Staging Lymphoma:
Comparison With CT in a Prospective Multicenter Study. Journal of Magnetic Resonance Imaging 40(1),
2014, p.26-36. (AMC)
Kwint M, Conijn S, Schaake E, Knegjens J, Rossi M, Remeijer P, Sonke JJ, Belderbos J. Intra thoracic
anatomical changes in lung cancer patients during the course of radiotherapy. Radiother Oncol 2014;
113:392-7 (NKI)
Kwon ED, Drake CG, Scher HI, Fizazi K, Bossi A, van den Eertwegh AJM, Krainer M, Houede N, Santos R,
Mahammedi H, Ng S, Di Maio M, Franke FA, Sundar S, Agarwal N, Bergman AM, Ciuleanu TE, Korbenfeld
E, Sengelov L, Hansen S, Logothetis C, Beer TM, McHenry. Ipilimumab versus placebo after radiotherapy
in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel
chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol 2014;
15: 700-712. (VUmc/NKI)
Kwong L, Bijlsma MF, Roelink H. Shh-mediated degradation of Hhip allows cell autonomous and non-cell
autonomous Shh signalling. Nature Communications 5, 2014, p.4849-. (AMC)
Labots M, Buffart TE, Haan JC, van Grieken NCT, Tijssen M, van de Velde CJH, Grabsch HI, Ylstra B,
Carvalho B, Fijneman RJA, Verheul HMW, Meijer GA. High-level copy number gains of established and
potential drug target genes in gastric cancer as a lead for treatment development and selection. Cell
Oncol 2014; 37: 41-52. (VUmc)
Labots M, Schutte LM, van der Mun JC, Pham TV, Jimenez CR, Verheul HMW. Mass Spectrometry-Based
Serum and Plasma Peptidome Profiling for Prediction of Treatment Outcome in Patients With Solid
Malignancies. Oncologist 2014; 19: 1028-1039. (VUmc)
Lacko M, Braakhuis BJ, Sturgis EM, Boedeker CC, Suarez C, Rinaldo A, Ferlito A, Takes RP. Genetic
Susceptibility to Head and Neck Squamous Cell Carcinoma. Int J Radiat Oncol 2014; 89: 38-48. (VUmc)
Laguna MP. Are we ready for molecular imaging-guided surgery? European Urology 65(5), 2014,
p.965-966. (AMC)
Scientific publications - 119
791.
792.
793.
794.
795.
796.
797.
798.
799.
800.
801.
802.
803.
804.
805.
806.
807.
808.
809.
810.
811.
812.
Lahrouchi N, Bosscha MI, Moll AC. A Child With a White Pupil. JAMA-J Am Med Accoc 2014; 311: 17991800. (VUmc)
Lal JA, Morré SA, Brand A. The overarching framework of translation and integration into healthcare: a
case for the LAL model. Personalized Medicine 2014; 11: 41-62. (VUmc)
Lalic D, Hackenberg M, Bijnsdorp IV, van Eijndhoven MAJ, Sadek P, Sie DLS, Zini N, Middeldorp JM,
Ylstra B, Menezes R, Wurdinger T, Meijer GA, Pegtel DM. Nontemplated Nucleotide Additions Distinguish
the Small RNA Composition in Cells from Exosomes. Cell reports 2014; 8: 1649-1658. (VUmc)
Lam SW, de Groot SM, Honkoop AH, Jager A, ten Tije AJ, Bos MMEM, Linn SC, Bosch J, Kroep JR, Braun
JJ, van Tinteren H, Boven E. Paclitaxel and bevacizumab with or without capecitabine as first-line
treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label,
randomised phase 2 trial. Eur J Cancer 2014; 50: 3077-3088. (VUmc/NKI)
Lam SW, Jimenez CR, Boven E. Breast cancer classification by proteomic technologies: Current state of
knowledge. Cancer Treat Rev 2014; 40: 129-138. (VUmc)
Lamba S, Russo M, Sun C, Lazzari L, Cancelliere C, Grernrum W, Lieftink C, Bernards R, Di Nicolantonio
F, Bardelli A. RAF Suppression Synergizes with MEK Inhibition in KRAS Mutant Cancer Cells. Cell Rep
2014; 8:1475-83 (NKI)
Lameris R, de Bruin RC, Schneiders FL, Henegouwen PM, Verheul HMW, de Gruijl TD, van der Vliet HJ.
Bispecific antibody platforms for cancer immunotherapy. Crit Rev Oncol Hemat 2014; 92: 153-165.
(VUmc)
Lameris R, Schneiders FL, de Gruijl TD, van der Vliet HJ. Exploiting theCD1d-iNKT cell axis for
potentiation of DC-based cancer vaccines. Methods Mol Biol 2014; 1139: 155-165. (VUmc)
Lancini C, van den Berk PC, Vissers JH, Gargiulo G, Song JY, Hulsman D, Serresi M, Tanger E, Blom M,
Vens C, van Lohuizen M, Jacobs H, Citterio E. Tight regulation of ubiquitin-mediated DNA damage
response by USP3 preserves the functional integrity of hematopoietic stem cells. J Exp Med 2014;
211:1759-77 (NKI)
Lange I, Geerts D, Feith DJ, Mocz G, Koster J, Bachmann AS. Novel interaction of ornithine
decarboxylase with sepiapterin reductase regulates neuroblastoma cell proliferation. Journal of
Molecular Biology 426(2), 2014, p.332-346. (AMC)
Langhout GC, Grootendorst DJ, Nieweg OE, Wouters MW, van der Hage JA, Jose J, van Boven H,
Steenbergen W, Manohar S, Ruers TJM. Detection of melanoma metastases in resected human lymph
nodes by noninvasive multispectral photoacoustic imaging. Int J Biomed Imaging 2014; 2014:163652-(7
pp) (NKI)
Langius JAE, Weijs PJM. Response to the letter to the editor "The use of oral nutritional supplements in
patients with head and neck cancer receiving (chemo)radiotherapy". Clin Nutr 2014; 33: 369. (VUmc)
Lankheet NA, Kloth JS, Gadellaa-van Hooijdonk CG, Cirkel GA, Mathijssen RH, Lolkema MP, Schellens
JHM, Voest EE, Sleijfer S, de Jonge MJ, Haanen JB, Beijnen JH, Huitema AD, Steeghs N.
Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours.
Br J Cancer 2014; 110:2441-9 (NKI)
Lankheet NA, Knapen LM, Schellens JHM, Beijnen JH, Steeghs N, Huitema AD. Plasma concentrations of
tyrosine kinase inhibitors imatinib, erlotinib, and sunitinib in routine clinical outpatient cancer care.
Ther Drug Monit 2014; 36:326-34 (NKI)
Lanting CI, de Vroome EM, Elias SG, van den Brandt PA, van Leeuwen FE, Kampman E, Kiemeney LA,
Peeters PH, de Vries E, Bausch-Goldbohm RA. [Contribution of lifestyle factors to cancer: secondary
analysis of Dutch data over 2010 and a projection for 2020] Bijdrage van leefstijlfactoren aan kanker.
Ned Tijdschr Geneeskd 2014; 159:A8085 (NKI)
Larkin J, Del Vecchio M, Ascierto PA, Krajsova I, Schachter J, Neyns B, Espinosa E, Garbe C, Sileni VC,
Gogas H, Miller WH, Jr., Mandala M, Hospers GA, Arance A, Queirolo P, Hauschild A, Brown MP, Mitchell
L, Veronese L, Blank CU. Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an
open-label, multicentre, safety study. Lancet Oncol 2014; 15:436-44 (NKI)
Laschen J, Datema FR, Koot VC, Lohuis PJFM. Bilateral auricular pseudocyst: recognizing and treating.
Facial Plast Surg 2014; 30:690-3 (NKI)
Laval S, Laklai H, Fanjul M, Pucelle M, Laurell H, Billon-Galés A, Le Guellec S, Delisle MB, Sonnenberg A,
Susini C, Pyronnet S, Bousquet C. Dual roles of hemidesmosomal proteins in the pancreatic epithelium:
the phosphoinositide 3-kinase decides. Oncogene 2014; 33:1934-44 (NKI)
Lawler M, Le Chevalier T, Banks I, Conte P, De Lorenzo F, Meunier F, Pinedo HM, Selby P, Murphy MJ,
Johnston PG. A Bill of Rights for patients with cancer in Europe. Lancet Oncol 2014; 15: 258-260. (VUmc)
Le Cesne A, Ouali M, Leahy MG, Santoro A, Hoekstra HJ, Hohenberger P, van Coevorden F, Rutkowski P,
Van Hoesel R, Verweij J, Bonvalot S, Steward WP, Gronchi A, Hogendoorn PC, Litiere S, Marreaud S, Blay
JY, van der Graaf WT. Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis
of two STBSG-EORTC phase III clinical trials. Ann Oncol 2014; 25(12):2425-32:2425-32 (NKI)
Le Deley M-C, Paulussen M, Lewis I, Brennan B, Ranft A, Whelan J, Le Teuff G, Michon J, Ladenstein R,
Marec-Bérard P, van den Berg H, Hjorth L, Wheatley K, Judson I, Juergens H, Craft A, Oberlin O, Dirksen
U. Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing
sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial. Journal of Clinical Oncology
32(23), 2014, p.2440-2448. (AMC)
Lee E, de RJ, Kool J, Wessels LFA, Bussemaker HJ. Identifying regulatory mechanisms underlying
tumorigenesis using locus expression signature analysis. Proc Natl Acad Sci U S A 2014; 111:5747-52
120 - Scientific publications
813.
814.
815.
816.
817.
818.
819.
820.
821.
822.
823.
824.
825.
826.
827.
828.
829.
Lee S, Rahnenführer J, Lang M, de Preter K, Mestdagh P, Koster J, Versteeg R, Stallings Raymond L.,
Varesio L, Asgharzadeh S, Schulte JH, Fielitz K, Schwermer M, Morik K, Schramm A. Robust Selection of
Cancer Survival Signatures from High-Throughput Genomic Data Using Two-Fold Subsampling. PLOS ONE
9(10), 2014, p.e108818-. (AMC)
Leeuwenburgh MMN, Jensch S, Gratama JWC, Spilt A, Wiarda BM, van Es HW, Cobben LPJ, Bossuyt PMM,
Boermeester MA, Stoker J. MRI features associated with acute appendicitis. European Radiology 24(1),
2014, p.214-222. (AMC)
Leeuwenburgh MMN, Stockmann HBAC, Bouma WH, Houdijk APJ, Verhagen MF, Vrouenraets B, Cobben
LPJ, Bossuyt PMM, Stoker J, Boermeester MA. A simple clinical decision rule to rule out appendicitis in
patients with nondiagnostic ultrasound results. Academic Emergency Medicine 21(5), 2014, p.488-496.
(AMC)
Leeuwenburgh MMN, Wiarda BM, Jensch S, van Es HW, Stockmann HBAC, Gratama JWC, Cobben LPJ,
Bossuyt PMM, Boermeester MA, Stoker J. Accuracy and interobserver agreement between MR-non-expert
radiologists and MR-experts in reading MRI for suspected appendicitis. European Journal of Radiology
83(1), 2014, p.103-110. (AMC)
Lekkerkerker SJ, van der Horst A, Lens E, Davila Fajardo R, van Hooft JE. EUS-guided gold fiducial
placement and migration rate : Response. Gastrointestinal Endoscopy 80(3), 2014, p.534-. (AMC)
Lens E, van der Horst A, Kroon PS, van Hooft JE, Dávila Fajardo R, Fockens P, van Tienhoven G, Bel A.
Differences in respiratory-induced pancreatic tumor motion between 4D treatment planning CT and
daily cone beam CT, measured using intratumoral fiducials. ACTA Oncologica 53(9), 2014, p.1257-1264.
(AMC)
Leon LG, Gemelli M, Sciarrillo R, Avan A, Funel N, Giovannetti E. Synergistic Activity of the c-Met and
Tubulin Inhibitor Tivantinib (ARQ197) with Pemetrexed in Mesothelioma Cells. Current Drug Targets
2014; 15: 1331-1340. (VUmc)
Lerman YV, Lim K, Hyun YM, Falkner KL, Yang H, Pietropaoli AP, Sonnenberg A, Sarangi PP, Kim M.
Sepsis lethality via exacerbated tissue infiltration and TLR-induced cytokine production by neutrophils is
integrin alpha3beta1-dependent. Blood 2014; 124:3515-23 (NKI)
Letourneau A, Santoni FA, Bonilla X, Sailani MR, Gonzalez D, Kind J, Chevalier C, Thurman R, Sandstrom
RS, Hibaoui Y, Garieri M, Popadin K, Falconnet E, Gagnebin M, Gehrig C, Vannier A, Guipponi M, Farinelli
L, Robyr D, Migliavacca E, Borel C, Deutsch S, Feki A, Stamatoyannopoulos JA, Herault Y, van Steensel
B, Guigo R, Antonarakis SE. Domains of genome-wide gene expression dysregulation in Down's syndrome.
Nature 2014; 508:345-50 (NKI)
Leyten GHJM, Hessels D, Jannink SA, Smit FP, de Jong H, Cornel EB, de Reijke TM, Vergunst H, Kil P,
Knipscheer BC, van Oort IM, Mulders PFA, Hulsbergen-van de Kaa CA, Schalken JA. Prospective
multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary
biomarkers for prostate cancer. European Urology 65(3), 2014, p.534-542 (AMC)
Li J, Lindstrom LS, Foo JN, Rafiq S, Schmidt MK, Pharoah PD, Michailidou K, Dennis J, Bolla MK, Wang Q,
'T Veer LJ, Cornelissen S, Rutgers E, Southey MC, Apicella C, Dite GS, Hopper JL, Fasching PA, Haeberle
L, Ekici AB, Beckmann MW, Blomqvist C, Muranen TA, Aittomaki K, Lindblom A, Margolin S, Mannermaa
A, Kosma VM, Hartikainen JM, Kataja V, Chenevix-Trench G, Phillips KA, McLachlan SA, Lambrechts D,
Thienpont B, Smeets A, Wildiers H, Chang-Claude J, Flesch-Janys D, Seibold P, Rudolph A, Giles GG,
Baglietto L, Severi G, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Kristensen V, Alnaes GI,
Borresen-Dale AL, Nord S, Winqvist R, Pylkas K, Jukkola-Vuorinen A, Grip M, Andrulis IL, Knight JA,
Glendon G, Tchatchou S, Devilee P, Tollenaar R, Seynaeve C, Hooning M, Kriege M, Hollestelle A, van
den Ouweland A, Li Y, Hamann U, Torres D, Ulmer HU, Rudiger T, Shen CY, Hsiung CN, Wu PE, Chen ST,
Teo SH, Taib NA, Har Yip C, Fuang Ho G, Matsuo K, Ito H, Iwata H, Tajima K, Kang D, Choi JY, Park SK,
Yoo KY, Maishman T, Tapper WJ, Dunning A, Shah M, Luben R, Brown J, Khor CC, Eccles DM, Nevanlinna
H, Easton D, Humphreys K, Liu J, Hall P, Czene K. 2q36.3 is associated with prognosis for oestrogen
receptor-negative breast cancer patients treated with chemotherapy. Nat Commun 2014; 5:4051 (NKI)
Li WW, van Boven WJ, Hartemink KJ, de Mol BA. Internal mammary artery pedicle: a solution for
prophylactic flap coverage in high-risk trans-sternal thoracic surgery. Eur J Cardiothorac Surg 2014;
46:740-2 (NKI)
Lievens Y, Defourny N, Coffey M, Borras JM, Dunscombe P, Slotman B, Malicki J, Bogusz M, Gasparotto
C, Grau C. Radiotherapy staffing in the European countries: Final results from the ESTRO-HERO survey.
Radiother Oncol 2014; 112: 178-186. (VUmc)
Limperg PF, Haverman L, van Oers HA, van Rossum MAJ, Maurice-Stam H, Grootenhuis MA. Health
related quality of life in Dutch young adults: psychometric properties of the PedsQL generic core scales
young adult version. Health and Quality of Life Outcomes 12(1), 2014, p.9-.
Lin C, Duitman J, Daalhuisen J, ten Brink M, von der Thüsen J, van der Poll T, Borensztajn K, Spek CA.
Targeting protease activated receptor-1 with P1pal-12 limits bleomycin-induced pulmonary fibrosis.
Thorax 69(2), 2014, p.152-160. (AMC)
Lin F, de Gooijer MC, Roig EM, Buil LC, Christner SM, Beumer JH, Wurdinger T, Beijnen JH, van Tellingen
O. ABCB1, ABCG2, and PTEN determine the response of glioblastoma to temozolomide and ABT-888
therapy. Clin Cancer Res 2014; 20:2703-13 (NKI)
Lin F, de Gooijer MC, Roig EM, Buil LCM, Christner SM, Beumer JH, Wurdinger T, Beijnen JH, van
Tellingen O. ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and
ABT-888 Therapy. Clin Cancer Res 2014; 20: 2703-2713. (VUmc)
Scientific publications - 121
830.
831.
832.
833.
834.
835.
836.
837.
838.
839.
840.
841.
842.
843.
844.
845.
846.
847.
848.
Lindenberg JJ, van de Ven R, Oosterhoff D, Sombroek CC, Lougheed SM, Stam AGM, Koenen HJPM, van
den Eertwegh AJM, Scheper RJ, de Gruijl TD. Induction of dendritic cell maturation in the skin
microenvironment by soluble factors derived from colon carcinoma. Hum Vacc Immunother 2014; 10:
1622-1632. (VUmc)
Lindsay PE, Granton PV, Gasparini A, Jelveh S, Clarkson R, van Hoof S, Hermans J, Kaas J, Wittkamper
F, Sonke JJ, Verhaegen F, Jaffray DA. Multi-institutional dosimetric and geometric commissioning of
image-guided small animal irradiators. Med Phys 2014; 41:031714 (NKI)
Linnemann C, Mezzadra R, Schumacher TN. TCR repertoires of intratumoral T-cell subsets. Immunol Rev
2014; 257:72-82 (NKI)
Littooij AS, Kwee TC, Barber I, Granata C, Vermoolen MA, Enríquez G, Zsíros J, Soh Shui Y, de Keizer B,
Beek FJA, Hobbelink MG, Bierings MB, Stoker J, Nievelstein RAJ. Whole-body MRI for initial staging of
paediatric lymphoma: prospective comparison to an FDG-PET/CT-based reference standard. European
Radiology 24(5), 2014, p.1153-1165. (AMC)
Lodder WL, Vogel WV, Lange CA, Hamming-Vrieze O, van Velthuysen ML, Pameijer FA, Balm AJ, van den
Brekel MW. Detection of extranodal spread in head and neck cancer with [18F]FDG PET and MRI:
improved accuracy?. Quarterly Journal of Nuclear Medicine and Molecular Imaging [aheadofprint], 2014,
p.-. (AMC)
Loeffen EAH, Mulder RL, Kremer LCM, Michiels EMC, Abbink FCH, Ball LM, Segers H,
Mavinkurve-Groothuis AMC., Smit FJ, Vonk IJM, van de Wetering MD, Tissing WJE. Development of
clinical practice guidelines for supportive care in childhood cancer-prioritization of topics using a Delphi
approach. Supportive Care in Cancer -, 2014, p.--. (AMC)
Long GV, Stroyakovskiy D, Gogas H, Levchenko E, de BF, Larkin J, Garbe C, Jouary T, Hauschild A, Grob
JJ, Chiarion S, V, Lebbe C, Mandala M, Millward M, Arance A, Bondarenko I, Haanen JB, Hansson J,
Utikal J, Ferraresi V, Kovalenko N, Mohr P, Probachai V, Schadendorf D, Nathan P, Robert C, Ribas A,
DeMarini DJ, Irani JG, Casey M, Ouellet D, Martin AM, Le N, Patel K, Flaherty K. Combined BRAF and MEK
inhibition versus BRAF inhibition alone in melanoma. N Engl J Med 2014; 371:1877-88 (NKI)
Louie AV, Rodrigues GB, Palma DA, Senan S. Measuring the Population Impact of Introducing Stereotactic
Ablative Radiotherapy for Stage I Non-Small Cell Lung Cancer in Canada. Oncologist 2014; 19: 880-885.
(VUmc)
Louie AV, Senan S, Dahele M, Slotman BJ, Verbakel WFAR. Stereotactic Ablative Radiation Therapy for
Subcentimeter Lung Tumors: Clinical, Dosimetric, and Image Guidance Considerations. Int J Radiat
Oncol 2014; 90: 843-849. (VUmc)
Louie AV, Senan S, Patel P, Ferket BS, Lagerwaard FJ, Rodrigues GB, Salama JK, Kelsey C, Palma DA,
Hunink MG. When Is a Biopsy-Proven Diagnosis Necessary Before Stereotactic Ablative Radiotherapy for
Lung Cancer? A Decision Analysis. Chest (Amer Coll Chest Phys) 2014; 146: 1021-1028. (VUmc)
Louie AV, Senan S. Computed Tomography Surveillance of Patients with Resected Lung Cancer:
Recurrence Or Second Primary Lung Cancer?. J Thorac Cardiov Sur 2014; 147: 1715. (VUmc)
Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A, Aldape K, Brat D, Collins VP,
Eberhart C, Figarella-Branger D, Fuller GN, Giangaspero F, Giannini C, Hawkins C, Kleihues P, Korshunov
A, Kros JM, Lopes MB, Ng HK, Ohgaki H, Paulus W,. International Society of Neuropathology-Haarlem
Consensus Guidelines for Nervous System Tumor Classification and Grading. Brain Pathol 2014; 24: 429435. (VUmc)
Loveman E, Jones J, Clegg AJ, Picot J, Colquitt JL, Mendes D, Breen DJ, Moore E, George S, Poston G,
Cunningham D, Ruers T, Primrose J. The clinical effectiveness and cost-effectiveness of ablative
therapies in the management of liver metastases: systematic review and economic evaluation. Health
Technol Assess 2014; 18:vii-viii, 1 (NKI)
Löwenberg M, Duijvis NW, Ponsioen C, van den Brink GR, Fockens P, D'Haens GRAM. Length of hospital
stay and associated hospital costs with infliximab versus cyclosporine in severe ulcerative colitis.
European Journal of Gastroenterology&Hepatology 26(11), 2014, p.1240-1246. (AMC)
Lu Y, Kham SKY, Ariffin H, Oei AMI, Lin HP, Tan AM, Quah TC, Yeoh AEJ. Host genetic variants of ABCB1
and IL15 influence treatment outcome in paediatric acute lymphoblastic leukaemia. Brit J Cancer 2014;
110: 1673-1680. (VUmc)
Luethi D, Durmus S, Schinkel AH, Schellens JHM, Beijnen JH, Sparidans RW. Liquid chromatographytandem mass spectrometric assay for the multikinase inhibitor regorafenib in plasma. Biomed
Chromatogr 2014; 28:1366-70 (NKI)
Lund VJ, Stammberger H, Fokkens WJ, Beale T, Bernal-Sprekelsen M, Eloy P, Georgalas C, Gerstenberger
C, Hellings P, Herman P, Hosemann WG, Jankowski R, Jones N, Jorissen M, Leunig A, Onerci M, Rimmer
J, Rombaux P, Simmen D, Tomazic PV, Tschabitscherr M, Welge-Luessen A. European position paper on
the anatomical terminology of the internal nose and paranasal sinuses. Rhinology 50(Suppl. 24), 2014,
p.1-34. (AMC)
Lundy JJ, Coons SJ, Aaronson NK. Testing the measurement equivalence of paper and interactive voice
response system versions of the EORTC QLQ-C30. Qual Life Res 2014; 23:229-37 (NKI)
Luteijn RD, Hoelen H, Kruse E, van Leeuwen WF, Grootens J, Horst D, Koorengevel M, Drijfhout JW,
Kremmer E, Fruh K, Neefjes JJ, Killian A, Lebbink RJ, Ressing ME, Wiertz EJ. Cowpox Virus Protein
CPXV012 Eludes CTLs by Blocking ATP Binding to TAP. J Immunol 2014; 193:1578-89 (NKI)
122 - Scientific publications
849.
850.
851.
852.
853.
854.
855.
856.
857.
858.
859.
860.
861.
862.
863.
864.
865.
866.
867.
Luttje MP, Italiaander MG, Orteaga de Castro CS, van der Kemp WJ, Luijten PR, van VM, van der Heide
UA, Klomp DW. (31) P MR spectroscopic imaging combined with (1) H MR spectroscopic imaging in the
human prostate using a double tuned endorectal coil at 7T. Magn Reson Med 2014; 72:1516-21 (NKI)
Luyten A, Buttmann-Schweiger N, Luyten K, Mauritz C, Reinecke-Luthge A, Pietralla M, Meijer CJLM,
Petry KU. Early detection of CIN3 and cervical cancer during long-term follow-up using HPV/Pap smear
co-testing and risk-adapted follow-up in a locally organised screening programme. International journal
of cancer Journal international du cancer 2014; 135: 1408-1416. (VUmc)
Maas KW, Biere SSAY, van Hoogstraten IMW, van der Peet DL, Cuesta MA. Immunological changes after
minimally invasive or conventional esophageal resection for cancer: a randomized trial. World J Surg
2014; 38: 131-137. (VUmc)
Macefield RC, Jacobs M, Korfage IJ, Nicklin J, Whistance RN, Brookes ST, Sprangers MAG, Blazeby JM.
Developing core outcomes sets: methods for identifying and including patient-reported outcomes
(PROs). Trials 15(1), 2014, p.49-. (AMC)
Mack SC, Witt H, Piro RM, Gu L, Zuyderduyn S, Stütz AM, Wang X, Gallo M, Garzia L, Zayne K, Zhang X,
Ramaswamy V, Jäger N, Jones DTW, Sill M, Pugh TJ, Ryzhova M, Wani KM, Shih DJH, Head R, Remke M,
Bailey S. D, Zichner T, Faria CC, Barszczyk M, Stark S, Seker-Cin H, Hutter S, Johann P, Bender S,
Hovestadt V, Tzaridis T, Dubuc AM, Northcott PA, Peacock J, Bertrand KC, Agnihotri S, Cavalli FMG,
Clarke I, Nethery-Brokx K, Creasy CL, Verma SK, Koster J, Wu X, Yao Y, Milde T, Sin-Chan P, Zuccaro J,
Lau L, Pereira S, Castelo-Branco P, Hirst M, Marra MA, Roberts SS, Fults D, Massimi L, Cho YJ, van Meter
T, Grajkowska W, Lach B, Kulozik AE, von Deimling A, Witt O, Scherer SW, Fan X, Muraszko KM, Kool M,
Pomeroy SL, Gupta N, Phillips J, Huang A, Tabori U, Hawkins C, Malkin D, Kongkham PN, Weiss WA,
Jabado N, Rutka JT, Bouffet E, Korbel JO, Lupien M, Aldape KD, Bader GD, Eils R, Lichter P, Dirks PB,
Pfister SM, Korshunov A, Taylor MD. Epigenomic alterations define lethal CIMP-positive ependymomas of
infancy. Nature 506(7489), 2014, p.445-+. (AMC)
Maffei M, Mongera S, Terpstra L, Donadini A, Voorham QJM, Meijer GA, Giaretti W, Carvalho B,
Castagnola P. Chromosome 20 aberrations at the diploid-aneuploid transition in sporadic colorectal
cancer. Cytogenetic and genome research 2014; 144: 9-14. (VUmc)
Maftouh M, Avan A, Funel N, Frampton AE, Fiuji H, Pelliccioni S, Castellano L, Galla V, Peters GJ,
Giovannetti E. Mir-211 Modulates Gemcitabine Activity Through Downregulation of Ribonucleotide
Reductase and Inhibits the Invasive Behavior of Pancreatic Cancer Cells. Nucleos Nucleot Nucl 2014; 33:
384-393. (VUmc)
Maftouh M, Avan A, Funel N, Paolicchi E, Vasile E, Pacetti P, Vaccaro V, Faviana P, Campani D, Caponi S,
Mambrini A, Boggi U, Cantore M, Milella M, Peters GJ, Reni M, Giovannetti E. A polymorphism in the
promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer
patients. Pharmacogenomics 2014; 15: 609-618. (VUmc)
Maftouh M, Avan A, Sciarrillo R, Granchi C, Leon LG, Rani R, Funel N, Smid K, Honeywell RJ, Boggi U,
Minutolo F, Peters GJ, Giovannetti E. Synergistic interaction of novel lactate dehydrogenase inhibitors
with gemcitabine against pancreatic cancer cells in hypoxia. Brit J Cancer 2014; 110: 172-182. (VUmc)
Maftouh M, Da Silva Aresta Belo van Wijk, Avan A, Funel N, Peters GJ, Giovannetti E, van Die I. Galectin4 expression is associated with reduced lymph node metastasis and modulation of Wnt/beta-catenin
signalling in pancreatic adenocarcinoma. Oncotarget 2014; 5: 5335-5349. (VUmc)
Maia AR, van Heesbeen RG, Medema RH. A growing role for Aurora A in chromosome instability. Nat Cell
Biol 2014; 16:739-41 (NKI)
Makris NE, Boellaard R, Visser EP, de Jong JR, Vanderlinden B, Wierts R, van der Veen BJ, Greuter
HJNM, Vugts DJ, van Dongen GAMS, Lammertsma AA, Huisman MC. Multicenter Harmonization of Zr-89
PET/CT Performance. J Nucl Med 2014; 55: 264-267. (VUmc)
Makris NE, van Velden FHP, Huisman MC, Menke CW, Lammertsma AA, Boellaard R. Validation of
simplified dosimetry approaches in (89) Zr-PET/CT: The use of manual versus semi-automatic
delineation methods to estimate organ absorbed doses. Med Phys 2014; 41: 102503. (VUmc)
Mandonnet E, Versélewel de Witt Hamer PC, Pallud J, Bauchet L, Whittle I, Duffau H. Silent Diffuse
Low-Grade Glioma: Toward Screening and Preventive Treatment?. Cancer 2014; 120: 1758-1762. (VUmc)
Mank APM, Schoonenberg C, Bleeker K, Heijmenberg S, de Heer K, van Oers MHJ, Kersten MJ. Early
discharge after high dose chemotherapy is safe and feasible: a prospective evaluation of 6 years of
home care. Leukemia & Lymphoma [aheadofprint], 2014, p.1-20. (AMC)
Marchetti S, Pluim D, Beijnen JH, Mazzanti R, van Tellingen O, Schellens JHM. "Effect of the drug
transporters ABCB1, ABCC2, and ABCG2 on the disposition and brain accumulation of the taxane analog
BMS-275,183". Invest New Drugs 2014; 32:1083-95 (NKI)
Mari L, Milano F, Parikh Kl, Straub D, Everts V, Hoeben KK, Fockens P, Buttar NS, Krishnadath KK. A
pSMAD/CDX2 Complex Is Essential for the Intestinalization of Epithelial Metaplasia. Cell Reports 7(4),
2014, p.1197-1210. (AMC)
Marres CCM, de Ridder M, Hegger I, van Velthuysen MLF, Hauptmann M, Navran A, Balm AJM. The
influence of nodal yield in neck dissections on lymph node ratio in head and neck cancer. Oral Oncology
50(1), 2014, p.59-64. (AMC/NKI)
Marsh Durban V, Jansen M, Davies EJ, Morsink FH, Offerhaus GJA., Clarke AR. Epithelial-specific loss of
PTEN results in colorectal juvenile polyp formation and invasive cancer. American Journal of Pathology
184(1), 2014, p.86-91. (AMC)
Scientific publications - 123
868.
869.
870.
871.
872.
873.
874.
875.
876.
877.
878.
879.
880.
881.
882.
883.
884.
885.
886.
887.
888.
889.
890.
Martin-Gomez L, Villalba A, Kerkhoven RH, Abollo E. Role of microRNAs in the immunity process of the
flat oyster Ostrea edulis against bonamiosis. Infect Genet Evol 2014; 27C:40-50 (NKI)
Mason S, Moutloatse G, van Furth AM, Solomons RS, van Reenen M, Reinecke C, Koekemoer G. KEMREP:
A New Qualitative Method for the Assessment of an Analyst’s Ability to Generate a Metabolomics Data
Matrix by Gas Chromatography– Mass Spectrometry. Current Metabolomics 2014; 2: 15-26. (VUmc)
Massl R, van Blankenstein M, Jeurnink S, Hermans JJ, de Haan MC, Stoker J, Koek M, Niessen WJ,
Steyerberg EW, Looman CW, Kuipers EJ. Visceral adipose tissue: the link with esophageal
adenocarcinoma. Scandinavian Journal of Gastroenterology 49(4), 2014, p.449-457. (AMC)
Massl R, van Putten PG, Steyerberg EW, van Tilburg AJ, Lai JY, de Ridder RJ, Brouwer JT, Verburg RJ,
Alderliesten J, Schoon EJ, van Leerdam ME, Kuipers EJ. Comparing quality, safety, and costs of
colonoscopies performed by nurse vs physician trainees. Clin Gastroenterol Hepatol 2014; 12:470-7 (NKI)
Mast M, Coerkamp E, Heijenbrok M, Scholten A, Jansen W, Kouwenhoven E, Nijkamp J, de WS,
Petoukhova A, Struikmans H. Target volume delineation in breast conserving radiotherapy: are coregistered CT and MR images of added value? Radiat Oncol 2014; 9:65 (NKI)
Mathus-Vliegen EMH, Alders PRH, Chuttani R, Scherpenisse J. Outcomes of intragastric balloon
placements in a private practice setting. Endoscopy [aheadofprint], 2014, p.-. (AMC)
Mathus-Vliegen EMH, de Jong L, Kos-Foekema HA. Significant and safe shortening of the recovery time
after flumazenil-reversed midazolam sedation. Digestive Diseases and Sciences 59(8), 2014,
p.1717-1725. A(MC)
Mathus-Vliegen EMH. Endoscopic treatment: the past, the present and the future. Best Practice &
Research in Clinical Gastroenterology 28(4), 2014, p.685-702. (AMC)
Mathus-Vliegen EMH. The cooperation between endoscopists and surgeons in treating complications of
bariatric surgery. Best Practice & Research in Clinical Gastroenterology 28(4), 2014, p.703-725. (AMC)
Mattiroli F, Sixma TK. Lysine-targeting specificity in ubiquitin and ubiquitin-like modification pathways.
Nat Struct Mol Biol 2014; 21:308-16 (NKI)
Mattiroli F, Uckelmann M, Sahtoe DD, van Dijk WJ, Sixma TK. The nucleosome acidic patch plays a
critical role in RNF168-dependent ubiquitination of histone H2A. Nat Commun 2014; 5:3291 (NKI)
Mattonen SA, Huang K, Ward AD, Senan S, Palma DA. New techniques for assessing response after
hypofractionated radiotherapy for lung cancer. Journal of Thoracic Disease 2014; 6: 375-386. (VUmc)
Mattonen SA, Palma DA, Haasbeek CJA, Senan S, Ward AD. Early prediction of tumor recurrence based
on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer. Med Phys 2014;
41: 033502. (VUmc)
Mattonen SA, Palma DA, Haasbeek CJA, Senan S, Ward AD. Early prediction of lung cancer recurrence
after stereotactic radiotherapy using second order texture statistics. SPIE Proceedings Series 2014;
9038: 90380T. (VUmc)
Maurice-Stam H, Scholten L, de Gee EA, van der Zanden RA, Conijn B, Last BF, Grootenhuis MA.
Feasibility of an Online Cognitive Behavioral-Based Group Intervention for Adolescents Treated for
Cancer: A Pilot Study. Journal of Psychosocial Oncology 32(3), 2014, p.310-321. (AMC)
Mavroidis P, Giantsoudis D, Awan MJ, Nijkamp J, Rasch CRN, Duppen JC, Thomas CR, Okunieff P, Jones
WE, Kachnic LA, Papanikolaou N, Fuller CD. Consequences of anorectal cancer atlas implementation in
the cooperative group setting: Radiobiologic analysis of a prospective randomized in silico target
delineation study. Radiotherapy and Oncology 112(3), 2014, p.418-424. (AMC/NKI)
McArthur GA, Chapman PB, Robert C, Larkin J, Haanen JB, Dummer R, Ribas A, Hogg D, Hamid O,
Ascierto PA, Garbe C, Testori A, Maio M, Lorigan P, Lebbe C, Jouary T, Schadendorf D, O'Day SJ,
Kirkwood JM, Eggermont AM, Dreno B, Sosman JA, Flaherty KT, Yin M, Caro I, Cheng S, Trunzer K,
Hauschild A. Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive
melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study. Lancet Oncol 2014;
15:323-32 (NKI)
McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang
Y, Wang Z, Darby S. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence
and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22
randomised trials. Lancet 383(9935), 2014, p.2127-2135. (AMC)
McLean CM, Karemaker ID, van Leeuwen F. The emerging roles of DOT1L in leukemia and normal
development. Leukemia 2014; 28:2131-8 (NKI)
Mebius M, Westerman M, Smorenburg CH. Skin lesions in a patient with multiple myeloma. Neth J Med
2014; 72:330, 334 (NKI)
Meesters AA, van der Veen JPW, Wolkerstorfer A. Long-term remission of folliculitis decalvans after
treatment with the long-pulsed Nd:YAG laser. Journal of Dermatological Treatment 25(2), 2014,
p.167-168. (AMC)
Mehta AM, Van den Hoven JM, Rosing H, Hillebrand MJX, Nuijen B, Huitema ADR, Beijnen JH, Verwaal
VJ. Stability of oxaliplatin in chloride-containing carrier solutions used in hyperthermic intraperitoneal
chemotherapy. Int J Pharm 2014; 479:23-7 (NKI)
Mei M, Wondergem MJ, Palmer JM, Shimoni A, Hasenkamp J, Tsai NC, Simpson J, Nademanee A,
Raubitschek A, Forman SJ, Krishnan AY. Autologous Transplantation for Transformed Non-Hodgkin
Lymphoma Using an Yttrium-90 Ibritumomab Tiuxetan Conditioning Regimen. Biology of Blood and
Marrow Transplantation 2014; 20: 2072-2075. (VUmc)
124 - Scientific publications
891.
892.
893.
894.
895.
896.
897.
898.
899.
900.
901.
902.
903.
904.
905.
906.
907.
908.
909.
910.
911.
912.
913.
914.
Meijer CJLM, Snijders PJF. Cervical cancer in 2013 screening comes of age and treatment progress
continues. Nature reviews clinical oncology 2014; 11: 77-78. (VUmc)
Meijer RP, Mertens LS, van Rhijn BW, Bex A, van der Poel HG, Meinhardt W, Kerst J, Bergman AM,
Fioole-Bruining A, van Werkhoven E, Horenblas S. Induction Chemotherapy Followed by Surgery in Node
Positive Bladder Cancer. Urology 2014; 83: 134-139. (VUmc/NKI)
Mekenkamp LJM, Haan JC, Israeli D, van Essen HFB, Dijkstra JR, van Cleef P, Punt CJA, Meijer GA,
Nagtegaal ID, Ylstra B. Chromosomal Copy Number Aberrations in Colorectal Metastases Resemble Their
Primary Counterparts and Differences Are Typically Non-Recurrent. PLoS One 2014; 9: e86833.
(VUmc/AMC)
Melenhorst M, Hehenkamp W, de Heer K, Berger F. CT features in uterine necrosis of unknown cause: a
case report. Clinical Imaging 38(4), 2014, p.543-546 (AMC)
Melero I, Gaudemack G, Gerritsen W, Huber C, Parmiani G, Scholl S, Thatcher N, Wagstaff J, Zielinski C,
Faulkner I, Mellstedt H. Therapeutic vaccines for cancer: an overview of clinical trials. Nature reviews
clinical oncology 2014; 11: 509-524. (VUmc)
Melief CJM, Scheper RJ, de Vries IJM. Scientific contributions toward successful cancer immunotherapy
in The Netherlands. Immunol Lett 2014; 162: 121-126. (VUmc)
Mellema WW, Hoek D, Postmus PE, Smit EF. Retrospective evaluation of thromboembolic events in
patients with non-small cell lung cancer treated with platinum-based chemotherapy. Lung Cancer 2014;
86: 73-77. (VUmc)
Melo CA, Melo SA. MicroRNA Biogenesis: Dicing Assay. Methods Mol Biol 2014; 1182:219-26 (NKI)
Melo SA, Sugimoto H, O'Connell JT, Kato N, Villanueva A, Vidal A, Qiu L, Vitkin E, Perelman LT, Melo CA,
Lucci A, Ivan C, Calin GA, Kalluri R. Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis
and Promote Tumorigenesis. Cancer Cell 2014; 26:707-21 (NKI)
Menard C, van der Heide UA. Introduction: Magnetic resonance imaging comes of age in radiation
oncology. Semin Radiat Oncol 2014; 24:149-50 (NKI)
Menard C, van der HU. Introduction: Systems for magnetic resonance image guided radiation therapy.
Semin Radiat Oncol 2014; 24:192 (NKI)
Mencarelli A, van Beek S, Zijp LJ, Rasch C, van Herk M, Sonke JJ. Automatic detection system for
multiple region of interest registration to account for posture changes in head and neck radiotherapy.
Phys Med Biol 2014; 59:2005-21 (NKI/AMC)
Mencarelli A, van Kranen SR, Hamming-Vrieze O, van Beek S, Nico Rasch CR, van Herk M, Sonke J-J.
Deformable Image Registration for Adaptive Radiation Therapy of Head and Neck Cancer: Accuracy and
Precision in the Presence of Tumor Changes. International Journal of Radiation Oncology and Biology
Physics 90(3), 2014, p.680-687. (AMC/NKI)
Menko FH, Maher ER, Schmidt LS, Middelton LA, Aittomaki K, Tomlinson I, Richard S, Linehan W.
Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment.
Fam Cancer 2014; 13: 637-644. (VUmc/NKI)
Merckel LG, Verkooijen HM, Peters NHGM, Mann RM, Veldhuis WB, Storm RK, Weits T, Duvivier KM, van
Dalen T, Mali WPTM, Peeters PHM, van den Bosch MAAJ. The Added Diagnostic Value of Dynamic
Contrast-Enhanced MRI at 3.0 T in Nonpalpable Breast Lesions. PLoS One 2014; 9: e94233. (VUmc)
Merks JHM, de Salvo GL, Bergeron C, Bisogno G, de Paoli A, Ferrari A, Rey A, Oberlin O, Stevens MCG,
Kelsey A, Michalski J, Hawkins DS, Anderson JR. Parameningeal rhabdomyosarcoma in pediatric age:
results of a pooled analysis from North American and European cooperative groups. Annals of Oncology
25(1), 2014, p.231-236. (AMC)
Mertens LS, Meijer RP, de Vries RR, Nieuwenhuijzen JA, van der Poel HG, Bex A, Rhijn BWG, Meinhardt
W, Horenblas S. Prostate Sparing Cystectomy for Bladder Cancer: 20-Year Single Center Experience. J
Urology 2014; 191: 1250-1255. (VUmc/NKI)
Mertens LS, Meijer RP, Meinhardt W, van der Poel HG, Bex A, Kerst J, van der Heijden MS, Bergman AM,
Horenblas S, van Rhijn BW. Occult lymph node metastases in patients with carcinoma invading bladder
muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy alone. BJU INT
2014; 114: 67-74. (VUmc/NKI)
Mertens LS, Mir M, Scott AM, Lee ST, Fioole-Bruining A, Vegt E, Vogel WV, Manecksha R, Bolton D, Davies
I, Horenblas S, van Rhijn BW, Lawrentschuk N. F-18-fluorodeoxyglucose-Positron Emission
Tomography/Computed Tomography Aids Staging and Predicts Mortality in Patients With Muscle-invasive
Bladder Cancer. Urology 2014; 83: 393-398. (VUmc/NKI)
Mertens LS, Mir MC, Scott AM, Lee ST, Fioole-Bruining A, Vegt E, Vogel WV, Manecksha R, Bolton D,
Mertens LS, Mir MC, van Rhijn BW, Lawrentschuk N. F-18-fluorodeoxyglucose-Positron Emission
Tomography/Computed Tomography Aids Staging and Predicts Mortality in Patients With Muscle-invasive
Bladder Cancer REPLY. Urology 2014; 83: 399. (VUmc)
Mertens LS, Mir MC, van Rhijn BW, Lawrentschuk N. Reply: To PMID 24468513. Urology 2014; 83:399
(NKI)
Mertens LS, Neuzillet Y, Horenblas S, van Rhijn BW. TIMELINE Landmarks in non-muscle-invasive bladder
cancer. Nature reviews urology 2014; 11: 476-480. (VUmc/NKI)
Meulenaar J, Keizer RJ, Beijnen JH, Schellens JHM, Huitema AD, Nuijen B. Development of an extendedrelease formulation of capecitabine making use of in vitro-in vivo correlation modelling. J Pharm Sci
2014; 103:478-84 (NKI)
Scientific publications - 125
915.
916.
917.
918.
919.
Meulendijks D, Dewit L, Tomasoa NB, Van Tinteren H, Beijnen JH, Schellens JHM, Cats A.
Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment
option. Br J Cancer 2014; 111:1726-33 (NKI)
Meulepas JM, Ronckers CM, Smets AMJB, Nievelstein RAJ, Jahnen A, Lee C, Kieft M, Laméris JS, van
Herk M, Greuter MJW, Jeukens CRLPN, van Straten M, Visser O, van Leeuwen FE, Hauptmann M.
Leukemia and brain tumors among children after radiation exposure from CT scans: design and
methodological opportunities of the Dutch Pediatric CT Study. European Journal of Epidemiology 29(4),
2014, p.293-301. (AMC/NKI)
Milne RL, Burwinkel B, Michailidou K, Arias-Perez JI, Zamora MP, Menendez-Rodriguez P, Hardisson D,
Mendiola M, Gonzalez-Neira A, Pita G, Alonso MR, Dennis J, Wang Q, Bolla MK, Swerdlow A, Ashworth A,
Orr N, Schoemaker M, Ko YD, Brauch H, Hamann U, Andrulis IL, Knight JA, Glendon G, Tchatchou S,
Investigators K, Matsuo K, Ito H, Iwata H, Tajima K, Li J, Brand JS, Brenner H, Dieffenbach AK, Arndt V,
Stegmaier C, Lambrechts D, Peuteman G, Christiaens MR, Smeets A, Jakubowska A, Lubinski J,
Jaworska-Bieniek K, Durda K, Hartman M, Hui M, Lim WY, Chan CW, Marme F, Yang R, Bugert P,
Lindblom A, Margolin S, Garcia-Closas M, Chanock SJ, Lissowska J, Figueroa JD, Bojesen SE,
Nordestgaard BG, Flyger H, Hooning MJ, Kriege M, van den Ouweland AM, Koppert LB, Fletcher O,
Johnson N, Dos-Santos-Silva I, Peto J, Zheng W, Deming-Halverson S, Shrubsole MJ, Long J, ChangClaude J, Rudolph A, Seibold P, Flesch-Janys D, Winqvist R, Pylkas K, Jukkola-Vuorinen A, Grip M, Cox A,
Cross SS, Reed MW, Schmidt MK, Broeks A, Cornelissen S, Braaf L, Kang D, Choi JY, Park SK, Noh DY,
Simard J, Dumont M, Goldberg MS, Labreche F, Fasching PA, Hein A, Ekici AB, Beckmann MW, Radice P,
Peterlongo P, Azzollini J, Barile M, Sawyer E, Tomlinson I, Kerin M, Miller N, Hopper JL, Schmidt DF,
Makalic E, Southey MC, Teo SH, Yip CH, Sivanandan K, Tay WT, Shen CY, Hsiung CN, Yu JC, Hou MF,
Guenel P, Truong T, Sanchez M, Mulot C, Blot W, Cai Q, Nevanlinna H, Muranen TA, Aittomaki K,
Blomqvist C, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Bogdanova N, Dork T, Muir K, Lophatananon
A, Stewart-Brown S, Siriwanarangsan P, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Shu XO, Lu
W, Gao YT, Zhang B, Couch FJ, Toland AE, Yannoukakos D, Sangrajrang S, McKay J, Wang X, Olson JE,
Vachon C, Purrington K, Severi G, Baglietto L, Haiman CA, Henderson BE, Schumacher F, Le Marchand L,
Devilee P, Tollenaar RA, Seynaeve C, Czene K, Eriksson M, Humphreys K, Darabi H, Ahmed S, Shah M,
Pharoah PD, Hall P, Giles GG, Benitez J, Dunning AM, Chenevix-Trench G, Easton DF. Common nonsynonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer
Association Consortium. Hum Mol Genet 2014; 23(22):6096-111:6096-111 (NKI)
Milne RL, Burwinkel B, Michailidou K, rias-Perez JI, Zamora MP, Menendez-Rodriguez P, Hardisson D,
Mendiola M, Gonzalez-Neira A, Pita G, Alonso MR, Dennis J, Wang Q, Bolla MK, Swerdlow A, Ashworth A,
Orr N, Schoemaker M, Ko YD, Brauch H, Hamann U, Andrulis IL, Knight JA, Glendon G, Tchatchou S,
Matsuo K, Ito H, Iwata H, Tajima K, Li J, Brand JS, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C,
Lambrechts D, Peuteman G, Christiaens MR, Smeets A, Jakubowska A, Lubinski J, Jaworska-Bieniek K,
Durda K, Hartman M, Hui M, Yen Lim W, Wan Chan C, Marme F, Yang R, Bugert P, Lindblom A, Margolin
S, Garcia-Closas M, Chanock SJ, Lissowska J, Figueroa JD, Bojesen SE, Nordestgaard BG, Flyger H,
Hooning MJ, Kriege M, van den Ouweland AMW, Koppert LB, Fletcher O, Johnson N, Dos-Santos-Silva I,
Peto J, Zheng W, ming-Halverson S, Shrubsole MJ, Long J, Chang-Claude J, Rudolph A, Seibold P, FleschJanys D, Winqvist R, Pylkas K, Jukkola-Vuorinen A, Grip M, Cox A, Cross SS, Reed MWR, Schmidt MK,
Broeks A, Cornelissen S, Braaf L, Kang D, Choi JY, Park SK, Noh DY, Simard J, Dumont M, Goldberg MS,
Labreche F, Fasching PA, Hein A, Ekici AB, Beckmann MW, Radice P, Peterlongo P, Azzollini J, Barile M,
Sawyer E, Tomlinson I, Kerin M, Miller N, Hopper JL, Schmidt DF, Makalic E, Southey MC, Hwang Teo S,
Har Yip C, Sivanandan K, Tay WT, Shen CY, Hsiung CN, Yu JC, Hou MF, Guenel P, Truong T, Sanchez M,
Mulot C, Blot W, Cai Q, Nevanlinna H, Muranen TA, Aittomaki K, Blomqvist C, Wu AH, Tseng CC, Van Den
Berg D, Stram DO, Bogdanova N, Dork T, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P,
Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Shu XO, Lu W, Gao YT, Zhang B, Couch FJ, Toland
AE, Yannoukakos D, Sangrajrang S, McKay J, Wang X, Olson JE, Vachon C, Purrington K, Severi G,
Baglietto L, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Devilee P, Tollenaar RAEM,
Seynaeve C, Czene K, Eriksson M, Humphreys K, Darabi H, Ahmed S, Shah M, Pharoah PDP, Hall P, Giles
GG, Benitez J, Dunning AM, Chenevix-Trench G, Easton DF. Common non-synonymous SNPs associated
with breast cancer susceptibility: findings from the Breast Cancer Association Consortium. Hum Mol
Genet 2014; 23:6096-111 (NKI)
Milne RL, Herranz J, Michailidou K, Dennis J, Tyrer JP, Zamora MP, Arias-Perez JI, Gonzalez-Neira A,
Pita G, Alonso MR, Wang Q, Bolla MK, Czene K, Eriksson M, Humphreys K, Darabi H, Li J, Anton-Culver H,
Neuhausen SL, Ziogas A, Clarke CA, Hopper JL, Dite GS, Apicella C, Southey MC, Chenevix-Trench G,
Swerdlow A, Ashworth A, Orr N, Schoemaker M, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K,
Andrulis IL, Knight JA, Glendon G, Mulligan AM, Bojesen SE, Nordestgaard BG, Flyger H, Nevanlinna H,
Muranen TA, Aittomaki K, Blomqvist C, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Wang X,
Olson JE, Vachon C, Purrington K, Winqvist R, Pylkas K, Jukkola-Vuorinen A, Grip M, Dunning AM, Shah
M, Guenel P, Truong T, Sanchez M, Mulot C, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Lindblom
A, Margolin S, Hooning MJ, Hollestelle A, Collee JM, Jager A, Cox A, Brock IW, Reed MW, Devilee P,
Tollenaar RA, Seynaeve C, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Simard J, Dumont
M, Soucy P, Dork T, Bogdanova NV, Hamann U, Forsti A, Rudiger T, Ulmer HU, Fasching PA, Haberle L,
Ekici AB, Beckmann MW, Fletcher O, Johnson N, Dos Santos Silva I, Peto J, Radice P, Peterlongo P,
Peissel B, Mariani P, Giles GG, Severi G, Baglietto L, Sawyer E, Tomlinson I, Kerin M, Miller N, Marme F,
126 - Scientific publications
920.
921.
922.
923.
924.
925.
926.
927.
928.
929.
930.
931.
932.
933.
934.
935.
936.
937.
Burwinkel B, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Lambrechts D, Yesilyurt BT, Floris G,
Leunen K, Alnaes GG, Kristensen V, Borresen-Dale AL, Garcia-Closas M, Chanock SJ, Lissowska J,
Figueroa JD, Schmidt MK, Broeks A, Verhoef S, Rutgers EJ, Brauch H, Bruning T, Ko YD, Couch FJ, Toland
AE, Yannoukakos D, Pharoah PD, Hall P, Benitez J, Malats N, Easton DF. A large-scale assessment of twoway SNP interactions in breast cancer susceptibility using 46 450 cases and 42 461 controls from the
breast cancer association consortium. Hum Mol Genet 2014; 23:1934-46 (NKI/AMC)
Miltenburg NC, Boogerd W. Chemotherapy-induced neuropathy: A comprehensive survey. Cancer Treat
Rev 2014; 40:872-82 (NKI)
Miok V, Wilting SM, van de Wiel MA, Jaspers A, van Noort PI, Brakenhoff RH, Snijders PJF, Steenbergen
RDM, van Wieringen WN. tigaR: integrative significance analysis of temporal differential gene expression
induced by genomic abnormalities. BMC Bioinformatics 2014; 15: 327. (VUmc)
Miranda RN, Aladily TN, Prince HM, Kanagal-Shamanna R, de Jong D, Fayad LE, Amin MB, Haideri N,
Bhagat G, Brooks GS, Shifrin DA, O'Malley DP, Cheah CY, Bacchi CE, Gualco G, Li SY, Keech JA, Hochberg
EP, Carty MJ, Hanson SE, Mustafa E, Sanchez S, Manning J. Breast Implant-Associated Anaplastic LargeCell Lymphoma: Long-Term Follow-Up of 60 Patients. J Clin Oncol 2014; 32: 114-120. (VUmc/NKI)
Mirnezami R, Mehta AM, Chandrakumaran K, Cecil T, Moran BJ, Carr N, Verwaal VJ, Mohamed F,
Mirnezami AH. Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy
improves survival in patients with colorectal peritoneal metastases compared with systemic
chemotherapy alone. Br J Cancer 2014; 111:1500-8 (NKI)
Mischi M, Turco S, Lavini C, Kompatsiari K, de La Rosette JJMCH, Breeuwer M, Wijkstra H. Magnetic
Resonance Dispersion Imaging for Localization of Angiogenesis and Cancer Growth. Investigative
Radiology 49(8), 2014, p.561-569. (AMC)
Moelans CB, van der Groep P, Hoefnagel LD, van de Vijver MJ, Wesseling P, Wesseling J, van der Wall E,
van Diest PJ. Genomic evolution from primary breast carcinoma to distant metastasis: Few copy number
changes of breast cancer related genes. Cancer Lett 2014; 344: 138-146. (VUmc/NKI)
Moelans CB, van der Groep P, Hoefnagel LDC, van de Vijver MJ, Wesseling P, Wesseling J, van der Wall
E, van Diest PJ. Genomic evolution from primary breast carcinoma to distant metastasis: Few copy
number changes of breast cancer related genes. Cancer Letters 344(1), 2014, p.138-146. (AMC)
Mol BM, Massink MPG, van der Hout AH, Dommering CJ, Zaman JMA, Bosscha MI, Kors WA, MeijersHeijboer HE, Kaspers GJL, te Riele H, Moll AC, Cloos J, Dorsman JC. High resolution SNP array profiling
identifies variability in retinoblastoma genome stability. Gene Chromosome Canc 2014; 53: 1-14.
(VUmc/NKI)
Molenaar RJ, Radivoyevitch T, Maciejewski JP, van Noorden CJF, Bleeker FE. The driver and passenger
effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation.
Biochimica et Biophysica ACTA-Reviews on Cancer 1846(2), 2014, p.326-341. (AMC)
Molenaar RJ, van Noorden CJ. Type 2 diabetes and cancer as redox diseases? Lancet 384(9946), 2014,
p.853-. (AMC)
Molenaar RJ, Verbaan D, Lamba S, Zanon C, Jeuken JWM, Boots-Sprenger SHE, Wesseling P, Hulsebos
TJM, Troost D, van Tilborg AA, Leenstra S, Vandertop WP, Bardelli A, van Noorden CJF, Bleeker FE. The
combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better
than either IDH1 or MGMT alone. Neuro-oncology 2014; 16: 1263-1273. (VUmc/AMC)
Mollers M, Lubbers K, Spoelstra SK, Weijmar-Schultz WCM, Daemen T, Westra TA, van der Sande MAB,
Nijman HW, de Melker HE, Tami A. Equity in human papilloma virus vaccination uptake?: sexual
behaviour, knowledge and demographics in a cross-sectional study in (un)vaccinated girls in the
Netherlands. BMC Public Health 2014; 14: 288. (VUmc)
Mollers M, Vriend HJ, van der Sande MAB, Van Bergen JEAM, King AJ, Lenselink CH, Bekkers RLM, Meijer
CJLM, de Melker HE, Bogaards JA. Population- and Type-Specific Clustering of Multiple HPV Types Across
Diverse Risk Populations in the Netherlands. Am J Epidemiol 2014; 179: 1236-1246. (VUmc)
Mooi WJ. "Lentiginous Melanoma": Full-fledged Melanoma or Melanoma Precursor?. Adv Anat Pathol
2014; 21: 181-187. (VUmc)
Mooij MG, van Duijn E, Knibbe CAJ, Windhorst AD, Hendrikse NH, Vaes WHJ, Spaans E, Fabriek BO,
Sandman H, Grossouw D, Hanff LM, Janssen PJJM, Koch BCP, Tibboel D, De Wildt SN. Pediatric
Microdose Study of [C-14] Paracetamol to Study Drug Metabolism Using Accelerated Mass Spectrometry:
Proof of Concept. Clinical Pharmacokinetics 2014; 53: 1045-1051. (VUmc)
Mooij SH, Boot HJ, Speksnijder AGCL, Meijer CJLM, King AJ, Verhagen DWM, de vries HJC, Quint WGV,
Molijn A, de Koning MNC, van der Sande MAB, van der Loeff MFS. Six-Month Incidence and Persistence of
Oral HPV Infection in HIV-Negative and HIV-Infected Men Who Have Sex with Men. PLoS One 2014; 9:
e98955. (VUmc)
Mooij SH, Landen O, van der Klis FRM, van der Sande MAB, de Melker HE, Coutinho RA, van Eeden A, van
Rooijen MS, Meijer CJLM, van der Loeff MFS. No evidence for a protective effect of naturally induced
HPV antibodies on subsequent anogenital HPV infection in HIV-negative and HIV-infected MSM. J
Infection 2014; 69: 375-386. (VUmc)
Mooij SH, Landen O, van der Klis FRM, van der Sande MAB, de Melker HE, Xiridou M, van Eeden A,
Heijman T, Speksnijder AGCL, Snijders PJF, Schim van der Loeff M. HPV Seroconversion Following Anal
and Penile HPV Infection in HIV-Negative and HIV-Infected MSM. Cancer Epidem Biomar 2014; 23: 24552461. (VUmc)
Scientific publications - 127
938.
939.
940.
941.
942.
943.
944.
945.
946.
947.
948.
949.
950.
951.
952.
953.
954.
955.
956.
957.
Mooiman KD, Goey AK, Huijbregts TJ, Maas-Bakker RF, Beijnen JH, Schellens JHM, Meijerman I. The invitro effect of complementary and alternative medicines on cytochrome P450 2C9 activity. J Pharm
Pharmacol 2014; 66:1339-46 (NKI)
Mooiman KD, Maas-Bakker RF, Hendrikx JJ, Bank PC, Rosing H, Beijnen JH, Schellens JHM, Meijerman I.
The effect of complementary and alternative medicines on CYP3A4-mediated metabolism of three
different substrates: 7-benzyloxy-4-trifluoromethyl-coumarin, midazolam and docetaxel. J Pharm
Pharmacol 2014; 66:865-74 (NKI)
Moos SI, Stoker J, Nagan G, de Weijert RS, van Vemde DNH, Bipat S. Prediction of presence of kidney
disease in a general patient population undergoing intravenous iodinated contrast enhanced computed
tomography. European Radiology 24(6), 2014, p.1266-1275. (AMC)
Morabito F, Bringhen S, Larocca A, Wijermans P, Mateos MV, Gimsing P, Mazzone C, Gottardi D, Omede
P, Zweegman S, Lahuerta JJ, Zambello R, Musto P, Magarotto V, Schaafsma M, Oriol A, Juliusson G,
Cerrato C, Catalano L, Gentile M, Turel AI, Liberati AM, Ca. Bortezomib, melphalan, prednisone (VMP)
versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients:
A retrospective case-matched study. Am J Hematol 2014; 89: 355-362. (VUmc)
Mordang J-J, Hauth J, den Heeten GJ, Karssemeijer N. Automated Labeling of Screening Mammograms
with Arterial Calcifications. Lecture Notes in Computer Science 8539, 2014, p.589-596 (AMC)
Moreno Garcia V, Olmos D, Gomez-Roca C, Cassier P, Morales-Barrera R, Del Conte G, Gallerani E,
Brunetto A, Schoffski P, Marsoni S, Schellens JHM, Penel N, Voest E, Evans TR, Plummer ER, Wilson RH,
Soria JC, Tabernero J, Verweij J, Kaye SB. Dose-response relationship in phase i clinical trials: a
european drug development network (eddn) collaboration study. Clin Cancer Res 2014; 20(22):566371:5663-71 (NKI)
Morrissey ER, Vermeulen LK. Stem cell competition: how speeding mutants beat the rest. EMBO Journal
33(20), 2014, p.2277-2278. (AMC)
Morton LM, Gilbert ES, Stovall M, van Leeuwen FE, Dores GM, Lynch CF, Hall P, Smith SA, Weathers RE,
Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser
M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Lamart S, Simon SL, Fraumeni JF, Jr.,
Aleman BM, Curtis RE. Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma.
Haematologica 2014; 99:e193-e196 (NKI)
Mostert S, Njuguna F, Langat SC, Slot AJM, Skiles J, Sitaresmi MN, van de Ven PM, Musimbi J, Vreeman
RC, Kaspers GJL. Two overlooked contributors to abandonment of childhood cancer treatment in Kenya:
parents' social network and experiences with hospital retention policies. Psycho-Oncol 2014; 23: 700707. (VUmc)
Mostert S, Njuguna F, van de Ven PM, Olbara G, Kemps LJPA, Musimbi J, Strother RM, Aluoch LM, Skiles
J, Buziba NG, Sitaresmi MN, Vreeman RC, Kaspers GJL. Influence of Health-Insurance Access and
Hospital Retention Policies on Childhood Cancer Treatment in Kenya. Pediatr Blood Cancer 2014; 61:
913-918. (VUmc)
Mourits DL, Hartong DT, Moll AC, Mourits MP. Management of Porous Orbital Implants Requiring
Explantation: A Clinical and Histopathological Study. Ophthalmic plastic and reconstructive surgery
2014; 30: 528. (VUmc)
Mulder MP, El Oualid F, ter Beek J, Ovaa H. A native chemical ligation handle that enables the synthesis
of advanced activity-based probes: diubiquitin as a case study. Chembiochem 2014; 15:946-9 (NKI)
Mulder SF, Bertens D, Desar IME, Vissers KCP, Mulders PFA, Punt CJA, van Spronsen D-J, Langenhuijsen
JF, Kessels RPC, van Herpen CML. Impairment of cognitive functioning during Sunitinib or Sorafenib
treatment in cancer patients: a cross sectional study. BMC Cancer 14, 2014, p.219-. (AMC)
Mulder SF, Boers-Sonderen MJ, van der Heijden HFM, Vissers KCP, Punt CJA, van Herpen CML. A phase II
study of cediranib as palliative treatment in patients with symptomatic malignant ascites or pleural
effusion. Targeted Oncology 9(4), 2014, p.331-338. (AMC)
Muller BG, Fütterer JJ, Gupta RT, Katz A, Kirkham A, Kurhanewicz J, Moul JW, Pinto PA, Rastinehad AR,
Robertson C, de la Rosette J, Sanchez-Salas R, Jones JS, Ukimura O, Verma S, Wijkstra H, Marberger M.
The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations
from a consensus panel. BJU International 113(2), 2014, p.218-227. (AMC)
Muller BG, van den Bos W, Brausi M, Cornud F, Gontero P, Kirkham A, Pinto PA, Polascik TJ, Rastinehad
AR, de Reijke TM, de la Rosette JJ, Ukimura O, Villers A, Walz J, Wijkstra H, Marberger M. Role of
multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: a Delphi
consensus project. BJU International 114(5), 2014, p.698-707. (AMC)
Muller BG, van den Bos W, Pinto PA, de la Rosette JJ. Imaging modalities in focal therapy: patient
selection, treatment guidance, and follow-up. Current Opinion in Urology 24(3), 2014, p.218-224. (AMC)
Muller J, Krijgsman O, Tsoi J, Robert L, Hugo W, Song C, Kong X, Possik PA, Cornelissen-Steijger PD,
Foppen MH, Kemper K, Goding CR, McDermott U, Blank C, Haanen J, Graeber TG, Ribas A, Lo RS, Peeper
DS. Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma. Nat Commun
2014; 5:5712 (NKI)
Munneke JM, Björklund AT, Mjösberg JM, Garming-Legert K, Bernink JH, Blom B, Huisman C, van Oers
MHJ, Spits H, Malmberg K-J, Hazenberg MD. Activated innate lymphoid cells are associated with a
reduced susceptibility to graft-versus-host disease. Blood 124(5), 2014, p.812-821. (AMC)
Naik SH, Schumacher TN, Perie L. Cellular barcoding: A technical appraisal. Exp Hematol 2014; 42:598608 (NKI)
128 - Scientific publications
958.
959.
960.
961.
962.
963.
964.
965.
966.
967.
968.
969.
970.
971.
972.
973.
974.
975.
976.
977.
978.
979.
Naipal KAT, Verkaik NS, Ameziane N, van Deurzen CHM, ter Brugge P, Meijers M, Sieuwerts AM, Martens
JW, O'Connor MJ, Vrieling H, Hoeijmakers JHJ, Jonkers J, Kanaar R, de Winter JP, Vreeswijk MP, Jager
A, van Gent DC. Functional Ex Vivo Assay to Select Homologous Recombination-Deficient Breast Tumors
for PARP Inhibitor Treatment. Clin Cancer Res 2014; 20: 4816-4826. (VUmc/NKI)
Nedaeinia R, Avan A, Manian M, Salehi R, Ghayour-Mobarhan M. EGFR as a Potential Target for the
Treatment of Pancreatic Cancer: Dilemma and Controversies. Current Drug Targets 2014; 15: 1293-1301.
(VUmc)
Neefjes ECW, van der Vorst MJDL, Boddaert MSA, Zuurmond WWA, van der Vliet HJ, Beeker A, van den
Berg HP, van Groeningen CJ, Vrijaldenhoven S, Verheul HMW. Clinical evaluation of the efficacy of
methylnaltrexone in resolving constipation induced by different opioid subtypes combined with
laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone. BMC
Palliative Care 2014; 13: 42. (VUmc)
Neefjes J, van der Kant R. Stuck in traffic: an emerging theme in diseases of the nervous system. Trends
Neurosci 2014; 37:66-76 (NKI)
Nelson DS, Quispel W, Badalian-Very G, van Halteren AGS, van den Bos C. Bovée JVMG, Tian SY, van
Hummelen P, Ducar M, MacConaill LE, Egeler RM, Rollins BJ. Somatic activating ARAF mutations in
Langerhans cell histiocytosis. Blood 123(20), 2014, p.3152-3155. (AMC)
Neuzillet Y, van Rhijn BW, Prigoda NL, Bapat B, Liu L, Bostrom PJ, Fleshner NE, Gallie BL, Zlotta AR,
Jewett MA, van der Kwast TH. FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number
variations, are associated with favourable non-muscle invasive bladder cancer. Virchows Arch 2014;
465:207-13 (NKI)
Nielsen K, Scheffer HJ, Pieters IC, van Tilborg AAJM, van Waesberghe JHTM, Oprea D, Meijerink MR,
Kazemier G, Hoekstra OS, Schreurs HWH, Sietses C, Meijer S, Comans EFI, van den Tol PMP. The use of
PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases.
BMC Medical Imaging 2014; 14: 27. (VUmc)
Nielsen K, Scheffer HJ, Vieveen JM, van Tilborg AAJM, Meijer S, van Kuijk C, van den Tol MP, Meijerink
MR, Bouwman RA. Anaesthetic management during open and percutaneous irreversible electroporation.
Brit J Anaesth 2014; 113: 985-992. (VUmc)
Nieuwenhuijzen JA, de Vries R, van Tinteren H, Bex A, Poel H, Meinhardt W, Horenblas S. Follow-up
after cystectomy: Regularly scheduled, risk adjusted, or symptom guided?: Patterns of recurrence,
relapse presentation, and survival after cystectomy. EJSO-Eur J Surg Oncol 2014; 40: 1677-1685.
(VUmc/NKI)
)
Nieweg OE. Combinatiebehandeling van nietresectabele melanoomprocessen. Ned Tijdschr Oncol 2014;
11:65-8 (NKI)
Niewerth D, Jansen G, Riethoff LFV, van Meerloo J, Kale AJ, Moore BS, Assaraf YG, Anderl JL, Zweegman
S, Kaspers GJL, Cloos J. Antileukemic Activity and Mechanism of Drug Resistance to the Marine
Salinispora tropica Proteasome Inhibitor Salinosporamide A (Marizomib). Mol Pharmacol 2014; 86: 12-19.
(VUmc)
Niewerth D, Kaspers GJL, Assaraf YG, van Meerloo J, Kirk CJ, Anderl J, Blank JL, van de Ven PM,
Zweegman S, Jansen G, Cloos J. Interferon-gamma-induced upregulation of immunoproteasome subunit
assembly overcomes bortezomib resistance in human hematological cell lines. Journal of hematology &
oncology 2014; 7: 7. (VUmc)
Niewerth D, van Meerloo J, Jansen G, Assaraf YG, Hendrickx TC, Kirk CJ, Anderl JL, Zweegrnan S,
Kaspers GJL, Cloos J. Anti-leukemic activity and mechanisms underlying resistance to the novel
immunoproteasome inhibitor PR-924. Biochem Pharmacol 2014; 89: 43-51. (VUmc)
Nijenhuis CM, Rosing H, Schellens JHM, Beijnen JH. Development and validation of a high-performance
liquid chromatography-tandem mass spectrometry assay quantifying vemurafenib in human plasma. J
Pharm Biomed Anal 2014; 88:630-5 (NKI)
Nijenhuis CM, Rosing H, Schellens JHM, Beijnen JH. Quantifying vemurafenib in dried blood spots using
high-performance LC-MS/MS. Bioanalysis 2014; 6:3215-24 (NKI)
Nijhuis LE, Olivier BJ, Dhawan S, Hilbers FW, Boon L, Wolkers MC, Samsom JN, de Jonge WJ. Adrenergic
β2 receptor activation stimulates anti-inflammatory properties of dendritic cells in vitro. Plos One 9(1),
2014, p.e85086-. (AMC)
Njuguna F, Mostert S, Slot A, Langat S, Skiles J, Sitaresmi MN, van de Ven PM, Musimbi J, Muliro H,
Vreeman RC, Kaspers GJL. Abandonment of childhood cancer treatment in Western Kenya. Arch Dis
Child 2014; 99: 609-614. (VUmc)
Noij DP, Boerhout EJ, Bos I, Comans EFI, Oprea-Lager D, Reinhard R, Hoekstra OS, de Bree R, de Graaf
P, Castelijns JA. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck
squamous cell carcinoma: A feasibility study. Eur J Radiol 2014; 83: 1144-1151. (VUmc)
Noordman BJ, Comans EFI, Lips PTAM, Rinkel RN. False-Positive Uptake of I-124 in a Laryngeal Cyst
Mimicking Thyroid Remnant After Thyroidectomy and I-131 Therapy for Follicular Thyroid Carcinoma.
Clin Nucl Med 2014; 39: 898-899. (VUmc)
Nordman JT, Kozhevnikova EN, Verrijzer CP, Pindyurin AV, Andreyeva EN, Shloma VV, Zhimulev IF, OrrWeaver TL. DNA copy-number control through inhibition of replication fork progression. Cell Rep 2014;
9:841-9 (NKI)
Northcott PA, Lee C, Zichner T, Stütz AM, Erkek S, Kawauchi D, Shih DJH, Hovestadt V, Zapatka M,
Scientific publications - 129
980.
981.
982.
983.
984.
985.
986.
987.
988.
989.
990.
991.
992.
993.
994.
995.
996.
Sturm D, Jones DTW, Kool M, Remke M, Cavalli FMG, Zuyderduyn S, Bader GD, VandenBerg S, Esparza
LA, Ryzhova M, Wang W, Wittmann A, Stark S, Sieber L, Seker-Cin H, Linke L, Kratochwil F, Jäger N,
Buchhalter I, Imbusch CD, Zipprich G, Raeder B, Schmidt S, Diessl N, Wolf S, Wiemann S, Brors B,
Lawerenz C, Eils J, Warnatz H-J, Risch T, Yaspo M-L, Weber UD, Bartholomae CC, von Kalle C, Turányi E,
Hauser P, Sanden E, Darabi A, Siesjö P, Sterba J, Zitterbart K, Sumerauer D, van Sluis P, Versteeg R,
Volckmann R, Koster J, Schuhmann MU, Ebinger M, Grimes HL, Robinson GW, Gajjar A, Mynarek M, von
Hoff K, Rutkowski S, Pietsch T, Scheurlen W, Felsberg J, Reifenberger G, Kulozik AE, von Deimling A,
Witt O, Eils R, Gilbertson RJ, Korshunov A, Taylor MD, Lichter P, Korbel JO, Wechsler-Reya RJ, Pfister
SM. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature 511(7510), 2014,
p.428-434. (AMC)
Notten KJB, Kluivers KB., Fütterer JJ, Schweitzer KJ, Stoker J, Mulder FE, Beets-Tan RG, Vliegen RFA,
Bossuyt PM, Kruitwagen RFPM, Roovers J-PWR, Weemhoff M. Translabial three-dimensional
ultrasonography compared with magnetic resonance imaging in detecting levator ani defects. Obstetrics
and Gynecology 124(6), 2014, p.1190-1197. (AMC)
Oates CJ, Mukherjee S. Joint Structure Learning of Multiple Non-Exchangeable Networks. Proceedings
of the Seventeenth International Conference on Artificial Intelligence and Statistics (AISTATS 2014).
2014: p. 687-695 (NKI)
Obulkasim A, van de Wiel MA. StepwiseCM: An R Package for Stepwise Classification of Cancer Samples
Using Multiple Heterogeneous Data Sets. Cancer Inform 2014; 13: 1-11. (VUmc)
Ocio EM, Richardson PG, Rajkumar SV, Palumbo A, Mateos MV, Orlowski R, Kumar S, Usmani S, Roodman
D, Niesvizky R, Einsele H, Anderson KC, Dimopoulos MA, vet-Loiseau H, Mellqvist UH, Turesson I, Merlini
G, Schots R, McCarthy P, Bergsagel L, Chim CS, Lahuer. New drugs and novel mechanisms of action in
multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG). Leukemia
2014; 28: 525-542. (VUmc)
Oddens JR, Sylvester RJ, Brausi MA, Kirkels WJ, van de Beek C, van Andel G, de Reijke TM, Prescott S,
Witjes JA, Oosterlinck W. The Effect of Age on the Efficacy of Maintenance Bacillus Calmette-Guerin
Relative to Maintenance Epirubicin in Patients with Stage Ta T1 Urothelial Bladder Cancer: Results from
EORTC Genito-Urinary Group Study 30911. European Urology 66(4), 2014, p.694-701. (AMC)
Odusola AO, Hendriks M, Schultsz C, Bolarinwa OA, Akande T, Osibogun A, Agyemang C, Ogedegbe G,
Agbede K, Adenusi P, Lange J, van Weert H, Stronks K, Haafkens JA. Perceptions of inhibitors and
facilitators for adhering to hypertension treatment among insured patients in rural Nigeria: a qualitative
study. BMC Health Services Research 14(1), 2014, p.624-. (AMC)
Oei GTML, Heger M, van Golen RF, Alles LK, Flick M, van der Wal AC, van Gulik TM, Hollmann MW,
Preckel B, Weber NC. Reduction of cardiac cell death after helium postconditioning in rats:
transcriptional analysis of cell death and survival pathways. Molecular Medicine [aheadofprint], 2014,
p.-. (AMC)
Oerlemans S, Issa DE, van den Broek EC, Nijziel MR, Coebergh JWW, Huijgens PC, Mols F, van de PollFranse L. Health-related quality of life and persistent symptoms in relation to (R-)CHOP14, (R-)CHOP21,
and other therapies among patients with diffuse large B-cell lymphoma: results of the population-based
PHAROS-registry. Ann Hematol 2014; 93: 1705-1715. (VUmc)
Oerlemans S, Issa DE, van den Broek EC, Nijziel MR, Coebergh JWW, Mols F, van de Poll-Franse L. Impact
of therapy and disease-related symptoms on health-related quality of life in patients with follicular
lymphoma: results of the population-based PHAROS-registry. Eur J Haematol 2014; 93: 229-238. (VUmc)
Offiah AC, Adamsbaum C, van Rijn RR. ESPR adopts British guidelines for imaging in suspected
non-accidental injury as the European standard. Pediatric Radiology 44(11), 2014, p.1338-. (AMC)
Offiah AC, Andronikou S, Avni F, Daltro P, Donnelly LF, Jaramillo D, Kim In O, Nievelstein RAJ, Owens
CM, Slovis TL, van Rijn R, Lee EY. Expert opinion: what are the greatest challenges and barriers to
applying evidence-based and practical approaches to preclinical and clinical research in the field of
pediatric radiology? Pediatric Radiology 44(10), 2014, p.1209-1212. (AMC)
Olsman E, Leget C, Onwuteaka-Philipsen BD, Willems D. Should palliative care patients' hope be
truthful, helpful or valuable? An interpretative synthesis of literature describing healthcare
professionals' perspectives on hope of palliative care patients. Palliative Med 2014; 28: 59-70. (VUmc)
Olthof ED, Versleijen MW, Huisman-de Waal G, Feuth T, Kievit W, Wanten GJ. Taurolidine Lock Is
Superior to Heparin Lock in the Prevention of Catheter Related Bloodstream Infections and Occlusions.
PLoS One 2014; 9:e111216 (NKI)
Onstenk W, Kraan J, Mostert B, Timmermans MM, Charehbili A, Smit VTHBM, Kroep JR, Nortier JWR, van
de Ven S, Heijns JB, Kessels LW, van Laarhoven HWM, Bos MMEM, van de Velde CJH, Gratama JW,
Sieuwerts AM, Martens JWM, Foekens JA, Sleijfer S. Improved circulating tumor cell detection by a
combined EpCAM and MCAM CellSearch enrichment approach in breast cancer patients undergoing
neoadjuvant chemotherapy. Molecular Cancer Therapeutics [aheadofprint], 2014, p.-. (AMC)
Oomens MAEM, van der Waal I. Epidemiology of ameloblastomas of the jaws; A report from the
Netherlands. Medicina oral patologia oral y cirugia bucal 2014; 19: E581-E583. (VUmc)
Oosterkamp HM, Hijmans EM, Brummelkamp TR, Canisius S, Wessels LFA, Zwart W, Bernards R. USP9X
Downregulation Renders Breast Cancer Cells Resistant to Tamoxifen. Cancer Res 2014; 74:3810-20 (NKI)
Oostvogels R, Lokhorst HM, Minnema MC, van e, van den Oudenalder K, Spierings E, Mutis T, Spaapen
RM. Identification of minor histocompatibility antigens based on the 1000 Genomes Project. HaematolHematol J 2014; 99: 1854-1859. (VUmc)
130 - Scientific publications
997.
998.
999.
1000.
1001.
1002.
1003.
1004.
1005.
1006.
1007.
1008.
1009.
1010.
1011.
Oostvogels R, Lokhorst HM, Minnema MC, van Elk M, van den Oudenalder K, Spierings E, Mutis T,
Spaapen RM. Identification of minor histocompatibility antigens based on the 1000 Genomes Project.
Haematologica 2014; 99:1854-9 (NKI)
Opdam FL, Huitema ADR, Beijnen JH, Schellens JHM. [Hyperglycaemia during treatment with
everolimus] Hyperglykemie bij gebruik van everolimus. Ned Tijdschr Geneeskd 2014; 158:A7544 (NKI)
Oppedijk V, van der Gaast A, van Lanschot JJB, van Hagen P, van Os R, van Rij CM, van der Sangen MJ,
Beukema JC, Rutten H, Spruit PH, Reinders JG, Richel DJ, Henegouwen MIV, Hulshof MCCM. Patterns of
Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials.
J Clin Oncol 2014; 32: 385-391. (VUmc/AMC)
Orem J, Sandin S, Mbidde E, Mangen FW, Middeldorp JM, Weiderpass E. Epstein-Barr Virus Viral Load and
Serology in Childhood Non-Hodgkin's Lymphoma and Chronic Inflammatory Conditions in Uganda:
Implications for Disease Risk and Characteristics. J Med Virol 2014; 86: 1796-1803. (VUmc)
Ortiz-Munoz G, Mallavia B, Bins A, Headley M, Krummel MF, Looney MR. Aspirin-triggered 15-epi-lipoxin
A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice. Blood 2014;
124:2625-34 (NKI)
Osorio A, Milne RL, Kuchenbaecker K, Vaclova T, Pita G, Alonso R, Peterlongo P, Blanco I, de la Hoya M,
Duran M, Diez O, Ramon YC, Konstantopoulou I, Martinez-Bouzas C, Andres Conejero R, Soucy P,
McGuffog L, Barrowdale D, Lee A, Swe B, Arver B, Rantala J, Loman N, Ehrencrona H, Olopade OI,
Beattie MS, Domchek SM, Nathanson K, Rebbeck TR, Arun BK, Karlan BY, Walsh C, Lester J, John EM,
Whittemore AS, Daly MB, Southey M, Hopper J, Terry MB, Buys SS, Janavicius R, Dorfling CM, van
Rensburg EJ, Steele L, Neuhausen SL, Ding YC, Hansen TV, Jonson L, Ejlertsen B, Gerdes AM, Infante M,
Herraez B, Moreno LT, Weitzel JN, Herzog J, Weeman K, Manoukian S, Peissel B, Zaffaroni D, Scuvera G,
Bonanni B, Mariette F, Volorio S, Viel A, Varesco L, Papi L, Ottini L, Tibiletti MG, Radice P, Yannoukakos
D, Garber J, Ellis S, Frost D, Platte R, Fineberg E, Evans G, Lalloo F, Izatt L, Eeles R, Adlard J, Davidson
R, Cole T, Eccles D, Cook J, Hodgson S, Brewer C, Tischkowitz M, Douglas F, Porteous M, Side L, Walker
L, Morrison P, Donaldson A, Kennedy J, Foo C, Godwin AK, Schmutzler RK, Wappenschmidt B, Rhiem K,
Engel C, Meindl A, Ditsch N, Arnold N, Plendl HJ, Niederacher D, Sutter C, Wang-Gohrke S, Steinemann
D, Preisler-Adams S, Kast K, Varon-Mateeva R, Gehrig A, Stoppa-Lyonnet D, Sinilnikova OM, Mazoyer S,
Damiola F, Poppe B, Claes K, Piedmonte M, Tucker K, Backes F, Rodriguez G, Brewster W, Wakeley K,
Rutherford T, Caldes T, Nevanlinna H, Aittomaki K, Rookus MA, van Os TA, van der Kolk L, de Lange JL,
Meijers-Heijboer HE, van der Hout AH, van Asperen CJ, Gomez Garcia EB, Hoogerbrugge N, Collee JM,
van Deurzen CH, van der Luijt RB, Devilee P, Hebon, Olah E, Lazaro C, Teule A, Menendez M,
Jakubowska A, Cybulski C, Gronwald J, Lubinski J, Durda K, Jaworska-Bieniek K, Johannsson OT,
Maugard C, Montagna M, Tognazzo S, Teixeira MR, Healey S, Investigators K, Olswold C, Guidugli L,
Lindor N, Slager S, Szabo CI, Vijai J, Robson M, Kauff N, Zhang L, Rau-Murthy R, Fink-Retter A, Singer
CF, Rappaport C, Geschwantler Kaulich D, Pfeiler G, Tea MK, Berger A, Phelan CM, Greene MH, Mai PL,
Lejbkowicz F, Andrulis I, Mulligan AM, Glendon G, Toland AE, Bojesen A, Pedersen IS, Sunde L,
Thomassen M, Kruse TA, Jensen UB, Friedman E, Laitman Y, Shimon SP, Simard J, Easton DF, Offit K,
Couch FJ, Chenevix-Trench G, Antoniou AC, Benitez J. DNA glycosylases involved in base excision repair
may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers. PLoS Genet 2014;
10:e1004256 (NKI/AMC/VUmc)
Ossenkoppele GJ, Schuurhuis GJ. MRD in AML: It is time to change the definition of remission. Best
practice & research clinical haematology 2014; 27: 265-271. (VUmc)
Overbeek A, van den Berg MMHE, Louwe L, Wendel E, ter Kuile M, Kaspers G, Stiggelbout A, van D,
Hilders C. Practice, attitude and knowledge of Dutch paediatric oncologists regarding female fertility.
Neth J Med 2014; 72: 264-270. (VUmc)
Overwater E, Smulders YM, van der Burg M, Lombardi MP, Meijers-Heijboer HE, Kuijpers TW, Houweling
AC. The value of DNA storage and pedigree analysis in rare diseases: a 17-year-old boy with X-linked
lymphoproliferative disease (XLP) caused by a de novo SH2D1A mutation. Eur J Pediatr 2014; 173: 16951698. (VUmc/AMC)
Paap E, Verbeek ALM, Botterweck AAM, van Doorne-Nagtegaal HJ, Imhof-Tas M, de Koning HJ, Otto SJ,
de Munck L, van der Steen A, Holland R, den Heeten GJ, Broeders MJM. Breast cancer screening halves
the risk of breast cancer death: A case-referent study. Breast 23(4), 2014, p.439-444. (AMC)
Paci A, Veal G, Bardin C, Leveque D, Widmer N, Beijnen J, Astier A, Chatelut E. Review of therapeutic
drug monitoring of anticancer drugs part 1 - Cytotoxics. Eur J Cancer 2014; 50:2010-9 (NKI)
Paff T, Daniels JMA, Pals G, Haarman EG. Primary ciliary dyskinesia: From diagnosis to molecular
mechanisms. Journal of Pediatric Genetics 2014; 3: 115-127. (VUmc)
Paganini I, Chang VY, Capone GL, Vitte J, Benelli M, Barbetti L, Sestini R, Trevisson E, Hulsebos TJM,
Giovannini M, Nelson SF, Papi L. Expanding the mutational spectrum of LZTR1 in schwannomatosis.
(AMC) European Journal of Human Genetics [aheadofprint], 2014, p.-. (AMC)
Paleri V, Drinnan M, van den Brekel MW, Hinni ML, Bradley PJ, Wolf GT, de Bree R, Fagan JJ, Hamoir M,
Strojan P, Rodrigo JP, Olsen KD, Pellitteri PK, Shaha AR, Genden EM, Silver CE, Suarez C, Takes RP,
Rinaldo A, Ferlito A. Vascularized Tissue to Reduce Fistula Following Salvage Total Laryngectomy: A
Systematic Review. Laryngoscope 2014; 124: 1848-1853. (VUmc/NKI)
Pallasch CP, Leskov I, Braun CJ, Vorholt D, Drake A, Soto-Feliciano YM, Bent EH, Schwamb J, Iliopoulou
B, Kutsch N, van Rooijen N, Frenzel LP, Wendtner CM, Heukamp L, Kreuzer KA, Hallek M, Chen JZ,
Scientific publications - 131
1012.
1013.
1014.
1015.
1016.
1017.
1018.
1019.
1020.
1021.
1022.
1023.
1024.
1025.
1026.
1027.
1028.
Hemann MT. Sensitizing Protective Tumor Microenvironments to Antibody-Mediated Therapy. Cell 2014;
156: 590-602. (VUmc)
Palma DA, Salama JK, Lo SS, Senan S, Treasure T, Govindan R, Weichselbaum R. The oligometastatic
state-separating truth from wishful thinking. Nature reviews clinical oncology 2014; 11: 549-557. (VUmc)
Palumbo A, Bringhen S, Kumar SK, Lupparelli G, Usmani S, Waage A, Larocca A, van der Holt B, Musto P,
Offidani M, Petrucci MT, Evangelista A, Zweegman S, Nooka AK, Spencer A, Dimopoulos MA, Hajek R,
Cavo M, Richardson P, Lonial S, Ciccone G, Boccadoro M,. Second primary malignancies with
lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data. Lancet
Oncol 2014; 15: 333-342. (VUmc)
Parikh K, Zhou L, Somasundaram R, Fuhler GM, Deuring JJ, Blokzijl T, Regeling A, Kuipers EJ, Weersma
RK, Nuij VJ, Alves M, Vogelaar L, Visser L, de Haar C, Krishnadath KK, van der Woude CJ, Dijkstra G,
Faber KN, Peppelenbosch MP. Suppression of p21Rac signaling and increased innate immunity mediate
remission in Crohn's disease. Science Translational Medicine 6(233), 2014, p.233ra53-. (AMC)
Paspatis GA, Dumonceau JM, Barthet M, Meisner S, Repici A, Saunders BP, Vezakis A, Gonzalez JM,
Turino SY, Tsiamoulos ZP, Fockens P, Hassan C, Schulz HJ. Diagnosis and Management of Iatrogenic
Endoscopic Perforations: Position Statement from the European Society of Gastrointestinal Endoscopy
(ESGE). Endoskopie Heute 27(3), 2014, p.176-195. (AMC)
Paspatis GA., Dumonceau JM, Barthet M, Meisner S, Repici A, Saunders BP, Vezakis A, Gonzalez JM,
Turino SY, Tsiamoulos ZP, Fockens P, Hassan C. Diagnosis and management of iatrogenic endoscopic
perforations: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy
46(8), 2014, p.693-711. (AMC)
Patton S, Normanno N, Blackhall F, Murray S, Kerr KM, Dietel M, Filipits M, Benlloch S, Popat S, Stahel R,
Thunnissen E. Assessing standardization of molecular testing for non-small-cell lung cancer: results of a
worldwide external quality assessment (EQA) scheme for EGFR mutation testing. Brit J Cancer 2014;
111: 413-420. (VUmc)
Pautier P, Ji Nam E, Provencher DM, Hamilton AL, Mangili G, Siddiqui Nadeem A, Westermann AM, Reed
NS, Harter P, Ray-Coquard I. Gynecologic Cancer InterGroup (GCIG) Consensus Review for High-Grade
Undifferentiated Sarcomas of the Uterus. International Journal of Gynecological cancer 24(9 Suppl 3),
2014, p.S73-S77. (AMC)
Peeper DS. Cancer drug resistance: old concept, novel solutions required. Mol Oncol 2014; 8:1064-6
Peeters M, Price TJ, Cervantes A, Sobrero AF, Ducreux M, Hotko Y, André T, Chan E, Lordick F, Punt
CJA, Strickland AH, Wilson G, Ciuleanu TE, Roman L, van Cutsem E, Tian Y, Sidhu R. Final results from a
randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic
colorectal cancer. Annals of Oncology 25(1), 2014, p.107-116. (AMC)
Peguret N, Dahele M, Lagerwaard F, Senan S, Slotman B. A Brief Report of 10-Year Trends in the Use of
Stereotactic Lung Radiotherapy at a Dutch Academic Medical Center. Journal of Thoracic Oncology 2014;
9: 114-117. (VUmc)
Pengel KE, Koolen BB, Loo CE, Vogel WV, Wesseling J, Lips EH, Rutgers EJ, Valdes Olmos RA, Vrancken
Peeters MJ, Rodenhuis S, Gilhuijs KG . Combined use of (18)F-FDG PET/CT and MRI for response
monitoring of breast cancer during neoadjuvant chemotherapy. Eur J Nucl Med Mol Imaging 2014;
41:1515-24 (NKI)
Pengel KE, Loo CE, Wesseling J, Pijnappel RM, Rutgers EJ, Gilhuijs KG. Avoiding preoperative breast MRI
when conventional imaging is sufficient to stage patients eligible for breast conserving therapy. Eur J
Radiol 2014; 83:273-8 (NKI)
Perez Castro E, Osther PJS, Jinga V, Razvi H, Stravodimos KG, Parikh K, Kural AR, de la Rosette JJ.
Differences in Ureteroscopic Stone Treatment and Outcomes for Distal, Mid-, Proximal, or Multiple
Ureteral Locations: The Clinical Research Office of the Endourological Society Ureteroscopy Global
Study. European Urology 66(1), 2014, p.102-109.
(AMC)
Perie L, Hodgkin PD, Naik SH, Schumacher TN, De Boer RJ, Duffy KR. Determining lineage pathways from
cellular barcoding experiments. Cell Rep 2014; 6:617-24 (NKI)
Perie L, Riboli-Sasco L, Ribrault C, Zlotek-Zlotkiewicz E. Outside the Tower. Kids' questions transcend
conflict. Science 2014; 345:740 (NKI)
Perrakis A, Moolenaar WH. Autotaxin: structure-function and signaling. J Lipid Res 2014; 55:1010-8 (NKI)
Perry JR, Day F, Elks CE, Sulem P, Thompson DJ, Ferreira T, He C, Chasman DI, Esko T, Thorleifsson G,
Albrecht E, Ang WQ, Corre T, Cousminer DL, Feenstra B, Franceschini N, Ganna A, Johnson AD, Kjellqvist
S, Lunetta KL, McMahon G, Nolte IM, Paternoster L, Porcu E, Smith AV, Stolk L, Teumer A, Tsernikova N,
Tikkanen E, Ulivi S, Wagner EK, Amin N, Bierut LJ, Byrne EM, Hottenga JJ, Koller DL, Mangino M, Pers
TH, Yerges-Armstrong LM, Hua Zhao J, Andrulis IL, Anton-Culver H, Atsma F, Bandinelli S, Beckmann
MW, Benitez J, Blomqvist C, Bojesen SE, Bolla MK, Bonanni B, Brauch H, Brenner H, Buring JE, ChangClaude J, Chanock S, Chen J, Chenevix-Trench G, Collee JM, Couch FJ, Couper D, Coviello AD, Cox A,
Czene K, D'adamo AP, Davey Smith G, De Vivo I, Demerath EW, Dennis J, Devilee P, Dieffenbach AK,
Dunning AM, Eiriksdottir G, Eriksson JG, Fasching PA, Ferrucci L, Flesch-Janys D, Flyger H, Foroud T,
Franke L, Garcia ME, Garcia-Closas M, Geller F, de Geus EE, Giles GG, Gudbjartsson DF, Gudnason V,
Guenel P, Guo S, Hall P, Hamann U, Haring R, Hartman CA, Heath AC, Hofman A, Hooning MJ, Hopper
JL, Hu FB, Hunter DJ, Karasik D, Kiel DP, Knight JA, Kosma VM, Kutalik Z, Lai S, Lambrechts D, Lindblom
A, Magi R, Magnusson PK, Mannermaa A, Martin NG, Masson G, McArdle PF, McArdle WL, Melbye M,
Michailidou K, Mihailov E, Milani L, Milne RL, Nevanlinna H, Neven P, Nohr EA, Oldehinkel AJ, Oostra BA,
132 - Scientific publications
1029.
1030.
1031.
1032.
1033.
1034.
1035.
1036.
1037.
1038.
1039.
1040.
1041.
1042.
1043.
Palotie A, Peacock M, Pedersen NL, Peterlongo P, Peto J, Pharoah PD, Postma DS, Pouta A, Pylkas K,
Radice P, Ring S, Rivadeneira F, Robino A, Rose LM, Rudolph A, Salomaa V, Sanna S, Schlessinger D,
Schmidt MK, Southey MC, Sovio U, Stampfer MJ, Stockl D, Storniolo AM, Timpson NJ, Tyrer J, Visser JA,
Vollenweider P, Volzke H, Waeber G, Waldenberger M, Wallaschofski H, Wang Q, Willemsen G, Winqvist
R, Wolffenbuttel BH, Wright MJ, Boomsma DI, Econs MJ, Khaw KT, Loos RJ, McCarthy MI, Montgomery
GW, Rice JP, Streeten EA, Thorsteinsdottir U, van Duijn CM, Alizadeh BZ, Bergmann S, Boerwinkle E,
Boyd HA, Crisponi L, Gasparini P, Gieger C, Harris TB, Ingelsson E, Jarvelin MR, Kraft P, Lawlor D,
Metspalu A, Pennell CE, Ridker PM, Snieder H, Sorensen TI, Spector TD, Strachan DP, Uitterlinden AG,
Wareham NJ, Widen E, Zygmunt M, Murray A, Easton DF, Stefansson K, Murabito JM, Ong KK. Parent-oforigin-specific allelic associations among 106 genomic loci for age at menarche. Nature 2014; 514:92-7
(NKI)
Perry JR, Hsu YH, Chasman DI, Johnson AD, Elks C, Albrecht E, Andrulis IL, Beesley J, Berenson GS,
Bergmann S, Bojesen SE, Bolla MK, Brown J, Buring JE, Campbell H, Chang-Claude J, Chenevix-Trench G,
Corre T, Couch FJ, Cox A, Czene K, D'adamo AP, Davies G, Deary IJ, Dennis J, Easton DF, Engelhardt EG,
Eriksson JG, Esko T, Fasching PA, Figueroa JD, Flyger H, Fraser A, Garcia-Closas M, Gasparini P, Gieger
C, Giles G, Guenel P, Hagg S, Hall P, Hayward C, Hopper J, Ingelsson E, Kardia SL, Kasiman K, Knight JA,
Lahti J, Lawlor DA, Magnusson PK, Margolin S, Marsh JA, Metspalu A, Olson JE, Pennell CE, Polasek O,
Rahman I, Ridker PM, Robino A, Rudan I, Rudolph A, Salumets A, Schmidt MK, Schoemaker MJ, Smith EN,
Smith JA, Southey M, Stockl D, Swerdlow AJ, Thompson DJ, Truong T, Ulivi S, Waldenberger M, Wang Q,
Wild S, Wilson JF, Wright AF, Zgaga L, Ong KK, Murabito JM, Karasik D, Murray A. DNA mismatch repair
gene MSH6 implicated in determining age at natural menopause. Hum Mol Genet 2014; 23:2490-7 (NKI)
Peter S, Bultinck J, Myant K, Jaenicke LA, Walz S, Muller J, Gmachl M, Treu M, Boehmelt G, Ade CP,
Schmitz W, Wiegering A, Otto C, Popov N, Sansom O, Kraut N, Eilers M. Tumor cell-specific inhibition of
MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase. EMBO Mol Med 2014;
6(12):1525-41:1525-41 (NKI)
Peters CP, Eshuis EJ, Toxopeüs FM, Hellemons ME, Jansen JM, D'Haens GRAM, Fockens P, Stokkers PCF,
Tuynman Hans ARE, van Bodegraven AA, Ponsioen CY. Adalimumab for Crohn's disease: Long-term
sustained benefit in a population-based cohort of 438 patients. Journal of Chrohs&Colitis 8(8), 2014,
p.866-875. (AMC)
Peters GJ, Avan A, Gallegos-Ruiz MI, Orsini V, Avan A, Giovannetti E, Smit EF. Predictive Role of Repair
Enzymes in the Efficacy of Cisplatin Combinations in Pancreatic and Lung Cancer. Anticancer Res 2014;
34: 435-442. (VUmc)
Peters GJ, Honeywell RJ, Maulandi M, Giovannetti E, Losekoot N, Etienne-Grimaldi MC, Milano G,
Serdjebi C, Ciccolini J. Selection of the Best Blood Compartment to Measure Cytidine Deaminase Activity
to Stratify for Optimal Gemcitabine Or Cytarabine Treatment. Nucleos Nucleot Nucl 2014; 33: 403-412.
(VUmc)
Peters GJ. Novel Developments in the Use of Antimetabolites. Nucleos Nucleot Nucl 2014; 33: 358-374.
(VUmc)
Peters S, Smit E. Pan-HER inhibition in EGFR wild-type non-small-cell lung cancer. Lancet Oncol 2014;
15: 1289-1290. (VUmc)
Peters S, Weder W, Dafni U, Kerr KM, Bubendorf L, Meldgaard P, O'Byrne KJ, Wrona A, Vansteenkiste J,
Felip E, Marchetti A, Savic S, Lu S, Smit E, Dingemans AM, Blackhall FH, Baas P, Camps C, Rosell R,
Stahel RA. Lungscape: Resected Non-Small-Cell Lung Cancer Outcome by Clinical and Pathological
Parameters. Journal of Thoracic Oncology 2014; 9: 1675-1684. (VUmc)
Peulen H, Belderbos J, Rossi M, Sonke JJ. Mid-ventilation based PTV margins in Stereotactic Body
Radiotherapy (SBRT): a clinical evaluation. Radiother Oncol 2014; 110:511-6 (NKI)
Phesse TJ, Myant KB, Cole AM, Ridgway RA, Pearson H, Muncan V, van den Brink GR, Vousden KH, Sears
R, Vassilev LT, Clarke AR, Sansom OJ. Endogenous c-Myc is essential for p53-induced apoptosis in
response to DNA damage in vivo. Cell Death and Differentation 21(6), 2014, p.956-966. (AMC)
Phoa KN, van Vilsteren FGI, Weusten BLAM, Bisschops R, Schoon EJ, Ragunath K, Fullarton G, Di Pietro
M, Ravi N, Visser M, Offerhaus GJ, Seldenrijk CA, Meijer SL, ten Kate FJW, Tijssen JGP, Bergman JJGHM.
Radiofrequency Ablation vs Endoscopic Surveillance for Patients With Barrett Esophagus and Low-Grade
Dysplasia A Randomized Clinical Trial. Jama-Journal of American Medical Association 311(12), 2014,
p.1209-1217. (AMC)
Pianko MJ, Terpos E, Roodman GD, Divgi CR, Zweegman S, Hillengass J, Lentzsch S. Whole-Body LowDose Computed Tomography and Advanced Imaging Techniques for Multiple Myeloma Bone Disease. Clin
Cancer Res 2014; 20: 5888-5897. (VUmc)
Pickholtz I, Saadyan S, Keshet GI, Wang VS, Cohen R, Bouwman P, Jonkers J, Byers SW, Papa MZ, Yarden
RI. Cooperation between BRCA1 and vitamin D is critical for histone acetylation of the p21waf1
promoter and growth inhibition of breast cancer cells and cancer stem-like cells. Oncotarget 2014;
5:11827-46 (NKI)
Pijpe A, Slottje P, van Pelt C, Stehmann F, Kromhout H, van Leeuwen FE, Vermeulen RC, Rookus MA.
The Nightingale study: rationale, study design and baseline characteristics of a prospective cohort study
on shift work and breast cancer risk among nurses. BMC Cancer 2014; 14:47 (NKI)
Pinheiro C, Garcia EA, Morais-Santos F, Scapulatempo-Neto C, Mafra A, Steenbergen RDM, Boccardo E,
Villa LL, Baltazar F, Longatto A. Lactate transporters and vascular factors in HPV-induced squamous cell
carcinoma of the uterine cervix. BMC Cancer 2014; 14: 751. (VUmc)
Scientific publications - 133
1044. Pivodic L, Block L, Pardon K, Miccinesi G, Alonso TV, Boffin N, Donker GA, Cancian M, Lopez-Maside A,
Onwuteaka-Philipsen BD, Deliens L. Burden on family carers and care-related financial strain at the end
of life: a cross-national population-based study. Eur J Public Health 2014; 24: 819-826. (VUmc)
1045. Poddighe PJ, Wessels H, Merle P, Westers TM, Bhola SL, Loonen A, Zweegman S, Ossenkoppele GJ,
Wondergem MJ. Genomic amplification of MYC as double minutes in a patient with APL-like leukemia.
Molecular cytogenetics 2014; 7: 67. (VUmc)
1046. Porcelli L, Giovannetti E, Assaraf YG, Jansen G, Scheffer GL, Kathman I, Azzariti A, Paradiso A, Peters
GJ. The EGFR Pathway Regulates BCRP Expression in NSCLC Cells: Role of Erlotinib. Current Drug Targets
2014; 15: 1322-1330. (VUmc)
1047. Porwit A, van de Loosdrecht AA, Bettelheim P, Brodersen LE, Burbury K, Cremers E, la Porta MG, Ireland
R, Johansson U, Matarraz S, Ogata K, Orfao A, Preijers F, Psarra K, Subiraa D, Valent P, van der Velden
VHJ, Wells D, Westers TM, Kern W, Bene MC. Revisiting guidelines for integration of flow cytometry
results in the WHO classification of myelodysplastic syndromes-proposal from the
International/European LeukemiaNet Working Group for Flow Cytometry in MDS. Leukemia 2014; 28:
1793-1798. (VUmc)
1048. Possik PA, Muller J, Gerlach C, Kenski JC, Huang X, Shahrabi A, Krijgsman O, Song JY, Smit MA,
Gerritsen B, Lieftink C, Kemper K, Michaut M, Beijersbergen RL, Wessels L, Schumacher TN, Peeper DS.
Parallel In Vivo and In Vitro Melanoma RNAi Dropout Screens Reveal Synthetic Lethality between Hypoxia
and DNA Damage Response Inhibition. Cell Rep 2014; 9:1375-86 (NKI)
1049. Postma AV, Alders M, Sylva M, Bilardo CM, Pajkrt E, van Rijn RR, Schulte-Merker S, Bulk S, Stefanovic S,
Ilgun A, Barnett P, Mannens MMAM, Moorman AFM, Oostra RJ, van Maarle MC. Mutations in the T
(brachyury) gene cause a novel syndrome consisting of sacral agenesis, abnormal ossification of the
vertebral bodies and a persistent notochordal canal. Journal of Medical Genetics 51(2), 2014, p.90-97.
(AMC)
1050. Postma ILE, Beenen LFM, Bijlsma TS, Berger FH, Heetveld MJ, Bloemers FW, Goslings JC. Radiological
work-up after mass casualty incidents: are ATLS guidelines applicable?. Eur J Radiol 2014; 24: 785-791.
(VUmc)
1051. Postmus PE, Johannesma PC, Menko FH, Paul MA. In-flight pneumothorax: diagnosis may be missed
because of symptom delay. Am J Respir Crit Care Med 2014; 190:704-5 (NKI)
1052. Potze L, Mullauer FB, Colak S, Kessler JH, Medema JP. Betulinic acid-induced mitochondria-dependent
cell death is counterbalanced by an autophagic salvage response. Cell Death & Disease 5, 2014,
p.e1169-. (AMC)
1053. Pouw B, de Wit-van der Veen LJ, Hellingman D, Brouwer OR, Vrancken Peeters MJTFD, Stokkel MPM,
Valdes Olmos RA. Feasibility of preoperative (125)I seed-guided tumoural tracer injection using freehand
SPECT for sentinel lymph node mapping in non-palpable breast cancer. EJNMMI Res 2014; 4:19-(8 pp)
(NKI)
1054. Pouw B, de Wit-van der Veen LJ, van der Hage JA, Vrancken Peeters MJ, Wesseling J, Stokkel MP, Valdes
Olmos RA. Radio-guided seed localization for breast cancer excision: an ex-vivo specimen-based study to
establish the accuracy of a freehand-SPECT device in predicting resection margins. Nucl Med Commun
2014; 35:961-6 (NKI)
1055. Pouw RE, Bergman JJGHM. Argon plasma coagulation for Barrett's neoplasia: the right hot ingredient for
a successful recipe? Endoscopy 46(1), 2014, p.13-15. (AMC)
1056. Pouw RE, Visser M , Odze RD, Sondermeijer CM, ten Kate FJW, Weusten BLAM, Bergman JJ.
Pseudo-buried Barrett's post radiofrequency ablation for Barrett's esophagus, with or without prior
endoscopic resection. Endoscopy 46(2), 2014, p.105-109. (AMC)
1057. Prabowo AS, Iyer AM, Veersema TJ, Anink JJ, Schouten-van Meeteren AYN, Spliet WGM, van Rijen PC,
Ferrier CH, Thom M, Aronica E. Expression of neurodegenerative disease-related proteins and caspase-3
in glioneuronal tumours. Neuropahtology and Applied Neurobiology [aheadofprint], 2014, p.-. (AMC)
1058. Prabowo AS, Iyer AM, Veersema TJ, Anink JJ, Schouten-van Meeteren AYN, Spliet WGM, van Rijen PC,
Ferrier CH, Capper D, Thom M, Aronica E. BRAF V600E Mutation Is Associated with mTOR Signaling
Activation in Glioneuronal Tumors. Brain Pathology 24(1), 2014, p.52-66. (AMC)
1059. Price TJ, Segelov E, Burge M, Haller DG, Tebbutt NC, Karapetis CS, Punt CJA, Pavlakis N, Arnold D,
Gibbs P, Shapiro JD. Current opinion on optimal systemic treatment for metastatic colorectal cancer:
outcome of the ACTG/AGITG expert meeting ECCO 2013. Expert Review of Anti Cancer Therapy 14(12),
2014, p.1477-1493. (AMC)
1060. Prinsen H, van Dijk JP, Zwarts MJ, Leer Jan WH, Bleijenberg G, van Laarhoven HW. The Role of Central
and Peripheral Muscle Fatigue in Postcancer Fatigue: A Randomized Controlled Trial. Journal of Pain and
System Management [aheadofprint], 2014, p.-. (AMC)
1061. Pronk IM, van der Hage JA, van der Hiel B, Mallo H, Ter Meulen S, Haanen JBAG. Combinatiebehandeling
voor stadium III/IV -melanoom. Oncologie Up-to-date 2014; 5:4-5 (NKI)
1062. Pullens B, Dekker E, Ellis AJ, Guy R, Madronal K, Chetty R, East JE. Impact of the consideration of
serrated polyps to the interval of colonoscopic surveillance in the NHS Bowel Cancer Screening
Programme. Colorectal Disease 16(9), 2014, p.O320-O326. (AMC)
1063. Purrington KS, Slettedahl S, Bolla MK, Michailidou K, Czene K, Nevanlinna H, Bojesen SE, Andrulis IL, Cox
A, Hall P, Carpenter J, Yannoukakos D, Haiman CA, Fasching PA, Mannermaa A, Winqvist R, Brenner H,
Lindblom A, Chenevix-Trench G, Benitez J, Swerdlow A, Kristensen V, Guenel P, Meindl A, Darabi H,
Eriksson M, Fagerholm R, Aittomaki K, Blomqvist C, Nordestgaard BG, Nielsen SF, Flyger H, Wang X,
134 - Scientific publications
1064.
1065.
1066.
1067.
1068.
1069.
1070.
1071.
1072.
1073.
1074.
1075.
1076.
1077.
1078.
1079.
Olswold C, Olson JE, Mulligan AM, Knight JA, Tchatchou S, Reed MW, Cross SS, Liu J, Li J, Humphreys K,
Clarke C, Scott R, Fostira F, Fountzilas G, Konstantopoulou I, Henderson BE, Schumacher F, Le Marchand
L, Ekici AB, Hartmann A, Beckmann MW, Hartikainen JM, Kosma VM, Kataja V, Jukkola-Vuorinen A,
Pylkas K, Kauppila S, Dieffenbach AK, Stegmaier C, Arndt V, Margolin S, Balleine R, Arias Perez JI, Pilar
Zamora M, Menendez P, Ashworth A, Jones M, Orr N, Arveux P, Kerbrat P, Truong T, Bugert P, Toland
AE, Ambrosone CB, Labreche F, Goldberg MS, Dumont M, Ziogas A, Lee E, Dite GS, Apicella C, Southey
MC, Long J, Shrubsole M, Deming-Halverson S, Ficarazzi F, Barile M, Peterlongo P, Durda K, JaworskaBieniek K, Tollenaar RA, Seynaeve C, Bruning T, Ko YD, van Deurzen CH, Martens JW, Kriege M, Figueroa
JD, Chanock SJ, Lissowska J, Tomlinson I, Kerin MJ, Miller N, Schneeweiss A, Tapper WJ, Gerty SM,
Durcan L, Mclean C, Milne RL, Baglietto L, Dos Santos Silva I, Fletcher O, Johnson N, van't Veer LJ,
Cornelissen S, Forsti A, Torres D, Rudiger T, Rudolph A, Flesch-Janys D, Nickels S, Weltens C, Floris G,
Moisse M, Dennis J, Wang Q, Dunning AM, Shah M, Brown J, Simard J, Anton-Culver H, Neuhausen SL,
Hopper JL, Bogdanova N, Dork T, Zheng W, Radice P, Jakubowska A, Lubinski J, Devillee P, Brauch H,
Hooning M, Garcia-Closas M, Sawyer E, Burwinkel B, Marmee F, Eccles DM, Giles GG, Peto J, Schmidt M,
Broeks A, Hamann U, Chang-Claude J, Lambrechts D, Pharoah PD, Easton D, Pankratz VS, Slager S,
Vachon CM, Couch FJ. Genetic variation in mitotic regulatory pathway genes is associated with breast
tumor grade. Hum Mol Genet 2014; 23:6034-46 (NKI)
Queiroz KCS, Shi K, Duitman J, Aberson HL, Wilmink JW, van Noesel CJM, Richel DJ, Spek CA.
Protease-activated receptor-1 drives pancreatic cancer progression and chemoresistance. International
Journal of Cancer 135(10), 2014, p.2294-2304. (AMC)
Quinten C, Martinelli F, Coens C, Sprangers MAG, Ringash J, Gotay C, Bjordal K, Greimel E, Reeve BB,
Maringwa J, Ediebah DE, Zikos E, King MT, Osoba D, Taphoorn MJ, Flechtner H, Koch J, Weis J,
Bottomley A. Global Analysis of Multitrial Data Investigating Quality of Life and Symptoms as Prognostic
Factors for Survival in Different Tumor Sites. Cancer 2014; 120: 302-311. (VUmc)
Raaijmakers JA, Medema RH. Function and regulation of dynein in mitotic chromosome segregation.
Chromosoma 2014; 123:407-22 (NKI)
Ragin C, Obikoya-Malomo M, Kim S, Chen Z, Flores-Obando R, Gibbs D, Koriyama C, Aguayo F, Koshiol J,
Caporaso NE, Carpagnano GE, Ciotti M, Haka-Akita H, Fukayama M, Goto A, Spandidos DA, Gorgoulis V,
Heideman DAM, van Boerdonk RAA, Hiroshima K, Iwakawa R,. HPV-associated lung cancers: an
international pooled analysis. Carcinogenesis 2014; 35: 1267-1275. (VUmc)
Rajcevic U, Knol JC, Piersma S, Bougnaud S, Fack F, Sundlisaeter E, Sondenaa K, Myklebust R, Pham TV,
Niclou SP, Jimenez CR. Colorectal cancer derived organotypic spheroids maintain essential tissue
characteristics but adapt their metabolism in culture. Proteome Sci 2014; 12: 39. (VUmc)
Rajendran L, Bali J, Barr MM, Court FA, Kramer-Albers EM, Picou F, Raposo G, van der Vos KE, van Niel
G, Wang J, Breakefield XO. Emerging roles of extracellular vesicles in the nervous system. J Neurosci
2014; 34:15482-9 (NKI)
Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, Kumar S, Hillengass J, Kastritis
E, Richardson P, Landgren O, Paiva B, Dispenzieri A, Weiss B, Leleu X, Zweegman S, Lonial S, Rosinol L,
Zamagni E, Jagannath S, Sezer O, Kristinsson SY,. International Myeloma Working Group updated criteria
for the diagnosis of multiple myeloma. Lancet Oncol 2014; 15: E538-E548. (VUmc)
Ramdayal K, Stobbe MD, Mishra T, Michaut M. Building the future of bioinformatics through studentfacilitated conferencing. PLoS Comput Biol 2014; 10:e1003458 (NKI)
Ramos de Carvalho JE, Verbraak FD, Aalders MC, van Noorden CJ, Schlingemann RO. Recent advances in
ophthalmic molecular imaging. Survey of Ophthalmology 59(4), 2014, p.393-413. (AMC)
Ramrattan MA, Boeker EB, Ram K, Burgers DMT, de Boer M, Lie-A-Huen L, Mulder WMC, Boermeester MA.
Evidence based development of bedside clinical drug rules for surgical patients. International Journal of
Clinical Pharmacy 36(3), 2014, p.581-588. (AMC)
Ranzani M, Annunziato S, Calabria A, Brasca S, Benedicenti F, Gallina P, Naldini L, Montini E. Lentiviral
vector-based insertional mutagenesis identifies genes involved in the resistance to targeted anticancer
therapies. Mol Ther 2014; 22:2056-68 (NKI)
Raphael MF, Laheij-de Boer AM, Kollen WJW, Mekelenkamp H, Abbink FCH, Kaspers GJL, Zomer-Kooijker
K, Molmans BHW, Tissing WJE. Caphosol, a therapeutic option in case of cancer therapy-induced oral
mucositis in children? Results from a prospective multicenter double blind randomized controlled trial.
Support Care Cancer 2014; 22: 3-6. (VUmc)
Rastogi A, Rao DS, Gupta N, Grisolano SW, Buckles DC, Sidorenko E, Bonino J, Matsuda T, Dekker E,
Kaltenbach T, Singh R, Wani S, Sharma P, Olyaee MS, Bansal A, East JE. Impact of a computer-based
teaching module on characterization of diminutive colon polyps by using narrow-band imaging by
non-experts in academic and community practice: a video-based study. Gastrointestinal Endoscopy
79(3), 2014, p.390-398. (AMC)
Rees CJ, Rajasekhar PT, Rutter MD, Dekker E. Quality in colonoscopy: European perspectives and
practice. Experts Review of Gastroenterology & Hepatology 8(1), 2014, p.29-47. (AMC)
Reeve BB, Mitchell SA, Dueck AC, Basch E, Cella D, Reilly CM, Minasian LM, Denicoff AM, O'Mara AM,
Fisch MJ, Chauhan C, Aaronson NK, Coens C, Bruner DW. Recommended patient-reported core set of
symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst 2014; 106:...-(8 pp) (NKI)
Reich M, Leemans C, Vermorken J, Bernier J, Licitra L, Parmar S, Golusinski W, Lefebvre J. Best
practices in the management of the psycho-oncologic aspects of head and neck cancer patients:
Scientific publications - 135
1080.
1081.
1082.
1083.
1084.
1085.
1086.
1087.
1088.
1089.
1090.
1091.
1092.
1093.
1094.
1095.
1096.
1097.
recommendations from the European Head and Neck Cancer Society Make Sense Campaign. Ann Oncol
2014; 25: 2115-2124. (VUmc)
Reinders JSK, Gouma DJ, Ubbink DT, van Ramshorst B, Boerma D. Transcystic or Transductal Stone
Extraction during Single-Stage Treatment of Choledochocystolithiasis: A Systematic Review. World
Journal of Surgery 38(9), 2014, p.2403-2411. (AMC)
Reiniers MJ, van Golen RF, Heger M, Mearadji B, Bennink RJ, Verheij J, van Gulik TM. In situ
hypothermic perfusion with retrograde outflow during right hemihepatectomy: first experiences with a
new technique. Journal of the American College of Surgeons 218(1), 2014, p.e7-16. (AMC)
Reuschenbach M, Wentzensen N, Dijkstra MG, Doeberitz MV, Arbyn M. p16(INK4a) Immunohistochemistry
in Cervical Biopsy Specimens A Systematic Review and Meta-Analysis of the Interobserver Agreement.
Am J Clin Pathol 2014; 142: 767-772. (VUmc)
Richel O, Quint KD, Lindeman J, van Noesel CJM, de Koning MNC, van den Munckhof HAM, de Vries HJC,
Prins JM, Quint WGV. One lesion, one virus: individual components of high-grade anal intraepithelial
neoplasia in HIV-positive men contain a single HPV type. Journal of Infectious diseases 210(1), 2014,
p.111-120. (AMC)
Rieken M, Djajadiningrat RS, Kluth LA, Favaretto RL, Xylinas E, Guimaraes GC, Soares FA, Kent M,
Sjoberg DD, Horenblas S, Shariat SF. Predictors of Cancer-specific Mortality After Disease Recurrence in
Patients with Squamous Cell Carcinoma of the Penis. Eur Urol 2014; 66(5):811-4:811-4 (NKI)
Ries CH, Cannarile MA, Hoves S, Benz J, Wartha K, Runza V, Rey-Giraud F, Pradel LP, Feuerhake F,
Klaman I, Jones T, Jucknischke U, Scheiblich S, Kaluza K, Gorr IH, Walz A, Abiraj K, Cassier PA, Sica A,
Gomez-Roca C, de Visser KE, Italiano A, Le Tourneau C, Delord JP, Levitsky H, Blay JY, Ruttinger D.
Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer
therapy. Cancer Cell 2014; 25:846-59 (NKI)
Rietbergen MM, Braakhuis BJM, Moukhtari N, Bloemena E, van den Brink A, Sie DLS, Ylstra B, de Jong
RJB, Snijders PJF, Brakenhoff RH, Leemans CR. No evidence for active human papillomavirus (HPV) in
fields surrounding HPV-positive oropharyngeal tumors. Journal of Oral Pathology and Medicine 2014; 43:
137-142. (VUmc)
Rietbergen MM, Martens-de Kemp SR, Bloemena E, Witte BI, van den Brink A, de Jong RJB, Leemans CR,
Braakhuis BJM, Brakenhoff RH. Cancer stem cell enrichment marker CD98: A prognostic factor for
survival in patients with human papillomavirus-positive oropharyngeal cancer. Eur J Cancer 2014; 50:
765-773. (VUmc)
Rietbergen MM, Snijders PJF, Beekzada D, Braakhuis BJM, van den Brink A, Heideman DAM, Hesselink
AT, Witte BI, Bloemena E, Baatenburg de Jong RJ, Leemans CR, Brakenhoff RH. Molecular
characterization of p16-immunopositive but HPV DNA- negative oropharyngeal carcinomas. Int J Cancer
2014; 134: 2366-2372. (VUmc)
Rihani A, de Wilde B, Zeka F, Laureys G, Francotte N, Tonini Gian P, Coco S, Versteeg R, Noguera R,
Schulte JH, Eggert A, Stallings RL, Speleman F, Vandesompele J, van Maerken T. CASP8 SNP D302H
(rs1045485) Is Associated with Worse Survival in MYCN-Amplified Neuroblastoma Patients. Plos One
9(12), 2014, p.e114696-. (AMC)
Rihani A, van Maerken T, de Wilde B, Zeka F, Laureys G, Norga K, Tonini Gian P, Coco S, Versteeg R,
Noguera R, Schulte JH, Eggert A, Stallings RL, Speleman F, Vandesompele J. Lack of association
between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma. Pediatric
Blood&Cancer 61(10), 2014, p.1867-1870. (AMC)
Rimsa V, Eadsforth TC, Joosten RP, Hunter WN. High-resolution structure of the M14-type cytosolic
carboxypeptidase from Burkholderia cenocepacia refined exploiting PDB_REDO strategies. Acta
Crystallogr D Biol Crystallogr 2014; 70:279-89 (NKI)
Rinkel NPM, de Leeuw IM, van den Brakel N, de Bree R, Eerenstein SE, Aaronson NK, Leemans CR.
Patient-reported symptom questionnaires in laryngeal cancer: Voice, speech and swallowing. Oral Oncol
2014; 50: 759-764. (VUmc)
Rinkel RN, Verdonck-de Leeuw IM, van den Brakel N, De Bree R, Eerenstein SE, Aaronson N, Leemans CR.
Patient-reported symptom questionnaires in laryngeal cancer: voice, speech and swallowing. Oral Oncol
2014; 50:759-64 (NKI)
Rintoul RC, Glover MJ, Jackson C, Hughes V, Tournoy KG, Dooms C, Annema JT, Sharples LD. Cost
effectiveness of endosonography versus surgical staging in potentially resectable lung cancer: a health
economics analysis of the ASTER trial from a European perspective. Thorax 69(7), 2014, p.679-681.
(AMC)
Rios VE, Hoebers F, Aerts HJ, Rietbergen MM, Brakenhoff RH, Leemans CR, Speel EJ, Straetmans J,
Kremer B, Lambin P. Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma
patients yields more accurate predictions than TNM staging. Radiother Oncol 2014; 113: 324-330.
(VUmc)
Robert J, Le Morvan V, Giovannetti E, Peters GJ. On the use of pharmacogenetics in cancer treatment
and clinical trials. Eur J Cancer 2014; 50: 2532-2543. (VUmc)
Rocha C, Papon L, Cacheux W, Marques Sousa P, Lascano V, Tort O, Giordano T, Vacher S, Lemmers B,
Mariani P, Meseure D, Medema JP, Bièche I, Hahne M, Janke C. Tubulin glycylases are required for
primary cilia, control of cell proliferation and tumor development in colon. EMBO Journal 33(19), 2014,
p.2247-2260. ( AMC)
136 - Scientific publications
1098. Rodrigo JP, Heideman DAM, Garcia-Pedrero JM, Fresno MF, Brakenhoff RH, Molina JPD, Snijders PJF,
Hermsen MA. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in
northern Spain (1990-2009). Int J Cancer 2014; 134: 487-492. (VUmc)
1099. Rodrigues G, Warner A, Bauman G, Senan S, Lagerwaard FJ. Systematic review of fractionated brain
metastases radiotherapy. Journal of Radiation Oncology 2014; 3: 29-41. (VUmc)
1100. Rodrigues G, Warner A, Zindler J, Slotman B, Lagerwaard F. A clinical nomogram and recursive
partitioning analysis to determine the risk of regional failure after radiosurgery alone for brain
metastases. Radiother Oncol 2014; 111: 52-58. (VUmc)
1101. Roepman P, Schlicker A, Tabernero J, Majewski I, Tian S, Moreno V, Snel MH, Chresta CM, Rosenberg R,
Nitsche U, Macarulla T, Capella G, Salazar R, Orphanides G, Wessels LF, Bernards R, Simon IM.
Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and
epithelial-to-mesenchymal transition. Int J Cancer 2014; 134:552-62 (NKI)
1102. Rohof WO, Bennink RJ, Boeckxstaens GE. Proton Pump Inhibitors Reduce the Size and Acidity of the Acid
Pocket in the Stomach. Clinical Gastroenterology and Hepatology 12(7), 2014, p.1101-+. (AMC)
1103. Rohof WO, Bennink RJ, de Jonge H, Boeckxstaens GE. Increased Proximal Reflux in a Hypersensitive
Esophagus Might Explain Symptoms Resistant to Proton Pump Inhibitors in Patients With
Gastroesophageal Reflux Disease. Clinical Gastroenterology and Hepatology 12(10), 2014, p.1647-1655.
(AMC)
1104. Rohr JC, Gerlach C, Kok L, Schumacher TN. Single cell behavior in T cell differentiation. Trends
Immunol 2014; 35:170-7 (NKI)
1105. Rolfo C, Fanale D, Hong DS, Tsimberidou AM, Piha-Paul SA, Pauwels P, van Meerbeeck JP, Caruso S,
Bazan V, Cicero G, Russo A, Giovannetti E. Impact of microRNAs in Resistance to Chemotherapy and
Novel Targeted Agents in Non-Small Cell Lung Cancer. Curr Pharm Biotech 2014; 15: 475-485. (VUmc)
1106. Rolfo C, Giovannetti E, Hong DS, Bivona T, Raez LE, Bronte G, Buffoni L, Reguart N, Santos ES,
Germonpre P, Taron M, Passiglia F, van Meerbeeck JP, Russo A, Peeters M, Gil-Bazo I, Pauwels P, Rosell
R. Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR
inhibitors. Cancer Treat Rev 2014; 40: 990-1004. (VUmc)
1107. Ronco G, Dillner J, Elfstrom KM, Tunesi S, Snijders PJF, Arbyn M, Kitchener H, Segnan N, Gilham C,
Giorgi-Rossi P, Berkhof J, Peto J, Meijer CJLM. Efficacy of HPV-based screening for prevention of
invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 2014; 383:
524-532. (VUmc)
1108. Ronco G, Meijer CJLM, Segnan N, Kitchener H, Giorgi-Rossi P, Peto J, Dillner J. HPV-based screening for
prevention of invasive cervical cancer Reply. Lancet 2014; 383: 1295. (VUmc)
1109. Rood MT, Oikonomou M, Buckle T, Raspe M, Urano Y, Jalink K, Velders AH, van Leeuwen FW. An
activatable, polarity dependent, dual-luminescent imaging agent with a long luminescence lifetime.
Chem Commun (Camb) 2014; 50:9733-6 (NKI)
1110. Rooney AG, Brown PD, Reijneveld JC, Grant R. Depression in glioma: a primer for clinicians and
researchers. J Neurol Neurosur PS 2014; 85: 230-235. (VUmc)
1111. Rooswinkel RW, van de Kooij B, de Vries E, Paauwe M, Braster R, Verheij M, Borst J. Antiapoptotic
potency of Bcl-2 proteins primarily relies on their stability, not binding selectivity. Blood 2014;
123:2806-15 (NKI)
1112. Rosell M, Nevedomskaya E, Stelloo S, Nautiyal J, Poliandri A, Steel J, Wessels L, Carroll JS, Parker M,
Zwart W. Complex formation and function of estrogen receptor-a in transcription requires RIP140.
Cancer Res 2014; 74:5469-79 (NKI)
1113. Roupret M, Morgan TM, Bostrom PJ, Cooperberg MR, Kutikov A, Linton KD, Palou J, Martinez-Pineiro L,
van der Poel H, Wijburg C, Winterbottom A, Woo HH, Wirth MP, Catto JW. European Association of
Urology (@Uroweb) Recommendations on the Appropriate Use of Social Media. Eur Urol 2014; 66:628-32
(NKI)
1114. Rouvinski A, Karniely S, Kounin M, Moussa S, Goldberg MD, Warburg G, Lyakhovetsky R, Papy-Garcia D,
Kutzsche J, Korth C, Carlson GA, Godsave SF, Peters PJ, Luhr K, Kristensson K, Taraboulos A. Live
imaging of prions reveals nascent PrPSc in cell-surface, raft-associated amyloid strings and webs. J Cell
Biol 2014; 204:423-41 (NKI)
1115. Rozendaal RA, Mijnheer BJ, van Herk M, Mans A. In vivo portal dosimetry for head-and-neck VMAT and
lung IMRT: Linking γ-analysis with differences in dose-volume histograms of the PTV. RADIOTHERAPY
AND ONCOLOGY 112(3), 2014, p.396-401. (AMC/NKI)
1116. Ruben JM, Bontkes HJ, Westers TM, Hooijberg E, Ossenkoppele GJ, van de Loosdrecht AA, de Gruijl TD.
In situ loading of skin dendritic cells with apoptotic bleb-derived antigens for the induction of tumordirected immunity. Oncoimmunology 2014; 3: e946360. (VUmc)
1117. Ruben JM, van den Ancker W, Bontkes HJ, Westers TM, Hooijberg E, Ossenkoppele GJ, de Gruijl TD, van
de Loosdrecht AA. Apoptotic blebs from leukemic cells as a preferred source of tumor-associated
antigen for dendritic cell-based vaccines. Cancer Immunol Immun 2014; 63: 335-345. (VUmc)
1118. Rudraraju B, Droog M, Abdel-Fatah TM, Zwart W, Giannoudis A, Malki MI, Moore D, Patel H, Shaw J, Ellis
IO, Chan S, Brooke GN, Nevedomskaya E, Lo Nigro C, Carroll J, Coombes RC, Bevan C, Ali S, Palmieri C.
Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key
determinant of sensitivity to tamoxifen in breast cancer. Breast Cancer Res Treat 2014; 147:295-309
(NKI)
1119. Ruhé HG, Koster M, Booij J, van Herk M, Veltman DJ, Schene AH. Occupancy of serotonin transporters in
Scientific publications - 137
1120.
1121.
1122.
1123.
1124.
1125.
1126.
1127.
1128.
1129.
1130.
1131.
1132.
1133.
1134.
1135.
1136.
1137.
1138.
1139.
the amygdala by paroxetine in association with attenuation of left amygdala activation by negative
faces in major depressive disorder. Psychiatry Research 221(2), 2014, p.155-161. (AMC/NKI)
Ruijs CD, van der Wal G, Kerkhof AJ, Onwuteaka-Philipsen BD. Unbearable suffering and requests for
euthanasia prospectively studied in end-of-life cancer patients in primary care. BMC Palliat Care 2014;
13: 62. (VUmc)
Ruijter J, Broere L, Mulder MF, van der Ploeg AT, Rubio-Gozalbo ME, Wortmann SB, Visser G, Wijburg
FA. Growth in patients with mucopolysaccharidosis type III (Sanfilippo disease). J Inherit Metab Dis 2014;
37: 447-454. (VUmc)
Runge JH, Bakker PJ, Gaemers IC, Verheij J, Hakvoort TBM, Ottenhoff R, Nederveen AJ, Stoker J.
Measuring liver triglyceride content in mice: non-invasive magnetic resonance methods as an alternative
to histopathology. Magnetic Resonance Materials in Physics Biology and Medicine 27(4), 2014, p.317-327.
(AMC)
Runge JH, Bakker PJ, Gaemers IC, Verheij J, Hakvoort TBM, Ottenhoff R, Stoker J, Nederveen AJ.
Quantitative Determination of Liver Triglyceride Levels with 3T (1)H-MR Spectroscopy in Mice with
Moderately Elevated Liver Fat Content. Academic Radiology 21(11), 2014, p.1446-1454. (AMC)
Rutkowski P, Blank C. Dabrafenib for the treatment of BRAF V600-positive melanoma: a safety
evaluation. Expert Opin Drug Saf 2014; 13:1249-58 (NKI)
Rutten MJ, Boldingh JHL, Schuit E, Trum H, van Driel W, Mol BWJ, Kenter GG, Buist MR. Development
and internal validation of a prognostic model for survival after debulking surgery for epithelial ovarian
cancer. Gynecologic Oncology 135(1), 2014, p.13-18. (AMC/NKI)
Rutten MJ, Boldingh JHL, Schuit E, Trum H, van Driel W, Mol BWJ, Kenter GG, Buist MR. Development
and internal validation of a prognostic model for survival after debulking surgery for epithelial ovarian
cancer. Gynecol Oncol 2014; 135: 13-18. (VUmc)
Rutten MJ, Dijk F, Savci-Heijink CD, Buist MR, Kenter GG, van de Vijver MJ, Jordanova ES. HLA-G
Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian Carcinomas. Journal
of immunology research 2014; 2014: 274584. (VUmc)
Rutten MJ, Leeflang MMG, Kenter GG, Mol BW, Buist M. Laparoscopy for diagnosing resectability of
disease in patients with advanced ovarian cancer. Cochrane database of Systematic Reviews 2014(2),
2014, p.CD009786-. (AMC/NKI)
Ruys AT, Groot Koerkamp B, Wiggers JK, Klümpen H-J, ten Kate FJ, van Gulik TM. Prognostic biomarkers
in patients with resected cholangiocarcinoma: a systematic review and meta-analysis. Annals of Surgical
Oncology 21(2), 2014, p.487-500. (AMC)
Ruys AT, Heuts SG, Rauws EA, Busch ORC, Gouma DJ, van Gulik TM. Delay in surgical treatment of
patients with hilar cholangiocarcinoma: does time impact outcomes? HPB 16(5), 2014, p.469-474. (AMC)
Rybalov M, Ananias HJ, Hoving HD, van der Poel HG, Rosati S, de Jong IJ. PSMA, EpCAM, VEGF and GRPR
as imaging targets in locally recurrent prostate cancer after radiotherapy. Int J Mol Sci 2014; 15:6046-61
(NKI)
Saadatmand S, Vos JR, Hooning MJ, Oosterwijk JC, Koppert LB, de Bock GH, Ausems MG, van Asperen
CJ, Aalfs CM, Gómez Garcia EB, Meijers-Heijboer H, Hoogerbrugge N, Piek M, Seynaeve C, Verhoef C,
Rookus M, Tilanus-Linthorst MM. Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2
mutation carriers above 60 years: A national cohort study. International Journal of Cancer 135(12),
2014, p.2940-2949. (VUmc/AMC/NKI)
Sachs N, Secades P, van Hulst L, Song JY, Sonnenberg A. Reduced Susceptibility to Two-Stage Skin
Carcinogenesis in Mice with Epidermis-Specific Deletion of Cd151. J Invest Dermatol 2014; 134:221-8
(NKI)
Sadanandam A, Wang X, de Sousa E Melo F, Gray JW, Vermeulen L, Hanahan D, Medema JP.
Reconciliation of classification systems defining molecular subtypes of colorectal cancer:
interrelationships and clinical implications. Cell Cycle 13(3), 2014, p.353-357. (AMC)
Sadri-Ardekani H, Homburg CH, van Capel TMM, van den Berg H, van der Veen F, van der Schoot CE, van
Pelt AMM, Repping S. Eliminating acute lymphoblastic leukemia cells from human testicular cell
cultures: a pilot study. Fertility and Sterility 101(4), 2014, p.1072-1078.e1. (AMC)
Saghatchian M, Thonon F, Boomsma F, Hummel H, Koot B, Harrison C, Rajan A, de Valeriola D, Otter R,
Laranja Pontes J, Lombardo C, McGrath E, Ringborg U, Tursz T, van Harten W. Pioneering quality
assessment in European cancer centers: a data analysis of the organization for European cancer
institutes accreditation and designation program. J Oncol Pract 2014; 10:e342-e349 (NKI)
Salphati L, Chu X, Chen L, Prasad B, Dallas S, Evers R, Mamaril-Fishman D, Geier EG, Kehler J, Kunta J,
Mezler M, Laplanche L, Pang J, Rode A, Soars MG, Unadkat JD, van Waterschoot RA, Yabut J, Schinkel
AH, Scheer N. Evaluation of organic anion transporting polypeptide 1B1 and 1B3 humanized mice as a
translational model to study the pharmacokinetics of statins. Drug Metab Dispos 2014; 42:1301-13 (NKI)
Sandahl JD, Coenen EA, Forestier E, Harbott J, Johansson B, Kerndrup G, Adachi S, Auvrignon A,
Beverloo HB, Cayuela JM, Chilton L, Fornerod M, de Haas V, Harrison CJ, Inaba H, Kaspers GJL, Liang
DC, Locatelli F, Masetti R, Perot C, Raimondi SC, Reinhardt. t(6;9)(p22; q34)/DEK-NUP214-rearranged
pediatric myeloid leukemia: an international study of 62 patients. Haematol-Hematol J 2014; 99: 865872. (VUmc)
Sander B, de Jong D, Rosenwald A, Xie W, Balagué O, Calaminici M, Carreras J, Gaulard P, Gribben J,
Hagenbeek A, Kersten MJ, Molina TJ, Lee A, Montes-Moreno S, Ott G, Raemaekers J, Salles G, Sehn L,
Thorns C, Wahlin BE, Gascoyne RD, Weller E. The reliability of immunohistochemical analysis of the
138 - Scientific publications
1140.
1141.
1142.
1143.
1144.
1145.
1146.
1147.
1148.
1149.
1150.
1151.
1152.
1153.
tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma
Biomarker Consortium. Haematologica-The Hematology Journal 99(4), 2014, p.715-725. (AMC)
Sanders SJWJ, Bijleveld YA, Sinkeler F, Kemper EM, Pajkrt D, van de Wetering M, van Eijkelenburg NKA,
Mathôt RAA. Clinical evaluation of vancomycin dosage in pediatric oncology patients. Pediatric
Infectious Disease Journal 33(7), 2014, p.731-733. (AMC)
Sanduleanu S, le Clercq CMC, Dekker E, Meijer GA, Rabeneck L, Rutter MD, Valori R, Young GP, Schoen
RE. Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature.
GUT [aheadofprint], 2014, p.-. (AMC)
Santegoets SJAM, Stam AGM, Lougheed SM, Gall H, Jooss K, Sacks N, Hege K, Lowy I, Scheper RJ,
Gerritsen WR, van den Eertwegh AJM, de Gruijl TD. Myeloid derived suppressor and dendritic cell
subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and
ipilimumab. Journal for Immunotherapy of Cancer 2014; 2: 31. (VUmc)
Sapino A, Roepman P, Linn SC, Snel MH, Delahaye LJ, van den Akker J, Glas AM, Simon IM, Barth N, de
Snoo FA, van 't Veer LJ, Molinaro L, Berns EM, Wesseling J, Riley LB, Anderson D, Nguyen B, Cox CE.
MammaPrint molecular diagnostics on formalin-fixed, paraffin-embedded tissue. J Mol Diagn 2014;
16:190-7 (NKI)
Sardanelli F, Bashir H, Berzaczy D, Cannella G, Espeland A, Flor N, Helbich T, Hunink M, Malone DE,
Mann R, Muzzupappa C, Petersen LJ, Riklund K, Sconfienza LM, Serafin Z, Spronk S, Stoker J, van Beek
EJR, Vorwerk D, Leo G.Di. The role of imaging specialists as authors of systematic reviews on diagnostic
and interventional imaging and its impact on scientific quality: report from the EuroAIM Evidence-based
Radiology Working Group. Radiology 272(2), 2014, p.533-540. (AMC)
Sarhadi VK, Lahti L, Scheinin I, Ellonen P, Kettunen E, Serra M, Scotlandi K, Picci P, Knuutila S. Copy
Number Alterations and Neoplasia-Specific Mutations in MELK, PDCD1LG2, TLN1, and PAX5 at 9p in
Different Neoplasias. Gene Chromosome Canc 2014; 53: 579-588. (VUmc)
Sarkar S, Doring A, Zemp FJ, Silva C, Lun X, Wang X, Kelly J, Hader W, Hamilton M, Mercier P, Dunn JF,
Kinniburgh D, van Rooijen N, Robbins S, Forsyth P, Cairncross G, Weiss S, Yong VW. Therapeutic
activation of macrophages and microglia to suppress brain tumor-initiating cells. Nat Neurosci 2014; 17:
46-55. (VUmc)
Sathe P, Metcalf D, Vremec D, Naik SH, Langdon WY, Huntington ND, Wu L, Shortman K. Lymphoid tissue
and plasmacytoid dendritic cells and macrophages do not share a common macrophage-dendritic cellrestricted progenitor. Immunity 2014; 41:104-15 (NKI)
Sawyer E, Roylance R, Petridis C, Brook MN, Nowinski S, Papouli E, Fletcher O, Pinder S, Hanby A, Kohut
K, Gorman P, Caneppele M, Peto J, Dos Santos Silva I, Johnson N, Swann R, Dwek M, Perkins KA, Gillett
C, Houlston R, Ross G, De Ieso P, Southey MC, Hopper JL, Provenzano E, Apicella C, Wesseling J,
Cornelissen S, Keeman R, Fasching PA, Jud SM, Ekici AB, Beckmann MW, Kerin MJ, Marme F, Schneeweiss
A, Sohn C, Burwinkel B, Guenel P, Truong T, Laurent-Puig P, Kerbrat P, Bojesen SE, Nordestgaard BG,
Nielsen SF, Flyger H, Milne RL, Perez JI, Menendez P, Benitez J, Brenner H, Dieffenbach AK, Arndt V,
Stegmaier C, Meindl A, Lichtner P, Schmutzler RK, Lochmann M, Brauch H, Fischer HP, Ko YD,
Nevanlinna H, Muranen TA, Aittomaki K, Blomqvist C, Bogdanova NV, Dork T, Lindblom A, Margolin S,
Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Chenevix-Trench G, Investigators K, Lambrechts D,
Weltens C, Van Limbergen E, Hatse S, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Radice P,
Peterlongo P, Bonanni B, Volorio S, Giles GG, Severi G, Baglietto L, McLean CA, Haiman CA, Henderson
BE, Schumacher F, Le Marchand L, Simard J, Goldberg MS, Labreche F, Dumont M, Kristensen V,
Winqvist R, Pylkas K, Jukkola-Vuorinen A, Kauppila S, Andrulis IL, Knight JA, Glendon G, Mulligan AM,
Devillee P, Tollenaar RA, Seynaeve CM, Kriege M, Figueroa J, Chanock SJ, Sherman ME, Hooning MJ,
Hollestelle A, van den Ouweland AM, van Deurzen CH, Li J, Czene K, Humphreys K, Cox A, Cross SS,
Reed MW, Shah M, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Swerdlow A, Ashworth A, Orr
N, Schoemaker M, Couch FJ, Hallberg E, Gonzalez-Neira A, Pita G, Alonso MR, Tessier DC, Vincent D,
Bacot F, Bolla MK, Wang Q, Dennis J, Michailidou K, Dunning AM, Hall P, Easton D, Pharoah P, Schmidt
MK, Tomlinson I, Garcia-Closas M. Genetic predisposition to in situ and invasive lobular carcinoma of the
breast. PLoS Genet 2014; 10:e1004285 (NKI)
Schaake EE, Rossi MM, Buikhuisen WA, Burgers JA, Smit AA, Belderbos JS, Sonke JJ. Differential motion
between mediastinal lymph nodes and primary tumor in radically irradiated lung cancer patients. Int J
Radiat Oncol Biol Phys 2014; 90:959-66 (NKI)
Schagen SB, Klein M, Reijneveld JC, Brain E, Deprez S, Joly F, Scherwath A, Schrauwen W, Wefel JS.
Monitoring and optimising cognitive function in cancer patients: Present knowledge and future
directions. EJC Suppl 2014; 12: 29-40. (VUmc)
Scharpfenecker M, Floot B, Russell NS, Coppes RP, Stewart FA. Thalidomide ameliorates inflammation
and vascular injury but aggravates tubular damage in the irradiated mouse kidney. Int J Radiat Oncol
Biol Phys 2014; 89:599-606 (NKI)
Scheenstra AEH, Rossi MMG, Belderbos JSA, Damen EMF, Lebesque JV, Sonke JJ. Alpha/beta ratio for
normal lung tissue as estimated from lung cancer patients treated with stereotactic body and
conventionally fractionated radiation therapy. Int J Radiat Oncol Biol Phys 2014; 88:224-8 (NKI)
Scheeren FA, Kuo AH, van Weele LJ, Cai S, Glykofridis I, Sikandar SS, Zabala M, Qian D, Lam JS,
Johnston D, Volkmer JP, Sahoo D, van de Rijn M, Dirbas FM, Somlo G, Kalisky T, Rothenberg ME, Quake
SR, Clarke MF. A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesis.
Nat Cell Biol 2014; 16:1238-48 (NKI)
Scientific publications - 139
1154. Scheffer HJ, Nielsen K, de Jong MC, van Tilborg AAJM, Vieveen JM, Bouwman RA, Meijer S, van Kuijk C,
van den Tol MP, Meijerink MR. Irreversible Electroporation for Nonthermal Tumor Ablation in the Clinical
Setting: A Systematic Review of Safety and Efficacy. Journal of vascular and interventional radiology
2014; 25: 997-1011. (VUmc)
1155. Scheffer HJ, Nielsen K, van Tilborg AAJM, Vieveen JM, Bouwman RA, Kazemier G, Niessen HWM, Meijer
S, van Kuijk C, van den Tol MP, Meijerink MR. Ablation of colorectal liver metastases by irreversible
electroporation: results of the COLDFIRE-I ablate-and-resect study. Eur J Radiol 2014; 24: 2467-2475.
(VUmc)
1156. Scheid C, Sonneveld P, Schmidt-Wolf IGH, van der Holt B, el Jarari L, Bertsch U, Salwender H,
Zweegman S, Blau IW, Vellenga E, Weisel K, Pfreundschuh M, Jie KS, Neben K, van der Velde H,
Duehrsen U, Schaafsma MR, Lindemann W, Kersten MJ, Peter N, Hanel M,. Bortezomib before and after
autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in
newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial.
Haematol-Hematol J 2014; 99: 148-154. (VUmc/AMC)
1157. Scheinin I, Sie DLS, Bengtsson H, van de Wiel MA, Olshen AB, van Thuijl HF, van Essen HF, Eijk PP,
Rustenburg F, Meijer GA, Reijneveld JC, Wesseling P, Pinkel D, Albertson DG, Ylstra B. DNA copy number
analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification
and exclusion of problematic regions in the genome assembly. Genome Res 2014; 24: 2022-2032. (VUmc)
1158. Schellekens PP, Aukema TS, Hage JJ, Prevoo W, Kon M. Can previous diagnostic examinations prevent
preoperative angiographic assessment of the internal mammary perforators for (micro)surgical use? Ann
Plast Surg 2014; 72:560-5 (NKI)
1159. Schepers SA, Engelen VE, Haverman L, Caron HN, Hoogerbrugge PM, Kaspers GJL, Egeler RM,
Grootenhuis MA. Patient Reported Outcomes in Pediatric Oncology Practice: Suggestions for Future
Usage by Parents and Pediatric Oncologists. Pediatr Blood Cancer 2014; 61: 1707-1710. (VUmc/AMC)
1160. Scheurleer J, Koken PW, Wessel R. Potential interoperability problems facing multi-site radiation
oncology centers in The Netherlands. J Phys Conf Ser 2014; 489: 012080. (VUmc)
1161. Schimmel J, Eifler K, Sigurethsson JO, Cuijpers SA, Hendriks IA, Verlaan-de Vries M, Kelstrup CD,
Francavilla C, Medema RH, Olsen JV, Vertegaal AC. Uncovering SUMOylation dynamics during cell-cycle
progression reveals FoxM1 as a key mitotic SUMO target protein. Mol Cell 2014; 53:1053-66 (NKI)
1162. Schinkelshoek M, Lopci E, Clerici E, Alongi F, Mancosu P, Rodari M, Navarria P, van der Hiel B, Scorsetti
M, Chiti A. Impact of 11C-methionine positron emission tomography/computed tomography on radiation
therapy planning and prognosis in patients with primary brain tumors. Tumori 2014; 100:636-44 (NKI)
1163. Schipper-Krom S, Juenemann K, Jansen A, Wiemhoefer A, van den Nieuwendijk R, Smith D, Hink M,
Bates G, Overkleeft H, Ovaa H, Reits E. Dynamic recruitment of active proteasomes into polyglutamine
initiated inclusion bodies. FEBS Lett 2014; 588:151-9 (NKI)
1164. Schmitz AM, Loo CE, Wesseling J, Pijnappel RM, Gilhuijs KG. Association between rim enhancement of
breast cancer on dynamic contrast-enhanced MRI and patient outcome: impact of subtype. Breast
Cancer Res Treat 2014; 148:541-51 (NKI)
1165. Schmitz MF, Otten HG, Franssen LE, van Dorp S, Strooisma T, Lokhorst HM, van de Donk NW. Secondary
monoclonal gammopathy of undetermined significance after allogeneic stem cell transplantation in
multiple myeloma. Haematol-Hematol J 2014; 99: 1846-1853. (VUmc)
1166. Schmitz-Drager BJ, Todenhofer T, van Rhijn B, Pesch B, Hudson MA, Chandra A, Ingersoll MA, Kassouf W,
Palou J, Taylor J, Vlahou A, Behrens T, Critelli R, Grossman HB, Sanchez-Carbayo M, Kamat A.
Considerations on the use of urine markers in the management of patients with low-/intermediate-risk
non-muscle invasive bladder cancer. Urol Oncol 2014; 32:1061-8 (NKI)
1167. Schneiders FL, Prodohl J, Ruben JM, O'Toole TG, Scheper RJ, Bonneville M, Scotet E, Verheul HMW, de
Gruijl TD, van der Vliet HJ. CD1d-Restricted Antigen Presentation by V gamma 9V delta 2-T Cells
Requires Trogocytosis. Cancer immunology research 2014; 2: 732-740. (VUmc)
1168. Schoenmaker NJ, Haverman L, Tromp W, van der Lee JH, Offringa M, Adams B, Bouts AHM, Collard L,
Cransberg K, van Dyck M, Godefroid N, van Hoeck K, Koster-Kamphuis L, Lilien MR, Raes A, Taylan C,
Grootenhuis MA, Groothoff JW. Children of non-Western origin with end-stage renal disease in the
Netherlands, Belgium and a part of Germany have impaired health-related quality of life compared with
Western children. Nephrooogy Dialysis Transplantation 29(2), 2014, p.448-457. (AMC)
1169. Schoeps A, Rudolph A, Seibold P, Dunning AM, Milne RL, Bojesen SE, Swerdlow A, Andrulis I, Brenner H,
Behrens S, Orr N, Jones M, Ashworth A, Li J, Cramp H, Connley D, Czene K, Darabi H, Chanock SJ,
Lissowska J, Figueroa JD, Knight J, Glendon G, Mulligan AM, Dumont M, Severi G, Baglietto L, Olson J,
Vachon C, Purrington K, Moisse M, Neven P, Wildiers H, Spurdle A, Kosma VM, Kataja V, Hartikainen JM,
Hamann U, Ko YD, Dieffenbach AK, Arndt V, Stegmaier C, Malats N, Arias Perez JI, Benitez J, Flyger H,
Nordestgaard BG, Truong T, Cordina-Duverger E, Menegaux F, Dos Santos Silva I, Fletcher O, Johnson N,
Haberle L, Beckmann MW, Ekici AB, Braaf L, Atsma F, van den Broek AJ, Makalic E, Schmidt DF, Southey
MC, Cox A, Simard J, Giles GG, Lambrechts D, Mannermaa A, Brauch H, Guenel P, Peto J, Fasching PA,
Hopper J, Flesch-Janys D, Couch F, Chenevix-Trench G, Pharoah PD, Garcia-Closas M, Schmidt MK, Hall
P, Easton DF, Chang-Claude J. Identification of new genetic susceptibility loci for breast cancer through
consideration of gene-environment interactions. Genet Epidemiol 2014; 38:84-93 (NKI)
1170. Schols RM, Lodewick TM, Bouvy ND, van Dam DA, Meijerink WJHJ, van Dam GM, Dejong CHC, Stassen
LPS. Near-Infrared Fluorescence Laparoscopy of the Cystic Duct and Artery in Pigs: Performance of a
Preclinical Dye. J Laparoendosc Adv Surg Tech 2014; 24: 318-322. (VUmc)
140 - Scientific publications
1171. Scholten L, Willemen AM, Napoleone E, Maurice-Stam H, Last BF, van Dijk-Lokkart EM, Zandbelt N,
Ensink E, Grootenhuis MA, Schuengel C. Moderators of the Efficacy of a Psychosocial Group Intervention
for Children With Chronic Illness and Their Parents: What Works for Whom? Journal of Pediatric
Psychology[aheadofprint], 2014, p.-. (AMC)
1172. Schölvinck DW, Alvarez HL, Goto O, Meijer SL, Neuhaus H, Schumacher B, Bergman JJGHM, Weusten
BLAM. Efficacy and safety of a novel submucosal lifting gel used for endoscopic submucosal dissection: a
study in a porcine model. Surgical Endoscopy and Other Interventional Techniques [aheadofprint], 2014,
p.-. (AMC)
1173. Schölvinck DW, Alvarez HL, Visser M, Bergman JJGHM, Weusten BLAM. Effects of Lugol staining on
stenosis formation induced by radiofrequency ablation of esophageal squamous epithelium: a study in a
porcine model. Diseases of the Esophagus [aheadofprint], 2014, p.-. (AMC)
1174. Schook RM, Koudstaal LG, Comans EFI, Postmus PE, Grunberg K, Paul MA, Smit EF, Sutedja GT. Benefit
of a second opinion: From metastatic disease to resectable lung cancer with sarcoid-like reaction.
Respiratory Medicine Case Reports 2014; 13: 26-27. (VUmc)
1175. Schook RM, Linssen C, Schramel FMNH, Festen JM, Lammers E, Smit EF, Postmus PE, Westerman MJ.
Why Do Patients and Caregivers Seek Answers From the Internet and Online Lung Specialists? A
Qualitative Study. J Med Internet Res 2014; 16: e37. (VUmc)
1176. Schook RM, ter Avest MJ, van Setten CH, de Man FS, Smit EF, Postmus PE. Lung Cancer Patients Benefit
from Second Opinions by Improvement of Diagnosis and Therapy. Cancer and Clinical Oncology 2014; 3:
43-57. (VUmc)
1177. Schorch B, Song S, van Diemen FR, Bock HH, May P, Herz J, Brummelkamp TR, Papatheodorou P,
Aktories K. LRP1 is a receptor for Clostridium perfringens TpeL toxin indicating a two-receptor model of
clostridial glycosylating toxins. Proc Natl Acad Sci U S A 2014; 111:6431-6 (NKI)
1178. Schouten CS, de Bree R, van der Putten L, Noij DP, Hoekstra OS, Comans EFI, Witte BI, Doornaert PA,
Leemans CR, Castelijns JA. Diffusion-weighted EPI- and HASTE-MRI and 18F-FDG-PET-CT early during
chemoradiotherapy in advanced head and neck cancer. Quantitative Imaging in Medicine and Surgery
2014; 4: 239-250. (VUmc)
1179. Schreuder SM, Lensing R, Stoker J, Bipat S. Monitoring treatment response in patients undergoing
chemoradiotherapy for locally advanced uterine cervical cancer by additional diffusion-weighted
imaging: A systematic review. Journal of Magnetic Resonance Imaging [aheadofprint], 2014, p.-. (AMC)
1180. Schreuder WH, Coumou AW, Kessler PA, de Lange J. Alternative pharmacologic therapy for aggressive
central giant cell granuloma: denosumab. J Oral Maxillofac Surg 2014; 72:1301-9 (NKI)
1181. Schreurs LMA, Janssens ACJW, Groen H, Fockens P, van Dullemen HM, van Berge Henegouwen MI, Sloof
GW, Pruim J, van Lanschot JJB, Steyerberg EW, Plukker JThM. Value of EUS in Determining Curative
Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of
Esophageal Cancer? Annals of Surgical Oncology [aheadofprint], 2014, p.-. (AMC)
1182. Schulkens IA, Heusschen R, van den Boogaart V, van Suylen RJ, Dingemans AMC, Griffioen AW, Thijssen
VLJL. Galectin Expression Profiling Identifies Galectin-1 and Galectin-9 Delta 5 as Prognostic Factors in
Stage I/II Non-Small Cell Lung Cancer. PLoS One 2014; 9: e107988. (VUmc)
1183. Schultheiss SJ, Yang JS, Iwasaki W, Lin SH, Jean A, Michaut M. Crossing borders for science. PLoS
Comput Biol 2014; 10:e1003519 (NKI)
1184. Schutze DM, Snijders PJF, ten Bosch L, Kramer D, Meijer CJLM, Steenbergen RDM. Differential In Vitro
Immortalization Capacity of Eleven, Probable High-Risk Human Papillomavirus Types. J Virol 2014; 88:
1714-1724. (VUmc)
1185. Sciarrillo R, Minutolo F, Peters GJ, Giovannetti E. Lactate dehydrogenase acetylation adds another piece
to the puzzle of metabolic reprogramming in pancreatic cancer. Translational gastrointestinal cancer
2014; 3: 64-66. (VUmc)
1186. Seemann I, Te Poele JA, Hoving S, Stewart FA. Mouse bone marrow-derived endothelial progenitor cells
do not restore radiation-induced microvascular damage. ISRN Cardiol 2014; 2014:506348 (NKI)
1187. Segawa K, Kurata S, Yanagihashi Y, Brummelkamp TR, Matsuda F, Nagata S. Caspase-mediated cleavage
of phospholipid flippase for apoptotic phosphatidylserine exposure. Science 2014; 344:1164-8 (NKI)
1188. Sehouli J, Pietzner K, Wimberger P, Vergote I, Rosenberg P, Schneeweiss A, Bokemeyer C, Salat C,
Scambia G, Berton-Rigaud D, Santoro A, Cervantes A, Trédan O, Tournigand C, Colombo N, Dudnichenko
AS, Westermann A, Friccius-Quecke H, Lordick F. Catumaxomab with and without prednisolone
premedication for the treatment of malignant ascites due to epithelial cancer: results of the
randomised phase IIIb CASIMAS study. Medical Oncology 31(8), 2014, p.76-. (AMC)
1189. Senkus E, Gomez H, Dirix L, Jerusalem G, Murray E, van Tienhoven G, Westenberg AH, Bottomley A,
Rapion J, Bogaerts J, Di Leo A, Nešković-Konstantinović Z. Attitudes of young patients with breast
cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3-98. PsychoOncology 23(2), 2014, p.173-182. (AMC)
1190. Senthi S, Dahele M, Slotman B, Senan S. Investigating strategies to reduce toxicity in stereotactic
ablative radiotherapy for central lung tumors. ACTA Oncol 2014; 53: 330-335. (VUmc)
1191. Senthi S, Senan S. Surgery for early-stage lung cancer: Post-operative 30-day versus 90-day mortality
and patient-centred care. Eur J Cancer 2014; 50: 675-677. (VUmc)
1192. Sero V, Tavanti E, Vella S, Hattinger CM, Fanelli M, Michelacci F, Versteeg R, Valsasina B, Gudeman B,
Picci P, Serra M. Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma cell lines inhibits tumor cell
growth and partially overcomes drug resistance. Investigational New Drugs 32(6), 2014, p.1167-1180.
Scientific publications - 141
(AMC)
1193. Sewing ACP, Caretti V, Lagerweij T, Schellen P, Jansen MHA, van Vuurden DG, Idema S, Molthoff CPM,
Vandertop WP, Kaspers GJL, Noske DP, Hulleman E. Convection enhanced delivery of carmustine to the
murine brainstem: A feasibility study. J Neurosci Meth 2014; 238: 88-94. (VUmc)
1194. Shaltiel IA, Aprelia M, Saurin AT, Chowdhury D, Kops GJ, Voest EE, Medema RH. Distinct phosphatases
antagonize the p53 response in different phases of the cell cycle. Proc Natl Acad Sci U S A 2014;
111:7313-8 (NKI)
1195. Shapiro J, van Hagen P, Lingsma HF, Wijnhoven BPL, Biermann K, ten Kate FJW, Steyerberg EW, van der
Gaast A, van Lanschot JJB. Prolonged time to surgery after neoadjuvant chemoradiotherapy increases
histopathological response without affecting survival in patients with esophageal or junctional cancer.
Annals of Surgery 260(5), 2014, p.807-13; discussion 813-4. (AMC)
1196. Sharma R, Jost D, Kind J, Gomez-Saldivar G, van Steensel B, Askjaer P, Vaillant C, Meister P.
Differential spatial and structural organization of the X chromosome underlies dosage compensation in
C. elegans. Genes Dev 2014; 28:2591-6 (NKI)
1197. Shelat VG, Serin K, Samim M, Besselink MG, Al Saati H, Di Gioia P, Pearce NW, Abu Hilal M. Outcomes of
repeat laparoscopic liver resection compared to the primary resection. World Journal of Surgery 38(12),
2014, p.3175-3180.
1198. Shi K, Queiroz KCS, Roelofs JJTH, van Noesel CJM, Richel DJ, Spek CA. Protease-activated receptor 2
suppresses lymphangiogenesis and subsequent lymph node metastasis in a murine pancreatic cancer
model. Journal of Pathology 234(3), 2014, p.398-409 (AMC)
1199. Shi K, Spek CA. May protease activated receptor-2 antagonists have clinical potential? Journal of
Patholgoy [aheadofprint], 2014, p.-. (AMC)
1200. Shiu K-K, Wetterskog D, Mackay A, Natrajan R, Lambros M, Sims D, Bajrami I, Brough R, Frankum J,
Sharpe R, Marchio C, Horlings H, Reyal F, van der Vijver M, Turner N, Reis-Filho JS, Lord CJ, Ashworth A.
Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic
dependencies. Oncogene 33(5), 2014, p.619-631. (AMC)
1201. Shrinet J, Nandal Umesh K , Adak T, Bhatnagar RK., Sunil S. Inference of the Oxidative Stress Network in
Anopheles stephensi upon Plasmodium Infection. Plos One 9(12), 2014, p.e114461-. (AMC)
1202. Shugay M, Britanova OV, Merzlyak EM, Turchaninova MA, Mamedov IZ, Tuganbaev TR, Bolotin DA,
Staroverov DB, Putintseva EV, Plevova K, Linnemann C, Shagin D, Pospisilova S, Lukyanov S, Schumacher
TN, Chudakov DM. Towards error-free profiling of immune repertoires. Nat Methods 2014; 11:653-5 (NKI)
1203. Sie DLS, Snijders PJF, Meijer GA, Doeleman MW, van Moorsel MIH, van Essen HF, Eijk PP, Grunberg K,
van Grieken NCT, Thunnissen E, Verheul HM, Smit EF, Ylstra B, Heideman DAM. Performance of
amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in
oncopathology. Cell Oncol 2014; 37: 353-361. (VUmc)
1204. Sieben JM, van Otten I, Lataster A, Froeling M, Nederveen AJ, Strijkers GJ, Drost MR. In Vivo
Reconstruction of Lumbar Erector Spinae Architecture Using Diffusion Tensor MRI. Journal of Spinal
DIsorders & Techniques [aheadofprint], 2014, p.-. (AMC)
1205. Sierink JC, de Castro SM, Russell NS, Geenen MM, Steller EP, Vrouenraets BC. Treatment strategies in
elderly breast cancer patients: Is there a need for surgery? Breast 2014; 23(6):793-8:793-8 (NKI)
1206. Siesling S, Tjan-Heijnen VC, de Roos M, Snel Y, van Dalen T, Wouters MW, Struikmans H, van der Hoeven
JJ, Maduro JH, Visser O. Impact of hospital volume on breast cancer outcome: a population-based study
in the Netherlands. Breast Cancer Res Treat 2014; 147:177-84 (NKI)
1207. Sieswerda-Hoogendoorn T, Postema FAM, Verbaan D, Majoie CB, van Rijn RR. Age determination of
subdural hematomas with CT and MRI: A systematic review. European Journal of Radiology 83(7), 2014,
p.1257-1268. (AMC)
1208. Sieuwerts AM, Willis S, Burns MB, Look MP, Gelder ME, Schlicker A, Heideman MR, Jacobs H, Wessels L,
Leyland-Jones B, Gray KP, Foekens JA, Harris RS, Martens JW. Elevated APOBEC3B Correlates with Poor
Outcomes for Estrogen-Receptor-Positive Breast Cancers. Horm Cancer 2014; 5:405-13 (NKI)
1209. Simkens LHJ, Koopman M, Punt CJA. Optimal duration of systemic treatment in metastatic colorectal
cancer. Current Opinion in Oncology 26(4), 2014, p.448-453. (AMC)
1210. Sissung TM, Price DK, Del Re M, Ley AM, Giovannetti E, Figg WD, Danesi R. Genetic variation: effect on
prostate cancer. BBA Reviews on Cancer 2014; 1846: 446-456. (VUmc)
1211. Sistonen J, Buechel B, Froehlich TK, Kummer D, Fontana S, Joerger M, van Kuilenburg ABP, Largiader
CR. Predicting 5-fluorouracil toxicity: DPD genotype and 5,6-dihydrouracil:uracil ratio.
Pharmacogenomics 15(13), 2014, p.1653-1666. (AMC)
1212. Sizoo EM, Dirven L, Reijneveld JC, Postma TJ, Heimans JJ, Deliens L, Pasman HRW, Taphoorn MJB.
Measuring health-related quality of life in high-grade glioma patients at the end of life using a proxyreported retrospective questionnaire. J Neuro-Oncol 2014; 116: 283-290. (VUmc)
1213. Sizoo EM, Grisold W, Taphoorn MJB. Neurologic aspects of palliative care: the end of life setting.
Handbook of Clinical Neurology 2014; 121: 1219-1225. (VUmc)
1214. Sizoo EM, Koekkoek JAF, Postma TJ, Heimans JJ, Pasman HR, Deliens L, Taphoorn MJB, Reijneveld JC.
Seizures in patients with high-grade glioma: a serious challenge in the end-of-life phase. BMJ Support
Palliative Care 2014; 4: 77-80. (VUmc)
1215. Sizoo EM, Pasman HRW, Dirven L, Marosi C, Grisold W, Stockhammer G, Egeter J, Grant R, Chang S,
Heimans JJ, Deliens L, Reijneveld JC, Taphoorn MJB. The end-of-life phase of high-grade glioma
patients: a systematic review. Support Care Cancer 2014; 22: 847-857. (VUmc)
142 - Scientific publications
1216. Skripcak T, Belka C, Bosch W, Brink C, Brunner T, Budach V, Buttner D, Debus J, Dekker A, Grau C,
Gulliford S, Hurkmans C, Just U, Krause M, Lambin P, Langendijk JA, Lewensohn R, Luhr A, Maingon P,
Masucci M, Niyazi M, Poortmans P, Simon M, Schmidberger H, Spezi E, Stuschke M, Valentini V, Verheij
M, Whitfield G, Zackrisson B, Zips D, Baumann M. Creating a data exchange strategy for radiotherapy
research: Towards federated databases and anonymised public datasets. Radiother Oncol 2014; 113:3039 (NKI)
1217. Slobbe P, Windhorst AD, Stigter-van Walsum M, Schuit RC, Smit EF, Niessen HG, Solca F, Stehle G, van
Dongen GAMS, Poot AJ. Development of [F-18]afatinib as new TKI-PET tracer for EGFR positive tumors.
Nucl Med Biol 2014; 41: 749-757. (VUmc)
1218. Sloothaak DAM, Gardenbroek TJ, Crezee J, Bemelman WA, Punt CJA, Buskens CJ, Tanis PJ. Feasibility of
adjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in a short stay setting in patients
with colorectal cancer at high risk of peritoneal carcinomatosis. EJSO : European Journal of Surgical
Oncology 40(11), 2014, p.1453-1458. (AMC)
1219. Sloothaak DAM, Mirck B, Punt CJA, Bemelman WA, van der Bilt JDW, D'Hoore A, Tanis PJ. Intraperitoneal
chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a
systematic review. British Journal of Cancer 111(6), 2014, p.1112-1121. (AMC)
1220. Sloothaak DAM, van den Berg MW, Dijkgraaf MGW, Fockens P, Tanis PJ, van Hooft JE, Bemelman WA.
Oncological outcome of malignant colonic obstruction in the Dutch Stent-In 2 trial. Britisch Journal of
Surgery 101(13), 2014, p.1751-1757. (AMC)
1221. Slort W, Blankenstein AH, Schweitzer BPM, Deliens L, Horst HE van der. Effectiveness of the 'availability,
current issues and anticipation' (ACA) training programme for general practice trainees on
communication with palliative care patients: a controlled trial.. Patient Education and Counseling 2014;
95(1): 83-90. (VUmc)
1222. Slort W, Blankenstein AH, Schweitzer BPM, Knol DL, Horst HE van der, Aaronson NK, Deliens L.
Effectiveness of the palliative care 'Availability, Current issues and Anticipation' (ACA) communication
training programme for general practitioners on patient outcomes: A controlled trial. Palliative Medicine
2014; 28(8): 1036-1045. (VUmc/NKI)
1223. Slot KM, Verbaan D, Uitdehaag BMJ, Wesseling P, Sanchez E, Vandertop WP, Peerdeman SM. Can
excision of meningiomas be limited to resection of tumor and radiologically abnormal dura mater?
Neuronavigation-guided biopsies of dural tail and seemingly normal dura mater, with a review of the
literature. World neurosurgery 2014; 82: e832-e836. (VUmc)
1224. Smit E. BRAF Mutations in Non-Small-Cell Lung Cancer. Journal of Thoracic Oncology 2014; 9: 1594-1595.
(VUmc)
1225. Smit JJ, Sixma TK. RBR E3-ligases at work. EMBO Rep 2014; 15:142-54 (NKI)
1226. Smit MA, Maddalo G, Greig K, Raaijmakers LM, Possik PA, van Breukelen B, Cappadona S, Heck AJ,
Altelaar AM, Peeper DS. ROCK1 is a potential combinatorial drug target for BRAF mutant melanoma. Mol
Syst Biol 2014; 10:772 (NKI)
1227. Smith LA, Stanley AJ, Bergman JJ, Kiesslich R, Hoffman A, Tjwa ET, Kuipers EJ, von Holstein CS, Oberg
S, Brullet E, Schmidt PN, Iqbal T, Mangiavillano B, Masci E, Prat F, Morris AJ. Hemospray Application in
Nonvariceal Upper Gastrointestinal Bleeding Results of the Survey to Evaluate the Application of
Hemospray in the Luminal Tract. Journal of Clinical Gastroenterology 48(10), 2014, p.E89-E92. (AMC)
1228. Smits AJ, Giannakopoulos GF, Zuidema WP. Long-term results and treatment modalities of
conservatively treated Broberg-Morrey type 1 radial head fractures. Injury 2014; 45: 1564-1568. (VUmc)
1229. Smorenburg CH, Crijns MB, Steeghs N. [A woman with purple-red nodules in an oedematous arm]
Een vrouw met paars-rode noduli op een oedeemarm. Ned Tijdschr Geneeskd 2014; 158:A7810 (NKI)
1230. Smorenburg CH, de Groot SM, Leeuwen-Stok AE, Hamaker ME, Wymenga AN, de Graaf H, de Jongh FE,
Braun JJ, Los M, Maartense E, Van Tinteren H, Nortier JW, Seynaeve C. A randomized phase III study
comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly
patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research
Group BOOG. Ann Oncol 2014; 25:599-605 (NKI)
1231. Snaebjornsson P, Coupe VMH, Jonasson L, Meijer GA, van Grieken NC, Jonasson JG. pT4 stage II and III
colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd's local peritoneal
involvement revisited. Int J Cancer 2014; 135: 467-478. (VUmc)
1232. Snellenberg S, Cillessen SAGM, Van Criekinge W, ten Bosch L, Meijer CJLM, Snijders PJF, Steenbergen
RDM. Methylation-mediated repression of PRDM14 contributes to apoptosis evasion in HPV-positive
cancers. Carcinogenesis 2014; 35: 2611-2618. (VUmc)
1233. Snijdewind MC, van Tol DG, Onwuteaka-Philipsen BD, Willems DL. Complexities in Euthanasia or
Physician-Assisted Suicide as Perceived by Dutch Physicians and Patients' Relatives. J Pain Symptom
Manag 2014; 48: 1125-1134. (VUmc)
1234. Spaargaren M, de Rooij MFM, Kater AP, Eldering E. BTK inhibitors in chronic lymphocytic leukemia: a
glimpse to the future. Oncogene [aheadofprint], 2014, p.-. (AMC)
1235. Spada C, Stoker J, Alarcon O, Barbaro F, Bellini D, Bretthauer M, de Haan MC., Dumonceau J-M,
Ferlitsch M, Halligan S, Helbren E, Hellstrom M, Kuipers EJ, Lefere P, Mang T, Neri E, Petruzziello L,
Plumb A, Regge D, Taylor SA, Hassan C, Laghi A. Clinical indications for computed tomographic
colonography: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of
Gastrointestinal and Abdominal Radiology (ESGAR) Guideline. Endoscopy 46(10), 2014, p.897-908. (AMC)
Scientific publications - 143
1236. Sparidans R, Durmus S, Schinkel A, Schellens J, Beijnen J. Liquid chromatography-tandem mass
spectrometric assay for the PARP inhibitor rucaparib in plasma. J Pharm Biomed Anal 2014; 88:626-9
(NKI)
1237. Spliethoff JW, Evers DJ, Jaspers JE, Hendriks BH, Rottenberg S, Ruers TJ. Monitoring of tumor response
to Cisplatin using optical spectroscopy. Transl Oncol 2014; 7:230-9 (NKI)
1238. Spliethoff JW, Tanis E, Evers DJ, Hendriks BH, Prevoo W, Ruers TJM. Monitoring of tumor radio
frequency ablation using derivative spectroscopy. J Biomed Opt 2014; 19:97004 (NKI)
1239. Sramek M, Keijzer C. Use of the i-gel in unexpected difficult airway. Br J Anaesth 2014; 112:386-7 (NKI)
1240. Staiger C, Cadot S, Gyorffy B, Wessels LFA, Klau GW. Current composite-feature classification methods
do not outperform simple single-genes classifiers in breast cancer prognosis. Front Genet 2013; 4:289
(NKI)
1241. Stankovic U, van Herk M, Ploeger LS, Sonke JJ. Improved image quality of cone beam CT scans for
radiotherapy image guidance using fiber-interspaced antiscatter grid. Med Phys 2014; 41:061910 (NKI)
1242. Steenbergen RDM, Snijders PJF, Heideman DAM, Meijer CJLM. Clinical implications of (epi)genetic
changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer 2014; 14: 395-405. (VUmc)
1243. Stegeman I, de Wijkerslooth TR, Stoop EM, van Leerdam ME, Dekker E, van Ballegooijen M, Kuipers EJ,
Fockens P, Kraaijenhagen RA, Bossuyt PM. Combining risk factors with faecal immunochemical test
outcome for selecting CRC screenees for colonoscopy. GUT 63(3), 2014, p.466-471. (AMC)
1244. Stegeman I, Willems DL, Dekker E, Bossuyt PM. Individual responsibility, solidarity and differentiation in
healthcare. Journal of Medical Ethics 40(11), 2014, p.770-773. (AMC)
1245. Stehouwer BL, Merckel LG, Verkooijen HM, Peters NHGM, Mann RM, Duvivier KM, Mali WPTM, Peeters
PHM, Veldhuis WB, van den Bosch MAAJ. 3-T breast magnetic resonance imaging in patients with
suspicious microcalcifications on mammography. Eur J Radiol 2014; 24: 603-609. (VUmc)
1246. Stewart GD, O'Mahony FC, Laird A, Rashid S, Martin SA, Eory L, Lubbock AL, Nanda J, O'Donnell M,
Mackay A, Mullen P, McNeill SA, Riddick AC, Aitchison M, Berney D, Bex A, Overton IM, Harrison DJ,
Powles T. Carbonic Anhydrase 9 Expression Increases with Vascular Endothelial Growth Factor-Targeted
Therapy and Is Predictive of Outcome in Metastatic Clear Cell Renal Cancer. Eur Urol 2014; 66:956-63
(NKI)
1247. Stiekema A, Lok CA, Kenter GG, Van Driel WJ, Vincent AD, Korse CM. A predictive model combining
human epididymal protein 4 and radiologic features for the diagnosis of ovarian cancer. Gynecol Oncol
2014; 132:573-7 (NKI)
1248. Stiekema J, Trip AK, Jansen EP, Boot H, Cats A, Ponz OB, Verheij M, van Sandick JW. The prognostic
significance of an R1 resection in gastric cancer patients treated with adjuvant chemoradiotherapy. Ann
Surg Oncol 2014; 21:1107-14 (NKI)
1249. Stiekema J, Vermeulen D, Vegt E, Voncken FE, Aleman BM, Sanders J, Boot H, van Sandick JW.
Detecting Interval Metastases and Response Assessment Using 18F-FDG PET/CT After Neoadjuvant
Chemoradiotherapy for Esophageal Cancer. Clin Nucl Med 2014; 39:862-7 (NKI)
1250. Stiksma J, Grootendorst DC, van der Linden PWG. CA 19-9 As a Marker in Addition to CEA to Monitor
Colorectal Cancer. Clin Colorectal Cancer 2014; 13: 239-244. (VUmc)
1251. Stoker SD, Wildeman MA, Fles R, Indrasari SR, Herdini C, Wildeman PL, van Diessen JN, Tjokronagoro M,
Tan IB. A prospective study: current problems in radiotherapy for nasopharyngeal carcinoma in
yogyakarta, indonesia. PLoS One 2014; 9:e85959 (NKI)
1252. Straatman J, Cuesta MA, Gisbertz SS, van der Peet DL. Value of a step-up diagnosis plan: CRP and CTscan to diagnose and manage postoperative complications after major abdominal surgery. Rev Esp
Enferm Dig 2014; 106: 515-521. (VUmc)
1253. Straatman J, Harmsen AM, Cuesta MA, de Lange-de Klerk ES, van der Peet DL. The effect of gender, age
and BMI on postoperative C-reactive protein levels after major abdominal surgery. Journal of Current
Surgery 2014; 4: 61-69. (VUmc)
1254. Stroom J, Gilhuijs K, Vieira S, Chen W, Salguero J, Moser E, Sonke JJ. Combined Recipe for Clinical
Target Volume and Planning Target Volume Margins. Int J Radiat Oncol Biol Phys 2014; 88:708-14 (NKI)
1255. Struemper H, Sale M, Patel BR, Østergaard M, Österborg A, Wierda WG, Hagenbeek A, Coiffier B, Jewell
RC. Population pharmacokinetics of ofatumumab in patients with chronic lymphocytic leukemia,
follicular lymphoma, and rheumatoid arthritis. Journal of Clinical Pharmacology 54(7), 2014, p.818-827.
(AMC)
1256. Studer UE, Whelan P, Wimpissinger F, Casselman J, de Reijke TM, Knönagel H, Loidl W, Isorna S,
Sundaram SK., Collette L. Differences in Time to Disease Progression Do Not Predict for Cancer-specific
Survival in Patients Receiving Immediate or Deferred Androgen-deprivation Therapy for Prostate Cancer:
Final Results of EORTC Randomized Trial 30891 with 12 Years of Follow-up. European Urology 66(5),
2014, p.829-838. (AMC)
1257. Stuiver MM, Westerduin E, Ter Meulen S, Vincent AD, Nieweg OE, Wouters MW. Surgical wound
complications after groin dissection in melanoma patients - A historical cohort study and risk factor
analysis. Eur J Surg Oncol 2014; 40:1284-90 (NKI)
1258. Stupp R, Hegi ME, Gorlia T, Erridge SC, Perry J, Hong YK, Aldape KD, Lhermitte B, Pietsch T, Grujicic D,
Steinbach JP, Wick W, Tarnawski R, Nam DH, Hau P, Weyerbrock A, Taphoorn MJB, Shen CC, Rao N,
Thurzo L, Herrlinger U, Gupta T, Kortmann RD, Adamska K,. Cilengitide combined with standard
treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC
144 - Scientific publications
1259.
1260.
1261.
1262.
1263.
1264.
1265.
1266.
1267.
1268.
1269.
1270.
1271.
1272.
1273.
1274.
1275.
1276.
1277.
EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 2014;
15: 1100-1108. (VUmc)
Sturm B, Fleskens SJHM, Bot FJ, van Velthuysen ML, Speel EJ, Slootweg PJ, van der Laak JAWM. Virtual
microscopy is a valid alternative for the diagnostic assessment of laryngeal premalignancies.
Histopathology 2014; 64:602-4 (NKI)
Sun C, Bernards R. Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer
therapies. Trends Biochem Sci 2014; 39:465-74 (NKI)
Sun C, Hobor S, Bertotti A, Zecchin D, Huang SD, Galimi F, Cottino F, Prahallad A, Grernrum W, Tzani A,
Schlicker A, Wessels LFA, Smit EF, Thunnissen E, Halonen P, Lieftink C, Beijersbergen RL, Di
Nicolantonio F, Bardelli A, Trusolino L, Bernards R. Intrinsic Resistance to MEK Inhibition in KRAS Mutant
Lung and Colon Cancer through Transcriptional Induction of ERBB3. Cell reports 2014; 7: 86-93.
(VUmc/NKI)
Sun C, Wang L, Huang S, Heynen GJ, Prahallad A, Robert C, Haanen J, Blank C, Wesseling J, Willems SM,
Zecchin D, Hobor S, Bajpe PK, Lieftink C, Mateus C, Vagner S, Grernrum W, Hofland I, Schlicker A,
Wessels LF, Beijersbergen RL, Bardelli A, Di Nicolantonio F, Eggermont AM, Bernards R. Reversible and
adaptive resistance to BRAF(V600E) inhibition in melanoma. Nature 2014; 508:118-22 (NKI)
Sutherland KD, Song JY, Kwon MC, Proost N, Zevenhoven J, Berns A. Multiple cells-of-origin of mutant KRas-induced mouse lung adenocarcinoma. Proc Natl Acad Sci U S A 2014; 111:4952-7 (NKI)
Swarts DRA, van Suylen RJ, den Bakker MA, van Oosterhout MFM, Thunnissen E, Volante M, Dingemans
AMC, Scheltinga MRM, Bootsma GP, Pouwels HMM, van den Borne BEEM, Ramaekers FCS, Speel EJM.
Interobserver Variability for the WHO Classification of Pulmonary Carcinoids. American Journal of
Surgical Pathology 2014; 38: 1429-1436. (VUmc)
Swellengrebel HA, Bosch SL, Cats A, Vincent AD, Dewit LG, Verwaal VJ, Nagtegaal ID, Marijnen CA.
Tumour regression grading after chemoradiotherapy for locally advanced rectal cancer: A near
pathologic complete response does not translate into good clinical outcome. Radiother Oncol 2014;
112(1):44-51:44-51 (NKI)
Synofzik M, Müller Vom Hagen J, Haack TB, Wilhelm C, Lindig T, Beck-Wödl S, Nabuurs SB., van
Kuilenburg ABP, de Brouwer APM, Schöls L. X-linked Charcot-Marie-Tooth disease, Arts syndrome, and
prelingual non-syndromic deafness form a disease continuum: evidence from a family with a novel PRPS1
mutation. Orphanet Journal of Rare Diseases 9(1), 2014, p.24-. (AMC)
't Lam-Boer J, Mol L, Verhoef C, de Haan AFJ, Yilmaz M, Punt CJA, de Wilt JHW, Koopman M.The CAIRO4
study: the role of surgery of the primary tumour with few or absent symptoms in patients with
synchronous unresectable metastases of colorectal cancer--a randomized phase III study of the Dutch
Colorectal Cancer Group (DCCG). BMC CANCER 14, 2014, p.741-. (AMC)
Taal W, Oosterkamp HM, Walenkamp AME, Dubbink HJ, Beerepoot LV, Hanse MCJ, Buter J, Honkoop AH,
Boerman D, de Vos FYF, Dinjens WNM, Enting RH, Taphoorn MJB, van den Berkmortel FWPJ, Jansen RLH,
Brandsma D, Bromberg JEC, van Heuvel I, Vernhout RM, van der. Single-agent bevacizumab or lomustine
versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB
trial): a randomised controlled phase 2 trial. Lancet Oncol 2014; 15: 943-953. (VUmc/NKI)
Tacke ZCA, Eikelenboom MJ, Vermeulen RJ, van der Knaap MS, Euser AM, van der Valk P, Kaspers GJL.
Childhood Lymphomatoid Granulomatosis: A Report of 2 Cases and Review of the Literature. J Pediat
Hematol Onc 2014; 36: E416-E422. (VUmc)
Tae Chung H, Pouw RE, Duits LC, Sung Young K, Min B-H, Lee Jun H, Rhee P-L, Kim K-M, Bergman
JJGHM, Kim JJ. Is endoscopic resection an alternative to surgery for early low-risk submucosal gastric
cancers: analysis of a large surgical database. Surgical Endoscopy and Other Interventional Techniques
[aheadofprint], 2014, p.-. (AMC)
Tafesse FG, Guimaraes CP, Maruyama T, Carette JE, Lory S, Brummelkamp TR, Ploegh HL. GPR107, a Gprotein-coupled Receptor Essential for Intoxication by Pseudomonas aeruginosa Exotoxin A, Localizes to
the Golgi and Is Cleaved by Furin. J Biol Chem 2014; 289:24005-18 (NKI)
Tame MA, Raaijmakers JA, van den Broek B, Lindqvist A, Jalink K, Medema RH. Astral microtubules
control redistribution of dynein at the cell cortex to facilitate spindle positioning. Cell Cycle 2014;
13:1162-70 (NKI)
Tamminga SJ, Verbeek JHAM, Frings-Dresen MHW, de Boer AGEM. Measurement properties of the Work
Limitations Questionnaire were sufficient among cancer survivors. Quality of Life Research 23(2), 2014,
p.515-525. (AMC)
Tan Puay H, Schnitt SJ, van de Vijver MJ, Ellis IO, Lakhani SR. Papillary and neuroendocrine breast
lesions: the WHO stance. Histopathology [aheadofprint], 2014, p.-. (AMC)
Tang SC, Nguyen LN, Sparidans RW, Wagenaar E, Beijnen JH, Schinkel AH. Increased oral availability and
brain accumulation of the ALK inhibitor crizotinib by coadministration of the P-glycoprotein (ABCB1) and
breast cancer resistance protein (ABCG2) inhibitor elacridar. Int J Cancer 2014; 134:1484-94 (NKI)
Tang SC, Sparidans RW, Cheung KL, Fukami T, Durmus S, Wagenaar E, Yokoi T, van Vlijmen BJ, Beijnen
JH, Schinkel AH. P-glycoprotein, CYP3A, and plasma carboxylesterase determine brain and blood
disposition of the mTOR Inhibitor everolimus (Afinitor) in mice. Clin Cancer Res 2014; 20:3133-45 (NKI)
Tanis E, Nordlinger B, Mauer M, Sorbye H, van Coevorden F, Gruenberger T, Schlag PM, Punt CJA,
Ledermann J, Ruers TJM. Local recurrence rates after radiofrequency ablation or resection of colorectal
liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004
and #40983. European Journal of Cancer 50(5), 2014, p.912-919. (AMC/NKI)
Scientific publications - 145
1278. Tan-Sindhunata MB, Mathijssen IB, Smit M, Baas F, de Vries JI, van der Voorn J. P, Kluijt I, Hagen MA,
Blom EW, Sistermans E, Meijers-Heijboer H, Waisfisz Q, Weiss MM, Groffen AJ. Identification of a Dutch
founder mutation in MUSK causing fetal akinesia deformation sequence. European Journal of Human
Genetics [aheadofprint], 2014, p.-. (AMC)
1279. te Raa GD, Derks IAM, Navrkalova V, Skowronska A, Moerland PD, van Laar J, Oldreive C, Monsuur H,
Trbusek M, Malcikova J, Lodén M, Geisler CH, Hüllein J, Jethwa A, Zenz T, Pospisilova S, Stankovic T,
van Oers MHJ, Kater AP, Eldering E. The impact of SF3B1 mutations in CLL on the DNA damage response.
Leukemia [aheadofprint], 2014, p.-. (AMC)
1280. te Raa GD, Malčiková J, Mraz M, Trbusek M, Le Garff-Tavernier M, Merle-Béral H, Greil R, Merkel O,
Pospíšilová S, Lin K, Pettitt AR, Stankovic T, van Oers MH, Eldering E, Stilgenbauer S, Zenz T, Kater AP.
Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC-wide
approach. British Journal of Haematology 167(4), 2014, p.565-569. (AMC)
1281. te Raa GD, Pascutti MF, Garcia Vallejo JJ, Reinen E, Remmerswaal EBM, ten Berge IJM, van Lier RAW,
Eldering E, van Oers MHJ, Tonino SH, Kater AP. CMV-specific CD8(+) T-cell function is not impaired in
chronic lymphocytic leukemia. Blood 2014; 123: 717-724. (VUmc/AMC)
1282. te Winkel ML, Pieters R, Hop WCJ, Roos JC, Bokkerink JPM, Leeuw JA, de Bruin MCA, Kollen WJW,
Veerman AJP, de Groot-Kruseman HA, van der Sluis IM, van den Heuvel-Eibrink MM. Bone mineral
density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated
according to the DCOG-ALL9 protocol. Bone 2014; 59: 223-228. (VUmc)
1283. Tembuyser L, Tack V, Zwaenepoel K, Pauwels P, Miller K, Bubendorf L, Kerr K, Schuuring E, Thunnissen
E, Dequeker EMC. The Relevance of External Quality Assessment for Molecular Testing for ALK Positive
Non-Small Cell Lung Cancer: Results from Two Pilot Rounds Show Room for Optimization. PLoS One
2014; 9: e112159. (VUmc)
1284. Teodoro-Morrison T, Diamandis EP, Rifai N, Weetjens BJC, Pennazza G, de Boer KHN, Bomers MK. Animal
Olfactory Detection of Disease: Promises and Pitfalls. Clin Chem 2014; 60: 1473-1479. (VUmc)
1285. ter Avest MJ, Schook RM, Koudstaal LG, Grunberg K, Paul MA, Smit EF, Postmus PE. Benefit of a second
opinion for lung cancer: no metastasis to the kidney but a synchronous primary renal neoplasm. Case
reports in oncology 2014; 7: 122-125. (VUmc)
1286. ter Heine R, Lange R, Breukels OB, Bloemendal HJ, Rummenie RG, Wakker AM, de Graaf H, Beekman FJ,
van der Westerlaken MML, Malingre MM, Wielders JPM, van den Berg L, Hendrikse NH, de Klerk JMH.
Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted
treatment of painful bone metastases. International journal of pharmaceutics 2014; 465: 317-324.
(VUmc)
1287. ter Voert EEGW, van Laarhoven HWM, Kok PJM, Oyen WJG, Visser EP, de Geus-Oei L-F. Comparison of
liver SUV using unenhanced CT versus contrast-enhanced CT for attenuation correction in (18)F-FDG
PET/CT. Nuclear Medicine Communications 35(5), 2014, p.472-477. (AMC)
1288. Terwijn M, Zeijlemaker W, Kelder A, Rutten AP, Snel AN, Scholten WJ, Pabst T, Verhoef G, Lowenberg
B, Zweegman S, Ossenkoppele GJ, Schuurhuis GJ. Leukemic Stem Cell Frequency: A Strong Biomarker
for Clinical Outcome in Acute Myeloid Leukemia. PLoS One 2014; 9: e107587. (VUmc)
1289. Terwisscha van Scheltinga CEJ, Spronk P, van Rosmalen J, Wijnen MHWA, Heij Hugo A, van Baren R,
Merks JHM, van Noesel MM, Wijnen RMH. Diagnosis and treatment of lymph node metastases in pediatric
rhabdomyosarcoma in the Netherlands: a retrospective analysis. Journal of Pediatric Surgery 49(3),
2014, p.416-419. (AMC)
1290. Teulings H-E, Willemsen KJ, Glykofridis I, Krebbers G, Komen L, Kroon MW, Kemp EH, Wolkerstorfer A,
van der Veen JPW, Luiten RM, Tjin EPM. The antibody response against MART-1 differs in patients with
melanoma-associated leucoderma and vitiligo. Pigment Cell & Melanoma Research 27(6), 2014,
p.1086-1096. (AMC)
1291. Teunissen MBM, Munneke JM, Bernink JH, Spuls PI, Res PCM, te Velde A, Cheuk S, Brouwer MWD,
Menting SP, Eidsmo L, Spits H, Hazenberg MD, Mjösberg J. Composition of innate lymphoid cell subsets
in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients. Journal of
Investigative Dermatology 134(9), 2014, p.2351-2360. (AMC)
1292. Textor J, Henrickson SE, Mandl JN, von Andrian UH, Westermann J, De Boer RJ, Beltman JB. Random
migration and signal integration promote rapid and robust T cell recruitment. PLoS Comput Biol 2014;
10:e1003752 (NKI)
1293. Than BLN, Goos JACM, Sarver AL, O'Sullivan MG, Rod A, Starr TK, Fijneman RJA, Meijer GA, Zhao L,
Zhang Y, Largaespada DA, Scott PM, Cormier RT. The role of KCNQ1 in mouse and human
gastrointestinal cancers. Oncogene 2014; 33: 3861-3868. (VUmc)
1294. Theunissen EA, Dreschler WA, Latenstein MN, Rasch CR, van der Baan S, de Boer JP, Balm AJ, Zuur CL. A
New Grading System for Ototoxicity in Adults. Ann Otol Rhinol Laryngol 2014; 123:711-8 (NKI)
1295. Theunissen EA, Zuur CL, Bosma SC, Lopez-Yurda M, Hauptmann M, van der Baan S, de Boer JP, van der
Molen L, Rasch CR, Dreschler WA, Balm AJM. Long-term hearing loss after chemoradiation in patients
with head and neck cancer. Laryngoscope 2014; 124:2720-5 (NKI)
1296. Theunissen EAR, Dreschler WA, Latenstein MN, Rasch CRN, van der Baan S, de Boer JP, Balm AJM, Zuur
CL. A New Grading System for Ototoxicity in Adults. Annals of Otology Rhinology and Laryngology
123(10), 2014, p.711-718. (AMC)
1297. Theunissen EAR, Zuur CL, Bosma SCJ, Lopez-Yurda M, Hauptmann M, van der Baan S, de Boer JP, van
der Molen L, Rasch CRN, Dreschler WA, Balm AJM. Long-term hearing loss after chemoradiation in
146 - Scientific publications
patients with head and neck cancer. Laryngoscope 124(12), 2014, p.2720-2725. (AMC/NKI)
1298. Theunissen EAR, Zuur CL, Yurda Lopes M, van der Baan S, Kornman AF, de Boer JP, Balm AJM, Rasch
CRN, Dreschler WA. Cochlea sparing effects of intensity modulated radiation therapy in head and neck
cancers patients: a long-term follow-up study. Journal of Otolaryngology-Head & Neck Surgery 43(1),
2014, p.30-. (AMC)
1299. Thieme ME, Leeuwenburgh MMN, Valdehueza ZD, Bouman DE, de Bruin IGJM, Schreurs W. Hermi,
Houdijk APJ, Stoker J, Wiarda BM. Diagnostic accuracy and patient acceptance of MRI in children with
suspected appendicitis. European Radiology 24(3), 2014, p.630-637. (AMC)
1300. Thijssen VLJL, Griffioen AW. Galectin-1 and-9 in angiogenesis: A sweet couple. Glycobiology 2014; 24:
915-920. (VUmc)
1301. Thijssen VLJL, Rabinovich GA. Glycans in vascular biology INTRODUCTION. Glycobiology 2014; 24: 12351236. (VUmc)
1302. Thomas G, van Voskuilen J, Truong H, Song JY, Gerritsen HC, Sterenborg HJ. In vivo nonlinear spectral
imaging as a tool to monitor early spectroscopic and metabolic changes in a murine cutaneous squamous
cell carcinoma model. Biomed Opt Express 2014; 5:4281-99 (NKI)
1303. Thomas LK, Bermejo JL, Vinokurova S, Jensen K, Bierkens M, Steenbergen RDM, Bergmann M, Doeberitz
M, Reuschenbach M. Chromosomal gains and losses in human papillomavirus-associated neoplasia of the
lower genital tract - A systematic review and meta-analysis. Eur J Cancer 2014; 50: 85-98. (VUmc)
1304. Thomassen I, van Gestel YR, Aalbers AG, van Oudheusden TR, Wegdam JA, Lemmens VE, de Hingh IH.
Peritoneal carcinomatosis is less frequently diagnosed during laparoscopic surgery compared to open
surgery in patients with colorectal cancer. Eur J Surg Oncol 2014; 40:511-4 (NKI)
1305. Thompson BA, Spurdle AB, Plazzer JP, Greenblatt MS, Akagi K, Al Mulla F, Bapat B, Bernstein I, Capella
G, den Dunnen JT, du Sart D, Fabre A, Farrell MP, Farrington SM, Frayling IM, Frebourg T, Goldgar DE,
Heinen CD, Holinski-Feder E, Kohonen-Corish M, Robinson KL, Leung SY, Martins A, Moller P, Morak M,
Nystrom M, Peltomaki P, Pineda M, Qi M, Ramesar R, Rasmussen LJ, Royer-Pokora B, Scott RJ, Sijmons
R, Tavtigian SV, Tops CM, Weber T, Wijnen J, Woods MO, Macrae F, Genuardi M. Application of a 5tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the
InSiGHT locus-specific database. Nat Genet 2014; 46:107-15 (NKI)
1306. Thong MSY, Sprangers MAG, Sloan JA, Patrick DL, Yang P, van Noorden CJF. Genetic variations
underlying self-reported physical functioning: a review. Quality of Life Research [aheadofprint], 2014,
p.-. (AMC)
1307. Thunnissen E, Noguchi M, Aisner S, Beasley MB, Brambilla E, Chirieac LR, Chung JH, Dacic S, Geisinger
KR, Hirsch FR, Ishikawa Y, Kerr KM, Lantejoul S, Matsuno Y, Minami Y, Moreira AL, Pelosi G, Petersen I,
Roggli V, Travis WD, Wistuba I, Yatabe Y, Dziadzi. Reproducibility of Histopathological Diagnosis in
Poorly Differentiated NSCLC An International Multiobserver Study. Journal of Thoracic Oncology 2014; 9:
1354-1362. (VUmc)
1308. Thunnissen E, van der Oord K, den Bakker MA. Prognostic and predictive biomarkers in lung cancer. A
review. Virchows Arch 2014; 464: 347-358. (VUmc)
1309. Tielbeek JAW, Bipat S, Boellaard TN, Nio CY, Stoker J. Training readers to improve their accuracy in
grading Crohn's disease activity on MRI. European Radiology 24(5), 2014, p.1059-1067. (AMC)
1310. Tielbeek JAW, Ziech MLW, Li Z, Lavini C, Bipat S, Bemelman WA, Roelofs JJTH, Ponsioen CY, Vos FM,
Stoker J. Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for
quantitative Crohn's disease assessment with histopathology of surgical specimens. European Radiology
24(3), 2014, p.619-629. (AMC)
1311. Timmer MR, Brankley SM, Gorospe EC, Sun G, Lutzke LS, Iyer PG, Halling KC, Krishnadath KK, Wang KK.
Prediction of response to endoscopic therapy of Barrett's dysplasia by using genetic biomarkers.
Gastrointestinal Endoscopy 80(6), 2014, p.984-991. (AMC)
1312. Timmermans AJ, Lansaat L, Kroon G, Hamming-Vrieze O, Hilgers FJM, van den Brekel MWM. Early oral
intake after total laryngectomy does not increase pharyngocutaneous fistulization. Eur Arch
Otorhinolaryngol 2014; 271:353-8 (NKI)
1313. Timmermans AJ, Lansaat L, Theunissen EA, Hamming-Vrieze O, Hilgers FJ, van den Brekel MW.
Predictive factors for pharyngocutaneous fistulization after total laryngectomy. Ann Otol Rhinol Laryngol
2014; 123:153-61 (NKI)
1314. Timmermans AJ, van Harten MC, Remmelts AJ, Hamming-Vrieze O, Klop WMC, Lohuis PJFM, van den
Brekel MWM. Complications after transoral excision in previously irradiated head and neck cancer
patients: Our experience in a retrospective cohort study of fifty-two patients. Clin Otolaryngol 2014;
39:245-51 (NKI)
1315. Timmers JM, Damen JA, Pijnappel RM, Verbeek AL, den Heeten GJ, Adang EM, Broeders MJ.
Cost-effectiveness of non-invasive assessment in the Dutch breast cancer screening program versus usual
care: A randomized controlled trial. Canadian Journal of Public Health 105(5), 2014, p.E342-E347. (AMC)
1316. Timmers JMH, Verbeek ALM, Pijnappel RM, Broeders MJM, den Heeten GJ. Experiences with a self-test
for Dutch breast screening radiologists: lessons learnt. Euroepean Radiology 24(2), 2014, p.294-304.
(AMC)
1317. Timmers L, Boons CCLM, Kropff F, van de Ven PM, Swart EL, Smit EF, Zweegman S, Kroep JR, TimmerBonte JNH, Boven E, Hugtenburg JG. Adherence and patients' experiences with the use of oral
anticancer agents. ACTA Oncol 2014; 53: 259-267. (VUmc)
1318. Tjaden LA, Vogelzang J, Jager KJ, van Stralen KJ, Maurice-Stam H, Grootenhuis MA, Groothoff JW.
Scientific publications - 147
1319.
1320.
1321.
1322.
1323.
1324.
1325.
1326.
1327.
1328.
1329.
1330.
1331.
1332.
1333.
1334.
1335.
1336.
Long-term quality of life and social outcome of childhood end-stage renal disease. Journal of Pediatrics
165(2), 2014, p.336-342.e1. (AMC)
Tjin EP, Krebbers G, Meijlink KJ, van de Kasteele W, Rosenberg EH, Sanders J, Nederlof PM, van de Wiel
BA, Haanen JB, Melief CJ, Vyth-Dreese FA, Luiten RM. Immune-escape markers in relation to clinical
outcome of advanced melanoma patients following immunotherapy. Cancer Immunol Res 2014; 2:538-46
(NKI)
Tjin EPM, Luiten RM. Tumor-infiltrating T-cells: important players in clinical outcome of advanced
melanoma patients. Oncoimmunology 3(9), 2014, p.e954862-. (AMC)
Tol JAMG, Brosens LAA, van Dieren S, van Gulik TM, Busch ORC, Besselink MGH, Gouma DJ. Impact of
lymph node ratio on survival in patients with pancreatic and periampullary cancer. British Journal of
Surgery [aheadofprint], 2014, p.-. (AMC)
Tol JAMG, Busch Olivier RC, van Delden OM, van Lienden KP, van Gulik TM, Gouma DJ. Shifting role of
operative and nonoperative interventions in managing complications after pancreatoduodenectomy:
what is the preferred intervention?SURGERY 156(3), 2014, p.622-631.
Tol JAMG, Gouma DJ, Bassi C, Dervenis C, Montorsi M, Adham M, Andrén-Sandberg A, Asbun HJ.,
Bockhorn M, Büchler MW, Conlon KC, Fernández-Cruz L, Fingerhut A, Friess H, Hartwig W, Izbicki JR,
Lillemoe KD, Milicevic MN, Neoptolemos JP, Shrikhande SV, Vollmer CM, Yeo CJ, Charnley RM. Definition
of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus
statement by the International Study Group on Pancreatic Surgery (ISGPS). Surgery 156(3), 2014,
p.591-600. (AMC)
Tol JP, Dahele M, Doornaert P, Slotman BJ, Verbakel WFAR. Toward optimal organ at risk sparing in
complex volumetric modulated arc therapy: An exponential trade-off with target volume dose
homogeneity. Med Phys 2014; 41: 021722. (VUmc)
Tol JP, Dahele M, Doornaert PA, Slotman BJ, Verbakel WFAR. Different treatment planning protocols can
lead to large differences in organ at risk sparing. Radiother Oncol 2014; 113: 267-271. (VUmc)
Tong WH, Pieters R, Kaspers GJL, te Loo DMWM, Bierings MB, Bos C, Kollen WJW, Hop WCJ, LanversKaminsky C, Relling MV, Tissing WJE, van der Sluis IM. A prospective study on drug monitoring of
PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic
leukemia. Blood 2014; 123: 2026-2033. (VUmc/AMC)
Tonino SH, Mulkens CE, van Laar J, Derks IAM, Suo G, Croon-de Boer F, van Oers MHJ, Eldering E, Wang
JY, Kater AP. Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53
dysfunctional chronic lymphocytic leukemia. Leukemia & Lymphoma [aheadofprint], 2014, p.1-21. (AMC)
Torres RJ, Peters GJ, Puig JG. Novel Developments in Metabolic Disorders of Purine and Pyrimidine
Metabolism and Therapeutic Applications of Their Analogs. Nucleos Nucleot Nucl 2014; 33: 165-173.
(VUmc)
Trip AK, Nijkamp J, Van Tinteren H, Cats A, Boot H, Jansen EP, Verheij M. IMRT limits nephrotoxicity
after chemoradiotherapy for gastric cancer. Radiother Oncol 2014; 112:289-94 (NKI)
Trip AK, Poppema BJ, van Berge Henegouwen MI, Siemerink E, Beukema JC, Verheij M, Plukker JTM,
Richel DJ, Hulshof MCCM, van Sandick JW, Cats A, Jansen EPM, Hospers GAP. Preoperative
chemoradiotherapy in locally advanced gastric cancer, a phase I/II feasibility and efficacy study.
Radiotherapy and Oncology 112(2), 2014, p.284-288. (AMC/NKI)
Tromp WG, van den Heuvel B, Dwars BJ. A new accurate method of physical examination for
differentiation of inguinal hernia types. Surg Endosc 2014; 28: 1460-1464. (VUmc)
Tseng DSJ, van Santvoort HC, Fegrachi S, Besselink MG, Zuithoff NPA, Borel Rinkes IH, van Leeuwen MS,
Molenaar IQ. Diagnostic accuracy of CT in assessing extra-regional lymphadenopathy in pancreatic and
peri-ampullary cancer: A systematic review and meta-analysis. Surgical Oncology-Oxford 23(4), 2014,
p.229-235. (AMC)
Tsounis M, Swart KMA, Georgalas C, Markou K, Menger DJ. The clinical value of peak nasal inspiratory
flow, peak oral inspiratory flow, and the nasal patency index. Laryngoscope 124(12), 2014, p.2665-2669.
(AMC)
Tubio JMC, Li Y, Ju Young S, Martincorena I, Cooke SL, Tojo M, Gundem G, Pipinikas CP, Zamora J,
Raine K, Menzies A, Roman-Garcia P, Fullam A, Gerstung M, Shlien A, Tarpey PS, Papaemmanuil E,
Knappskog S, van Loo P, Ramakrishna M, Davies HR, Marshall J, Wedge DC, Teague JW, Butler AP,
Nik-Zainal S, Alexandrov L, Behjati S, Yates LR, Bolli N, Mudie L, Hardy C, Martin S, McLaren S, O'Meara
S, Anderson E, Maddison M, Gamble S, Foster C, Warren AY, Whitaker H, Brewer D, Eeles R, Cooper C,
Neal D, Lynch AG, Visakorpi T, Isaacs WB, van't Veer L, Caldas C, Desmedt C, Sotiriou C, Aparicio S,
Foekens JA, Eyfjörd Jórunn E, Lakhani SR, Thomas G, Myklebost O, Span PN, Børresen-Dale A-L,
Richardson AL, van de Vijver M, Vincent-Salomon A, van den Eynden GG, Flanagan AM, Futreal PA, Janes
SM, Bova GS, Stratton MR, McDermott U, Campbell PJ. Extensive transduction of nonrepetitive DNA
mediated by L1 retrotransposition in cancer genomes. Science 345(6196), 2014, p.531-+. (AMC/NKI)
Tymoszuk P, Evens H, Marzola V, Wachowicz K, Wasmer MH, Datta S, Muller-Holzner E, Fiegl H, Bock G,
van Rooijen N, Theurl I, Doppler W. In situ proliferation contributes to accumulation of tumorassociated macrophages in spontaneous mammary tumors. Eur J Immunol 2014; 44: 2247-2262. (VUmc)
Uijterwaal MH, Kocken M, Berkhof J, Bekkers RLM, Verheijen RHM, Helmerhorst TJM, Meijer CJLM.
Posttreatment Assessment of Women at Risk of Developing High-Grade Cervical Disease: Proposal for
New Guidelines Based on Data From The Netherlands. Journal of Lower Genital Tract Disease 2014; 18:
338-343. (VUmc)
148 - Scientific publications
1337. Uijterwaal MH, Verhoef VMJ, Snijders PJF, Meijer CJLM. Arguments in favor of HPV testing for cervical
screening and post-treatment CIN2+ monitoring. Expert review of molecular diagnostics 2014; 14: 245248. (VUmc)
1338. Uijterwaal MH, Witte BI, van Kemenade FJ, Rijkaart D, Ridder R, Berkhof J, Balfoort-van de Meij GAMA,
Bleeker MCG, Snijders PJF, Meijer CJLM. Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki67 dual-stained cytology testing: cross-sectional and longitudinal outcome study. Brit J Cancer 2014;
110: 1579-1586. (VUmc)
1339. Unlü C, Beenen LFM, Fauquenot JMB, Jensch S, Bemelman WA, Dijkgraaf MGW, Vrouenraets BC,
Boermeester MA, Stoker J. Inter-observer reliability of computed tomographic classifications of
diverticulitis. Colorectal Disease 16(6), 2014, p.O212-O219. (AMC)
1340. Ureba A, Salguero FJ, Barbeiro AR, Jimenez-Ortega E, Baeza JA, Miras H, Linares R, Perucha M, Leal A.
MCTP system model based on linear programming optimization of apertures obtained from sequencing
patient image data maps. Med Phys 2014; 41:081719 (NKI)
1341. Uyterlinde W, Chen C, Nijkamp J, Obbink MG, Sonke JJ, Belderbos J, van den Heuvel M. Treatment
adherence in concurrent chemoradiation in patients with locally advanced non-small cell lung
carcinoma: results of daily intravenous prehydration. Radiother Oncol 2014; 110:488-92 (NKI)
1342. Valdes Olmos RA, Rietbergen DD, Vidal-Sicart S, Manca G, Giammarile F, Mariani G. Contribution of
SPECT/CT imaging to radioguided sentinel lymph node biopsy in breast cancer, melanoma, and other
solid cancers: from "open and see" to "see and open". Q J Nucl Med Mol Imaging 2014; 58:127-39 (NKI)
1343. Valdes Olmos RA, Vidal-Sicart S, Giammarile F, Zaknun JJ, van Leeuwen FW, Mariani G. The GOSTT
concept and hybrid mixed/virtual/augmented reality environment radioguided surgery. Q J Nucl Med
Mol Imaging 2014; 58:207-15 (NKI)
1344. Valentini V, Abrahamsson PA, Aranda SK, Astier A, Audisio RA, Boniol M, Bonomo L, Brunelli A, Bultz B,
Chiti A, De Lorenzo F, Eriksen JG, Goh V, Gospodarowicz MK, Grassi L, Kelly J, Kortmann RD, Kutluk T,
Plate A, Poston G, Saarto T, Soffietti R, Torresin A, Van Harten WH, Verzijlbergen JF, von Kalle C,
Poortmans P. Still a long way to go to achieve multidisciplinarity for the benefit of patients:
commentary on the ESMO position paper (Annals of Oncology 25(1): 9-15, 2014). Ann Oncol 2014;
25:1863-5 (NKI)
1345. Valkenet K, Trappenburg JCA, Gosselink R, Sosef MN, Willms J, Rosman C, Pieters H, Scheepers JJG, de
Heus SC, Reynolds JV, Guinan E, Ruurda JP, Rodrigo EHE, Nafteux P, Fontaine M, Kouwenhoven EA,
Kerkemeyer M, van der Peet DL, Hania SW, van Hillegersberg. Preoperative inspiratory muscle training
to prevent postoperative pulmonary complications in patients undergoing esophageal resection
(PREPARE study): study protocol for a randomized controlled trial. Trials 2014; 15: 144. (VUmc)
1346. van Akkooi AC, Eggermont AM. Melanoma: MSLT-1--SNB is a biomarker, not a therapeutic intervention.
Nat Rev Clin Oncol 2014; 11:248-9 (NKI)
1347. van Akkooi AC, Eggermont AM. SLNB in melanoma-DFS a true and cost-effective benefit? Nat Rev Clin
Oncol 2014; 11:680 (NKI)
1348. van Akkooi AC, Kukutsch NA, Soetekouw P. [Sentinel lymph node procedure in melanoma patients: a
staging procedure, not a therapy]
Schildwachtklierprocedure voor melanoom: niet therapeutisch, maar stagerend. Ned Tijdschr Geneeskd
2014; 158:A8113 (NKI)
1349. van Akkooi AC. Sentinel node followed by completion lymph node dissection versus nodal observation:
staging or therapeutic? Controversy continues despite final results of MSLT-1. Melanoma Res 2014;
24:291-4 (NKI)
1350. van Arensbergen J, van Steensel B, Bussemaker HJ. In search of the determinants of enhancer-promoter
interaction specificity. Trends Cell Biol 2014; 24:695-702 (NKI)
1351. Van As JW, van den Berg H, van Dalen EC. Different infusion durations for preventing platinum-induced
hearing loss in children with cancer. Cochrane database of Systematic Reviews 2014(6), 2014,
p.CD010885-. (AMC)
1352. Van As JW, van den Berg H, van Dalen EC. Medical interventions for the prevention of platinum-induced
hearing loss in children with cancer. Cochrane Database of Systematic Reviews 7(7), 2014, p.CD009219-.
(AMC)
1353. van Beek S, Mencarelli A, Remeijer P, Sonke JJ, Rasch CRN. Local interfractional setup reproducibility
for 2 individual head and neck supports in head and neck cancer patients. Pract Radiat Oncol 2014;
4:448-54 (NKI)
1354. Van Beekhuizen HJ, Auzin M, van den Einden LCG, de Hullu JA, van der Velden J, Wildhagen MF, van
Doorn HC.: Lymph Node Count at Inguinofemoral Lymphadenectomy and Groin Recurrences in Vulvar
Cancer. International Journal of Gynecological Cancer 24(4), 2014, p.773-778. (AMC)
1355. van Berge L, Hamilton EMC, Linnankivi T, Uziel G, Steenweg ME, Isohanni P, Wolf NI, Krageloh-Mann I,
Brautaset NJ, Andrews PI, Jong BA, al Ghamdi M, van Wieringen WN, Tannous BA, Hulleman E,
Wurdinger T, van Berkel CGM, Polder E, Abbink TEM, Struys EA, Sc. Leukoencephalopathy with
brainstem and spinal cord involvement and lactate elevation: clinical and genetic characterization and
target for therapy. Brain 2014; 137: 1019-1029. (VUmc)
1356. van Boerdonk RAA, Daniels JMA, Snijders PJF, Grünberg K, Thunnissen FBJM, van de Wiel M, Ylstra B,
Postmus PE, Meijer CJLM, Meijer GA, Smit EF, Sutedja TG, Heideman DAM. DNA copy number
aberrations in endobronchial lesions: a validated predictor for cancer. Thorax 2014; 69: 451-457. (VUmc)
1357. Van Bree SHW, Bemelman WA, Hollmann MW, Zwinderman AH, Matteoli G, El Temna S, The FO, Vlug MS,
Scientific publications - 149
1358.
1359.
1360.
1361.
1362.
1363.
1364.
1365.
1366.
1367.
1368.
1369.
1370.
1371.
1372.
1373.
1374.
1375.
1376.
1377.
Bennink RJ, Boeckxstaens GEE. Identification of Clinical Outcome Measures for Recovery of
Gastrointestinal Motility in Postoperative Ileus. Annals of Surgery 259(4), 2014, p.708-714. (AMC)
van Bruinessen IR, van Weel-Baumgarten EM, Snippe HW, Gouw H, Zijlstra JM, van Dulmen S. Active
Patient Participation in the Development of an Online Intervention. J Med Internet Res 2014; 16: e59.
(VUmc)
Van Brunschot S, Fockens P, Bakker OJ, Besselink MG, Voermans RP, Poley J-W, Gooszen HG, Bruno M,
van Santvoort HC. Endoscopic transluminal necrosectomy in necrotising pancreatitis: a systematic
review. Surgical Endoscopy and other Interventional Techniques 28(5), 2014, p.1425-1438. (AMC)
Van Brunschot S, Fockens P, Bakker OJ, Besselink MG, Voermans RP, Poley J-W, Gooszen HG, Bruno M,
van Santvoort HC. Erratum to: Endoscopic transluminal necrosectomy in necrotising pancreatitis: a
systematic review. Surgical Endoscopy and other interventional Techniques 28(6), 2014, p.2003-. (AMC)
van Buuren MM, Calis JJ, Schumacher TNM. High sensitivity of cancer exome-based CD8 T cell neoantigen identification. Oncoimmunology 2014; 3:e28836 (NKI)
van Buuren MM, Dijkgraaf FE, Linnemann C, Toebes M, Chang CX, Mok JY, Nguyen M, van Esch WJ,
Kvistborg P, Grotenbreg GM, Schumacher TNM. HLA micropolymorphisms strongly affect peptide-MHC
multimer-based monitoring of antigen-specific CD8+ T cell responses. J Immunol 2014; 192:641-8 (NKI)
Van Dalen EC, Raphael MF, Caron HN, Kremer LCM. Treatment including anthracyclines versus treatment
not including anthracyclines for childhood cancer. Cochrane Database of systemic Reviews 2014(9),
2014, p.CD006647-. (AMC)
van de Donk NW, Palumbo A, Johnsen HE, Engelhardt M, Gay F, Gregersen H, Hajek R, Kleber M, Ludwig
H, Morgan G, Musto P, Plesner T, Sezer O, Terpos E, Waage A, Zweegman S, Einsele H, Sonneveld P,
Lokhorst HM. The clinical relevance and management of monoclonal gammopathy of undetermined
significance and related disorders: recommendations from the European Myeloma Network. HaematolHematol J 2014; 99: 984-996. (VUmc)
Van de Laar R, Zusterzeel PLM, van Gorp T, Buist MR, van Driel WJ, Gaarenstroom KN, Arts HJG, van
Huisseling JCM, Hermans RHM, Pijnenborg JMA, Schutter EMJ, Pelikan HMP, Vollebergh JHA, Engelen
MJA, IntHout J, Kruitwagen RFPM, Massuger LFAG. Cytoreductive surgery followed by chemotherapy
versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a
multicenter randomised controlled study.
BMC Cancer 14(1), 2014, p.22-. (AMC/NKI)
Van de Schoot AJAJ, Schooneveldt G, Wognum S, Hoogeman MS, Chai X, Stalpers LJA, Rasch CRN, Bel A.
Generic method for automatic bladder segmentation on cone beam CT using a patient-specific bladder
shape model. Medical Physics 41(3), 2014, p.031707-. (AMC)
Van de Vijver MJ. Molecular tests as prognostic factors in breast cancer. Virchows Archiv 464(3), 2014,
p.283-291. (AMC)
van de Wiel MA, Neerincx M, Buffart TE, Sie DLS, Verheul HM. ShrinkBayes: a versatile R-package for
analysis of count-based sequencing data in complex study designs. BMC Bioinformatics 2014; 15: 116.
(VUmc)
van Dellen E, Douw L, Hillebrand A, Hamer PCD, Baayen JC, Heimans JJ, Reijneveld JC, Stam CJ.
Epilepsy surgery outcome and functional network alterations in longitudinal MEG: A minimum spanning
tree analysis. Neuroimage 2014; 86: 354-363. (VUmc)
van den Ancker W, van Luijn MM, Chamuleau MED, Kelder A, Feller N, Terwijn M, Zevenbergen A,
Schuurhuis GJ, van Ham SM, Westers TM, Ossenkoppele GJ, van de Loosdrecht AA. High class IIassociated invariant chain peptide expression on residual leukemic cells is associated with increased
relapse risk in acute myeloid leukemia. Leukemia Res 2014; 38: 691-693. (VUmc)
Van den Berg H, Merks JHM. Incidence and grading of cranio-facial osteosarcomas. International Journal
of Oral and Maxiillofacial Surgery 43(1), 2014, p.7-12. (AMC)
van den Berg JH, Oosterhuis K, Schumacher TN, Haanen JB, Bins AD. Intradermal vaccination by DNA
tattooing. Methods Mol Biol 2014; 1143:131-40 (NKI)
van den Berg MH, van D, Overbeek A, Ronckers CM, van Dorp W, Kremer LC, van den Heuvel-Eibrink MM,
Huizinga GA, Loonen JJ, Versluys AB, Bresters D, Lambalk CB, Kaspers GJL, van Leeuwen FE. Fertility
studies in female childhood cancer survivors: selecting appropriate comparison groups. Reprod Biomed
Online 2014; 29: 352-361. (VUmc/NKI)
Van den Berg MH, van Dulmen-den Broeder E, Overbeek A, Ronckers CM, van Dorp W, Kremer LC, van
den Heuvel-Eibrink MM, Huizinga GA, Loonen JJ, Versluys AB, Bresters D, Lambalk CB, Kaspers GJ, van
Leeuwen F: Fertility studies in female childhood cancer survivors: selecting appropriate comparison
groups. Reproductive Biomedicine Online 29(3), 2014, p.352-361. (AMC)
Van den Berg MW, Ledeboer M, Dijkgraaf MGW, Fockens P, ter Borg F, van Hooft JE. Long-term results of
palliative stent placement for acute malignant colonic obstruction. Surgical Endoscopy and Other
Interventional Techniques [aheadofprint], 2014, p.-. (AMC)
Van den Berg MW, Sloothaak DAM, Dijkgraaf MGW, van der Zaag ES, Bemelman WA, Tanis PJ, Bosker RJI,
Fockens P, ter Borg F, van Hooft JE. Bridge-to-surgery stent placement versus emergency surgery for
acute malignant colonic obstruction. Britisch Journal of Surgery 101(7), 2014, p.867-873. (AMC)
Van den Berg MW, Walter D, de Vries EMG, Vleggaar FP, van Berge Henegouwen MI, van Hillegersberg R,
Siersema PD, Fockens P, van Hooft JE. Biodegradable stent placement before neoadjuvant
chemoradiotherapy as a bridge to surgery in patients with locally advanced esophageal cancer.
Gastrointestinal Endoscopy 80(5), 2014, p.908-913. (AMC)
150 - Scientific publications
1378. Van den Berg MW, Walter D, Vleggaar FP, Siersema PD, Fockens P, van Hooft JE. High proximal
migration rate of a partially covered "big cup" duodenal stent in patients with malignant gastric outlet
obstruction. Endoscopy 46(2), 2014, p.158-161. (AMC)
1379. Van den Berg NS, Brouwer OR, Schaafsma BE, Mathéron HM, Klop WMC, Balm AJM, van Tinteren H,
Nieweg OE, van Leeuwen FWB, Valdés Olmos RA. Multimodal Surgical Guidance during Sentinel Node
Biopsy for Melanoma: Combined Gamma Tracing and Fluorescence Imaging of the Sentinel Node through
Use of the Hybrid Tracer Indocyanine Green-(99m)Tc-Nanocolloid. Radiology [aheadofprint], 2014,
p.140322- (AMC)
1380. van den Berg NS, Buckle T, Kleinjan GI, Klop WM, Horenblas S, van der Poel HG, Valdes-Olmos RA, Van
Leeuwen FI. Hybrid tracers for sentinel node biopsy. Q J Nucl Med Mol Imaging 2014; 58:193-206 (NKI)
1381. van den Bergh RC, De Blok W, Van Muilekom E, Tillier C, Venderbos LD, van der Poel HG. Impact on
quality of life of radical prostatectomy after initial active surveillance: more to lose? Scand J Urol 2014;
48:367-73 (NKI)
1382. van den Bergh RC, van der Poel HG. Re: M. Minhaj Siddiqui, Soroush Rais-Bahrami, Hong Truong, et al.
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus
systematic 12-core transrectal ultrasound biopsy. Eur Urol 2013;64:713-9 and Re: Mark Emberton. Has
magnetic resonance-guided biopsy of the prostate become the standard of care? Eur Urol 2013;64:720-1.
Eur Urol 2014; 65:e106-e107 (NKI)
1383. van den Boer C, Muller S, Vincent A, van den Brekel M, Hilgers F. Ex vivo assessment and validation of
water exchange performance of 23 Heat and Moisture Exchangers for laryngectomized patients. Respir
Care 2014; 59:1161-71 (NKI)
1384. van den Boer C, Muller SH, Vincent AD, Zuchner K, van den Brekel MWM, Hilgers FJM. Ex vivo water
exchange performance and short-term clinical feasibility assessment of newly developed heat and
moisture exchangers for pulmonary rehabilitation after total laryngectomy. Eur Arch Otorhinolaryngol
2014; 271:359-66 (NKI)
1385. van den Boer C, van Harten MC, Hilgers FJ, van den Brekel MW, Retel VP. Incidence of severe
tracheobronchitis and pneumonia in laryngectomized patients: a retrospective clinical study and a
European-wide survey among head and neck surgeons. Eur Arch Otorhinolaryngol 2014; 271:3297-303
(NKI)
1386. van den Boer C, Vas Nunes JH, Muller SH, van der Noort V, van den Brekel MWM, Hilgers FJM. Water
Uptake Performance of Hygroscopic Heat and Moisture Exchangers after 24-Hour Tracheostoma
Application. Otolaryngol Head Neck Surg 2014; 150:999-1004 (NKI)
1387. van den Boezem PB, Velthuis S, Lourens HJ, Cuesta MA, Sietses C. Single-incision and NOTES
Cholecystectomy, Are There Clinical or Cosmetic Advantages When Compared to Conventional
Laparoscopic Cholecystectomy? A Case-control Study Comparing Single-incision, Transvaginal, and
Conventional Laparoscopic Technique for Chol. World J Surg 2014; 38: 25-32. (VUmc)
1388. Van den Bos W, de Bruin DM, Muller BG, Varkarakis IM, Karagiannis AA, Zondervan PJ, Laguna Pes MP,
Veelo DP, Savci Heijink CD, Engelbrecht MRW, Wijkstra H, de Reijke TM, de la Rosette JJMCH. The
safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre
prospective human in vivo pilot study protocol. BMJ Open 4(10), 2014, p.e006382-. (AMC)
1389. Van den Bos W, Muller BG, Ahmed H, Bangma CH, Barret E, Crouzet S, Eggener SE, Gill IS, Joniau S,
Kovacs G, Pahernik S, de la Rosette JJ, Rouvière O, Salomon G, Ward JF, Scardino PT. Focal Therapy in
Prostate Cancer: International Multidisciplinary Consensus on Trial Design. European Urology 65(6),
2014, p.1078-1083. (AMC)
1390. Van den Bos W, Muller BG, Ehdaie B, Scardino P, de La Rosette JJMCH. What is still needed to make
focal therapy an accepted segment of standard therapy? Current Opinion in Urology 24(3), 2014,
p.247-255. (AMC)
1391. Van den Broek FJC, Stokkers PCF, Reitsma JB, Boltjes RPB, Ponsioen CY, Fockens P, Dekker E. Random
biopsies taken during colonoscopic surveillance of patients with longstanding ulcerative colitis: low yield
and absence of clinical consequences. American Journal of Gastroenterology 109(5), 2014, p.715-722.
(AMC)
1392. Van den Heuvel MM, Uyterlinde W, Vincent AD, de Jong J, Aerts J, Koppe F, Knegjens J, Codrington H,
Kunst PWE, Dieleman E, Verheij M, Belderbos J. Additional weekly Cetuximab to concurrent
chemoradiotherapy in locally advanced non-small cell lung carcinoma: efficacy and safety outcomes of a
randomized, multi-center phase II study investigating. Radiotherapy and Oncology 110(1), 2014,
p.126-131. (AMC/NKI)
1393. van der Born D, Sewing C, Herscheid JDM, Windhorst AD, Orru RVA, Vugts DJ. A Universal Procedure for
the [F-18]Trifluoromethylation of Aryl Iodides and Aryl Boronic Acids with Highly Improved Specific
Activity. Angew Chem Int Ed Engl 2014; 53: 11046-11050. (VUmc)
1394. Van der Gaag NA, Berkhemer OA, Sprangers MA, Busch ORC, Bruno MJ, de Castro SM, van Gulik TM,
Gouma DJ. Quality of Life and Functional Outcome After Resection of Pancreatic Cystic Neoplasm.
Pancreas 43(5), 2014, p.755-761. (AMC)
1395. Van der Gaag NA, Harmsen K, Eshuis WJ, Busch ORC, van Gulik TM, Gouma DJ. Pancreatoduodenectomy
associated complications influence cancer recurrence and time interval to death. EJSO : European
Journal of Surgical Oncology 40(5), 2014, p.551-558. (AMC)
1396. Van der Gaag NA, van Gulik TM, Gouma DJ. Role of Preoperative Biliary Drainage in Jaundiced Patients
Who Are Candidates for Pancreatoduodenectomy or Hepatic Resection. Annals of Surgery 259(4), 2014,
Scientific publications - 151
p.E74-E75. (AMC)
1397. Van der Have M, Belderbos TDG, Fidder HH, Leenders M, Dijkstra G, Peters CP, Eshuis EJ, Ponsioen CY,
Siersema PD, van Oijen MGH, Oldenburg B. Screening prior to biological therapy in Crohn's disease:
Adherence to guidelines and prevalence of infections. Results from a multicentre retrospective study.
Digestive and Liver Disease 46(10), 2014, p.881-886. (AMC)
1398. Van der Horst A, Lens E, Wognum S, de Jong R, van Hooft JE, van Tienhoven G, Bel A. Limited role for
biliary stent as surrogate fiducial marker in pancreatic cancer: stent and intratumoral fiducials
compared. International Journal of Radiation Oncology Biology Physics 89(3), 2014, p.641-648. (AMC)
1399. van der Kaaij MAE, van Echten-Arends J, Heutte N, Meijnders P, beilard-Lemoisson E, Spina M, Moser EC,
Allgeier A, Meulemans B, Lugtenburg PJ, Aleman BMP, Noordijk EM, Ferme C, Thomas J, Stamatoullas A,
Fruchart C, Eghbali H, Brice P, Smit WGJM, Sebban C,. Cryopreservation, semen use and the likelihood
of fatherhood in male Hodgkin lymphoma survivors: an EORTC-GELA Lymphoma Group cohort study. Hum
Reprod 2014; 29: 525-533. (VUmc/NKI)
1400. van der Kant R, Neefjes J. Small regulators, major consequences - Ca(2)(+) and cholesterol at the
endosome-ER interface. J Cell Sci 2014; 127:929-38 (NKI)
1401. van der Leij F, Elkhuizen PH, Janssen TM, Poortmans P, van der Sangen M, Scholten AN, VlietVroegindeweij C, Boersma LJ. Target volume delineation in external beam partial breast irradiation:
less inter-observer variation with preoperative- compared to postoperative delineation. Radiother Oncol
2014; 110:467-70 (NKI)
1402. van der Linden N, van Gils CWM, Pescott CP, Buter J, Uyl-de Groot CA. Cetuximab in locally advanced
squamous cell carcinoma of the head and neck: generalizability of EMR 062202-006 trial results. Eur
Arch Oto-Rhino-L 2014; 271: 1673-1678. (VUmc)
1403. van der Marel J, van Baars R, Quint WGV, Berkhof J, Del Pino M, Torne A, Ordi J, Wentzensen N,
Schiffman M, van de Sandt MMV, Lindeman J, Jenkins D, Helmerhorst TJM, Verheijen RHM, ter Harmsel
B, Alonso I. The impact of human papillomavirus genotype on colposcopic appearance: a cross-sectional
analysis. BJOG-Int J Obstet Gyn 2014; 121: 1117-1126. (VUmc)
1404. van der Marel J, van Baars R, Rodriguez A, Quint WGV, van de Sandt MM, Berkhof J, Schiffman M, Torne
A, Ordi J, Jenkins D, Verheijen RHM, Helmerhorst TJM, ter Harmsel B, Wentzensen N, Del Pino M. The
increased detection of cervical intraepithelial neoplasia when using a second biopsy at colposcopy.
Gynecol Oncol 2014; 135: 201-207. (VUmc)
1405. van der Meer L, Schiphorst A, Hahn D, Eijzenga W. Gespecialiseerde psychosociale zorg bij erfelijke
kanker. Kanker Breed 2014; 6:12-4 (NKI)
1406. van der Mijn JC, Mier JW, Broxterman HJ, Verheul HM. Predictive biomarkers in renal cell cancer:
insights in drug resistance mechanisms. Drug Resist Update 2014; 17: 77-88. (VUmc)
1407. van der Mijn JC, Sol N, Mellema W, Jimenez CR, Piersma SR, Dekker H, Schulte LM, Smit EF, Broxterman
HJ, Skog J, Tannous BA, Wurdinger T, Verheul HM. Analysis of AKT and ERK1/2 protein kinases in
extracellular vesicles isolated from blood of patients with cancer. Journal of Extracellular Vesicles 2014;
3: 25657. (VUmc)
1408. Van der Molen L, van Rossum MA, Rasch CRN., Smeele LE, Hilgers FJM. Two-year results of a prospective
preventive swallowing rehabilitation trial in patients treated with chemoradiation for advanced head
and neck cancer.
European Archives of Oto-rhino-laryngology 271(5), 2014, p.1257-1270. (AMC/NKI)
1409. Van der Paardt MP, Sprengers AMJ, Zijta FM, Lamerichs R, Nederveen AJ, Stoker J. Noninvasive
automated motion assessment of intestinal motility by continuously tagged MR imaging. Journal of
Magnetic Resonance Imaging 39(1), 2014, p.9-16. (AMC)
1410. Van der Paardt MP, Stoker J. Magnetic resonance colonography for screening and diagnosis of colorectal
cancer. Magnetic Resonance Imaging Clinics of Norht America 22(1), 2014, p.67-83. (AMC)
1411. Van der Paardt MP, Zijta FM, Boellaard TN, Jensch S, Baak LC, Depla ACTM, Dekker E, Nederveen AJ,
Bipat S, Stoker J. Magnetic resonance colonography with automated carbon dioxide insufflation:
Diagnostic accuracy and distension. European Journal of Radiology 83(5), 2014, p.743-750. (AMC)
1412. van der Plas AGM, Hagens M, Pasman HRW, Schweitzer B, Duijsters M, Onwuteaka-Philipsen BD. PaTz
groups for primary palliative care: reinventing cooperation between general practitioners and district
nurses in palliative care: an evaluation study combining data from focus groups and a questionnaire.
BMC Fam Pract 2014; 15: 14. (VUmc)
1413. van der Poel H. Words of wisdom. Re: Transurethral surgery and twice-daily radiation plus paclitaxelcisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for
patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial. Eur
Urol 2014; 65:1221-2 (NKI)
1414. van der Poel HG, van den Berg NS, Kleinjan GH, van Leeuwen FW. Reply from Authors re: Francesco
Montorsi, Giorgio Gandaglia. Sentinel Node Biopsy for Prostate Cancer: A Useless Surgical Exercise? Eur
Urol 2014;66:999-1000: Removing Nodes that Count Rather than Counting Nodes that Don't. Eur Urol
2014; 66:1000-1 (NKI)
1415. van der Poel HG. Extent of lymph node metastases. BJU Int 2014; 114:469-70 (NKI)
1416. van der Poel HG. Nationwide prostatectomy practice. BJU Int 2014; 113:513-4 (NKI)
1417. van der Poel MWM, Mulder WJM, Ossenkoppele GJ, Maartense E, Wijermans P, Hoogendoorn M, Schouten
HC. Comorbidity and treatment decision-making in elderly non-Hodgkin's lymphoma patients: a survey
among haematologists. Neth J Med 2014; 72: 165-169. (VUmc)
152 - Scientific publications
1418. Van der Pol E, Coumans FAW, Sturk A, Nieuwland R, van Leeuwen TG. Refractive Index Determination of
Nanoparticles in Suspension Using Nanoparticle Tracking Analysis. Nano Letters 14(11), 2014,
p.6195-6201. (AMC)
1419. van der Spek N, Uden-Kraan CF, Vos J, Breitbart W, Tollenaar RAEM, van Asperen CJ, Cuijpers P, de
Leeuw IM. Meaning-centered group psychotherapy in cancer survivors: a feasibility study. Psycho-Oncol
2014; 23: 827-831. (VUmc)
1420. van der Spek N, Vos J, van Uden-Kraan CF, Breitbart W, Cuijpers P, Knipscheer-Kuipers K, Willemsen
VWB, Tollenaar RA, van Asperen CJ, de Leeuw IM. Effectiveness and cost-effectiveness of meaningcentered group psychotherapy in cancer survivors: protocol of a randomized controlled trial. BMC
Psychiatry 2014; 14: 22. (VUmc)
1421. van der Veen BE, Harris HM, O'Toole PW, Claesson MJ. Metaphor: Finding Bi-directional Best Hit
homology relationships in (meta)genomic datasets. Genomics 2014; 104:459-63 (NKI)
1422. van der Veldt AAM, Lammertsma AA. In Vivo Imaging as a Pharmacodynamic Marker. Clin Cancer Res
2014; 20: 2569-2577. (VUmc)
1423. van der Veldt AAM, Smit EF, Comans EFI, Lammertsma AA. Effects of chemotherapy on the parotid and
submandibular glands in head and neck cancer patients treated with chemoradiotherapy. Strahlenther
Onkol 2014; 190: 221-222. (VUmc)
1424. van der Veldt AAM, Smit EF, Lammertsma AA. Does Drug Accumulation in Bone Explain the Efficacy and
Toxicity of Docetaxel in Prostate Cancer?. Clinical genitourinary cancer 2014; 12: E63-E64. (VUmc)
1425. van der Veldt AAM, Smit EF, Lammertsma AA. Pituitary Gland: Do Anticancer Drugs Sit in the Turkish
Saddle?. J Clin Oncol 2014; 32: 851-852. (VUmc)
1426. Van der Waal D, Verbeek ALM, den Heeten GJ, Ripping TM., Tjan-Heijnen VCG, Broeders MJM. Breast
cancer diagnosis and death in the Netherlands: a changing burden. European Journal of Public Health -,
2014, p.--. (AMC)
1427. van der Waal I. Oral potentially malignant disorders: Is malignant transformation predictable and
preventable?. Medicina oral patologia oral y cirugia bucal 2014; 19: E386-E390. (VUmc)
1428. van Dijk FS, Sillence DO. Osteogenesis imperfecta: Clinical diagnosis, nomenclature and severity
assessment. Am J Hum Genet A 2014; 164: 1470-1481. (VUmc)
1429. Van Dijk IWEM, van Os RM, van de Kamer JB, Franken NAP, van der Pal HJH, Koning CCE, Caron HN,
Ronckers CM, Kremer LCM. The use of equivalent radiation dose in the evaluation of late effects after
childhood cancer treatment. Journal of Cancer Survivorship-Research and Practice 8(4), 2014,
p.638-646. (AMC)
1430. Van Dijk-Lokkart EM, Braam KI, Huisman J, Kaspers GJL, Takken T, Veening MA, Bierings M, Merks JH,
Grootenhuis MA, van den Heuvel-Eibrink M, Streng IC, van Dulmen-den Broeder E. Factors influencing
childhood cancer patients to participate in a combined physical and psychosocial intervention program:
Quality of Life in Motion. Psycho-Oncology -, 2014, p.--. (AMC)
1431. Van Doorn SC, van Vliet J, Fockens P, Dekker E. A novel colonoscopy reporting system enabling quality
assurance. Endoscopy 46(3), 2014, p.181-187. (AMC)
1432. I)
1433. Van Eggermond AM, Schaapveld M, Lugtenburg PJ, Krol ADG, de Boer JP, Zijlstra JM, Raemaekers JMM,
Kremer LCM, Roesink JM, Louwman MWJ, Aleman BMP, van Leeuwen FE. Risk of multiple primary
malignancies following treatment of Hodgkin lymphoma. Blood 124(3), 2014, p.319-327.
(AMC/NK/VUmcI)
1434. Van Es N, Sturk A, Middeldorp S, Nieuwland R. Effects of cancer on platelets. Seminar in Oncology 41(3),
2014, p.311-318. (AMC)
1435. van Geel RMJM, Bernards R, Voest EE, Lolkema MPJK, Cats A, Sleijfer S, Eskens FALM, Schellens JHM.
Innovatieve combinatie van doelgerichte middelen voor de behandeling van gemetastaseerd
BRAFgemuteerd colorectaal carcinoom. Ned Tijdschr Oncol 2014; 11:69-72 (NKI)
1436. van Geemen D, Smeets MW, van Stalborch AM, Woerdeman LAE, Daemen MJ, Hordijk PL, Huveneers S. Factin-anchored focal adhesions distinguish endothelial phenotypes of human arteries and veins.
Arterioscler Thromb Vasc Biol 2014; 34:2059-67 (NKI)
1437. van Gent M, Braem SG, De Jong A, Delagic N, Peeters JG, Boer IG, Moynagh PN, Kremmer E, Wiertz EJ,
Ovaa H, Griffin BD, Ressing ME. Epstein-Barr virus large tegument protein BPLF1 contributes to innate
immune evasion through interference with toll-like receptor signaling. PLoS Pathog 2014; 10:e1003960
(NKI)
1438. Van Golen RF, Reiniers MJ, Verheij J, Heger M. Solutions to the discrepancies in liver damage profiles
following ischemia/reperfusion in standardized mouse models. Journal of Hepatology [aheadofprint],
2014, p.-. (AMC)
1439. Van Golen RF, Reiniers MJ, Vrisekoop N, Zuurbier CJ, Olthof PB, van Rheenen J, van Gulik TM, Parsons
BJ, Heger M. The Mechanisms and Physiological Relevance of Glycocalyx Degradation in Hepatic
Ischemia/Reperfusion Injury. Anitoxidants & Redox Signaling 21(7), 2014, p.1098-+. (AMC)
1440. van Gool MH, Aukema TS, Hartemink KJ, Valdes Olmos RA, Van Tinteren H, Klomp HM. FDG-PET/CT
response evaluation during EGFR-TKI treatment in patients with NSCLC. World J Radiol 2014; 6:392-8
(NKI)
1441. van Gool MH, Aukema TS, Schaake EE, Rijna H, Codrington HE, Valdes Olmos RA, Teertstra HJ, van Pel
R, Burgers SA, Van Tinteren H, Klomp HM. (18)F-Fluorodeoxyglucose Positron Emission Tomography
versus Computed Tomography in Predicting Histopathological Response to Epidermal Growth Factor
Scientific publications - 153
1442.
1443.
1444.
1445.
1446.
1447.
1448.
1449.
1450.
1451.
1452.
1453.
1454.
1455.
1456.
1457.
1458.
1459.
1460.
1461.
Receptor-Tyrosine Kinase Inhibitor Treatment in Resectable Non-Small Cell Lung Cancer. Ann Surg Oncol
2014; 21:2831-7 (NKI)
van Gool MH, Aukema TS, Schaake EE, Rijna H, Valdes Olmos RA, van Pel R, Burgers SA, Van Tinteren H,
Klomp HM. Timing of Metabolic Response Monitoring During Erlotinib Treatment in Non-Small Cell Lung
Cancer. J Nucl Med 2014; 55:1081-6 (NKI)
van Gorp F, van Rens MTM, Kuck EM, Rozemeijer R, Huitema ADR, Brouwers EEM. Dosing of carboplatin
in a patient with amputated legs: A case report. J Oncol Pharm Pract 2014; 20:473-5 (NKI)
van Grieken NCT, Aoyama T, Chambers P, Bottomley D, Ward L, Inam I, Buffart T, Das K, Lim T, Pang B,
Zhang S, Tan I, Carvalho B, Heideman DAM, Miyagi Y, Kameda Y, Arai T, Meijer GA, Tsuburaya A, Tan P,
Yoshikawa T, Grabsch H, I. KRAS and BRAF mutations are rare and related to DNA mismatch repair
deficiency in gastric cancer from the East and the West: Results from a large international multicentre
study (vol 108, pg 1495, 2013). Brit J Cancer 2014; 110: 546. (VUmc)
Van Halsema EE, van Hooft JE, Small AJ, Baron TH, García-Cano J, Cheon Jae H, Lee Moon S, Kwon Se H,
Mucci-Hennekinne S, Fockens P, Dijkgraaf MGW, Repici A. Perforation in colorectal stenting: a
meta-analysis and a search for risk factors. Gastrointestinal Endoscopy 79(6), 2014, p.970-82.e7; quiz
983.e2, 983.e5. (AMC)
van Harten MC, de Ridder M, Hamming-Vrieze O, Smeele LE, Balm AJM, van den Brekel MWM. The
association of treatment delay and prognosis in head and neck squamous cell carcinoma (HNSCC)
patients in a Dutch comprehensive cancer center. Oral Oncol 2014; 50:282-90 (NKI/AMC)
Van Harten WH. Comprehensive cancer centres based on a network: the OECI point of view.
Ecancermedicalscience 2014; 8:ed43 (NKI)
Van Hasselt J. G. C, van Eijkelenburg NKA, Beijnen JH, Schellens JHM, Huitema ADR. Design of a
drug-drug interaction study of vincristine with azole antifungals in pediatric cancer patients using
clinical trial simulation. Pediatric Blood and Cancer 61(12), 2014, p.2223-2229. (AMC/NKI)
van Hasselt JG, Van Calsteren K, Heyns L, Han S, Mhallem Gziri M, Schellens JHM, Beijnen JH, Huitema
AD, Amant F. Optimizing anti-cancer drug treatment in pregnant cancer patients: pharmacokinetic
analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel. Ann Oncol
2014; 25:2059-65 (NKI)
van Hasselt JGC, Allegaert K, Van Calsteren K, Beijnen JH, Schellens JHM, Huitema ADR.
Semiphysiological versus empirical modelling of the population pharmacokinetics of free and total
cefazolin during pregnancy. Biomed Res Int 2014; 2014:897216 (NKI)
van Hasselt JGC, van Eijkelenburg NKA, Beijnen JH, Schellens JHM, Huitema ADR. Design of a drug-drug
interaction study of vincristine with azole antifungals in pediatric cancer patients using clinical trial
simulation. Pediatr Blood Cancer 2014; 61:2223-9 (NKI)
Van Heek NT, Busch OR, van Gulik TM, Gouma DJ. Preoperative biliary drainage for pancreatic cancer.
Minerva Medica 105(2), 2014, p.99-107. (AMC)
van Heerde MJ, Buijs J, Hansen BE, de Waart M, van Eijck CHJ, Kazemier G, Pek CJ, Poley JW, Bruno
MJ, Kuipers EJ, van Buuren HR. Serum Level of Ca 19-9 Increases Ability of IgG4 Test to Distinguish
Patients with Autoimmune Pancreatitis from Those with Pancreatic Carcinoma. Digest Dis Sci 2014; 59:
1322-1329. (VUmc)
van Heesbeen RG, Tanenbaum ME, Medema RH. Balanced activity of three mitotic motors is required for
bipolar spindle assembly and chromosome segregation. Cell Rep 2014; 8:948-56 (NKI)
van Hell AJ, Klymchenko A, Gueth DM, van Blitterswijk WJ, Koning GA, Verheij M. Membrane
organization determines barrier properties of endothelial cells and short-chain sphingolipid-facilitated
doxorubicin influx. Biochim Biophys Acta 2014; 1841:1301-7 (NKI)
Van Hemert F, van der Kuyl AC, Berkhout B. On the nucleotide composition and structure of retroviral
RNA genomes.
Virus Research 193, 2014, p.16-23. (AMC)
Van Hooft JE, van Halsema EE, Vanbiervliet G, Beets-Tan RGH, Dewitt JM, Donnellan F, Dumonceau J-M,
Glynne-Jones RGT, Hassan C, Jiménez-Perez J, Meisner S, Muthusamy VR, Parker MC, Regimbeau J-M,
Sabbagh C, Sagar J, Tanis PJ, Vandervoort J, Webster GJ, Manes G, Barthet MA, Repici A.
Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of
Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy 46(11), 2014, p.990-1002. (AMC)
Van Hooft JE, van Halsema EE, Vanbiervliet G, Beets-Tan RGH, Dewitt JM, Donnellan F, Dumonceau JM,
Glynne-Jones RGT, Hassan C, Jiménez-Perez J, Meisner S, Muthusamy VR, Parker MC, Regimbeau J-M,
Sabbagh C, Sagar J, Tanis PJ, Vandervoort J, Webster GJ, Manes G, Barthet MA, Repici A.
Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of
Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Gastrointestinal Endoscopy 80(5), 2014,
p.747-761.e75. (AMC)
Van Huis-Tanja LH, Kweekel DM, Lu X, Franken K, Koopman M, Gelderblom H, Antonini NF, Punt CJA,
Guchelaar H-J, van der Straaten T. Excision Repair Cross-Complementation group 1 (ERCC1) C118T SNP
does not affect cellular response to oxaliplatin. Mutation Research-Fundamental and Molcular
Mechanisms of Mutagenesis. 759, 2014, p.37-44. (AMC)
Van Kasteren SI, Overkleeft H, Ovaa H, Neefjes J. Chemical biology of antigen presentation by MHC
molecules. Curr Opin Immunol 2014; 26:21-31 (NKI)
Van Keimpema M, Grüneberg LJ, Mokry M, van Boxtel R, Koster J, Coffer PJ, Pals ST, Spaargaren M.
FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-κB to promote
154 - Scientific publications
survival of human B cells. Blood 124(23), 2014, p.3431-3440. (AMC)
1462. van Kempen PM, Noorlag R, Braunius WW, Stegeman I, Willems SM, Grolman W. Differences in
methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma: a
systematic review. Epigenetics 2014; 9:194-203 (NKI)
1463. Van Kuilenburg ABP, Etienne-Grimaldi MC, Mahamat A, Meijer J, Laurent-Puig P, Olschwang S, Gaub MP,
Hennekam RCM, Benchimol D, Houry S, Letoublon C, Gilly FN, Pezet D, Andre T, Faucheron JL,
Abderrahim-Ferkoune A, Vijzelaar R, Pradere B, Milano G. Frequent intragenic rearrangements of DPYD
in colorectal tumours. Pharmacogenomics Journal [aheadofprint], 2014, p.-. (AMC)
1464. van la Parra RF, de Roos WK, Contant CM, Bavelaar-Croon CD, Barneveld PC, Bosscha K. A prospective
validation study of sentinel lymph node biopsy in multicentric breast cancer: SMMaC trial. Eur J Surg
Oncol 2014; 40:1250-5 (NKI)
1465. van la Parra RF, Peer PG, de Roos WK, Ernst MF, de Wilt JH, Bosscha K. A simple risk score to predict
the presence of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel
node. World J Surg 2014; 38:1070-6 (NKI)
1466. Van Laarhoven HWM, Henselmans I, de Haes JHC. To treat or not to treat: who should decide?
Oncologist 19(4), 2014, p.433-436. (AMC)
1467. van Leersum N, Martijnse I, den Dulk M, Kolfschoten N, Le Cessie S, van de Velde C, Tollenaar R,
Wouters M, Rutten HJ. Differences in circumferential resection margin involvement after
abdominoperineal excision and low anterior resection no longer significant. Ann Surg 2014; 259:1150-5
(NKI)
1468. Van Leersum NJ, Aalbers AG, Snijders HS, Henneman D, Wouters MW, Tollenaar RA, Eddes EH.
Synchronous colorectal carcinoma: a risk factor in colorectal cancer surgery. Dis Colon Rectum 2014;
57:460-6 (NKI)
1469. van Leeuwen FWB, Hruby S. Fluorescence guidance during radical prostatectomy. Eur Urol 2014;
65:1169- 70 (NKI)
1470. Van Leeuwen M, Efficace F, Fossa SD, Bolla M, De Giorgi U, de Wit R, Holzner B, van de Poll-Franse LV,
van Poppel H, White J, Collette L, Osanto S, Aaronson NK. Recruiting long-term survivors of European
Organisation for Research and Treatment of Cancer phase III clinical trials into quality of life studies:
challenges and opportunities. Eur J Cancer 2014; 50:1957-63 (NKI)
1471. Van Lith SAM, Molenaar R, van Noorden CJF, Leenders WPJ. Tumor cells in search for glutamate: an
alternative explanation for increased invasiveness of IDH1 mutant gliomas. Neuro-Oncology 16(12),
2014, p.1669-1670. (AMC)
1472. van Lith SAM, Navis AC, Verrijp K, Niclou SP, Bjerkvig R, Wesseling P, Tops B, Molenaar R, van Noorden
CJF, Leenders WPJ. Glutamate as chemotactic fuel for diffuse glioma cells: Are they glutamate
suckers?. BBA Reviews on Cancer 2014; 1846: 66-74. (VUmc/AMC)
1473. van Litsenburg RRL, Huisman J, Pieters R, Verhaak C, Kaspers GJ, Gemke RJ. Determinants of quality of
life during induction therapy in pediatric acute lymphoblastic leukemia. Support Care Cancer 2014; 22:
3235-3242. (VUmc)
1474. van Litsenburg RRL, Kunst A, Huisman J, Ket JC, Kaspers GJ, Gemke RJ. Health Status Utilities in
Pediatrics: A Systematic Review of Acute Lymphoblastic Leukemia. Med Decis Making 2014; 34: 21-32.
(VUmc)
1475. van Londen GJ, Donovan HS, Beckjord EB, Cardy AL, Bovbjerg DH, Davidson NE, Morse JQ, Switzer GE,
de Leeuw IM, Dew MA. Perspectives of postmenopausal breast cancer survivors on adjuvant endocrine
therapy-related symptoms. Oncol Nurs Forum 2014; 41: 660-668. (VUmc)
1476. van Luijn MM, van den Ancker W, van Ham SM, van de Loosdrecht AA. Class II-associated invariant chain
peptide as predictive immune marker in minimal residual disease in acute myeloid leukemia.
Oncoimmunology 2014; 3: e941737. (VUmc)
1477. van Maurik JFMM, Schouten MEL, ten Katen I, van Hal M, Peters EJG, Kon M. Ultrasound Findings After
Surgical Decompression of the Tarsal Tunnel in Patients With Painful Diabetic Polyneuropathy: A
Prospective Randomized Study. Diabetes Care 2014; 37: 767-772. (VUmc)
1478. van Maurik JFMM, van Hal M, van Eijk RPA, Kon M, Peters EJG. Value of Surgical Decompression of
Compressed Nerves in the Lower Extremity in Patients with Painful Diabetic Neuropathy: A Randomized
Controlled Trial. Plast Reconstr Surg 2014; 134: 325-332. (VUmc)
1479. Van Meurs HS, Buist MR, Westermann AM, Sonke GS, Kenter GG, van der Velden J. Effectiveness of
chemotherapy in measurable granulosa cell tumors: a retrospective study and review of literature.
International Journal of Gynecological Cancer 24(3), 2014, p.496-505. (AMC/NKI)
1480. Van Meurs HS, Schuit E, Horlings HM, van der Velden J, van Driel WJ, Mol BWJ, Kenter GG, Buist MR.
Development and internal validation of a prognostic model to predict recurrence free survival in
patients with adult granulosa cell tumors of the ovary. Gynecologic Oncology 134(3), 2014, p.498-504.
(AMC/NKI)
1481. Van Meurs HS, van Lonkhuijzen LRCW, Limpens J, van der Velden J, Buist MR. Hormone therapy in
ovarian granulosa cell tumors: a systematic review. Gynecologic Oncology 134(1), 2014, p.196-205.
(AMC)
1482. van Miltenburg MH, van Nimwegen MJ, Tijdens I, Lalai R, Kuiper R, Klarenbeek S, Schouten PC, de Vries
A, Jonkers J, van de Water B. Mammary gland-specific ablation of focal adhesion kinase reduces the
incidence of p53-mediated mammary tumour formation. Br J Cancer 2014; 110:2747-55 (NKI)
Scientific publications - 155
1483. van Mourik AM, Sonke JJ, Vijlbrief T, Dewit L, Damen EM, Remeijer P, van der Heide UA. Reproducibility
of the MRI-defined spinal cord position in stereotactic radiotherapy for spinal oligometastases.
Radiother Oncol 2014; 113:230-4 (NKI)
1484. Van Muijen P van, SFA Duijts, K. Bonefaas-Groenewoud, van der Beek AJ, Anema JR. Factors associated
with work disability in employed cancer survivors at 24-month sick leave. BMC Cancer 2014; 14: 236.
(VUmc)
1485. van Nieuwenhuizen AJ, Buffart LM, Smit JH, Brakenhoff RH, Braakhuis BJ, de Bree R, Leemans C, de
Leeuw IM. A comprehensive assessment protocol including patient reported outcomes, physical tests,
and biological sampling in newly diagnosed patients with head and neck cancer: is it feasible?. Support
Care Cancer 2014; 12: 3321-3330. (VUmc)
1486. Van Nimwegen FA, Schaapveld M, Janus CPM, Krol ADG, Raemaekers JMM, Kremer LCM, Stovall M,
Aleman BMP, van Leeuwen FE. Risk of diabetes mellitus in long-term survivors of Hodgkin lymphoma.
Journal of Clinical Oncology 32(29), 2014, p.3257-3263. (AMC/NKI)
1487. van Oers HA, Haverman L, Limperg PF, van Dijk-Lokkart EM, Maurice-Stam H, Grootenhuis MA. Anxiety
and Depression in Mothers and Fathers of a Chronically Ill Child. Maternal and child health journal 2014;
18: 1993-2002. (VUmc/AMC)
1488. Van Oers HA, Tacke CE, Haverman L, Kuipers IM, Maurice-Stam H, Kuijpers TW, Grootenhuis MA. Health
related quality of life and perceptions of child vulnerability among parents of children with a history of
Kawasaki disease. ACTA Paediatrica 103(6), 2014, p.671-677. (AMC)
1489. Van Oorschot B, Hovingh SE, Moerland PD, Medema JP, Stalpers LJA, Vrieling H, Franken NAP. Reduced
activity of double-strand break repair genes in prostate cancer patients with late normal tissue radiation
toxicity. Internation Journal of Radiation Oncolgoy Biology Physics 88(3), 2014, p.664-670. (AMC)
1490. Van Oorschot B, Oei AL, Nuijens AC, Rodermond H, Hoeben R, Stap J, Stalpers LJ, Franken NAP. Decay
of γ-H2AX foci correlates with potentially lethal damage repair and P53 status in human colorectal
carcinoma cells. Cellular & Molecular Biology Letters 19(1), 2014, p.37-51. (AMC)
1491. van Reij EJF, Dahele M, van de Ven PM, de Haan PF, Verbakel WFAR, Smit EF, Slotman BJ, Senan S.
Changes in non-surgical management of stage III non-small cell lung cancer at a single institution
between 2003 and 2010. ACTA Oncol 2014; 53: 316-323. (VUmc)
1492. Van Rhijn BD, Curvers WL, Bergman JJGHM, Verheij J, Bredenoord AJ. Esophageal perforation during
endoscopic removal of food impaction in eosinophilic esophagitis: stent well spent? Endoscopy 46(Suppl.
1 UCTN), 2014, p.E193-E194. (AMC)
1493. van Rhijn BW, Catto JW, Goebell PJ, Knuchel R, Shariat SF, van der Poel HG, Sanchez-Carbayo M,
Thalmann GN, Schmitz-Drager BJ, Kiemeney LA. Molecular markers for urothelial bladder cancer
prognosis: Toward implementation in clinical practice. Urol Oncol 2014; 32:1078-87 (NKI)
1494. Van Rijn RR, Nievelstein RAJ. Paediatric ultrasonography of the liver, hepatobiliary tract and pancreas.
European Journal of Radiology 83(9), 2014, p.1570-1581. (AMC)
1495. van Rijn S, Wurdinger T, Nilsson J. Multiplex functional bioluminescent reporters using Gaussia
luciferase fused to epitope tags in an immunobinding assay. Methods Mol Biol 2014; 1098: 231-247.
(VUmc)
1496. van Rijn VM, Mooij SH, Mollers M, Snijders PJF, Speksnijder AGCL, King AJ, de vries HJC, van Eeden A,
van der Klis FRM, de Melker HE, van der Sande MAB, van der Loeff MFS. Anal, Penile, and Oral High-Risk
HPV Infections and HPV Seropositivity in HIV-Positive and HIV-Negative Men Who Have Sex with Men.
PLoS One 2014; 9: e92208. (VUmc)
1497. van Rijssel MJ, Dahele M, Verbakel WFAR, Rosario TS. A critical approach to the clinical use of
deformable image registration software. In response to Meijneke et al. Radiother Oncol 2014; 112: 447448. (VUmc)
1498. Van Schaik B, Klarenbeek P, Doorenspleet M, van Kampen A, Moody DB, de Vries N, van Rhijn I.
Discovery of Invariant T Cells by Next-Generation Sequencing of the Human TCR α-Chain Repertoire.
Journal of Immunology 193(10), 2014, p.5338-5344. (AMC)
1499. Van Schie JJN, Lavini C, van Vliet LJ, Vos FM. Feasibility of a Fast Method for B1-Inhomogeneity
Correction for FSPGR Sequences. Magnetic Resonance Imaging [aheadofprint], 2014, p.-. (AMC)
1500. Van Schuppen J, Olthof DC, Wilde JCH, Beenen LFM, van Rijn RR, Goslings JC. Diagnostic accuracy of a
step-up imaging strategy in pediatric patients with blunt abdominal trauma. European Journal of
Radiology 83(1), 2014, p.206-211. (AMC)
1501. van Spronsen MF, Ossenkoppele GJ, Holman R, van de Loosdrecht AA. Improved risk stratification by the
integration of the revised International Prognostic Scoring System with the Myelodysplastic Syndromes
Comorbidity Index. Eur J Cancer 2014; 50: 3198-3205. (VUmc)
1502. van Stein-Callenfels D, Tan J, Bloemena E, van Vugt RM, Voskuyl AE, Santana NTY, van der Waal I. The
role of a labial salivary gland biopsy in the diagnostic procedure for Sjogren's syndrome; a study of 94
cases. Medicina oral patologia oral y cirugia bucal 2014; 19: E372-E376. (VUmc)
1503. van Thuijl HF, Scheinin I, Sie DLS, Alentorn A, van Essen HF, Cordes M, Fleischeuer R, Beute G, van den
Brink WA, Meijer GA, Havenith M, Idbaih A, Hoang-Xuan K, Mokhtari K, Verhaak RGW, van der Valk P,
van de Wiel MA, Heimans JJ, Aronica E, Reijneveld JC,. Spatial and temporal evolution of distal 10q
deletion, a prognostically unfavorable event in diffuse low-grade gliomas. Genome Biol 2014; 15: 472.
(VUmc)
1504. van Tilborg AAJM, Scheffer HJ, Nielsen K, van Waesberghe JHTM, Comans EFI, van Kuijk C, van den Tol
MP, Meijerink MR. Transcatheter CT Arterial Portography and CT Hepatic Arteriography for Liver Tumor
156 - Scientific publications
1505.
1506.
1507.
1508.
1509.
1510.
1511.
1512.
1513.
1514.
1515.
1516.
1517.
1518.
1519.
1520.
1521.
1522.
1523.
1524.
Visualization during Percutaneous Ablation. Journal of vascular and interventional radiology 2014; 25:
1101-1111. (VUmc)
van Turenhout ST, Oort FA, van der Hulst RWM, Visscher AP, Terhaar sive Droste JS, Scholten P, Bouman
AA, Meijer GA, Mulder CJJ, van Rossum LGM, Coupe VMH. Prospective cross-sectional study on faecal
immunochemical tests: sex specific cut-off values to obtain equal sensitivity for colorectal cancer?. Bmc
Gastroenterology 2014; 14: 217. (VUmc)
Van Uden DJP, van Laarhoven HWM, Westenberg AH, de Wilt JHW, Blanken-Peeters CFJM. Inflammatory
breast cancer: An overview. Critical Reviews in Oncology Hematology 14, 2014, p.S1040--. (AMC)
van Veen-Berkx E, Bitter J, Elkhuizen SG, Buhre WF, Kalkman CJ, Gooszen HG, Kazemier G. Comment on
Research Article Entitled "Variability of Subspecialty-Specific Anesthesia-Controlled Times at Two
Academic Institutions" as published in J Med Syst 2014; 38 (11). Journal of medical systems 2014; 38: 51.
(VUmc)
van Veen-Berkx E, Bitter J, Elkhuizen SG, Buhre WF, Kalkman CJ, Gooszen HG, Kazemier G. The
influence of anesthesia-controlled time on operating room scheduling in Dutch university medical
centres. Canadian journal of anesthesia 2014; 61: 524-532. (VUmc)
van Veen-Berkx E, Elkhuizen SG, Kalkman CJ, Buhre WF, Kazemier G. Successful interventions to reduce
first-case tardiness in Dutch university medical centers: Results of a nationwide operating room
benchmark study. American Journal of Surgery 2014; 207: 949-959. (VUmc)
van Velden FHP, Nissen IA, Hayes W, Velasquez LM, Hoekstra OS, Boellaard R. Effects of Reusing
Baseline Volumes of Interest by Applying (Non-)Rigid Image Registration on Positron Emission
Tomography Response Assessments. PLoS One 2014; 9: e87167. (VUmc)
van Velden FHP, Nissen IA, Jongsma F, Velasquez LM, Hayes W, Lammertsma AA, Hoekstra OS, Boellaard
R. Test-Retest Variability of Various Quantitative Measures to Characterize Tracer Uptake and/or Tracer
Uptake Heterogeneity in Metastasized Liver for Patients with Colorectal Carcinoma. Mol Imaging Biol
2014; 16: 13-18. (VUmc)
van Velthuysen ML, Groen EJ, Sanders J, Prins FA, van der Noort V, Korse CM. Reliability of Proliferation
Assessment by Ki-67 Expression in Neuroendocrine Neoplasms: Eyeballing or Image Analysis?
Neuroendocrinology 2014; 100:288-92 (NKI)
van Velthuysen MLF, Groen EJ, van der Noort V, van de Pol A, Tesselaar ME, Korse CM. Grading of
Neuroendocrine Neoplasms: Mitoses and Ki-67 Are Both Essential. Neuroendocrinology 2014; 100:221-7
(NKI)
van Verschuer VM, Heemskerk-Gerritsen BA, van Deurzen CH, Obdeijn IM, Tilanus-Linthorst MM, Verhoef
C, Schmidt MK, Koppert LB, Hooning MJ, Seynaeve C. Lower mitotic activity in BRCA1/2-associated
primary breast cancers occurring after risk-reducing salpingo-oophorectomy. Cancer Biol Ther 2014;
15:371-9 (NKI)
van Vuurden DG, Aronica E, Hulleman E, Wedekind LE, Biesmans D, Malekzadeh A, Bugiani M, Geerts D,
Noske DP, Vandertop WP, Kaspers GJ, Cloos J, Wurdinger T, van der Stoop PM. Pre-B-cell leukemia
homeobox interacting protein 1 is overexpressed in astrocytoma and promotes tumor cell growth and
migration. Neuro-oncology 2014; 16: 946-959. (VUmc)
van Wieringen WN, van de Wiel MA. Penalized differential pathway analysis of integrative oncogenomics
studies. Stat Appl Genet Mol 2014; 13: 141-158. (VUmc)
Vandertop WP. Syringomyelia. Neuropediatrics 2014; 45: 3-9. (VUmc)
Vansteenkiste J, Crino L, Dooms C, Douillard JY, Faivre-Finn C, Lim E, di Rocco G, Senan S, Van Schil P,
Veronesi G, Stahel R, Peters S, Felip E. 2nd ESMO Consensus Conference on Lung Cancer: early-stage
non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol 2014; 25: 14621474. (VUmc)
Vardi Y, Kitrey ND, Meuleman EJH, Scranton RE. Erectile Dysfunction Diagnosis and Treatment as a
Means to Improve Medication Adherence and Optimize Comorbidity Management. Journal of Sexual
Medicine 2014; 11: 888-890. (VUmc)
Vasen HFA, Ghorbanoghli Z, Bourdeaut F, Cabaret O, Caron O, Duval A, Entz-Werle N, Goldberg Y,
Ilencikova D, Kratz CP, Lavoine N, Loeffen J, Menko FH, Muleris M, Sebille G, Colas C, Burkhardt B,
Brugieres L, Wimmer K. Guidelines for surveillance of individuals with constitutional mismatch repairdeficiency proposed by the European Consortium "Care for CMMR-D" (C4CMMR-D). J Med Genet 2014; 51:
283-293. (VUmc)
Veenstra HJ, Klop WMC, Lohuis PJFM, Nieweg OE, van Velthuysen MLF, Balm AJM. Cadaver study on the
location of suboccipital lymph nodes: Guidance for suboccipital node dissection. Head Neck 2014;
36:682-6 (NKI/AMC)
Velthuis S, Nieuwenhuis DH, Ruijter TEG, Cuesta MA, Bonjer HJ, Sietses C. Transanal versus traditional
laparoscopic total mesorectal excision for rectal carcinoma. Surg Endosc 2014; 28: 3494-3499. (VUmc)
Venderbosch S, Nagtegaal ID, Maughan TS, Smith CG, Cheadle JP, Fisher D, Kaplan R, Quirke P, Seymour
MT, Richman SD, Meijer GA, Ylstra B, Heideman DAM, de Haan AFJ, Punt CJA, Koopman M. Mismatch
Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of
the CAIRO, CAIRO2, COIN, and FOCUS Studies. Clin Cancer Res 2014; 20: 5322-5330. (VUmc/AMC)
Verbovšek U, Motaln H, Rotter A, Atai NA, Gruden K, van Noorden CJF, Lah TT. Expression Analysis of All
Protease Genes Reveals Cathepsin K to Be Overexpressed in Glioblastoma. PLOS ONE 9(10), 2014,
p.e111819-. (AMC)
Scientific publications - 157
1525. Verbrugge I, Gasparini A, Haynes NM, Hagekyriakou J, Galli M, Stewart TJ, Abrams SI, Yagita H, Verheij
M, Johnstone RW, Borst J, Neefjes J. The curative outcome of radio-immunotherapy in a mouse breast
cancer model relies on mTOR signaling. Radiat Res 2014; 182:219-29 (NKI)
1526. Verdonck-de Leeuw IM, Buffart LM, Heymans MW, Rietveld DH, Doornaert P, De Bree R, Buter J,
Aaronson NK, Slotman BJ, Leemans CR, Langendijk JA. The course of health-related quality of life in
head and neck cancer patients treated with chemoradiation: a prospective cohort study. Radiother
Oncol 2014; 110:422-8 (NKI)
1527. Verhaegh W, van Ooijen H, Inda MA, Hatzis P, Versteeg R, Smid M, Martens J, Foekens J, van de Wiel P,
Clevers H, van de Stolpe A. Selection of personalized patient therapy through the use of
knowledge-based computational models that identify tumor-driving signal transduction pathways.
Cancer Research 74(11), 2014, p.2936-2945.(AMC)
1528. Verhagen HJMP, de Leeuw DC, Roemer MGM, Denkers F, Pouwels W, Rutten A, Celie PH, Ossenkoppele
GJ, Schuurhuis GJ, Smit L. IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with
chemotherapy in suppression of leukemia cell survival. Cell death & disease 2014; 5: e1300. (VUmc/NKI)
1529. Verheecke M, Halaska MJ, Lok CA, Ottevanger PB, Fruscio R, Dahl-Steffensen K, Kolawa W, Gziri MM,
Han SN, Van Calsteren K, van den Heuvel F, De Vleeschouwer S, Clement PM, Menten J, Amant F.
Primary brain tumours, meningiomas and brain metastases in pregnancy: report on 27 cases and review
of literature. Eur J Cancer 2014; 50:1462-71 (NKI)
1530. Verheij M, Leer JW. Obituary: Adrian C. Begg. Radiother Oncol 2014; 110:562-3 (NKI)
1531. Verheij M, Moolenaar WH, Blitterswijk WJ. Combining anti-tumor alkyl-phospholipid analogs and
radiotherapy: rationale and clinical outlook. Anticancer Agents Med Chem 2014; 14:618-28 (NKI)
1532. Verhoef VMJ, Bosgraaf RP, van Kemenade FJ, Rozendaal L, Heideman DAM, Hesselink AT, Bekkers RLM,
Steenbergen RDM, Massuger LFAG, Melchers WJG, Bulten J, Overbeek LIH, Berkhof J, Snijders PJF,
Meijer CJLM. Triage by methylation-marker testing versus cytology in women who test HPV-positive on
self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial.
Lancet Oncol 2014; 15: 315-322. (VUmc)
1533. Verhoef VMJ, Heideman DAM, van Kemenade FJ, Rozendaal L, Bosgraaf RP, Hesselink AT, Bekkers RLM,
Massuger LFAG, Steenbergen RDM, Snijders PJF, Berkhof J, Meijer CJLM. Methylation marker analysis
and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high
grade CIN or cervical cancer. Gynecol Oncol 2014; 135: 58-63. (VUmc)
1534. Verhoest G, Patard J, Oger E, Rioux-Leclercq N, Peyronnet B, Bessede T, Laguna P, Barwari K, Rigaud J,
Roupret M, Coffin G, Bernhard J, Long J, Zisman A, Berger J, Paparel P, Maurin C, Lechevallier E, Bertini
R, Ouzaid I, Salomon L, Bex A, Farfara R, Ljungberg B, Rodriguez AR, Bensalah K. Predictive factors of
chronic kidney disease stage V after partial nephrectomy in a solitary kidney: a multi-institutional study.
Urol Oncol 2014; 32:e21-e26 (NKI)
1535. Verhoeven R, Karim-Kos H, Coebergh J, Brink M, Horenblas S, de Wit R, Kiemeney B. Markedly increased
incidence and improved survival of testicular cancer in the Netherlands. Acta Oncol 2014; 53:342-50
(NKI)
1536. Verma J, Lal S, van Noorden CJF. Nanoparticles for hyperthermic therapy: synthesis strategies and
applications in glioblastoma. International Journal of Nanomedicine 9, 2014, p.2863-2877. (AMC)
1537. Verma J, Lal S, van Veen HA, van Noorden CJF. A Novel Strategy for Synthesis of Gold Nanoparticle Self
Assemblies. Current Nanoscience 10(5), 2014, p.670-675. (AMC)
1538. Verma J, van Veen HA, Lal S, van Noorden CJF. Wet Chemistry Approaches for Synthesis of Gold
Nanospheres, Nanorods and Nanostars. Current Nanoscience 10(5), 2014, p.660-669. (AMC)
1539. Vermeer T, Orsini R, Daams F, Nieuwenhuijzen G, Rutten H. Anastomotic leakage and presacral abscess
formation after locally advanced rectal cancer surgery: Incidence, risk factors and treatment. EJSO-Eur
J Surg Oncol 2014; 40: 1502-1509. (VUmc)
1540. Vermeulen E, Boeckhout M, Zielhuis GA, Bakker R, Janssens AC, Schmidt MK. [Biobanks and the return of
results to donors] Biobanken en de terugkoppeling van onderzoeksbevindingen aan donoren. Ned
Tijdschr Geneeskd 2014; 158:A6653 (NKI)
1541. Vermeulen E, Henneman L, van El CG, Cornel MC. Public attitudes towards preventive genomics and
personal interest in genetic testing to prevent disease: a survey study. Eur J Public Health 2014; 24:76875 (NKI)
1542. Vermeulen L, Snippert HJ. Stem cell dynamics in homeostasis and cancer of the intestine. Nature
Reviews Cancer 14(7), 2014, p.468-480. (AMC)
1543. Versteeg KS, Konings IRHM, Lagaay AM, van de Loosdrecht AA, Verheul HMW. Prediction of treatmentrelated toxicity and outcome with geriatric assessment in elderly patients with solid malignancies
treated with chemotherapy: a systematic review. Ann Oncol 2014; 25: 1914-1918. (VUmc)
1544. Versteeg R. CANCER Tumours outside the mutation box. Nature 506(7489), 2014, p.438-439. (AMC)
1545. Versteijne E, van Laarhoven HWM, van Hooft JE, van Os RM, Geijsen ED, van Berge Henegouwen MI,
Hulshof MCCM. Definitive chemoradiation for patients with inoperable and/or unresectable esophageal
cancer: locoregional recurrence pattern. Diseases of the Esophagus [aheadofprint], 2014, p.-. (AMC)
1546. Verwer E, Bahce I, van Velden FHP, Yaqub MM, Schuit RC, Windhorst AD, Raijmakers P, Hoekstra OS,
Lammertsma AA, Smit EF, Boellaard R. Parametric Methods for Quantification of F-18-FAZA Kinetics in
Non-Small Cell Lung Cancer Patients. J Nucl Med 2014; 55: 1772-1777. (VUmc)
1547. Verwer E, Boellaard R, van der Veldt AAM. Positron emission tomography to assess hypoxia and perfusion
in lung cancer. World journal of clinical oncology 2014; 5: 824-844. (VUmc)
158 - Scientific publications
1548. Viale G, Slaets L, Bogaerts J, Rutgers E, Van't Veer L, Piccart-Gebhart MJ, de Snoo FA, Stork-Sloots L,
Russo L, Dell'Orto P, van den Akker J, Glas A, Cardoso F. High concordance of protein (by IHC), gene (by
FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC
10041/BIG 03-04 MINDACT trial. Ann Oncol 2014; 25:816-23 (NKI)
1549. Victorson DE, Brucker PS, Bode RK, Eton DT, Talcott JA, Clark JA, Knight SJ, Litwin MS, Moinpour CM,
Reeve BB, Aaronson NK, Bennett CL, Herr HW, McGuire M, Shevrin D, McVary K, Cella D. Ensuring
comprehensive assessment of urinary problems in prostate cancer through patient-physician
concordance. Urol Oncol 2014; 32:26.e25-3 (NKI)
1550. Vidal-Sicart S, Rioja ME, Paredes P, Keshtgar MR, Valdes Olmos RA. Contribution of perioperative
imaging to radioguided surgery. Q J Nucl Med Mol Imaging 2014; 58:140-60 (NKI)
1551. Visser A, de Witte T, Speckens AEM, Prins JB, van Laarhoven HWM. A qualitative analysis of experiences
of patients with metastatic breast cancer participating in a mindfulness-based intervention. Palliative
Medicine -, 2014, p.--. (AMC)
1552. Visser A, Ubbink DT, Gouma DJ, Goslings JC. Surgeons are overlooking post-discharge complications: a
prospective cohort study. World Journal of Surgery 38(5), 2014, p.1019-1025 (AMC)
1553. Visser D, Middelbeek J, van Leeuwen FN, Jalink K. Function and regulation of the channel-kinase TRPM7
in health and disease. Eur J Cell Biol 2014; 93:455-65 (NKI)
1554. Vlaming H, van Welsem T, de Graaf EL, Ontoso D, Altelaar AM, San Segundo PA, Heck AJ, van Leeuwen
F. Flexibility in crosstalk between H2B ubiquitination and H3 methylation in vivo. EMBO Rep 2014;
15:1077-84 (NKI)
1555. Vlaming ML, Teunissen SF, Van De Steeg E, Van Esch A, Wagenaar E, Brunsveld L, de Greef TF, Rosing H,
Schellens JHM, Beijnen JH, Schinkel AH. Bcrp1;Mdr1a/b;Mrp2 combination knockout mice: altered
disposition of the dietary carcinogen PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) and its
genotoxic metabolites. Mol Pharmacol 2014; 85:520-30 (NKI)
1556. Voest EE. Samenwerken om een behandeling op maat te ontwikkelen - Expert opinion. Medische
Oncologie 2014; 17:10-1 (NKI)
1557. Vollebergh MA, Klijn C, Schouten PC, Wesseling J, Israeli D, Ylstra B, Wessels LFA, Jonkers J, Linn SC.
Lack of Genomic Heterogeneity at High-Resolution aCGH between Primary Breast Cancers and Their
Paired Lymph Node Metastases. PLoS One 2014; 9: e103177. (VUmc/NKI)
1558. Vollebergh MA, Lips EH, Nederlof PM, Wessels LF, Wesseling J, van de Vijver MJ, de Vries EG, Van
Tinteren H, Jonkers J, Hauptmann M, Rodenhuis S, Linn SC. Genomic patterns resembling B. Breast
Cancer Res 2014; 16:R47 (NKI)
1559. Von Bartheld MB, van Breda A, Annema JT. Complication Rate of Endosonography (Endobronchial and
Endoscopic Ultrasound): A Systematic Review. Respiration 87(4), 2014, p.343-351. (AMC)
1560. Voncken FE, Jiang H, Kim J, Guindi M, Brierley J, Knox J, Liu G, Horgan AM, Lister J, Darling G, Metser
U, Wong RK. Degree of tumor shrinkage following neoadjuvant chemoradiotherapy: a potential predictor
for complete pathological response in esophageal cancer? Dis Esophagus 2014; 27:552-9 (NKI)
1561. Voorneveld PW, Kodach LL, Jacobs RJ, Liv N, Zonnevylle AC, Hoogenboom JP, Biemond I, Verspaget HW,
Hommes DW, de Rooij K, van Noesel CJM, Morreau H, van Wezel T, Offerhaus GJA, van den Brink GR,
Peppelenbosch MP, ten Dijke P, Hardwick JCH. Loss of SMAD4 alters BMP signaling to promote colorectal
cancer cell metastasis via activation of Rho and ROCK. Gastroenterology 147(1), 2014, p.196-208.e13.
(AMC)
1562. Voortman LM, Vulovic M, Maletta M, Voigt A, Franken EM, Simonetti A, Peters PJ, van Vliet LJ, Rieger B.
Quantifying resolution limiting factors in subtomogram averaged cryo-electron tomography using
simulations. J Struct Biol 2014; 187:103-11 (NKI)
1563. Vormer TL, Wojciechowicz K, Dekker M, de Vries S, van der Wal A, zenne-Goette E, Naik SH, Song JY,
Dannenberg JH, Hansen JB, te Riele H. RB Family Tumor Suppressor Activity May Not Relate to Active
Silencing of E2F Target Genes. Cancer Res 2014; 74: 5266-5276. (VUmc/NKI)
1564. Vos CG, Dahele MR, de Koste JRV, Senan S, Bahce I, Paul MA, Thunnissen E, Smit EF, Hartemink KJ.
Semiautomated volumetric response evaluation as an imaging biomarker in superior sulcus tumors.
Strahlenther Onkol 2014; 190: 204-209. (VUmc)
1565. Vos JR, Teixeira N, van der Kolk DM, Mourits MJE, Rookus MA, van Leeuwen FE, Collée M, van Asperen
CJ, Mensenkamp AR, Ausems MGEM, van Os TAM, Meijers-Heijboer HEJ, Gómez-Garcia EB, Vasen HF,
Brohet RM, van der Hout AH, Jansen L, Oosterwijk JC, de Bock GH. Variation in Mutation Spectrum
Partly Explains Regional Differences in the Breast Cancer Risk of Female BRCA Mutation Carriers in the
Netherlands. Cancer Epidemiology & Prevention 23(11), 2014, p.2482-2491. (AMC/NKI/VUmc)
1566. Vosbergen S, Mahieu GR, Laan EK, Kraaijenhagen RA, Jaspers MW, Peek N. Evaluating a web-based
health risk assessment with tailored feedback: what does an expert focus group yield compared to a
web-based end-user survey? Journal of Medical Internet Research 16(1), 2014, p.e1-. (AMC)
1567. Vosbergen S, Peek N, Mulder-Wiggers JMR, Kemps HMC, Kraaijenhagen RA, Jaspers MWM, Lacroix JPW.
An online survey to study the relationship between patients' health literacy and coping style and their
preferences for self-management-related information. Patient Preference and Adherence 8, 2014,
p.631-642. (AMC)
1568. Vriend LEM, Jasin M, Krawczyk PM. Assaying Break and Nick-Induced Homologous Recombination in
Mammalian Cells Using the DR-GFP Reporter and Cas9 Nucleases. Methods in Enzymology 546C, 2014,
p.175-191. (AMC)
Scientific publications - 159
1569. Vugts DJ, Heuveling DA, Stigter-van Walsum M, Weigand S, Bergstrom M, van Dongen GAMS, Nayak TK.
Preclinical evaluation of Zr-89-labeled anti-CD44 monoclonal antibody RG7356 in mice and cynomolgus
monkeys Prelude to Phase 1 clinical studies. MABS 2014; 6: 567-575. (VUmc)
1570. Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer: ESMO-ESSOESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol 2014;
40:584-91 (NKI)
1571. Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer: ESMO-ESSOESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Radiother Oncol 2014;
110:189-94 (NKI)
1572. Wagemakers A, Mason LM, Oei A, de Wever B, van der Poll T, Bins AD, Hovius JW. Rapid outer-surface
protein C DNA tattoo vaccination protects against Borrelia afzelii infection. Gene Ther 2014; 21:1051-7
(NKI)
1573. Wagstaff P, Ingels A, Zondervan P, de La Rosette JJMCH, Laguna MP. Thermal ablation in renal cell
carcinoma management: a comprehensive review. Current Opinion in Urology 24(5), 2014, p.474-482.
(AMC)
1574. Wagstaff PGK, de Bruin DM, van den Bos W, Ingels A, van Gemert MJC,Zondervan PJ, Verdaasdonk RM,
van Lienden KP, van Leeuwen TG, de La Rosette JJMCH, Laguna PMP. Irreversible Electroporation of the
Porcine Kidney: Temperature Development and Distribution. Urologic Oncology-seminars and Original
Investigations -, 2014, p.--. (AMC)
1575. Wagstaff PGK, de Bruin DM, van den Bos W, Ingels A, van Gemert MJC, Zondervan PJ, Verdaasdonk RM,
van Lienden KP, van Leeuwen TG, de La Rosette JJMCH, Laguna Pes MP. Irreversible electroporation of
the porcine kidney: Temperature development and distribution. Urologic Oncolgy Seminars and Original
Investigations [aheadofprint], 2014, p.-. (AMC)
1576. Wals K, Ovaa H. Unnatural amino acid incorporation in E. coli: current and future applications in the
design of therapeutic proteins. Front Chem 2014; 2:15-(12 pp) (NKI)
1577. Walter D, van den Berg MW, van Hooft JE, Boot H, Scheffer RCH, Vleggaar FP, Siersema PD. A new fully
covered metal stent with anti-migration features for the treatment of malignant dysphagia. Endoscopy
46(12), 2014, p.1101-1105. (AMC/NKI)
1578. Wanders LK, van Doorn SC, Fockens P, Dekker E. Quality of colonoscopy and advances in detection of
colorectal lesions: a current overview. Experts Review of Gastroenterology & Hepatology [aheadofprint],
2014, p.1-14. (AMC)
1579. Wang C, Allegaert K, Tibboel D, Danhof M, van der Marel CD, Mathot RAA, Knibbe CAJ. Population
pharmacokinetics of paracetamol across the human age-range from (pre)term neonates, infants,
children to adults. Journal of Clinical Pharmacology 54(6), 2014, p.619-629. (AMC)
1580. Warmann SW, Godzinski J, van Tinteren H, Heij H, Powis M, Sandstedt B, Graf N, Fuchs J. Minimally
invasive nephrectomy for Wilms tumors in children - data from SIOP 2001. J Pediatr Surg 2014; 49: 15441548. (VUmc/NKI)
1581. Webb KC, Eby JM, Hariharan V, Hernandez C, Luiten RM, Le Poole IC. Enhanced bleaching treatment:
opportunities for immune-assisted melanocyte suicide in vitiligo. Experimental Dermatology 23(8), 2014,
p.529-533. (AMC)
1582. Wefel JS, Kornet RL, Schagen SB. Systemically treated breast cancer patients and controls: an
evaluation of the presence of noncredible performance. J Int Neuropsychol Soc 2014; 20:357-69 (NKI)
1583. Wefel JS, Schagen SB. Cognitive complaints after breast cancer treatments: examining the relationship
with neuropsychological test performance - Commentary. Breast Diseases - A Year Book Quarterly. Los
Angeles: University of California, 2014: p. 92-93 (NKI)
1584. Wefers AK, Warmuth-Metz M, Poschl J, von Bueren AO, Monoranu CM, Seelos K, Peraud A, Tonn JC, Koch
A, Pietsch T, Herold-Mende C, Mawrin C, Schouten-van Meeteren AYN, van Vuurden DG, von Hoff K,
Rutkowski S, Pfister SM, Kool M, Schuller U. Subgroup-specific localization of human medulloblastoma
based on pre-operative MRI. ACTA Neuropathol 2014; 127: 931-933. (VUmc/AMC)
1585. Wegdam W, Argmann CA, Kramer G, Vissers JP, Buist MR, Kenter GG, Aerts JMFG, Meijer D, Moerland
PD. Label-Free LC-MSe in Tissue and Serum Reveals Protein Networks Underlying Differences between
Benign and Malignant Serous Ovarian Tumors. PLOS ONE 9(9), 2014, p.e108046-(12 p.). (AMC)
1586. Wegner I, Wilhelm AJ, Lambrechts DAJE, Sander JW, Lindhout D. Effect of oral contraceptives on
lamotrigine levels depends on comedication. ACTA Neurol Scand 2014; 129: 393-398. (VUmc)
1587. Weiss A, Berndsen RH, Dubois M, Muller C, Schibli R, Griffioen AW, Dyson PJ, Nowak-Sliwinska P. In vivo
anti-tumor activity of the organometallic ruthenium(II)-arene complex [Ru(eta(6)-p-cymene)-Cl-2(pta)]
(RAPTA-C) in human ovarian and colorectal carcinomas. Chemical Science 2014; 5: 4742-4748. (VUmc)
1588. Weiss A, van Beijnum JR, Bonvin D, Jichlinski P, Dyson PJ, Griffioen AW, Nowak-Sliwinska P. Low-dose
angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular
normalization. Journal of Cellular and Molecular Medicine 2014; 18: 480-491. (VUmc)
1589. Wen BL, Brewer MA, Nadiarnykh O, Hocker J, Singh V, Mackie TR, Campagnola PJ. Texture analysis
applied to second harmonic generation image data for ovarian cancer classification. Journal of
Biomedical Optics 2014; 19: 096007. (VUmc)
1590. Werter IM, Schneiders FL, Scotet E, Verheul HMW, de Gruijl TD, van der Vliet HJ. Vgamma9Vgamma2-T
cells as antigen presenting cells for iNKT cell based cancer immunotherapy. Oncoimmunology 2014; 3:
e955343. (VUmc)
160 - Scientific publications
1591. Wesseling P. Embryonal tumor with multilayered rosettes (ETMR): signed, sealed, delivered. ACTA
Neuropathol 2014; 128: 305-308. (VUmc)
1592. Wessels R, de Bruin DM, Faber DJ, van Leeuwen TG, van Beurden M, Ruers TJM. Optical biopsy of
epithelial cancers by optical coherence tomography (OCT). Lasers in Medical Science 29(3), 2014,
p.1297-1305. (AMC/NKI)
1593. Wessels R, de Bruin DM, Relyveld GN, Faber DJ, Vincent AD, Sanders J, van Leeuwen TG, Ruers TJM.
Functional optical coherence tomography of pigmented lesions. Journal of the European Academy of
Dermatology and Venereology [aheadofprint], 2014, p.-. (AMC)
1594. West E, Costantini M, Pasman HRW, Onwuteaka-Philipsen BD. A comparison of drugs and procedures of
care in the Italian hospice and hospital settings: the final three days of life for cancer patients. BMC
Health Serv Res 2014; 14: 496. (VUmc)
1595. West E, Romoli V, Leo S Di, Higginson IJ, Miccinesi G, Costantini M. Feasibility of assessing quality of
care at the end of life in two cluster trials using an after-death approach with multiple assessments.
BMC Palliative Care 2014; 13: 36. (VUmc)
1596. Westerhuis G, de Witte M, Schumacher TN, Toes RE, Fibbe WE. Barriers to chimerism after MHCmismatched stem cell transplantation: a potential role for heterologous immunity. Exp Hematol 2014;
42:753-60 (NKI)
1597. Wevers MR, Aaronson NK, Verhoef S, Bleiker EM, Hahn DE, Kuenen MA, Sanden-Melis J, Brouwer T,
Hogervorst FB, van der Luijt RB, Valdimarsdottir HB, van Dalen T, Theunissen EB, van Ooijen B, de Roos
MA, Borgstein PJ, Vrouenraets BC, Vriens E, Bouma WH, Rijna H, Vente JP, Witkamp AJ, Rutgers EJ,
Ausems MG. Impact of rapid genetic counselling and testing on the decision to undergo immediate or
delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised
controlled trial. Br J Cancer 2014; 110:1081-7 (NKI)
1598. Wicks P, Stamford J, Grootenhuis MA, Haverman L, Ahmed S. Innovations in e-health. Quality of Life
Research 23(1), 2014, p.195-203. (AMC)
1599. Widmer N, Bardin C, Chatelut E, Paci A, Beijnen J, Leveque D, Veal G, Astier A. Review of therapeutic
drug monitoring of anticancer drugs part two - Targeted therapies. Eur J Cancer 2014; 50:2020-36 (NKI)
1600. Wielders EAL, Hettinger J, Dekker R, Kets CM, Ligtenberg MJ, Mensenkamp AR, van den Ouweland AMW,
Prins J, Wagner A, Dinjens WNM, Dubbink HJ, van Hest LP, Menko F, Hogervorst F, Verhoef S, te Riele H.
Functional analysis of MSH2 unclassified variants found in suspected Lynch syndrome patients reveals
pathogenicity due to attenuated mismatch repair. J Med Genet 2014; 51: 245-253. (VUmc/NKI)
1601. Wielenga MCB, van Lidth de Jeude JF, Rosekrans SL, Levin AD, Schukking M, D'Haens GRAM, Heijmans J,
Jansen M, Muncan V, van den Brink GR. Azathioprine does not reduce adenoma formation in a mouse
model of sporadic intestinal tumorigenesis. World Journal of Gastroenterology 20(44), 2014,
p.16683-16689. (AMC)
1602. Wierdsma NJ, Peters JHC, van Bokhorst-de van der Schueren, Mulder CJJ, Metgod I, van Bodegraven AA.
Bomb calorimetry, the gold standard for assessment of intestinal absorption capacity: normative values
in healthy ambulant adults. J Hum Nutr Diet 2014; 27: 57-64. (VUmc)
1603. Wiggenraad R, Bos P, Verbeek-de Kanter A, Nijeholt GLA, van Santvoort J, Taphoorn M, Struikmans H.
Pseudo-progression after stereotactic radiotherapy of brain metastases: lesion analysis using MRI cineloops. J Neuro-Oncol 2014; 119: 437-443. (VUmc)
1604. Wiggers JK, Groot Koerkamp B, Ovadia Z, Busch ORC, Gouma DJ, van Gulik TM. Patterns of recurrence
after resection of gallbladder cancer without routine extrahepatic bile duct resection. HPB 16(7), 2014,
p.635-640. (AMC)
1605. Wiggers JK, Rauws EA, Gouma DJ, van Gulik TM. Preoperative Endoscopic Nasobiliary Drainage in
Patients With Suspected Hilar Cholangiocarcinoma; Better Than Endoscopic or Percutaneous Biliary
Drainage? Annals of Surgery [aheadofprint], 2014, p.-. (AMC)
1606. Wiggers TGH, Westra G, Westers TM, Abbes AP, Strunk A, Kuiper-Kramer E, Poddighe PJ, van de
Loosdrecht AA, Chamuleau MED. ZAP70 in B-CLL Cells Related to the Expression in NK Cells is a
Surrogate Marker for Mutational Status. Cytom Part B- Clin CY 2014; 86: 280-287. (VUmc)
1607. Wijdeven RH, Neefjes J, Ovaa H. How chemistry supports cell biology: the chemical toolbox at your
service. Trends Cell Biol 2014; 24:751-60 (NKI)
1608. Wilbers J, Dorresteijn LD, Haast R, Hoebers FJ, Kaanders JH, Boogerd W, van Werkhoven ED, Nowee ME,
Hansen HH, de Korte CL, Kappelle AC, van Dijk EJ. Progression of carotid intima media thickness after
radiotherapy: A long-term prospective cohort study. Radiother Oncol 2014; 113:359-63 (NKI)
1609. Wilbers J, Hoebers FJ, Boogerd W, van Werkhoven ED, Nowee ME, Hart G, Bartelink H, van Dijk EJ,
Kappelle AC, Dorresteijn LD. Prospective Cohort Study of Carotid Intima-media Thickness after
Irradiation. J Stroke Cerebrovasc Dis 2014; 23:2701-7 (NKI)
1610. Wilbers J, Kappelle AC, Kessels RP, Steens SC, Meijer FJ, Kaanders JH, Haast RA, Versteeg LE, Tuladhar
AM, de Korte CL, Hansen HH, Hoebers FJ, Boogerd W, van Werkhoven ED, Nowee ME, Hart G, Bartelink
H, Dorresteijn LD, van Dijk EJ. Long term cerebral and vascular complications after irradiation of the
neck in head and neck cancer patients: a prospective cohort study: study rationale and protocol. BMC
Neurol 2014; 14:132 (NKI)
1611. Wilde JCH, Aronson DC, Sznajder B, van Tinteren H, Powis M, Okoye B, Cecchetto G, Audry G, Fuchs J,
von Schweinitz D, Heij HA, Graf N, Bergeron C, Pritchard-Jones K, van den Heuvel-Eibrink MM, di Carli
Scientific publications - 161
1612.
1613.
1614.
1615.
1616.
1617.
1618.
1619.
1620.
1621.
1622.
1623.
1624.
1625.
1626.
1627.
1628.
1629.
1630.
1631.
M, Oldenburger F, Sandstedt B, de Kraker J, Godzinski. Nephron Sparing Surgery (NSS) for Unilateral
Wilms Tumor (UWT): The SIOP 2001 Experience. Pediatr Blood Cancer 2014; 61: 2175-2179. (VUmc/NKI)
Wilhelm AJ, den Burger JCG, Swart EL. Therapeutic Drug Monitoring by Dried Blood Spot: Progress to
Date and Future Directions. Clinical Pharmacokinetics 2014; 53: 961-973. (VUmc)
Willems SM, Engelsman-Theelen W, Blaauwgeers JL. [Molecular pathology in tumour classification: the
present and future molecular revolution] Moleculaire pathologie bij tumorclassificatie: heden en
toekomst van de moleculaire revolutie. Ned Tijdschr Geneeskd 2014; 158:A7364 (NKI)
Wimmers F, Aarntzen EHJG, Schreibelt G, Jacobs JFM, Punt CJA, Figdor CG, de Vries IJM. Early
predictive value of multifunctional skin-infiltrating lymphocytes in anticancer immunotherapy.
Oncoimmunology 3(1), 2014, p.e27219-. (AMC)
Winter GE, Radic B, Mayor-Ruiz C, Blomen VA, Trefzer C, Kandasamy RK, Huber KV, Gridling M, Chen D,
Klampfl T, Kralovics R, Kubicek S, Fernandez-Capetillo O, Brummelkamp TR, Superti-Furga G. The solute
carrier SLC35F2 enables YM155-mediated DNA damage toxicity. Nat Chem Biol 2014; 10:768-73 (NKI)
Wit EM, Horenblas S. Urological complications after treatment of cervical cancer. Nat Rev Urol 2014;
11:110-7 (NKI)
Witte LPW, Teitsma CA, de La Rosette JJMCH, Michel MC. Muscarinic receptor subtype mRNA expression
in the human prostate: association with age, pathological diagnosis, prostate size, or potentially
interfering medications?. Naunyn-Schmiedebergs Archives of Pharmacology 387(2), 2014, p.207-214.
(AMC)
Woei AJF, van der Starre WE, Tesselaar ME, Garcia Rodriguez P, van Nieuwkoop C, Bertina RM, van
Dissel JT, Osanto S. Procoagulant tissue factor activity on microparticles is associated with disease
severity and bacteremia in febrile urinary tract infections. Thromb Res 2014; 133:799-803 (NKI)
Woerdeman LAE. Radiotherapie en de timing en complicatiekans van mammareconstructie Commentaar. Oncologie Up-to-date 2014; 5:11 (NKI)
Wognum S, Heethuis SE, Rosario TS, Hoogeman MS, Bel A. Validation of deformable image registration
algorithms on CT images of ex vivo porcine bladders with fiducial markers. Med Phys 2014; 41: 071916.
(VUmc/AMC)
Wojciechowicz K, Cantelli E, Van Gerwen B, Plug M, van der Wal A, zenne-Goette E, Song JY, de Vries S,
Dekker M, te Riele H. Temozolomide Increases the Number of Mismatch Repair - Deficient Intestinal
Crypts and Accelerates Tumorigenesis in a Mouse Model of Lynch Syndrome. Gastroenterology 2014; 147:
1064-1072. (VUmc/NKI)
Wojtuszkiewicz AM, Barcelos A, Dubbelman B, Abreu R, Brouwer C, Bokkerink JP, de Haas V, de GrootKruseman H, Jansen G, Kaspers GJL, Cloos J, Peters GJ. Assessment of Mercaptopurine (6Mp)
Metabolites and 6Mp Metabolic Key-Enzymes in Childhood Acute Lymphoblastic Leukemia. Nucleos
Nucleot Nucl 2014; 33: 422-433. (VUmc)
Wondergem MJ, Dijkstra FS, Visser OJ, Zweegman S, Ossenkoppele GJ, Witte BI, Janssen JJWM.
Allogeneic transplantation after reduced-intensity conditioning with fludarabine-CY for both indolent
and aggressive lymphoid malignancies. Bone Marrow Transpl 2014; 49: 513-518. (VUmc)
Wondergem MJ, Herrmann K, Syrbu S, Zijlstra JM, Hoetjes N, Hoekstra OS, Cillessen SAGM, Moesbergen
LM, Buck AK, Vose JM, Juweid ME. 18F-fluorothymidine uptake in follicular lymphoma and error-prone
DNA repair. EJNMMI research 2014; 4: 3. (VUmc)
Wopken K, van der Schaaf A, Christianen ME, Chouvalova O, Oosting SF, van der Laan BF, Roodenburg
JL, Leemans CR, Slotman BJ, Doornaert P, Steenbakkers RJ, de Leeuw IM, Langendijk H. Development
and validation of a prediction model for tube feeding dependence after curative (chemo-) radiation in
head and neck cancer. PLoS One 2014; 9: e94879. (VUmc)
Wopken K, van der Schaaf A, van der Laan HP, Chouvalova O, Steenbakkers RJ, Doornaert P, Slotman BJ,
Oosting SF, Christianen ME, van der Laan BF, Roodenburg JL, Leemans CR, de Leeuw IM, Langendijk JA.
Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding
dependence after curative radiotherapy/chemo-radiotherapy in head and neck cancer. Radiother Oncol
2014; 2014: 95-101. (VUmc)
Wouters MCA, Dijkgraaf EM, Kuijjer ML, Jordanova ES, Hollema H, Welters MJP, van der Hoeven JJM,
Daemen T, Kroep JR, Nijman HW, van der Burg S. Interleukin-6 receptor and its ligand interleukin-6 are
opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer.
Oncoimmunology 2014; 3: e962397. (VUmc)
Wouters R, Cucchi D, Kaspers GJL, Schuurhuis GJ, Cloos J. Relevance of leukemic stem cells in acute
myeloid leukemia: heterogeneity and influence on disease monitoring, prognosis and treatment design.
Expert Review of Hematology 2014; 7: 791-805. (VUmc)
Wurdinger T, Deumelandt K, van der Vliet HJ, Wesseling P, de Gruijl TD. Mechanisms of intimate and
long-distance cross-talk between glioma and myeloid cells: How to break a vicious cycle. BBA Reviews
on Cancer 2014; 1846: 560-575. (VUmc)
Yang J, Harte-Hargrove LC, Siao CJ, Marinic T, Clarke R, Ma Q, Jing D, Lafrancois JJ, Bath KG, Mark W,
Ballon D, Lee FS, Scharfman HE, Hempstead BL. proBDNF negatively regulates neuronal remodeling,
synaptic transmission, and synaptic plasticity in hippocampus. Cell Rep 2014; 7:796-806 (NKI)
Yang MY, Lee YB, Ahn CH, Kaye J, Fine T, Kashi R, Ohne O, Smid K, Peters GJ, Kim DJ. A Novel Cytidine
Analog, RX-3117, Shows Potent Efficacy in Xenograft Models, even in Tumors that Are Resistant to
Gemcitabine. Anticancer Res 2014; 34: 6951-6959. (VUmc)
162 - Scientific publications
1632. Yousefi A, Bourajjaj M, Babae N, van Noort PI, Schaapveld RQJ, van Beijnum JR, Griffioen AW, Storm G,
Schiffelers RM, Mastrobattista E. Anginex lipoplexes for delivery of anti-angiogenic siRNA. International
journal of pharmaceutics 2014; 472: 175-184. (VUmc)
1633. Yu H, Steeghs N, Nijenhuis CM, Schellens JHM, Beijnen JH, Huitema ADR. Practical guidelines for
therapeutic drug monitoring of anticancer tyrosine kinase inhibitors: focus on the pharmacokinetic
targets. Clin Pharmacokinet 2014; 53:305-25 (NKI)
1634. Yurtsever G, Weiss N, Kalkman J, van Leeuwen TG, Baets R. Ultra-compact silicon photonic integrated
interferometer for swept-source optical coherence tomography. Optics Letters 39(17), 2014,
p.5228-5231. (AMC)
1635. Zaal A, Zweemer RP, Zikan M, Dusek L, Querleu D, Lecuru F, Bats AS, Jach R, Sevcik L, Graf P, Klat J,
Dyduch G, von Mensdorff-Pouilly S, Kenter GG, Verheijen RHM, Cibula D. Pelvic Lymphadenectomy
Improves Survival in Patients With Cervical Cancer With Low-Volume Disease in the Sentinel Node A
Retrospective Multicenter Cohort Study. Int J Gynecol Cancer 2014; 24: 303-311. (VUmc/AMC)
1636. Zabriskie MS, Eide CA, Tantravahi SK, Vellore NA, Estrada J, Nicolini FE, Khoury HJ, Larson RA,
Konopleva M, Cortes JE, Kantarjian H, Jabbour EJ, Kornblau SM, Lipton JH, Rea D, Stenke L, Barbany G,
de Lange T, Hernandez-Boluda JC, Ossenkoppele GJ, Press R. BCR-ABL1 Compound Mutations Combining
Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive
Leukemia. Cancer Cell 2014; 26: 428-442. (VUmc)
1637. Zaidi AH, Gopalakrishnan V, Kasi PM, Zeng X, Malhotra U, Balasubramanian J, Visweswaran S, Sun M,
Flint MS, Davison JM, Hood BL, Conrads TP, Bergman JJ, Bigbee WL, Jobe BA. Evaluation of a 4-Protein
Serum Biomarker Panel-Biglycan, Annexin-A6, Myeloperoxidase, and Protein S100-A9 (B-AMP)-for the
Detection of Esophageal Adenocarcinoma. Cancer 120(24), 2014, p.3902-3913. (AMC)
1638. Zarza-Moreno M, Carreira P, Madureira L, Miras del Rio H, Salguero FJ, Leal A, Teixeira N, Jesus AP,
Mora G. Dosimetric effect by shallow air cavities in high energy electron beams. Phys Med 2014; 30:23441 (NKI)
1639. Zeestraten ECM, Reimers MS, Saadatmand S, Dekker JW, Liefers GJ, van den Elsen PJ, van de Velde CJH,
Kuppen PJK. Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer
patients. Brit J Cancer 2014; 110: 459-468. (VUmc)
1640. Zegers CML, van Elmpt W, Reymen B, Even AJG, Troost EGC, Ollers MC, Hoebers FJP, Houben RMA,
Eriksson J, Windhorst AD, Mottaghy FM, de Ruysscher D, Lambin P. In Vivo Quantification of Hypoxic and
Metabolic Status of NSCLC Tumors Using [F-18]HX4 and [F-18]FDG-PET/CT Imaging. Clin Cancer Res
2014; 20: 6389-6397. (VUmc)
1641. Zeijlemaker W, Gratama JW, Schuurhuis GJ. Tumor Heterogeneity Makes AML a "Moving Target" for
Detection of Residual Disease. Cytom Part B- Clin CY 2014; 86: 3-14. (VUmc)
1642. Zeilstra J, Joosten SPJ, van Andel H, Tolg C, Berns A, Snoek M, van de Wetering M, Spaargaren M,
Clevers H, Pals ST. Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice
downstream of Wnt signaling.
Oncogene 33(5), 2014, p.665-670. (AMC/NKI)
1643. Zerp SF, Vens C, Floot B, Verheij M, van Triest B. NAD(+) depletion by APO866 in combination with
radiation in a prostate cancer model, results from an in vitro and in vivo study. Radiother Oncol 2014;
110:348-54 (NKI)
1644. Zhang H, Tan W, Sonke JJ. Effect of compressed sensing reconstruction on target and organ delineation
in cone-beam CT of head-and-neck and breast cancer patients. Radiother Oncol 2014; 112:413-7 (NKI)
1645. Zhang Y, Vanoli F, LaRocque JR, Krawczyk PM, Jasin M. Biallelic targeting of expressed genes in mouse
embryonic stem cells using the Cas9 system. Methods 69(2), 2014, p.171-178. (AMC)
1646. Zhao Q, Piyush T, Chen C, Hollingsworth MA, Hilkens J, Rhodes JM, Yu LG. MUC1 extracellular domain
confers resistance of epithelial cancer cells to anoikis. Cell Death Dis 2014; 5:e1438 (NKI)
1647. Zhou ZN, Sharma VP, Beaty BT, Roh-Johnson M, Peterson EA, van Rooijen N, Kenny PA, Wiley HS,
Condeelis JS, Segall JE. Autocrine HBEGF expression promotes breast cancer intravasation, metastasis
and macrophage-independent invasion in vivo. Oncogene 2014; 33: 3784-3793. (VUmc)
1648. Ziech MLW, Hummel TZ, Smets AMJB, Nievelstein RAJ, Lavini C, Caan MWA, Nederveen AJ, Roelofs
JJTH, Bipat S, Benninga MA, Kindermann A, Stoker J. Accuracy of abdominal ultrasound and MRI for
detection of Crohn disease and ulcerative colitis in children. Pediatric Radiology 44(11), 2014,
p.1370-1378. (AMC)
1649. Ziglinas P, Menger DJ, Georgalas C. The body dysmorphic disorder patient: to perform rhinoplasty or
not?. European Archives of Oto-Rhino-Laryngology 271(9), 2014, p.2355-2358. (AMC)
1650. Zimmer L, Barlesi F, Martinez-Garcia M, Dieras V, Schellens JHM, Spano JP, Middleton MR, Calvo E, PazAres L, Larkin J, Pacey S, Venturi M, Kraeber-Bodere F, Tessier JJ, Eberhardt WE, Paques M, Guarin E,
Meresse V, Soria JC. Phase I Expansion and Pharmacodynamic Study of the Oral MEK Inhibitor RO4987655
(CH4987655) in Selected Patients with Advanced Cancer with RAS-RAF Mutations. Clin Cancer Res 2014;
20:4251-61 (NKI)
1651. Zindler JD, Slotman B, Lagerwaard FJ. Patterns of distant brain recurrences after radiosurgery alone for
newly diagnosed brain metastases: Implications for salvage therapy. Radiother Oncol 2014; 112: 212216. (VUmc)
1652. Zwaginga JJ, van der Holt B, te Boekhorst PA, Biemond BJ, Levin M-D, van der Griend R, Brand A,
Zweegman S, Pruijt HFM, Novotny VMJ, Vreugdenhil A, de Groot MR, de Weerdt O, van Pampus ECM, van
Maanen-Lamme TM, Wittebol S, Schipperus MR, Silbermann MHJ, Huijgens PC, Luten M, Hollestein R,
Scientific publications - 163
Brakenhoff JAC, Schrama JG, Valster FAA, Velders GA, Koene HR. Multi-center randomized open label
phase II trial on 3 rituximab dosing schemes in immune thrombocytopenia patients. Heamatologica-The
Hematology Journal [aheadofprint], 2014, p.-. (AMC)
1653. Zweegman S, Palumbo A, Bringhen S, Sonneveld P. Age and aging in blood disorders: multiple myeloma.
Haematol-Hematol J 2014; 99: 1133-1137. (VUmc)
164 - Scientific publications
Document related concepts
no text concepts found